Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men. by Robertson, C. et al.
HEALTH TECHNOLOGY ASSESSMENT
VOLUME 18 ISSUE 35 MAY 2014
ISSN 1366-5278
DOI 10.3310/hta18350
Systematic reviews of and integrated report on the 
quantitative, qualitative and economic evidence base 
for the management of obesity in men
Clare Robertson, Daryll Archibald, Alison Avenell, Flora Douglas,  
Pat Hoddinott, Edwin van Teijlingen, Dwayne Boyers,  
Fiona Stewart, Charles Boachie, Evie Fioratou, David Wilkins,  
Tim Street, Paula Carroll and Colin Fowler

Systematic reviews of and integrated
report on the quantitative, qualitative
and economic evidence base for the
management of obesity in menClare Robertson,1 Daryll Archibald,1
Alison Avenell,1* Flora Douglas,2 Pat Hoddinott,1,3
Edwin van Teijlingen,4 Dwayne Boyers,1,5
Fiona Stewart,1 Charles Boachie,1,6 Evie Fioratou,1,7
David Wilkins,8 Tim Street,9 Paula Carroll10
10and Colin Fowler
1Health Services Research Unit, University of Aberdeen, Aberdeen, UK
2Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, UK
3School of Nursing, Midwifery and Health, University of Stirling, Stirling, UK
4Centre for Midwifery, Maternal & Perinatal Health, Bournemouth University,
Bournemouth, UK
5Health Economics Research Unit, University of Aberdeen, Aberdeen, UK
6Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK
7School of Medicine, University of Dundee, Dundee, UK
8Men’s Health Forum England and Wales, London, UK
9Men’s Health Forum Scotland, Glasgow, UK
10Men’s Health Forum in Ireland, Dublin, Republic of Ireland
*Corresponding authorDeclared competing interests of authors: nonePublished May 2014
DOI: 10.3310/hta18350This report should be referenced as follows:
Robertson C, Archibald D, Avenell A, Douglas F, Hoddinott P, van Teijlingen E, et al. Systematic
reviews of and integrated report on the quantitative, qualitative and economic evidence base for
the management of obesity in men. Health Technol Assess 2014;18(35).
Health Technology Assessment is indexed and abstracted in Index Medicus/MEDLINE, Excerpta
Medica/EMBASE, Science Citation Index Expanded (SciSearch®) and Current Contents®/
Clinical Medicine.

Health Technology Assessment HTA/HTA TARISSN 1366-5278 (Print)
ISSN 2046-4924 (Online)
Five-year impact factor: 5.804
Health Technology Assessment is indexed in MEDLINE, CINAHL, EMBASE, The Cochrane Library and the ISI Science Citation Index and is
assessed for inclusion in the Database of Abstracts of Reviews of Effects.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE) (www.publicationethics.org/).
Editorial contact: nihredit@southampton.ac.uk
The full HTA archive is freely available to view online at www.journalslibrary.nihr.ac.uk/hta. Print-on-demand copies can be purchased from the
report pages of the NIHR Journals Library website: www.journalslibrary.nihr.ac.uk
Criteria for inclusion in the Health Technology Assessment journal
Reports are published in Health Technology Assessment (HTA) if (1) they have resulted from work for the HTA programme, and (2) they
are of a sufficiently high scientific quality as assessed by the reviewers and editors.
Reviews in Health Technology Assessment are termed ‘systematic’ when the account of the search appraisal and synthesis methods (to
minimise biases and random errors) would, in theory, permit the replication of the review by others.
HTA programme
The HTA programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research
information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS.
‘Health technologies’ are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation
and long-term care.
The journal is indexed in NHS Evidence via its abstracts included in MEDLINE and its Technology Assessment Reports inform National Institute
for Health and Care Excellence (NICE) guidance. HTA research is also an important source of evidence for National Screening Committee (NSC)
policy decisions.
For more information about the HTA programme please visit the website: www.hta.ac.uk/
This report
The research reported in this issue of the journal was funded by the HTA programme as project number 09/127/01. The contractual start date
was in October 2011. The draft report began editorial review in April 2013 and was accepted for publication in August 2013. The authors
have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher
have tried to ensure the accuracy of the authors’ report and would like to thank the reviewers for their constructive comments on the draft
document. However, they do not accept liability for damages or losses arising from material published in this report.
This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by
authors in this publication are those of the authors and do not necessarily reﬂect those of the NHS, the NIHR, NETSCC, the HTA programme
or the Department of Health. If there are verbatim quotations included in this publication the views and opinions expressed by the
interviewees are those of the interviewees and do not necessarily reﬂect those of the authors, those of the NHS, the NIHR, NETSCC, the HTA
programme or the Department of Health.
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Robertson et al. under the terms of a
commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of
private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for
commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation,
Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.
Published by the NIHR Journals Library (www.journalslibrary.nihr.ac.uk), produced by Prepress Projects Ltd, Perth, Scotland
(www.prepress-projects.co.uk).
Editor-in-Chief of Health Technology Assessment and NIHR  
Journals Library
Professor Tom Walley Director, NIHR Evaluation, Trials and Studies and Director of the HTA Programme, UK
NIHR Journals Library Editors
Professor Ken Stein Chair of HTA Editorial Board and Professor of Public Health, University of Exeter Medical 
School, UK
Professor Andree Le May Chair of NIHR Journals Library Editorial Group (EME, HS&DR, PGfAR, PHR journals)
Dr Martin Ashton-Key Consultant in Public Health Medicine/Consultant Advisor, NETSCC, UK
Professor Matthias Beck Chair in Public Sector Management and Subject Leader (Management Group),  
Queen’s University Management School, Queen’s University Belfast, UK
Professor Aileen Clarke Professor of Public Health and Health Services Research, Warwick Medical School,  
University of Warwick, UK
Dr Tessa Crilly Director, Crystal Blue Consulting Ltd, UK
Dr Peter Davidson Director of NETSCC, HTA, UK
Ms Tara Lamont Scientific Advisor, NETSCC, UK
Professor Elaine McColl Director, Newcastle Clinical Trials Unit, Institute of Health and Society,  
Newcastle University, UK
Professor William McGuire Professor of Child Health, Hull York Medical School, University of York, UK
Professor Geoffrey Meads Professor of Health Sciences Research, Faculty of Education, University of Winchester, UK
Professor Jane Norman Professor of Maternal and Fetal Health, University of Edinburgh, UK
Professor John Powell Consultant Clinical Adviser, National Institute for Health and Care Excellence (NICE), UK
Professor James Raftery Professor of Health Technology Assessment, Wessex Institute, Faculty of Medicine, 
University of Southampton, UK
Dr Rob Riemsma Reviews Manager, Kleijnen Systematic Reviews Ltd, UK
Professor Helen Roberts Professorial Research Associate, University College London, UK
Professor Helen Snooks Professor of Health Services Research, Institute of Life Science, College of Medicine, 
Swansea University, UK
Please visit the website for a list of members of the NIHR Journals Library Board: 
www.journalslibrary.nihr.ac.uk/about/editors
Editorial contact: nihredit@southampton.ac.ukNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35AbstractSystematic reviews of and integrated report on the
quantitative, qualitative and economic evidence base for the
management of obesity in menClare Robertson,1 Daryll Archibald,1 Alison Avenell,1* Flora Douglas,2
Pat Hoddinott,1,3 Edwin van Teijlingen,4 Dwayne Boyers,1,5
Fiona Stewart,1 Charles Boachie,1,6 Evie Fioratou,1,7 David Wilkins,8
Tim Street,9 Paula Carroll10 and Colin Fowler10
1Health Services Research Unit, University of Aberdeen, Aberdeen, UK
2Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, UK
3School of Nursing, Midwifery and Health, University of Stirling, Stirling, UK
4Centre for Midwifery, Maternal & Perinatal Health, Bournemouth University, Bournemouth, UK
5Health Economics Research Unit, University of Aberdeen, Aberdeen, UK
6Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK
7School of Medicine, University of Dundee, Dundee, UK
8Men’s Health Forum England and Wales, London, UK
9Men’s Health Forum Scotland, Glasgow, UK
10Men’s Health Forum in Ireland, Dublin, Republic of Ireland
*Corresponding author
Background: Obesity increases the risk of many serious illnesses such as coronary heart disease, type 2
diabetes and osteoarthritis. More men than women are overweight or obese in the UK but men are less
likely to perceive their weight as a problem and less likely to engage with weight-loss services.
Objective: The aim of this study was to systematically review evidence-based management strategies for
treating obesity in men and investigate how to engage men in obesity services by integrating the
quantitative, qualitative and health economic evidence base.
Data sources: Electronic databases including MEDLINE, EMBASE, PsycINFO, the Cochrane Central Register
of Controlled Trials, the Database of Abstracts of Reviews of Effects and the NHS Economic Evaluation
Database were searched from inception to January 2012, with a limited update search in July 2012.
Subject-speciﬁc websites, reference lists and professional health-care and commercial organisations were
also consulted.
Review methods: Six systematic reviews were conducted to consider the clinical effectiveness,
cost-effectiveness and qualitative evidence on interventions for treating obesity in men, and men in
contrast to women, and the effectiveness of interventions to engage men in their weight reduction.
Randomised controlled trials (RCTs) with follow-up data of at least 1 year, or any study design and length
of follow-up for UK studies, were included. Qualitative and mixed-method studies linked to RCTs and
non-randomised intervention studies, and UK-based, men-only qualitative studies not linked to
interventions were included. One reviewer extracted data from the included studies and a second reviewer
checked data for omissions or inaccuracies. Two reviewers carried out quality assessment. We undertook
meta-analysis of quantitative data and a realist approach to integrating the qualitative and quantitative
evidence synthesis.v
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ABSTRACT
viResults: From a total of 12,764 titles reviewed, 33 RCTs with 12 linked reports, 24 non-randomised
reports, ﬁve economic evaluations with two linked reports, and 22 qualitative studies were included. Men
were more likely than women to beneﬁt if physical activity was part of a weight-loss programme. Reducing
diets tended to produce more favourable weight loss than physical activity alone (mean weight change
after 1 year from a reducing diet compared with an exercise programme –3.2 kg, 95% CI –4.8 kg to
–1.6 kg). The type of reducing diet did not affect long-term weight loss. A reducing diet plus physical
activity and behaviour change gave the most effective results. Low-fat reducing diets, some with meal
replacements, combined with physical activity and behaviour change training gave the most effective
long-term weight change in men [–5.2 kg (standard error 0.2 kg) after 4 years]. Such trials may prevent
type 2 diabetes in men and improve erectile dysfunction. Although fewer men joined weight-loss
programmes, once recruited they were less likely to drop out than women (difference 11%, 95% CI 8%
to 14%). The perception of having a health problem (e.g. being deﬁned as obese by a health
professional), the impact of weight loss on health problems and desire to improve personal appearance
without looking too thin were motivators for weight loss amongst men. The key components differ from
those found for women, with men preferring more factual information on how to lose weight and more
emphasis on physical activity programmes. Interventions delivered in social settings were preferred to those
delivered in health-care settings. Group-based programmes showed beneﬁts by facilitating support for
men with similar health problems, and some individual tailoring of advice assisted weight loss in some
studies. Generally, men preferred interventions that were individualised, fact-based and ﬂexible,
which used business-like language and which included simple to understand information. Preferences for
men-only versus mixed-sex weight-loss group programmes were divided. In terms of context,
programmes which were cited in a sporting context where participants have a strong sense of afﬁliation
showed low drop out rates and high satisfaction. Although some men preferred weight-loss programmes
delivered in an NHS context, the evidence comparing NHS and commercial programmes for men was
unclear. The effect of family and friends on participants in weight-loss programmes was inconsistent in the
evidence reviewed – beneﬁts were shown in some cases, but the social role of food in maintaining
relationships may also act as a barrier to weight loss. Evidence on the economics of managing obesity in
men was limited and heterogeneous.
Limitations: The main limitations were the limited quantity and quality of the evidence base and narrow
outcome reporting, particularly for men from disadvantaged and minority groups. Few of the studies were
undertaken in the UK.
Conclusions: Weight reduction for men is best achieved and maintained with the combination of a
reducing diet, physical activity advice or a physical activity programme, and behaviour change techniques.
Tailoring interventions and settings for men may enhance effectiveness, though further research is needed
to better understand the inﬂuence of context and content. Future studies should include cost-effectiveness
analyses in the UK setting.
Funding: This project was funded by the NIHR Health Technology Assessment programme.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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Glycated haemoglobin Glucose sticks to the haemoglobin in red blood cells to make a ‘glycated
haemoglobin’ molecule called haemoglobin A1c (HbA1c). The higher the level of glucose in the blood long
term, the higher the level of HbA1c.xix
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Obesity increases the risk of many serious illnesses such as coronary heart disease, type 2 diabetes and
osteoarthritis. More men than women are overweight or obese in the UK and this difference is projected
to continue. Men appear more likely than women to misperceive their weight, less likely to consider their
body weight a risk for health and less likely to consider trying to manage their weight. Perceptions of
dieting and weight-loss programmes as a feminised realm have been cited as a possible explanation for
men’s under-representation in weight-loss services. That men are under-represented suggests that
methods to engage men in services, and the services themselves, are currently not optimal.
The aim of this study was to systematically review evidence-based management strategies for treating
obesity in men and investigate how to engage men in these obesity services. The overarching objective
was to integrate the quantitative, qualitative and health economic evidence base for the management
of men with obesity and their engagement in weight-loss services, researching concurrently to
systematically review:
l the clinical effectiveness and cost-effectiveness of interventions for obesity in men, and men in contrast
to women
l the clinical effectiveness and cost-effectiveness of interventions to engage men in their weight reduction
l qualitative research with men about obesity management, and providers of such services for men.Methods
We undertook six systematic reviews:
1. a systematic review of long-term randomised controlled trials (RCTs) of interventions with men only
2. a systematic review of long-term RCTs of interventions in which the results were presented separately
for men and women
3. a systematic review of interventions for men, or for men and women compared, in the UK, including
any setting, any study design and any duration
4. a systematic review of interventions to increase the engagement of men with services for obesity
management, including any study design
5. a systematic review of economic evaluations of obesity interventions in which data were presented
either for men only or for men compared with women
6. a systematic review of qualitative research with men with obesity, or with men compared with women,
and with providers of services.
The reviews were integrated in a mixed-method synthesis.Data sources
The following electronic databases were searched with no language restrictions from inception to January
2012 with an updated search of 15 databases carried out in July 2012: MEDLINE, MEDLINE-In-Process &
Other Non-Indexed Citations, EMBASE, Cumulative Index to Nursing and Allied Health Literature (CINAHL),
PsycINFO, Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Database of Systematic
Reviews (CDSR), the Database of Abstracts of Reviews of Effects (DARE), the NHS Economic Evaluation
Database (NHS EED), Health Technology Assessment (HTA), Applied Social Sciences Index and Abstracts
(ASSIA), Education Resources Information Center (ERIC), Anthropology Plus, British Nursing Index,xxiii
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xxivSocial Sciences Citation Index (SSCI), Health Management Information Consortium (HMIC), Conference
Proceedings Citation Index – Social Science & Humanities (CPCI-SSH), Cost-Effectiveness Analysis Registry
(CEA Registry), Research Papers in Economics (RePEc), ClinicalTrials.gov, CenterWatch, Current Controlled
Trials and International Clinical Trials Registry. Subject-speciﬁc websites were also consulted and reference
lists were searched. Additionally, we contacted professional health-care organisations and commercial
organisations to identify published and unpublished UK studies.Participants
Obese men with a body mass index (BMI) of ≥ 30 kg/m2 (or overweight men with a BMI of ≥ 28 kg/m2
with cardiac risk factors).Study designs and interventions
Studies had to be carried out in societies relevant to the UK setting.
l Interventions explicitly promoting weight loss or weight maintenance as their main outcome. We
considered lifestyle changes (e.g. diet, physical activity, behaviour change techniques or combinations
of any of these) and orlistat for the management of obesity in men. Studies evaluating complementary
therapy, over-the-counter non-diet products promoted for weight loss, or bariatric surgery, or
examining a combination of interventions, for example smoking cessation and weight loss at the same
time, were not included. We included RCTs with follow-up data of at least 1 year, but for UK studies
any study design and length of follow-up were acceptable.
l Evaluations of interventions to increase the participation of men in any services aiming to reduce
obesity, for example community outreach services, incentive schemes and web-based initiatives.
Any study design was considered.
l Qualitative and mixed-method studies linked to RCTs and non-randomised intervention studies.
UK-based, men-only qualitative studies not linked to interventions were also included.Outcome measures
The primary aim of the evidence synthesis was to uncover how effective interventions work and to
describe key intervention ingredients, processes and environmental and contextual factors that contribute
to effectiveness. Outcome measures were weight, waist circumference, cardiovascular risk factors,
disease-speciﬁc outcomes, adverse events, quality of life, process outcomes and economic costs.
We also aimed to identify the barriers and facilitators that men experience when engaging with a weight
management intervention. The following a priori research questions were developed to initially guide
our investigation:
1. What are the best evidence-based management strategies for treating obesity in men?
2. How can men’s engagement in obesity services be improved?
In addition to these a priori research questions we also developed more detailed research questions, which
emerged inductively from the initial ﬁndings of the effectiveness reviews:
1. How are men initially motivated to lose weight?
2. How are men attracted to taking part in the trial/intervention?
3. Are men consulted in the design of the intervention?
4. If it is found that interventions for men should be different from those for women, how should they
be different and why?
5. Are group-based interventions for men found to be more effective for weight loss than interventions
delivered to individual men?
6. Are certain features of diets found to be more attractive for obese men?
7. Are certain features of physical activity stated to be more attractive for obese men? How and why are
these features more attractive?NIHR Journals Library www.journalslibrary.nihr.ac.uk
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9. Do men state who they believe to be the best person/persons to deliver the intervention?
10. Are programmes deliberately involving partners/families more effective?Study appraisal
For each systematic review one reviewer extracted data from the included studies and a second reviewer
checked the data for omissions or inaccuracies. Two reviewers carried out the quality assessment.Synthesis
For quantitative data we reported means or changes in means or proportions between groups. For
continuous outcomes we reported the mean difference or standardised mean difference (different scales
for the same outcome) and for dichotomous outcomes we reported risk ratio data with 95% conﬁdence
intervals (CIs). For the analysis of mean weight loss, the mean difference between men and women and
the weighted mean difference were calculated for both men and women when more than one group was
reported. Because of the inherent heterogeneity in studies of obesity interventions, when study results
from more than one study could be quantitatively pooled we used random-effects meta-analysis.
We undertook a realist approach to integrating the qualitative and quantitative evidence synthesis,
conceptualising interventions by the:
1. context that an intervention/programme will be situated within so that factors that might inhibit or
enhance its effectiveness can be identiﬁed
2. mechanisms of the intervention/programme and how the intended programme beneﬁciaries will
interact and react to the intervention processes and mechanisms
3. outcomes, both positive and negative, that may arise from an individual’s engagement with the
proposed intervention.
Both deductive and inductive analytical approaches were employed throughout the review process.Results
Data were included for 1238 men from 11 trials and six linked reports for our review of men-only RCTs;
12,934 men and women from 20 RCTs and six linked reports for our review of RCTs in men and women;
and 11,426 men and 63,990 women from 26 reports of UK interventions; ﬁve economic evaluations and
two linked reports; 13 qualitative studies linked to interventions; and nine qualitative studies not linked to
interventions. We found no eligible studies for our review of interventions to increase the engagement of
men. We found some consistent ﬁndings across reviews and we present an integrated synthesis of our
results. Our ﬁndings should be interpreted with the knowledge that the evidence base, particularly in the
UK setting, is currently limited in the quality and number of studies and mainly reﬂects white, middle-class,
middle-aged men. In addition, few UK studies included long-term data and our results may not necessarily
be applicable to all men. We also had difﬁculties retrieving studies and it is possible that the studies that
we found had more promising results than those that we were not able to access.Types of effective interventions
Men may do well if physical activity is part of a weight-loss programme. One intensive supervised exercise
programme produced a mean weight change after 1 year of –4.6 kg (95% CI –6.2 kg to –3.0 kg). Men
may like exercise programmes and may be more likely to respond to them than women. Men enjoyed the
use of pedometers to monitor their physical activity. Reducing diets tended to produce more favourable
weight loss than physical activity alone (mean weight change after 1 year from a reducing diet compared
with an exercise programme –3.2 kg, 95% CI –4.8 kg to –1.6 kg). Reducing diets are more effective if an
exercise programme is also provided. Low-fat reducing diets, some with meal replacements, combinedxxv
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xxviwith physical activity and behaviour change training gave the most effective long-term weight change
[–5.2 kg (standard error 0.2 kg) after 4 years].
The type of reducing diet, such as increasing the protein content, was not shown to affect long-term
weight loss in men. Some men expressed a dislike of ‘strict’ diets. However, for men, intermittent periods
of very low-calorie dieting, as required, may be more effective than regular periods of dieting (mean
difference after 2 years –10.5 kg, 95% CI –16.2 kg to –4.8 kg).
Interventions including behaviour change training improved long-term weight loss and maintenance for
men (e.g. self-monitoring, goal setting, prompting self-monitoring, providing feedback, review of goals).
Behaviour change training signiﬁcantly improved weight-loss maintenance over the second year for men
who had used exercise to lose weight over the ﬁrst year (mean difference –3.1 kg, 95% CI –5.0 kg to
–1.2 kg) but not for men who had used diet to lose weight over the ﬁrst year (mean difference 0.6 kg,
95% CI –1.3 kg to 2.5 kg). Men might like less monitoring than women and too many sessions may be
counterproductive. Support by telephone and mail could be useful (mean difference after 1 year –1.4 kg,
95% CI –2.7 kg to –0.1 kg).
After a very low-calorie diet, men may be less likely than women to do well with orlistat to help long-term
weight-loss maintenance (for men: mean change after 3 years with orlistat –8.9 kg, with placebo –8.1 kg;
reported as not signiﬁcant).Motivators to lose weight
Although fewer men joined weight-loss programmes, once recruited they were signiﬁcantly less likely to
drop out than women (difference 11%, 95% CI 8% to 14%). The evidence suggested that middle-aged
men were motivated to lose weight once they perceived that they had a problem with their health, for
example being diagnosed or labelled as obese by a health professional. The health beneﬁts of losing
weight can act as a further motivator for men. Trials found that successful weight reduction with low-fat
reducing diets or physical activity advice or programmes, with or without behaviour change training, may
improve health problems, for example erectile dysfunction in men with and without type 2 diabetes
(reported p = 0.06 and p = 0.001 respectively). This type of intervention can also prevent diabetes (hazard
ratio for diabetes incidence 0.43, 95% CI 0.22 to 0.81). Successful weight loss might increase the risk of
osteoporosis for type 2 diabetics by reducing total hip bone density. The desire to improve personal
appearance was also cited as a motivator, although men were also keen to avoid looking too thin.Intervention setting and delivery and support
Group compared with individual programmes
Group-based weight management programmes were found to facilitate peer or social support amongst
men with similar health problems, despite the fact that some men were initially reluctant to take part in a
group. Some individual tailoring of advice or counselling for men could also assist with weight loss. Some
men found that being accountable to oneself and having to account for food choices to others within the
programme facilitated adherence. Some men stated that men-only group settings were important whereas
others stated that this was unimportant or preferred mixed-sex groups. Group-based programmes can be
logistically difﬁcult with regard to scheduling; programmes offering evening meetings at ﬁxed, regular
times were desirable. Group-based ﬁnancial contracts were reported to be signiﬁcantly more effective for
weight loss over 2 years than individual ﬁnancial contracts (reported p < 0.05), although the size of the
contract did not appear to be a signiﬁcant inﬂuence.Setting
Interventions situated in sporting contexts, for which men have a strong sense of afﬁliation and belonging,
have been instrumental in engaging men. Interventions with football fans have had low dropout rates and
have shown very positive responses from participants. Men largely welcomed the use of humour in
intervention design or delivery, although it was recognised that men’s health issues could be trivialised ifNIHR Journals Library www.journalslibrary.nihr.ac.uk
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individualised, fact based and ﬂexible, which used business-like language and which included simple to
understand information.
Some men favoured programmes delivered by the NHS in comparison to commercial companies, and in
contrast to female preferences, but data showed that commercial programmes were effective in helping
men to lose weight. Weight-loss programmes delivered in the NHS for men only have so far been few,
with limited follow-up, although feedback has generally been positive. The comparative effectiveness of
NHS and commercial programmes for long-term weight loss was unclear for men. In a 1-year UK-based
randomised trial of commercial and NHS-based programmes, only 31% of the participants were men.
In this trial only one intervention from a commercial weight-loss organisation, in which 28% of the
participants were men, resulted in signiﬁcantly greater weight loss than in the comparator arm
(adjusted mean difference –2.5 kg, 95% CI –4.2 kg to –0.8 kg).Delivery
Studies generally did not report the sex of the person delivering the intervention and whether or not this
was an inﬂuence. The beneﬁts of internet-based advice for men were unclear (mean difference for
internet-based advice after 1 year –0.9 kg, 95% CI –1.9 kg to 0.2 kg).Support from family and friends
The effect of support from partners to aid weight loss was inconsistent. There was evidence to suggest
that having a partner involved in a weight-loss programme might be beneﬁcial for weight loss but the
opposite effect was also found. Equally, the social role of food in maintaining relationships with family
members or friends was raised as a barrier to weight loss. Participating in a weight-loss intervention
appeared to encourage men’s partners (not signed up to the intervention) to lose weight through a
halo effect.Economics
No evidence was retrieved relating to the cost-effectiveness of interventions to tackle obesity in UK men.
Five studies in a European, Australian or American setting evaluated cost-effectiveness in men as a
subgroup analysis. Formal meta-analysis of the studies was not possible because of heterogeneity in the
study designs, modelling methods used and study populations. There was, however, some evidence that
general practitioner counselling interventions were more cost-effective than interventions delivered by a
dietitian. Lifestyle interventions also proved to be cost-effective as were group-based interventions. Orlistat
was found to be cost-effective in addition to a lifestyle intervention and was particularly cost-effective if
targeted at high-risk groups, especially people with type 2 diabetes. The results should be interpreted in
the light of the variable methodological quality of the studies.Strengths and limitations
The strengths of this study are the systematic and rigorous methods taken to review and integrate the
evidence. Exhaustive searches were undertaken with the aim of identifying all relevant published and grey
literature. Despite these efforts we identiﬁed limited data, especially for the UK, which were of moderate
quality. Furthermore, the diversity of men was not well-represented by the narrow evidence base as the
majority of participants considered by the included studies were white, middle class and middle aged.
The results should therefore be interpreted with caution.xxvii
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xxviiiConclusionsImplications for health care1. Weight reduction for men is best achieved and maintained with the combination of a reducing diet,
physical activity advice or a physical activity programme, and behaviour change techniques
(e.g. self-monitoring, goal setting, prompting self-monitoring, providing feedback, review of goals).
These key components differ from those found for women, with men preferring more factual
information on how to lose weight and more emphasis on physical activity programmes. Weight-loss
programmes can prevent type 2 diabetes and improve cardiovascular risk factors, erectile dysfunction,
self-esteem and quality of life.
2. For some men, but not all, the opportunity to attend men-only groups may enhance the effectiveness
of interventions. Individual tailoring and feedback may also be features of more effective services.
3. Weight-loss programmes for men may be better provided in social settings, such as sports clubs and
workplaces, which may be more successful at engaging men. Innovative means of delivering services
are needed for hard-to-reach groups.Recommendations for research1. Research is needed to examine the effectiveness and cost-effectiveness of new approaches to engaging
men with weight-loss services and the best design for those services.
2. Men (and women) are a heterogeneous group. Rigorous methods are needed to test more complex
interventions. Men should be consulted on how to optimise engagement and make interventions more
user-friendly, and these services need to be formally evaluated. The experiences and perspectives of
men (and women) who are black or from ethnic minority backgrounds, who are unemployed or on low
incomes, who are gay, bisexual or transgender or who are from rural and/or remote locations need to
be addressed. Rigorous feasibility studies and piloting with service user input at all stages is required
before undertaking deﬁnitive RCTs.
3. Health concerns, which may prompt contact with health service staff, motivate men to address their
obesity. Research is required to examine the most effective interventions delivered at these pivotal
health service encounters when an obesity-related diagnosis is made.
4. Although we found relatively few long-term RCTs, there were even fewer UK studies that provided
outcome data for men of more than a few months’ follow-up. As was clear from our reviews, men
would value longer-term support and there is a need to provide longer-term outcome data (at least
1 year of follow-up). These outcome data should include cardiovascular risk factors, the impact on
comorbidities and quality of life and economic outcomes. There is also a need to look speciﬁcally at
ways to enhance the maintenance of weight loss. The majority of the programmes did not make a
distinction between support for the initial weight loss and a different or modiﬁed programme to help
maintain that weight loss.
5. Qualitative research is needed with men to inform all aspects of intervention design, including the
setting, optimal recruitment processes and reasons for, and how processes might minimise, attrition.
Process evaluation of intervention studies should seek feedback on the marketing, content and delivery
of interventions and how the macro, meso and micro context interacts with the intervention.
6. Future research studies should adhere to best practice guidelines for health economic decision
modelling and particular attention should be given to assumptions regarding the continuation of
treatment effect and the modelled link between weight loss and longer-term costs and outcomes
(e.g. health events such as diabetes and myocardial infarction).NIHR Journals Library www.journalslibrary.nihr.ac.uk
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This study was registered as PROSPERO CRD42011001479.Funding
Funding for this study was provided by the Health Technology Assessment programme of the National
Institute for Health Research.xxix
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In this chapter we brieﬂy discuss deﬁnitions, epidemiology and risks of obesity and possible beneﬁts ofreducing obesity in men. We show that men are under-represented in weight-loss programmes in
developed countries and brieﬂy discuss the growing literature on possible explanations. Evidence from
qualitative and quantitative research is starting to accumulate on how men who are obese may be helped
to lose weight, but there has been little systematic research to synthesise the evidence base. This project
attempts to provide the current evidence base for engaging obese men with weight loss and provide
pointers to designing successful services. The literature is still limited and we acknowledge that, although
we would have liked to explore the effects of diversity, such as age, ethnic group, socioeconomic status,
disability or sexual orientation, the evidence for these was sparse.
In this report we have tried to stick to accepted deﬁnitions of the words ‘sex’ and ‘gender’:1© Que
Health
provid
addres
Park, SThe word ‘gender’ is used to define those characteristics of women and men that are socially
constructed, while ‘sex’ refers to those that are biologically determined. People are born female or
male but learn to be girls and boys who grow into women and men.Deﬁnitions of obesity in men and womenA body mass index (BMI) of ≥ 30 kg/m2 [weight in kg/(height in m)2] is widely used to deﬁne obesity in
both men and women, with a BMI of ≥ 25 kg/m2 and < 30 kg/m2 deﬁning overweight. The term ‘morbid
obesity’ is used to denote a BMI ≥ 40 kg/m2. BMI is widely used as an easy practical measure to classify the
degree of obesity, predict the risk of obesity-related diseases and identify individuals or communities at
risk. However, BMI does not distinguish between differences in body composition affected by sex,
physique or ethnicity. For example, men will have a lower percentage of fat than women of an
equivalent BMI.2
Waist circumference is also used to assess increased body fat, particularly intra-abdominal fat. Unlike BMI,
waist circumference cut-offs for risks of disease are sex speciﬁc. The National Institute for Health and Care
Excellence (NICE)3 has advised that both BMI and waist circumference should be used to assess the risk of
health problems (such as type 2 diabetes, coronary heart disease, osteoarthritis) in people with a BMI of
< 35 kg/m2; above this BMI, risk will be high irrespective of waist circumference (Table 1).
Demographics of obesity in men and women
Based on BMI, more men than women are overweight or obese in the UK and this difference is projected
to continue. In the Health Survey for England 2011,4 65% of men had a BMI of ≥ 25 kg/m2 whereas 58%
of women fell into this category. As the prevalence of obesity continues to increase, it is likely that people
who are overweight will become obese in the future. Thus, the Foresight report5 predicts that 36% of men
and 28% of women will be obese by 2015 and 47% of men and 36% of women by 2025 in England.
Figures from Wales6 (64% and 53%), Scotland7 (69.2% and 59.6%) and Northern Ireland8 (67% and
56%) show similar differences (men vs. women for overweight or obese respectively). In the UK, only in
England do ﬁgures show that the prevalence of obesity in men is less than that in women,4 whereas in
Scotland, Northern Ireland and Wales it is similar or higher in men.6,7,8 However, morbid obesity tends to
be less prevalent in men.4,7 Worldwide, fewer men are obese than women but men have a higher BMI
than women in high-income countries.91
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TABLE 1 Table for assessing increased risk of obesity-related disease
BMI (kg/m2)
Waist circumference
Lowa Highb Very highc
Normal: < 25 No increased risk No increased risk Increased risk
Overweight: 25 to < 30 No increased risk Increased risk High risk
Obese: 30 to < 35 Increased risk High risk Very high risk
a < 94 cm (men), < 80 cm (women).
b 94–102 cm (men), 80–88 cm (women).
c > 102 cm (men), > 88 cm (women).
Source: NICE.3
BACKGROUND
2However, if waist circumference alone is used to deﬁne risks from obesity then women are more
at risk, with 47% of women and 34% of men at risk in 2011 in England.4 Using both BMI and waist
circumference to deﬁne health risk, 18% of men had an increased risk, 15% had a high risk and 21% had
a very high risk compared with 15%, 18% and 26% of women respectively.4 Thus, measures of risk in
men and women differ depending on the obesity measure used.
In England, the age-standardised prevalence of obesity and raised waist circumference for men and
women was higher in households in lower quintiles than in households in higher quintiles of equivalised
household income.4 Some occupations, such as bus driving, may be at higher risk of obesity because of
the work environment.10 Work-related stress has different effects in men and women, increasing the risk
of type 2 diabetes in obese women but not apparently for obese men.11
Figures for different ethnic groups are not available from the recent Health Survey for England.4 However,
lower BMI and waist circumference cut-offs have been recommended for some ethnic groups, such as
South Asian populations, as a measure of risk, particularly for type 2 diabetes, and have recently been
recommended by NICE.12 If existing BMI cut-offs are used, then data from the Health Survey for England
from 200413 show lower prevalences of obesity in men from black African, Indian, Pakistani, Bangladeshi
and Chinese groups.
In England the prevalence of overweight and obese individuals using BMI increases with age in men and
women, with 29% of men and 32% of women aged ≥ 75 years being obese.4Risks of obesity in men and womenCollaborative analyses from 57 prospective studies, mainly from Western Europe and North America, with
a mean recruitment age of 46 years, have found that mortality in both men and women is lowest for a
baseline BMI of 22.5–25 kg/m2.14 Each additional 5 kg/m2 was approximately associated with 30% higher
overall mortality, 40% higher vascular mortality, 60–120% higher diabetic, renal and hepatic mortality,
20% higher respiratory disease mortality and 10% higher cancer mortality. Median survival was reduced
by 2–4 years for a BMI of 30–35 kg/m2 and by 8–10 years for a BMI of 40–45 kg/m2. However, others
have found that all-cause mortality does not appear to increase relative to normal weight until BMI
is ≥ 35 kg/m2.15
Pischon and colleagues16 found that waist circumference or waist-to-hip ratio enhanced the ability of BMI
to predict risk of death in men and women in nine countries in Europe. However, the Emerging Risk
Factors Collaboration17 found little difference in the ability of BMI, waist circumference and waist-to-hip
ratio to predict cardiovascular disease in men and women in developed countries, but BMI had greaterNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35reproducibility. Similarly, there was little difference in the ability of BMI or waist circumference to predict
the risk of developing type 2 diabetes in men, which is so strongly associated with obesity.18 However,
Cameron and colleagues19 considered that including both waist and hip circumference together, rather
than as a ratio, may improve risk prediction models for mortality and type 2 diabetes.
Positive associations have been found between increasing BMI and subsequent risk of death from liver,
kidney, prostate, breast, endometrial and large bowel cancer.14 Others have found strong associations
between obesity in men and subsequent oesophageal, thyroid, colon and renal cancer.20
Obesity is a risk factor for a very wide range of diseases impacting on health and quality of life. Men with
a BMI ≥ 30 kg/m2 and a waist circumference ≥ 102 cm have an increased risk of at least one symptom of
impaired physical, psychological or sexual function, and these symptoms are also more likely in men with
a raised waist circumference but a BMI of < 30 kg/m2.21 Men who are overweight or obese in midlife also
have a higher risk of frailty in old age.22Costs of obesityAlthough the Foresight report5 predicted that future costs to the NHS of elevated BMI could be £6.4B per
year by 2015 and £9.7B per year by 2050, no breakdown by sex was given, despite there being clear
differences for the risk of diseases related to obesity, such as coronary heart disease and type 2 diabetes.Beneﬁts of weight loss in men and womenAlthough there are many diseases associated with obesity, it has been difﬁcult to demonstrate that
prevention or treatment of obesity reduces the risk of disease long term, despite beneﬁcial changes in
cardiovascular risk factors in randomised controlled trials (RCTs) of lifestyle interventions.23 The evidence for
a reduction in mortality from long-term weight loss from cohort studies and randomised trials is strongest
for both overweight or obese men and overweight or obese women with diabetes.24 There is some
evidence that intentional weight loss may reduce mortality in women, but beneﬁts in men are not clear.24
Maintaining or increasing physical activity seems to be particularly beneﬁcial to survival.25
Randomised trials of lifestyle interventions for weight loss have conﬁrmed the long-term prevention of
type 2 diabetes in men and women.26–28 Randomised trials of weight-loss interventions in men and women
have also shown signiﬁcant reductions in blood pressure or cardiovascular events.23Under-representation of men in weight-loss programmesMen are under-represented in randomised trials of weight-loss interventions and in health services and
commercial programmes for weight loss. In a systematic review, Pagoto and colleagues29 found that only
27% of participants in randomised trials were men, although the percentage was higher in interventions
for obesity with related comorbidities (36% men). There was also a trend towards lower participation by
men in group formats (24%) compared with individual counselling (29%) or mail/e-mail/internet formats
(34%); however, the male/female mix of the groups was not speciﬁed. In another systematic review,
Moroshko and colleagues30 did not ﬁnd sex to be a predictor of dropout in weight-loss interventions.
Services for the treatment of adults with obesity in the UK have consistently shown an under-representation
of men. In the Counterweight programme in 65 general practices in seven UK regions, only 23% of
participants were men.31 Men made up only 27.6% of referrals to the NHS Glasgow and Clyde Weight
Management Service and, once referred, women were slightly more likely to opt in (73.6% vs. 69.4%),
but there was no signiﬁcant difference in completion rates by sex.323
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BACKGROUND
4Commercial programmes in the UK, such as Weight Watchers,33 Slimming World34 and LighterLife,35 and
some NHS organisations have only recently started to evaluate men-only weight-loss groups. When
services were not sex speciﬁc, men made up only 10.7% of 34,271 adults in a slimming on referral
scheme between Slimming World and 77 primary care trusts or NHS trusts,36 and 10.5% of 29,326 adults
referred from NHS primary care to Weight Watchers.37 Thus, UK ﬁgures suggest that men may be even
less likely to attend commercial weight-loss programmes than programmes provided by the NHS.
Two systematic reviews have examined the qualitative evidence on people’s views and experiences of
weight management.38,39 Most of the evidence came from studies with women or studies with groups of
men and women in which the majority of participants were women. The authors did not speciﬁcally
examine the evidence from male participants in these studies, or men compared with women, so it is
unclear whether or not their conclusions can be applied to men. There is evidence that since 1999
increasing numbers of both men and women in the UK are failing to recognise that they are overweight or
obese.40 Men may be more likely than women to misperceive their weight, less likely to consider their
body weight a risk for their health and less likely to consider managing or be actively trying to manage
their weight.41,42Men’s attitudes to lifestyle behaviour changeMen may be more reluctant to change their current lifestyle than women43 and may be cynical about
government health messages.44 Media and other sociocultural inﬂuences may also encourage men to
maintain a larger, more muscular, masculine body size.45 Men could be less interested in gaining an ideal
body weight, according to the medical deﬁnition, and more interested in physical activity and regaining
ﬁtness and a masculine body shape.46 There may also be differences in the way that men and women view
physical activity as a means of becoming stronger, ﬁtter and healthier.47
Weight-loss programmes and facilities, including commercial weight-loss programmes, could be seen as
feminised spaces,46,47 and there is some evidence to suggest that men may prefer masculine spaces, such
as their workplace, for such programmes.48,49 Fear and embarrassment may particularly deter men from
taking part in weight-loss programmes and could mean that talking to an advisor on a one-to-one basis,
rather than working in a group, is preferred.49 Some men have also cited that having a male advisor for
lifestyle change is important in the health-care setting.50
Men could be less interested in undertaking weight-loss diets, which are perceived as tasting poor and
failing to satisfy the appetite.44 Men could distance themselves from the feminised realm of dieting, in
which women are viewed as the experts.51Previous evidence associated with weight-loss management
programmes and menGiven that there are difﬁculties in encouraging men to undertake weight management, what is the
evidence for improving their engagement in services and should weight-loss programmes be designed
differently for men and women?
The National Institute for Health and Care Excellence3 and the Scottish Intercollegiate Guidelines Network
(SIGN)52 have not provided speciﬁc guidance for men, as opposed to women, for the prevention and
treatment of obesity. NICE guidance on behaviour change interventions called for research on the
cost-effectiveness of behaviour change interventions for men and women separately, but did not provide
evidence on the effectiveness of lifestyle interventions separately by sex.53NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35The Men’s Health Forum convened a conference in 2005 with 23 health and social policy researchers to
discuss men and weight issues; the outcomes of this conference were subsequently published in a book
entitled Hazardous Waist: Tackling Male Weight Problems.54 Evidence of effective interventions was not
reviewed, although several examples of innovative approaches in the UK were presented. The conference
conclusions included a need to invest in ‘male-sensitive approaches’, that ‘men’s attitudes to weight and
weight loss need to be more fully understood’ and that the ‘existing, broadly “unisex”, approach is failing
men’ (pp. 218–19).54
A systematic review was conducted by Robertson and colleagues55 in 2008 to explore the effectiveness of
male-speciﬁc health-promoting interventions covering a wide range of health behaviours. However, it did
not identify any intervention studies (at the time that the review was conducted) that had focused on men
and weight management or weight loss.
More recently, Young and colleagues56 systematically reviewed men-only weight-loss or weight-maintenance
interventions of any duration, limiting their review to the 18–65 years age group and people without
obesity-related morbidity, for example diabetes. Only 12 of the 23 identiﬁed studies were RCTs and six
included a follow-up of approximately a year or longer. Thirty-one different interventions were identiﬁed
with a median weight loss of 6.25%. A high frequency of contact (three or more per month), group
programmes, a mean age of ≤ 43 years in the sample and prescribing an energy-restricted diet were
associated with greater programme effectiveness. Only ﬁve of the studies tested interventions that were
speciﬁcally designed for men.Aims of this projectThe evidence brieﬂy discussed in this chapter suggests that methods to engage men in services, and the
services themselves, are currently not optimal. We set out to systematically review evidence-based
management strategies for treating obesity in men and how to engage men with obesity in weight
management programmes. Where we use the term ‘engagement’, this is to denote obese men deciding
to start using services to help them lose weight.
We asked the following questions:
l What works for obesity management for men?
l How can men be engaged with services?
l Should services for men and women be different?
Our overarching objective was to integrate the quantitative and qualitative evidence base by
systematically reviewing:
l the clinical effectiveness and cost-effectiveness of interventions for obesity in men, and in men
compared with women
l the clinical effectiveness and cost-effectiveness of interventions to engage men in their weight reduction
l qualitative research with men about obesity management and with providers of such services for men.5
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BACKGROUND
6This report is structured in the following way:
l Chapter 2 presents the methods for the quantitative and qualitative systematic reviews and the
mixed-methods synthesis of these reviews.
l Chapter 3 presents the systematic review of RCTs of interventions [lifestyle and/or the UK licensed
medication orlistat (a pharmaceutical agent to aid weight loss)] in any setting with men only who are
obese with a BMI of ≥ 30 kg/m2 (or overweight with a BMI of ≥ 28 kg/m2 and with cardiac risk factors
based on orlistat guidance) and with follow-up of at least 1 year. Chapter 3 also presents the
systematic review of RCTs of interventions (as above) in any setting including both men and women
who are obese with a BMI of ≥ 30 kg/m2 (or overweight with a BMI of ≥ 28 kg/m2 and with cardiac risk
factors based on orlistat guidance) in which the results are presented separately for men and women
in the same trial. We use trials with both men and women to look for differences in effectiveness.
l Chapter 4 presents the results of the systematic review of interventions for men with obesity in the UK,
of any setting, study design or duration. This includes data from UK studies with men and women in
which data are presented separately for men and women. This chapter also contains details of the
search carried out for the systematic review of studies to increase the engagement of men with obesity
services; however, no studies ﬁtting the inclusion criteria were found. However, information on
engaging men with services is available and discussed in the ﬁrst review in this chapter.
l Chapter 5 presents the systematic review of economic evaluations of obesity interventions, including
studies in which data were presented either for men only or for men compared with women.
l Chapter 6 presents the systematic review of qualitative studies that have explored men’s engagement
and experiences associated with weight management interventions linked to RCTs and other
intervention studies. We also included qualitative studies on obesity from the UK that were not linked
to interventions. This review focused on questions relating to the context of these interventions and
well as their mechanisms and outcomes. The ﬁndings from the qualitative studies were combined with
the ﬁndings from all of the quantitative reviews in a mixed-methods synthesis.
l Chapter 7 presents our overall discussion of the results from all of the reviews.
l Chapter 8 draws out the implications for health care and makes recommendations for future research.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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We undertook six systematic reviews as follows:
l a systematic review of RCTs of interventions with men only
l a systematic review of RCTs of interventions in which the results were presented separately for men
and women in the same trial
l a systematic review of interventions for men, or men and women compared, with obesity in the UK in
any setting, using any study design and of any duration
l a systematic review of interventions to increase the engagement of men with services for obesity
management, using any study design
l a systematic review of the cost-effectiveness of alternative strategies for the management of obesity in
adult men
l a systematic review of qualitative research with obese men, or obese men compared with obese
women, and with health professionals and commercial organisations managing obesity.
We prepared a priori protocols detailing the objectives; types of study design, participants, interventions
and outcomes considered; and the inclusion/exclusion criteria for all reviews. For quantitative reviews we
followed methodological guidance recommended by The Cochrane Collaboration57 and Centre for
Reviews and Dissemination.58 Details of the methods used for the cost-effectiveness review are provided
in Chapter 5.Inclusion and exclusion criteria
Types of study
The systematic reviews of men only and men and women compared included RCTs or quasi-randomised
trials (including trials with a cluster design) with a mean or median duration of ≥ 52 weeks for all groups.
This duration of follow-up for data was to ensure that long-term weight-loss and weight-maintenance
interventions were evaluated for their associated effects on weight- and obesity-related morbidities.23
This was also the minimum duration of studies adopted by NICE for its review of obesity.3
For the systematic review of UK interventions, any study design and duration were considered to include
and evaluate as much UK-relevant research as possible. We included studies of men only and studies of
men and women if data were presented separately for men.
For the systematic review of interventions to increase engagement, we included any study design that
examined interventions to increase the engagement of men with services for obesity management.Types of participants
Men aged ≥ 16 years were included, with no upper age limit. Participants in studies included in the
systematic reviews of men only, men and women compared and UK interventions had to have a mean or
median BMI of ≥ 30 kg/m2 (or ≥ 28 kg/m2 with cardiac risk factors based on criteria for receiving orlistat).
When body weight was reported instead of BMI, we calculated BMI using relevant population data for
heights to assess study eligibility.23 We recognised that the BMI of men targeted in systematic reviews of
engagement and cost-effectiveness may not have been clearly stated.Types of interventions and comparators
Systematic reviews of studies of men only, men and women compared and the UK interventions
considered interventions in the form of orlistat (but not sibutramine or rimonabant, which no longer have
UK licences), diet, physical activity, behaviour change techniques or combinations of any of these. For the7
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METHODS
8reviews of men-only RCTs and RCTs of men and women compared, we considered any of these
interventions along with placebo and ‘no treatment’ as comparators. For the systematic review of
engagement we considered any form of intervention to increase the engagement of men with services
for obesity management.Setting
We considered all settings for the lifestyle and drug interventions, including hospitals, primary care, the
community (including a community pharmacy), commercial organisations, the voluntary sector, leisure
centres, workplaces, the internet and other digital domains, for example mobile phone networks. This is
because there is increasing collaboration between the NHS and non-NHS organisations in the delivery of
services. It may also be the case that increasing the participation of men in obesity services requires their
engagement in settings outside primary and secondary care.Types of outcome measures
We developed our rationale for outcome measurement from our existing knowledge of the topic area and
in consultation with the project advisory group. Studies had to explicitly mention weight loss or weight-loss
maintenance as a main outcome to be eligible for inclusion.
We considered the following types of outcome:
l Primary outcome: weight change
l Secondary outcomes:
¢ waist circumference
¢ cardiovascular risk factors [decreases in these are generally beneﬁcial for cardiovascular risk,
with the exception of high-density lipoprotein (HDL) cholesterol]: total cholesterol, HDL cholesterol,
low-density lipoprotein (LDL) cholesterol, triglycerides, fasting glucose, glycated haemoglobin
(HbA1c), systolic and diastolic blood pressure
¢ disease-speciﬁc outcomes (e.g. erectile function)
¢ adverse events
¢ quality of life outcomes
¢ process outcomes (e.g. staff involvement, setting, type of intervention, timing, frequency,
individual and/or group setting, couple or family setting, proportion recruited and dropping out,
participants’ evaluations)
¢ economic costs.Exclusion criteria
We did not consider interventions including complementary therapy, for example acupuncture, or non-diet
products promoted for weight loss available solely over the counter. Studies evaluating bariatric surgery or
examining a combination of interventions, for example smoking cessation and weight loss at the same
time, or examining men with obesity receiving psychotropic medication, with learning disabilities or with a
diagnosed eating disorder, were also excluded.Search strategiesFor the search strategies there were no language restrictions and studies had to be set in societies
relevant to the UK setting. We maintained the comprehensive electronic search conducted in MEDLINE
and EMBASE in our previous systematic review23 of RCTs of lifestyle interventions for weight loss in obese
adults with 1 year of follow-up. From our existing searches for this review and subsequent updates we
identiﬁed approximately 800 potentially relevant reports, in any language, for full-text assessment for
the review of men-only RCTs and RCTs of men and women compared. In addition to this search we
conducted comprehensive electronic searches based on our existing search strategy to identify RCTs ofNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35interventions for obesity in men. To avoid unnecessary overlap with the pre-existing results from the review
by Avenell and colleagues,23 the search strategy for reviews of men-only RCTs and RCTs of men and
women compared excluded studies published before 2001.
Highly sensitive electronic searches were undertaken to inform the reviews of UK interventions and
interventions to increase engagement. The searches were designed to identify studies of interventions
for obese men in the UK, studies of interventions to increase the engagement of men with obesity
management services and qualitative research with obese men or obese men compared with obese
women. The searches for all reviews were designed to identify systematic reviews and other background
information relevant to the management of obesity in men. Additionally, a separate search was
undertaken to identify studies examining the cost-effectiveness of interventions for obese men. The
searches for each of the reviews were designed to be mutually exclusive, with the results of each new
search being deduplicated against the results of the previous searches. Table 2 details the databases
searched for each review.
The database searches were conducted over the following time periods:
l MEDLINE In-Process & Other Non-Indexed Citations: 1948 to 30 July 2012
l MEDLINE: 1948 to 2012 Week 31
l EMBASE: 1980 to 2012 Week 31
l Cumulative Index to Nursing and Allied Health Literature (CINAHL): 1981 to July 2012
l PsycINFO: 1800s to July 2012
l Social Sciences Citation Index (SSCI): 1970 to July 2012
l Conference Proceedings Citation Index – Social Science & Humanities (CPCI-SSH): 1990 to July 2012
l Cochrane Central Register of Controlled Trials (CENTRAL): The Cochrane Library, Issue 5, 2012
l Cochrane Database of Systematic Reviews (CDSR): The Cochrane Library, Issue 5, 2012
l ClinicalTrials.gov: September 2011
l CenterWatch: September 2011
l Current Controlled Trials: September 2011
l World Health Organization International Clinical Trials Registry: September 2011
l Applied Social Sciences Index and Abstracts (ASSIA): 1987 to July 2012
l Education Resources Information Center (ERIC): 1966 to July 2012
l Anthropology Plus: 1957 to July 2012
l British Nursing Index: 1994 to October 2011
l NHS Economic Evaluation Database (NHS EED): July 2012
l Health Technology Assessment (HTA) database: July 2012
l Database of Abstracts of Reviews of Effects (DARE): July 2012
l Health Management Information Consortium (HMIC): 1979 to November 2011
l Cost-Effectiveness Analysis Registry (CEA Registry): January 2012
l Research Papers in Economics (RePEc): January 2012.Hand searching
Reference lists of all included studies were scanned to identify any additional potentially relevant
reports. We also searched the internet for online weight-loss programmes speciﬁcally targeted at men
(e.g. www.fatmanslim.com) and the Picker Institute and Joanna Briggs Institute websites for grey literature.Other methods of ascertaining relevant information sources
When contact details were available, we contacted all authors of men-only RCTs to identify any qualitative
or other relevant published or unpublished reports. Our advisory group members provided details of
potentially relevant reports and further potentially useful contacts and information sources. Each of the
Men’s Health Forum representatives included articles in their newsletters highlighting our project and
providing details for readers to contact us with any relevant reports. The English Men’s Health Forum also
publicised the project through its Twitter account. Furthermore, we contacted the Association for the9
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TABLE 2 Databases searched for each review
Database
Men-only
RCTs
RCTs of
men and
women
compared
UK
interventions Engagement
Cost-
effectiveness
Qualitative
research
MEDLINE ✓ ✓ ✓ ✓ ✓ ✓
EMBASE ✓ ✓ ✓ ✓ ✓ ✓
Cumulative Index to
Nursing and Allied Health
Literature (CINAHL)
✓ ✓ – ✓ – ✓
PsycINFO ✓ ✓ ✓ ✓ – ✓
Cochrane Central Register
of Controlled Trials
(CENTRAL)
✓ ✓ – – – –
Cochrane Database of
Systematic Reviews (CDSR)
✓ ✓ – – – –
Database of Abstracts of
Reviews of Effects (DARE)
✓ ✓ – – – –
NHS Economic Evaluation
Database (NHS EED)
✓ ✓ – – ✓ –
Health Technology
Assessment (HTA) database
✓ ✓ – – – –
Applied Social Sciences
Index and Abstracts (ASSIA)
– – – ✓ – ✓
Education Resources
Information Center (ERIC)
– – – – – ✓
Anthropology Plus – – – – – ✓
British Nursing Index – – – – – ✓
Social Sciences Citation
Index (SSCI)
– – ✓ – – ✓
Health Management
Information Consortium
(HMIC)
– – – – ✓ –
Conference Proceedings
Citation Index – Social
Science & Humanities
(CPCI-SSH)
– – ✓ – – ✓
Cost-Effectiveness Analysis
Registry (CEA Registry)
– – – – ✓ –
Research Papers in
Economics (RePEc)
– – – – ✓ –
ClinicalTrials.gov ✓ ✓ – – – –
CenterWatch ✓ ✓ – – – –
Current Controlled Trials ✓ ✓ – – – –
International Clinical
Trials Registry
✓ ✓ – – – –
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published and unpublished UK studies (see Appendix 1).Quantitative reviews of randomised controlled trials and other
intervention studies
Data extraction strategy
One reviewer (CR) independently screened the titles and abstracts of all identiﬁed items. Full-text copies
of all potentially relevant reports were obtained and independently assessed for eligibility (CR assessed
reviews of men-only RCTs, RCTs of men and women compared and interventions to increase engagement;
AA assessed the review of UK interventions). One reviewer (CR) extracted details of study design, methods,
participants, interventions and outcomes using a data extraction form (see Appendix 2). The data
extraction was then checked by a second reviewer (AA) and any errors were corrected.Quality assessment strategy
We assessed the methodological quality of included RCTs using The Cochrane Collaboration’s tool for
assessing risk of bias57 (see Appendix 3). We assessed the methodological quality of non-randomised
comparative studies using a 17-item checklist, with the same checklist minus four questions used to assess
the quality of case series (see Appendix 4). The checklist was developed for NICE through the Review Body
for Interventional Procedures (ReBIP) and was adapted from several sources, including the NHS Centre for
Reviews and Dissemination’s guidance for those conducting or commissioning systematic reviews,58
Verhagen and colleagues,59 Downs and Black60 and the Generic Appraisal Tool for Epidemiology (GATE).61
Individual items within these tools were rated as ‘yes’, ‘no’ or ‘unclear’ so that a rating of ‘yes’ denoted
the optimal rating for methodological quality. Two reviewers independently assessed the quality of all
included full-text primary studies. In addition, we used an adapted version of the Campbell & Cochrane
Equity Methods Group checklist62 for each of the reviews to assess the effect of interventions reported in
the included studies on disadvantaged groups and/or their impact on reducing socioeconomic inequalities
(see Appendices 8, 10 and 12). Individual items were worded as ‘yes’, ‘no’ or ‘unclear/not reported.’
Conference abstracts and poster presentations were excluded unless sufﬁcient details were reported to
carry out quality, equity and sustainability assessments (e.g. protocols, internal reports). Any disagreements
or uncertainty were resolved by discussion between the two reviewers. A third reviewer acted as an
arbitrator when consensus could not be reached.Data analysis
We imported data into Review Manager (RevMan) software (version 5.1; The Cochrane Collaboration,
The Nordic Cochrane Centre, Copenhagen, Denmark) for data synthesis. We reported means or changes
in means or proportions between groups. For continuous outcomes we reported the mean difference or
standardised mean difference (different scales for the same outcome) and for dichotomous data we
presented the risk ratio with 95% conﬁdence intervals (CIs). Because of the inherent heterogeneity in
studies of obesity interventions, when study results could be quantitatively pooled we used random-effects
meta-analysis throughout. For meta-analysis plots of only one study we used ﬁxed effects. We used visual
inspection and the I2 statistic to assess heterogeneity in forest plots57 and planned funnel plot analysis
to investigate reporting biases for forest plots with ≥ 10 studies.
We planned to explore the role of sex as a treatment modiﬁer by conducting a meta-analysis of the
treatment by sex interaction effect across trials in which outcomes were presented separately by sex,63 but
this was not possible because of the heterogeneous nature of the interventions, particularly in terms of
dietary calorie prescription. For statistics on the proportion of participants completing the study, only
studies that reported the rate of dropout were included. The risk difference and its CI between men and
women were calculated with the p-value.11
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Robertson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
METHODS
12For the analysis of mean weight difference between men and women, the weighted mean difference
(WMD) was calculated for both men and women when more than one group was reported. The standard
deviation (SD) for the WMD was calculated using the formulae for calculating SD for grouped data.
Studies with no baseline weight values were excluded from the analysis of weight difference. In the
analysis of percentage weight loss the WMD was divided by the baseline weight. For each study the
number of participants, the WMD of weight or percentage weight loss from baseline and its SD were
entered into RevMan software. The random-effects model was used.
Subgroup analyses were planned to explore whether the effectiveness of interventions differed according
to whether participants were selected on the basis of newly diagnosed or pre-existing obesity-related
comorbidities (e.g. diabetes, hypertension). This was not possible because of the limited quantity
of data and the heterogeneity of the studies. Sufﬁcient data were not available to explore the effect of
deprivation, age and ethnicity on effectiveness nor were there sufﬁcient data to explore the effect
of assumed values for weight on meta-analyses.
The methods for incorporating economics evidence into the reviews followed those recommended in
The Cochrane Handbook.57 A narrative synthesis is presented.Integrated qualitative and quantitative evidence synthesisWe undertook a realist integrated qualitative and quantitative evidence synthesis to investigate what
weight management interventions work for men, with which men and under what circumstances. From
a realist perspective, it is important to conceptualise any intervention intended to improve health by
considering the:
1. context that an intervention/programme will be situated within so that factors that might inhibit or
enhance its effectiveness can be identiﬁed
2. mechanisms of the intervention/programme and how the intended programme beneﬁciaries will
interact and react to the intervention processes and mechanisms
3. outcomes, both positive and negative, that may arise from an individual’s engagement with the
proposed intervention.
A body of literature has emerged over recent years that has stressed the importance of considering
public health problems (such as obesity) from a so-called socioecological perspective.5,64–69 Hence, our
methodological approach investigated issues relating to the macro-, meso- and micro-level inﬂuences that
shape and inﬂuence men’s perspectives and experiences related to engaging with weight management
programmes. By macro-level inﬂuences we mean the wider social, cultural, economic and political factors
that overarch and inﬂuence the meso level of workplace, community, family, friends and peers, whereas
micro level refers to the individual psychological and biological determinants of health and well-being.A priori research questions
The primary aim of the evidence synthesis was to uncover how effective interventions work and to
describe key intervention ingredients, processes and environmental and contextual factors that contribute
to effectiveness.70 We also aimed to identify the barriers and facilitators that men experience when
engaging with a weight management intervention. Both deductive and inductive analytical approaches
were employed throughout the review process and as such the following a priori research questions were
developed to guide our initial investigation:
1. What are the best evidence-based management strategies for treating obesity in men?
2. How can men’s engagement in obesity services be improved?NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35In addition to these a priori research questions we also developed a series of 10 more detailed research
questions that emerged inductively from the initial ﬁndings of the review of men-only RCTs (see Chapter 3)
and also the expertise, knowledge and previous research of the chief investigator (AA) and principal
investigators (FD, PH, EvT). Generating inductive research questions in this way is an inherent property of
qualitative research and particularly of a grounded theory approach in which data collection and analysis
proceed iteratively to conﬁrm or refute an emerging theory:
1. How are men initially motivated to lose weight?
2. How are men attracted to taking part in the trial/intervention?
3. Are men consulted in the design of the intervention?
4. If it is found that interventions for men should be different from those for women, how should they
be different and why?
5. Are group-based interventions for men found to be more effective for weight loss than those
delivered to individual men?
6. Are certain features of diets found to be more attractive for obese men?
7. Are certain features of physical activity stated to be more attractive for obese men? How and why are
these features more attractive?
8. What efforts are made to help men continue with the programme?
9. Do men state who they believe to be the best person/persons to deliver the intervention?
10. Are programmes deliberately involving partners/families more effective?
These questions were incorporated into our data extraction form (see Appendix 15) to code the data from
studies linked to interventions to identify a priori themes. A full description of the data analysis cycle is
provided in The analysis cycle and thematic synthesis.Inclusion and exclusion criteria
We included any study reporting qualitative research with obese men, or obese men in contrast to obese
women. In addition we included qualitative data from both health professionals and commercial
organisations involved in managing obesity. The search included studies published from 1990 onwards
and no language restrictions were placed on any of the searches.
As stated above in the description of methods for quantitative reviews, the studies included men who
were 16 years or over, with no upper age limit, who had a mean or median BMI of 30 kg/m2. We included
data from qualitative and mixed method studies linked to the identiﬁed RCTs and linked to RCTs not
included in the quantitative reviews for this report. We also included any qualitative data reported as
part of papers reporting quantitative outcomes. Furthermore, we included data from qualitative studies
linked to non-randomised intervention studies and qualitative data from studies that were not linked
to any speciﬁc UK-based, men-only interventions that had reported on men’s experiences of
weight-loss attempts.
Studies conducted in developed countries were included if they contributed relevance to the UK context
and all settings for lifestyle and drug interventions were considered. These included workplaces, football
and rugby clubs, primary care, the internet, and religious and community settings.
We did not consider studies where men were not included and where obesity and weight management
were not the prime focus. In addition, studies that did not contain primary qualitative research with obese
men were not considered.13
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METHODS
14Identification of studies
The search methods for the review of qualitative studies have been reported earlier (see Search strategies).
Two researchers independently screened abstracts for inclusion and all eligible study reports were entered
into NVivo 9 qualitative data management software (QSR International, Southport, UK). Two researchers
then grouped the ﬁnal included studies into three categories:
1. qualitative and mixed-method studies linked to eligible RCTs, including any qualitative data reported as
part of papers reporting quantitative outcomes
2. qualitative and mixed-method studies linked to ineligible RCTs and identiﬁed non-randomised
intervention studies, including any qualitative data reported
3. UK-based qualitative studies not linked to any speciﬁc interventions that contained men-only samples.
Although it could be argued that separation of the studies into groups could cause further
decontextualisation, as the focus of this project is to assess the evidence for weight management
interventions, grouping the studies in this way assisted in the integration of the quantitative and qualitative
review processes.Data extraction strategy
For the studies linked to interventions, one reviewer (DA) used a data extraction form (see Appendix 15) to
extract details of study design, methods, participants, interventions, ﬁndings, data pertaining to area and
setting, and quality. Completed data extraction forms were checked by a second reviewer (either FD or
EvT). Any disagreements over the interpretation of extracted data were discussed at group meetings. After
agreement was reached the extraction forms were imported into NVivo 9 for analysis.
Following the analysis of the intervention study data, a further process of data extraction was applied to
the nine theoretical studies not linked to interventions to investigate whether these studies contained data
to conﬁrm, refute or add any new thematic insights. Three researchers (DA, FD and EvT) screened three of
the non-intervention studies each and extracted and inserted data into a Microsoft Excel spreadsheet
(2007; Microsoft Corporation, Redmond, WA, USA) containing our interpretive themes derived from the
intervention study data as headings. Data extraction of the non-intervention studies was cross-checked by
other researchers in the group.Quality assessment strategy
There is a great diversity of approaches to data collection and data analysis within qualitative research and
also a multiplicity of theoretical perspectives. This has made it difﬁcult to develop consensus over which
criteria are the most useful when assessing the quality of qualitative studies.1,71,72 At present, some
qualitative synthesis methods such as framework synthesis and thematic synthesis undertake highly
speciﬁed forms of quality appraisal that can result in the exclusion of studies that are judged to be of poor
methodological quality. However, other methods such as critical interpretive synthesis do not exclude
papers as long as they meet basic relevance criteria.73
With this in mind, there appears to be a growing argument amongst certain researchers72,74–77 that
qualitative studies should not be excluded from qualitative evidence syntheses based on quality
assessment. They argue that excluding studies because of methodological ﬂaws or incomplete reporting
may result in the loss of valuable new insights, whereas studies that are methodologically sound may
suffer from poor interpretation of data, leading to an insufﬁcient insight into the phenomenon under
study.76 In addition, Carroll and colleagues74 contend that a quality appraisal instrument can assess only
what is reported in a publication; thus, aspects such as the style of journal or word limits may have a
bearing on whether or not studies have adequate space to describe fully certain elements of a study that a
quality assessment tool may be investigating. For example, Garip and Yardley39 note that papers published
in medical journals were often rated poorly using the Critical Appraisal Skills Programme (CASP) tool78
because of the lack of space to provide full methodological details. We found these arguments against
excluding studies to be convincing and therefore did not exclude any of the 13 qualitative studies linked toNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35interventions on the basis of quality. Instead, we elected to formulate and apply a quality appraisal tool
during the process of data extraction.
Our quality assessment tool was formulated following a consultation of the following critical appraisal
checklists: CASP,78 the Consolidated Criteria for Reporting Qualitative Research79 and the Joanna Briggs
Institute Qualitative Assessment and Review Instrument.80 We included criteria from these that we
considered were key in terms of methodological rigour and also in terms of importance for our a priori
research questions, which are speciﬁcally concerned with informing policy and practice.
The criteria that we selected were:
1. Aims and methods:
¢ Research questions – stated explicitly or implicitly within the general text/topic guide? In what
section(s) of the paper are questions mentioned? Are they prospective or retrospective?
¢ Theoretical and epistemological perspective underpinning the qualitative research?
¢ Theoretical perspective underpinning the intervention?
¢ Qualitative methods used?
¢ Data analysis technique and procedure?
2. Sample:
¢ Sample size?
¢ Sample characteristics?
¢ Sample selection process?
¢ Sample inclusion and exclusion criteria?
3. Reﬂexivity:
¢ Evidence of researcher reﬂexivity?
4. Ethics:
¢ Evidence of attention to ethical issues?
5. General criteria:
¢ Are the ﬁndings adequately supported by the data presented?
¢ Is there potential for a ‘charisma effect’ with this study? (this relates to the potential inﬂuence of
the principal investigator)
¢ Any other quality issues not covered by previous items?The quality appraisal tool was integrated into the data extraction form and was applied by one researcher
(DA). The quality assessments were subsequently cross-checked by another researcher (either FD or EvT).
The ﬁndings and conclusions of our quality assessment are discussed in Chapter 6.The analysis cycle and thematic synthesis
We developed an analysis cycle that started with coding of the qualitative data from studies linked to
interventions followed by the development of initial descriptive themes and ﬁnally the development of
higher-order analytical and interpretive themes and concepts. This cyclical and iterative process was
conducted to identify the promising ‘ingredients’ of interventions that are likely to be effective in male
weight reduction, both in terms of essential and necessary contextual/environmental variables and
intervention processes.15
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16Development of a thematic index
To develop a thematic index, one researcher (DA) coded the ﬁndings reported in the included qualitative
studies linked to interventions line by line for content and meaning and categorised these according to
whether they corresponded to the a priori themes or whether they appeared to represent emergent
themes unconnected to the a priori themes.
After undertaking this process for all studies linked to interventions the coding was cross-checked by
another researcher (FD). The data then underwent a second importing process within NVivo 9 into
framework matrices for comparison of the a priori and emergent themes for effective and non-effective
interventions. Framework matrices were used to facilitate the use of the constant comparative method
to search for patterns and relationships and assist with developing theory. All qualitative researchers
(DA, FD, PH and EvT) then developed the descriptive thematic index over a series of meetings, with a tree
structure of themes and subthemes to enable us to remain close to the reported study ﬁndings. The
thematic framework was discussed at a meeting with the Men’s Health Forum representatives to
ascertain service users’ perspectives. The qualitative researchers decided that one of the 10 a priori themes
(‘Are programmes deliberately involving partners/families more effective?’) was not supported by the data
and it was rejected. To develop a thematic index, one researcher (DA) coded the ﬁndings reported in
the qualitative studies line by line.The development of interpretive themes
We then generated a more reﬁned set of interpretive themes from the a priori and emergent themes for
the effective management of obesity in men and the barriers to and facilitators of engaging in weight
management programmes. In meta-ethnography these are described as ‘third-order interpretations’.81
Following the completion of the analytical cycle for studies linked to interventions, the theoretical studies
not linked to interventions were then read to ascertain whether they provided disconﬁrming evidence or
added any new perspectives and all relevant data from these studies were extracted. This process was
conducted to test the robustness of the synthesis and has been recommended in previous narrative
synthesis methods literature.82
The ﬁnal stage of the analysis involved integrating the qualitative ﬁndings with ﬁndings from the
quantitative reviews. This was achieved through a process of in-depth reading of each results chapter
by all members of the research group to identify where qualitative ﬁndings were supported or refuted
by quantitative ﬁndings. The supporting or disconﬁrming quantitative data were then integrated into
the ﬁndings.Researcher perspectives
It is important to be aware of the researchers’ backgrounds and associated perspectives when interpreting
our ﬁndings. DA is a health services researcher with a background in sociology and mixed-methods
research methodologies. FD is a public health researcher with a background in health promotion and
nursing, with an interest in health inequalities and the social determinants of health outcomes and
behaviours. EvT is a medical sociologist with a background in qualitative and mixed-methods research
and an interest in public health in general and health promotion in particular. PH is an academic general
practitioner (GP) with expertise in qualitative and mixed-methods research, particularly when applied to
RCTs of complex interventions. None of the qualitative researchers can be considered obese. Throughout
the study reﬂexivity took place through weekly research team discussions until a consensus was reached.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Chapter 3 Systematic reviews of men-only
randomised controlled trials and randomised
controlled trials with data for men and
women compared
In this chapter we present two systematic reviews. The ﬁrst is a systematic review of RCTs of interventions(lifestyle and/or the UK-licensed medication orlistat) in any setting with men only who are obese with a
BMI of ≥ 30 kg/m2 (or overweight with a BMI of ≥ 28 kg/m2 and cardiac risk factors based on orlistat
guidance) and for which there are follow-up data for at least 1 year.
The second is a systematic review of RCTs of interventions (as above) in any setting with both men and
women who are obese with a BMI of ≥ 30 kg/m2 (or overweight with a BMI of ≥ 28 kg/m2 and cardiac risk
factors based on orlistat guidance) in which the results are presented separately for men and women in
the same trial. We use trials with both men and women to look for differences in effectiveness.Quantity of evidenceOur primary literature search identiﬁed 5498 potentially relevant titles and abstracts (Figure 1). In addition
to this, we identiﬁed 17 potentially relevant reports from other sources, such as commercial organisations
and expert opinion. We selected 255 reports for full-text assessment, of which 11 RCTs83–93 were included
in the review of men-only RCTs and 20 RCTs94–113 were included in the review of RCTs of men and
women, along with six reports114–119 linked to the review of men-only RCTs and six reports120–125 linked to
the review of RCTs of men and women.
Review of men-only randomised controlled trialsNumber and type of studies
Eleven RCTs including men only were identiﬁed as eligible for inclusion, nine of which investigated
weight-loss interventions.83,85–87,89–93 One trial examined a reducing diet for weight loss.93 Three trials
investigated the type of reducing diet to use.83,87,91 Three trials looked at the use of physical activity
in weight reduction.91–93 Three trials examined a diet plus behaviour therapy and exercise advice for
weight loss.85,89,90 Jeffery and colleagues86 investigated the use of various monetary contracts for
individual or group weight loss. Two trials investigated exercise or behaviour change training for weight
maintenance.84,88 The weight-maintenance trial conducted by King and colleagues88 randomised men who
had received active weight-loss interventions in the trial by Wood and colleagues.93 This was the only
weight-maintenance trial found that was linked to one of the eligible weight-loss intervention trials
identiﬁed by our screening process. Details of the interventions investigated by the individual trials are
presented in Table 3. None of the trials reported involving male service users in the design of the
intervention. The period of follow-up for all of the trials ranged from 12 to 36 months (median 15 months),
with ﬁve trials83,88,89,92,93 having a follow-up period of 1 year only.17
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Studies identified from searches for
UK interventions, engagement and
qualitative reviews and from
contact with experts and
commercial organisations
(n = 17)
Studies identified from
primary searches
(n = 5498)
Selected for full-text
screening from all sources
(n = 255)
Excluded
(n = 5260)
Selected for qualitative
review
(n = 3)
Excluded
(n = 209)
n = 12 abstracts/commentaries/errata/
evidence summaries/protocols/
recommendations/news articles
n = 3 different inclusion criteria for sexes
n = 4 cost-effectiveness reviews
n = 11 follow-up < 12 months
n = 1 ineligible comparator
n = 7 ineligible intervention
n = 24 ineligible population
n = 1 no comparator
n = 93 no data by sex
n = 14 no unique data
n = 4 no useable data
n = 2 no weight-loss data
n = 4 ongoing studies without results
n = 8 reviews
n = 19 ineligible study design
n = 2 unavailable
Included
(men and women RCTs)
(n = 20 studies;
26 reports)
Included
(men-only RCTs)
(n = 11 studies;
17 reports)
FIGURE 1 Flow chart of the number of potentially relevant reports and the numbers subsequently included and
excluded from the reviews.
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35The trials conducted by Jeffery and colleagues,86 Patrick and colleagues,90 Pavlou and colleagues91
and Wood and colleagues88,93 were carried out in the USA. Trials conducted by Benassi-Evans and
colleagues,83 Khoo and colleagues87 and Morgan and colleagues89 were carried out in Australia;
and studies conducted by Borg and colleagues,84 Esposito and colleagues85 and van Aggel-Leijssen and
colleagues92 were conducted in Finland, Italy and the Netherlands respectively. All trials were single-centre
RCTs. Seven trials reported interventions aimed at men individually.83,87–92 Men received group
interventions in three trials.84,85,93 Only one trial86 directly compared the effectiveness of group and
individual interventions. Details of the exact settings for the trials were generally not well described; most
appeared to be in a research setting. Only the trial by Esposito and colleagues85 appears to have been
conducted in a outpatient health service setting. One trial was conducted amongst university staff89
whereas Pavlou and colleagues91 recruited public sector workers, including those in the police department.
When e-mail addresses were valid,84–86,89 we contacted the authors requesting any additional relevant
reports and publications as well as any process or qualitative evaluations that they may have published
elsewhere. Of these, only the SHED-IT (Self-Help, Exercise and Diet using Information Technology)89 study
authors replied. We did not identify any additional eligible publications for inclusion in any of our reviews,
other than those we had already identiﬁed.Characteristics of the men
Men were mainly recruited through mass media advertising.83,84,87,90,92,93 Two studies recruited men
through the workplace (university staff in the SHED-IT trial89 and the police department and Metropolitan
District Commission in the trial by Pavlou and colleagues91) and one study85 recruited men from a hospital
outpatient clinic for weight loss. The studies conducted by Jeffery and colleagues86 and King and
colleagues88 recruited men from ongoing RCTs.93,114 All studies reported mean age, weight and, with
the exception of that by King and colleagues,88 BMI at baseline. Excluding data from the trial conducted
by King and colleagues,88 because of overlap of the participants with those in the trial by Wood and
colleagues,93 the majority of men were middle-aged with trials’ median (range) age of 46 years
(36–62 years), weight of 101.5 kg (93.0–112.7 kg) and BMI of 32.4 kg/m2 (30.1–36.9 kg/m2). A total of
1238 men were allocated to an intervention with 1098 included in the trial analyses. Details of the
inclusion/exclusion criteria for the individual trials are presented in Table 3.Overview of types of outcomes reported
Quantitative outcomes
All studies reported either baseline and end weights or changes in weight. Four studies reported change in
BMI.84,85,89,92 Three studies reported waist circumference87,89,90 and one reported waist-to-hip ratio.85
For cardiovascular risk factors, only two studies reported total cholesterol,85,91 three studies reported HDL
cholesterol,84,85,91 one study reported LDL cholesterol,84 two studies reported triglycerides85,91 and three
studies reported systolic and diastolic blood pressure.84,85,89 Systolic and diastolic blood pressure data for
the trial by Wood and colleagues93 were reported in a linked publication.115 The trials by Borg and
colleagues84 and Esposito and colleagues85 reported results for fasting plasma glucose.
Only two trials reported a male-speciﬁc disease outcome: erectile function following weight loss.85,87
One trial92 reported adverse events and one trial84 reported lack of adverse events. The trials did not
report quality of life, HbA1c levels or any economic outcomes.35
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSQuality of the evidence
Risk of bias
The risk of bias assessment for the individual trials is shown in Appendix 8 (see Table 56). Figure 2
summarises the assessment.
It was unclear whether random sequence generation was adequate in all but three studies,89,90,93 which
were judged to have adequately randomised participants. Five studies84,85,90,91,93 were judged to have
successfully concealed allocation, whereas this was unclear in the remaining trials. No trial was able to
carry out blinding of participants and the majority did not blind health-care providers, although this item
was uncertain in the trial by Benassi-Evans and colleagues83. This is because blinding of participants and
health-care providers would have largely been impossible because of the nature of the interventions
considered by the trials. Four trials did blind outcome assessors,85,88–90 whereas the trial conducted by Borg
and colleagues84 did not. It was unclear whether outcome assessors were blinded in the remaining trials.
The majority of the trials (10/11, 90.9%) were judged to have treated participants similarly apart from the
given intervention in each arm of the trial, with only the trial conducted by Esposito and colleagues85
causing uncertainty for this item. Over half of the trials were judged to be at low risk for incomplete
outcome data,84–87,89,92 with this item being unclear in the other trials.83,88,90,91,93 Only four trials85,86,89,90
carried out intention-to-treat analysis with the majority (6/11, 54.5%) of the trials analysing data for trial
completers only. It was unclear whether or not an intention-to-treat analysis was carried out in the trial
conducted by Benassi-Evans and colleagues.83
The trial by Khoo and colleagues87 was judged to be at high risk of selective reporting as the authors did
not report HbA1c outcomes. This was unclear for the SHED-IT trial89 as outcomes considered in the trial
protocol were not reported in the 6- and 12-month reports [e.g. Short Form questionnaire-12 items (SF-12)
and sexual function data]. All other trials were judged to be at low risk for this item.0 20 40 60 80 100
Other bias
Selective reporting
Intention-to-treat analysis (attrition bias)
Incomplete outcome data (attrition bias)
Groups treated identically (performance bias)
Blinding of outcome assessment (detection bias)
Blinding of health-care providers (performance bias)
Blinding of participants (performance bias)
Allocation concealment (selection bias)
Sequence generation (selection bias)
Low
High
Unclear
FIGURE 2 Summary of risk of bias assessment of trials included in the systematic review of men-only RCTs.
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35It was unclear for four studies83,84,91,93 whether or not the trials were at risk of any other bias. Five
trials85,87,88,90,92 were judged to be at low risk for this item, with the trial by Jeffery and colleagues86
considered to be at high risk as the participants paying larger monetary contracts in both the individual
arm and the group arm had a higher mean baseline weight than the participants paying smaller deposits.
The authors acknowledged that randomisation may have failed to equally distribute participants with
respect to their weight. The authors also experienced difﬁculty recruiting people to this trial, as only 50%
of those eligible signed monetary contracts. The SHED-IT trial89 was also judged to be at high risk of other
bias because of the limited generalisability of the participants, who were all staff or students recruited
from a single university, and because of the potential for contamination between participants because of
the work/student environment. It was unclear if the trial conducted by Pavlou and colleagues91 was at a
similar risk of workplace contamination.Assessment of equity and sustainability
Figure 3 summarises the equity assessment. Results for the individual trials are detailed in Appendix 8
(see Table 57).
The majority of equity items were not considered, were unclear or were not reported by the trial
authors. The trials did not report on diversity, sustainability or political context and did not describe
any partnerships.
Only three trials were considered to have been conducted in a way that could have excluded speciﬁc
groups of men, therefore inﬂuencing equity of access. The trial conducted by Jeffery and colleagues86 was
considered to have excluded men who could not afford to pay a ﬁnancial deposit. The SHED-IT trial89
was also judged to have potentially limited the inclusion of non-academic men because of the university
setting and the use of internet and mobile phone technologies. Similarly, the trial by Patrick and
colleagues90 required men to have internet access and to be computer literate.0 20 40 60 80 100
Harms/unintended effects
Author conflict
Referred partnerships
Political/organisational context
Sustainability
Providers reported
Process evaluation
Fidelity check
Diversity/disadvantage strategies
PROGRESS categories
Sociodemographic differences
Representativeness
Equity pointer
Yes
No
Unclear/not reported
FIGURE 3 Summary of the equity and sustainability assessment of trials included in the systematic review of
men-only RCTs.
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSThree trials considered unrepresentative samples of obese men: the trial by Esposito and colleagues85
recruited men from a weight-loss outpatient clinic who all had erectile dysfunction; men in the SHED-IT
trial89 were all university staff or students; and men in the Pavlou trial91 were all police ofﬁcers. Similarly,
the trials by Wood and colleagues93 and King and colleagues88 had very narrow inclusion criteria and
therefore excluded a wide number of potentially relevant men from their samples. It was unclear whether
or not the trial by Jeffery and colleagues86 included a representative sample of obese men as there was
insufﬁcient detail in the report. Inclusion criteria were not reported by Patrick and colleagues.90
The SHED-IT trial89 reported differences in compliance by occupation and age, with non-academic staff
members and older men showing greater compliance. It is unclear whether or not any socioeconomic
differences existed between withdrawals from each of the intervention groups. Patrick and colleagues90
reported that younger, non-white men were more likely to withdraw from their trial. The remaining trials
did not report on any socioeconomic differences between withdrawals and exclusions.
Only three trials86,89,90 reported on categories relating to place of residence, race/ethnicity, occupation,
gender, religion, education, socioeconomic status or social capital (PROGRESS). It was unclear in the trial
by Patrick and colleagues90 whether or not the authors had attempted to address diversity or disadvantage
with their trial intervention. All other trials did not address or report these items.
Four studies84,91–93 carried out ﬁdelity checks for physical activity by monitoring heart rate or maximal
oxygen consumption (VO2 max.) of the men during the exercise sessions, thus ensuring that the men
exercised at the required level of training intensity. The remaining studies did not report on ﬁdelity checks,
although the SHED-IT trial89 reported qualitative data concerning the enthusiasm of men for the internet
and control interventions.
Most trials83,85,89,90,92,93 (6/11, 54.5%) reported details of who provided the interventions. The other trials
did not report this item86–88,91 or it was unclear.84 Providers were dietitians, exercise instructors or
research staff.
The trial conducted by Borg and colleagues84 was partly funded by the Finnish pharmaceutical company
Leiras Oy. As this company manufactures a weight-loss product it is unclear whether or not this created
any author conﬂict. Patrick and colleagues90 also reported that three of the trial authors were co-owners of
Santech, Inc. (San Diego, CA, USA), which developed products related to the described research at the
time of publication. Both San Diego State University and the University of California approved this
arrangement in accordance with their conﬂict of interest policies. The other trials did not report whether or
not there was potential for author conﬂict.Assessment of effectiveness
An exercise programme compared with control
Wood and colleagues93 compared men in an exercise programme with a control group of men who
made no change to their diet or level of physical activity. Men in the exercise programme participated in
supervised exercise three times per week in 1-hour sessions with the aim of reducing their total body fat
by one-third over a 9-month period. Exercise activities included calisthenics, muscle stretching, brisk
walking and jogging. At 1 year the authors reported a signiﬁcant difference in weight in favour of a
programme of exercise compared with the control group (no diet or exercise) (mean difference –4.60 kg,
95% CI –6.18 kg to –3.02 kg) (Figure 4).NIHR Journals Library www.journalslibrary.nihr.ac.uk
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSAt 1 year, exercisers signiﬁcantly lowered their triglyceride levels compared with the control group
(reported p < 0.05) and signiﬁcantly improved their HDL cholesterol compared with the control group
(reported p < 0.01) (Table 4). No other differences for cholesterol, LDL cholesterol or systolic or diastolic
blood pressure (measured in the clinic) were reported as signiﬁcant, although changes in the exercise
group were all more beneﬁcial than those in the control group.
A reducing diet compared with control
Wood and colleagues93 also compared the control group with men who followed a reducing diet
(300–500 kcal per day deﬁcit) aimed at reducing total body fat by one-third over 9 months; this group also
made no alteration to their level of physical activity. At 1 year the diet group had lost signiﬁcantly more
weight than the control group, with a mean difference of –7.80 kg (95% CI –9.38 kg to –6.22 kg) (Figure 5).
At 1 year, dieters showed signiﬁcantly lower triglyceride levels (reported p < 0.05) and HDL cholesterol
levels (reported p < 0.001) than the control group (Table 5). No other risk factor changes were reported as
signiﬁcantly different, although changes in the diet group were all more beneﬁcial than changes in the
control group.TABLE 4 Mean change (SD) in cholesterol, triglycerides and blood pressure for the exercise programme group
vs. the control group after 1 year
Outcome Exercise (n = 47) Control (n = 42)
Total cholesterol (mmol/l) –0.25 (0.64) –0.23 (0.65)
LDL cholesterol (mmol/l) –0.25 (0.61) –0.21 (0.67)
HDL cholesterol (mmol/l) 0.11 (0.15) –0.02 (0.11) (n = 41)
Triglycerides (mmol/l) –0.16 (0.53) +0.08 (0.6)
Systolic blood pressure (mmHg) –6.6 (8.4) (n = 42) –4.1 (8.0) (n = 35)
Diastolic blood pressure (mmHg) –4.1 (8.0) (n = 42) –2.6 (8.1) (n = 35)
NIHR Journals Library www.journalslibrary.nihr.ac.uk
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TABLE 5 Mean change (SD) in cholesterol, triglycerides and blood pressure for the reducing diet group vs. the
control group after 1 year
Outcome Diet (n = 42) Control (n = 42)
Total cholesterol (mmol/l) –0.36 (0.56) –0.23 (0.65)
LDL cholesterol (mmol/l) –0.31 (0.64) –0.21 (0.67)
HDL cholesterol (mmol/l) 0.12 (0.16) (n = 41) –0.02 (0.11) (n = 41)
Triglycerides (mmol/l) –0.27 (0.72) +0.08 (0.6)
Systolic blood pressure (mmHg) –5.7 (7.9) (n = 38) –4.1 (8.0) (n = 35)
Diastolic blood pressure (mmHg) –5.6 (7.3) (n = 38) –2.6 (8.1) (n = 35)
42
SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSAn exercise programme compared with a reducing diet
A reducing diet was shown to produce a signiﬁcant reduction in weight compared with an exercise
programme at 1 year, with a mean difference of –3.20 kg (95% CI –4.78 kg to –1.62 kg) (Figure 6).93
None of the risk factor differences between the reducing diet group and the exercise programme group
(Table 6) were reported as statistically signiﬁcant.A low-fat reducing diet with behaviour therapy and exercise advice
compared with control
Three studies examined behavioural therapy, exercise advice and low-fat reducing diets compared with a
control group. In the SHED-IT trial by Morgan and colleagues,89 participants were given support and advice
through a free study website. The control group received an information booklet only. At 12 months the
internet group had lost more weight than the control group, with a mean difference of –2.20 kg (95% CI
–5.65 to 1.25 kg), but the difference in weight reduction was not signiﬁcant.
Similarly, Patrick and colleagues90 used the internet to deliver dietary and physical activity advice and
behavioural therapy. The trial authors held interviews with two male weight-loss experts and held focus
groups with men to tailor the intervention speciﬁcally for men described as overweight. The results of this
developmental work showed that men wanted an intervention that was individualised, fact based, ﬂexible
and simple to understand. Men also indicated that they preferred the use of ‘businesslike’ language.
Pedometers were provided to encourage physical activity and were enjoyed by the men for their novelty
and assistance with self-monitoring of their behaviour. Men in the control group were given access to a
website detailing general male-related health advice that was unlikely to lead to lifestyle changes that
would promote weight loss (e.g. dealing with stress, hair loss, worksite injury prevention). Men receiving
the weight-loss intervention lost more weight than men in the control group but the difference between
the groups at 12 months was also not signiﬁcant.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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TABLE 6 Mean change (SD) in cholesterol, triglycerides and blood pressure for an exercise programme group
vs. a reducing diet group after 1 year
Outcome Exercise (n = 47) Diet (n = 42)
Total cholesterol (mmol/l) –0.25 (0.64) –0.36 (0.56)
LDL cholesterol (mmol/l) –0.25 (0.61) –0.31 (0.64)
HDL cholesterol (mmol/l) 0.11 (0.15) 0.12 (0.16) (n = 41)
Triglycerides (mmol/l) –0.16 (0.53) –0.27 (0.72)
Systolic blood pressure (mmHg) –6.6 (8.4) (n = 42) –5.7 (7.9) (n = 38)
Diastolic blood pressure (mmHg) –4.1 (8.0) (n = 42) –5.6 (7.3) (n = 38)
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSThe trial by Esposito and colleagues85 examined behavioural therapy, advice on how to increase physical
activity and a low-fat reducing diet. The men were recruited because they were obese and had erectile
dysfunction [determined by a score of ≤ 21 on the International Index of Erectile Function (IIEF)126]. The
men met in groups but received advice tailored to their individual requirements. The control group in this
trial received general oral and written advice regarding healthy food choices and exercise at baseline only.
At 2 years the intervention group had lost signiﬁcantly more weight than the control group, with a mean
difference of –13.00 kg (95% CI –16.18 kg to –9.82 kg) (Figure 7).
At 12 months the only signiﬁcant difference between groups with regard to risk factors was in systolic
blood pressure in favour of the intervention group (reported p < 0.03)89 (Table 7).
At 24 months the intervention group in the trial by Esposito and colleagues85 showed signiﬁcant
improvements compared with the control group for total cholesterol, triglycerides and fasting plasma
glucose (reported p≤ 0.05). BMI, HDL cholesterol, systolic and diastolic blood pressure and waist-to-hip
ratio were also signiﬁcantly improved (reported p≤ 0.01) (see Table 7).
Esposito and colleagues85 also reported that 17 out of 55 men in the intervention group compared with
three out of 55 men in the control group reported an IIEF score of ≥ 22 (indicating regained sexual
function; reported p = 0.001).A diet and exercise programme compared with a diet only
Two trials reported the effect of adding an exercise programme to a diet compared with diet only. The trial
by van Aggel-Leijssen and colleagues92 was a small trial in which men were randomised to a diet only or a
diet and exercise programme. All men followed a 10-week diet. For the ﬁrst 6 weeks men followed a very
low energy (500 kcal per day) formula diet (Modifast) of 50 g of carbohydrate, 52 g of protein and 7 g of
fat. For weeks 7–8, men consumed 330 kcal per day of the formula diet and 840 kcal per day from foods
of their choice. During weeks 9–10, men consumed 170 kcal per day of the formula diet and 1170 kcal
per day from their chosen food. The men were then instructed to stabilise their body weight for weeks
11–12. Men in the diet and exercise group also participated in a low-intensity exercise programme (40%
VO2 max.) for 12 weeks, which was then continued to week 52. The men trained four times per week in
1-hour sessions. Three of these sessions were supervised by a personal trainer in the research laboratory
and the other session was unsupervised at home. The exercise sessions consisted of cycling, walking
and aqua-jogging. Attendance for supervised exercise sessions was 57% (SD 20%). Reasons for
non-attendance included illness, holidays and work commitments. Two of the men in the exercise groupNIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 7 Mean (95% CI) change in BMI, cholesterol, triglycerides, waist circumference and systolic and diastolic
blood pressure for a low-fat reducing diet with behaviour therapy and exercise advice group vs. a control group
Outcome
Low-fat reducing diet,
behaviour therapy and
exercise advice Total no. of men Control Total no. of men
BMI (kg/m2)
12 months –1.7 (–2.4 to –1.0) 34 –0.9 (–1.7 to –0.2) 31
24 months –5.7 55 –0.7 55
Systolic blood pressure (mmHg)
12 months –11 (–14 to –7) 34 –6 (–10 to –2) 31
24 months –3 55 –1 55
Diastolic blood pressure (mmHg)
12 months –6 (–10 to –2) 34 –4 (–9 to –1) 31
24 months –4 55 0 55
Waist circumference (cm)
12 months –5.8 (–7.9 to –3.6) 34 –3.8 (–6.1 to –1.6) 31
Total cholesterol (mmol/l)
24 months –0.29 55 0.05 55
HDL cholesterol (mmol/l)
24 months 0.23 55 0.03 55
Triglycerides (mmol/l)
24 months –0.22 55 –0.05 55
Fasting plasma glucose (mmol/l)
24 months –0.44 55 –0.06 55
Waist-to-hip ratio
24 months –0.09 55 0 55
12-month data taken from the study by Morgan and colleagues;89 24-month data taken from the study by Esposito
and colleagues.85
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35had to withdraw from the study because of knee injuries. There were no other reported adverse events.
Weight data for men at 12 months were reported in a linked report by Lejeune and colleagues.119 Men in
the diet and exercise group did not lose as much weight as men in the diet-only group (mean difference
4.20 kg, 95% CI –1.47 to 9.87 kg).
The study by Pavlou and colleagues91 consisted of a pilot trial and the main trial. The pilot trial compared
a low-calorie diet of 1000 kcal per day coupled with an exercise programme with a low-calorie diet only.
The pilot trial also compared a low-calorie, low-carbohydrate diet of 1000 kcal per day plus an exercise
programme with a very low-calorie diet only. The main trial compared the same two diets, with and
without an exercise programme, as the pilot trial. The main trial additionally compared the effect of
adding exercise to two types of very low-calorie diet (420 kcal per day and 800 kcal per day).45
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Robertson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSCombining results for all diet groups, the effect of adding an exercise programme to a diet was highly
signiﬁcant at 18 months (mean difference –7.63 kg, 95% CI –10.33 to –4.92 kg) and at 36 months (mean
difference –8.22 kg, 95% CI –15.27 to –1.16 kg). There were no signiﬁcant differences between the
1000 kcal per day low-carbohydrate diet and the 1000 kcal per day low-calorie diet, however, or for the
two forms of very low-calorie diet (420 and 800 kcal per day) at 18 or 36 months (Figure 8).
In the main trial,91 systolic (mean difference –8.90 mmHg, 95% CI 13.65 to –4.15 mmHg) and diastolic
(mean difference –12.10 mmHg, 95% –15.20 to –9.00mmHg) blood pressure were signiﬁcantly lower in
the diet and exercise groups compared with the diet only groups at 18 months.Type of diet
A high-protein reducing diet compared with a high-carbohydrate
reducing diet
The trial by Benassi-Evans and colleagues83 compared a high-protein diet with a high-carbohydrate diet.
Both diets consisted of 1670 kcal per day with some adjustment in energy to achieve an approximate
weight loss of 1 kg per week. At 12 months the high-protein diet group had not lost as much weight as
the high-carbohydrate diet group, although the difference between groups was not statistically signiﬁcant
(mean difference 1.55 kg, 95% CI –4.70 to 7.80 kg kg) (Figure 9).
A high-protein, low-fat diet compared with a low-calorie diet
Khoo and colleagues87 randomised men with type 2 diabetes mellitus to a modiﬁed low-calorie diet or a
high-protein, low-fat diet. By 12 months men in the low-calorie diet group had lost slightly more weight
than men in the high-protein diet group (–9.5 kg vs. –9.0 kg). For both groups the men lost a signiﬁcant
amount of weight, reduced their waist circumference measurement and saw improvements in erectile
function as measured by the IIEF-5, but the differences between groups were not statistically signiﬁcant.Monetary contracts: individual compared with group
The trial conducted by Jeffery and colleagues86 recruited 89 men to receive a 15-week behaviourally
oriented weight reduction programme with a goal of achieving a total weight loss of 30 lb (13.6 kg) at a
rate of 2 lb (0.2 kg) per week. Using a factorial design, men in the trial were randomised to pay monetary
deposits of US$30, US$150 or US$300 and to either a group contract or an individual contract. Refunds
were made at a rate of US$1, US$5 or US$10 per lb lost up to a maximum cumulative weight loss of 2 lb
per week. Men in the individual contract groups received refunds based on individual weight loss, whereas
those with group contracts were refunded based on the mean weight loss of their group. Group contracts
produced signiﬁcantly more weight loss than individual contracts both at 1 year and 2 years (reported
p < 0.05). Effects of contract size at 1 year86 and 2 years117 were reported as not signiﬁcant. Table 8 shows
the mean weight loss for group and individual contracts by contract size at 1 and 2 years.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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TABLE 8 Effect of contract size and group vs. individual monetary contracts on weight reduction at 1 and 2 years
Contract size
Calculated mean weight loss (kg)
Group contract Individual contract
1 year
US$30 –8.55 (n = 17) –5.35 (n = 16)
US$150 –10.02 (n = 13) –7.39 (n = 15)
US$300 –6.60 (n = 13) –6.24 (n = 14)
2 years
US$30 –6.40 (n = 17) –3.69 (n = 16)
US$150 –7.02 (n = 13) –3.78 (n = 15)
US$300 –6.31 (n = 13) –3.24 (n = 14)
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSWeight maintenance
Diet and exercise compared with diet for weight maintenance
The trial conducted by Borg and colleagues84 examined whether or not adding walking or resistance training
to diet compared with diet alone improved weight maintenance following a weight reduction period. During
the weight reduction period, participants followed a very low-calorie diet (Nutrilett) of 500 kcal per day for
2 months. The mean weight loss at the end of the weight reduction period was 14.2 kg. Participants were
then randomised to follow a low-fat diet of 1200 kcal per day only or to diet and walking or diet and
resistance training exercise groups. Other than reduced fat and calorie intake, the diet was unrestricted in
terms of choice or amount of food consumed. Exercise sessions were held three times a week and lasted
45 minutes each. The walking exercise was designed to produce an energy expenditure of 400 kcal per
session, whereas the resistance training produced an expenditure of 300 kcal per session. Men in the
diet-only group were advised not to increase their physical activity during the 6-month weight-maintenance
phase. At 31 months the walking group showed the greatest increase in weight with an average weight gain
of 10.1 kg. The resistance training and diet-only groups increased their weight by an average of 9.1 and
8.4 kg respectively. Differences between groups for weight gain were not statistically signiﬁcant, although
the waist-to-hip ratio for the resistance training group increased signiﬁcantly less than that of the walking
group despite the larger weight gain in this group (reported p = 0.04). Outcomes for waist-to-hip ratio,
LDL cholesterol, HDL cholesterol, fasting plasma glucose and systolic and diastolic blood pressure were not
signiﬁcantly different between the exercise groups and the diet-only group at 13 months. HDL cholesterol
improved signiﬁcantly more in the resistance training group than in the walking group (reported p = 0.03) at
31 months (Table 9). The energy expenditure of both physical activities in the exercise groups decreased
during the weight-maintenance period because of poor long-term adherence to the prescribed regimen.
A behavioural intervention for weight maintenance compared with control
The trial conducted by King and colleagues88 randomised men from the diet and exercise arms of the trial
by Wood and colleagues93 at the end of the 1-year trial period. These men were randomised within their
original intervention groups to receive behavioural support based on their original weight-loss method or
to two assessment-only control groups. The behavioural support intervention comprised monthly mailed
information packs including a supportive letter and a list of coping strategies for problems relevant to their
original intervention, for example holiday eating for dieters or ﬁnding time to engage in physical activity
for exercisers. The men were also telephoned regularly to discuss any concerns or questions related to their
problem areas and were weighed at 6-monthly intervals. Men in the assessment-only groups were given
written information about their original weight-loss method at the start of the weight-maintenance period.
The men received no other contact apart from the 6-monthly weight assessments.NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 9 Effect of diet and exercise vs. diet on risk factors [mean (SD)] at 31 months116
Outcome
Diet and resistance
training (n = 24)
Diet and walking
(n = 18)
Diet only (control)
(n = 19)
BMI (kg/m2) 32.0 (3.3) 32.0 (4.1) 31.3 (3.1)
Mean difference vs. control (95% CI) –0.2 (–2.0 to 1.5) 0.2 (–1.6 to 2.1)
Waist-to-hip ratio 0.98 (0.07) 1.01 (0.06) 1.00 (0.06)
Mean difference vs. control (95% CI) –0.04 (–0.07 to –0.00) 0.01 (–0.03 to 0.04)
Systolic blood pressure (mmHg) 136 (15) 131 (19) 132 (15)
Mean difference vs. control (95% CI) 1 (–8 to 10) –2 (–11 to 8)
Diastolic blood pressure (mmHg) 87 (10) 84 (10) 84 (10)
Mean difference vs. control (95% CI) –0 (–6 to 6) 1 (–6 to 7)
LDL cholesterol (mmol/l) 3.56 (0.58) 3.53 (0.93) 3.47 (0.74)
Mean difference vs. control (95% CI) 0.04 (–0.30 to 0.38) –0.11 (–0.47 to 0.25)
HDL cholesterol (mmol/l) 1.24 (0.31) 1.25 (0.20) 1.27 (0.27)
Mean difference vs. control (95% CI) 0.01 (–0.09 to 0.11) –0.01 (–0.11 to 0.10)
Fasting plasma glucose (mmol/l 5.01 (0.38) 5.00 (0.52) 5.12 (0.49)
Mean difference vs. control (95% CI) –0.05 (–0.30 to 0.21) –0.09 (–0.36 to 0.18)
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35The behavioural therapy intervention produced greater weight-maintenance success for the exercise group
compared with the control group than it did for dieters. After 1 year, exercisers who received the behavioural
intervention weighed signiﬁcantly less than control participants (–3.10 kg, 95% CI –5.04 kg to –1.16 kg).
Dieters in the behavioural intervention group were not signiﬁcantly different from control participants after
1 year (0.60 kg, 95% –1.27 kg to 2.47 kg) (Figure 10).
Discussion of results from the review of men-only trials
We identiﬁed very few long-term men-only randomised trials investigating interventions for reducing
male obesity. Only two of our 11 included trials investigated weight maintenance in men. Results from
this systematic review should therefore be treated with caution because of the limited evidence base.
Nevertheless, it is possible to conclude that interventions containing a prescribed dietary regimen will
produce greater reductions in weight for obese men than interventions that do not, for example
interventions including exercise alone.93 The type of reducing diet prescribed did not affect the amount
of weight reduction, and higher protein intakes could not be demonstrated to be more effective for
weight loss.83,87,91 Adding an exercise component to a dietary regimen produced a marked effect in the
long term, as reported in the trial conducted by Pavlou and colleagues (follow-up at 18 and 36 months).91
Shorter-term results reported in the small trial by van Aggel-Leijssen and colleagues92 seem to contradict
this, although it should be noted that the exercise protocols for these studies differed greatly.
When frequency of contact varied between interventions, the intervention with the greatest frequency of
contact (often supervised exercise classes) usually produced more favourable results. This is contradicted in
the trial by van Aggel-Leijssen and colleagues92 in which the diet and exercise group received more
contacts but did not lose as much weight as the diet-only group.
Only one trial, that conducted by Jeffery and colleagues,86 directly examined the effect of group compared
with individual interventions for weight loss. This trial suggested that men lose more weight if they attend
weight-loss sessions in groups, with group monetary contracts compared with individual contracts as
incentives. This is in keeping with the ﬁndings of a systematic review127 comparing group and individual
treatments for obesity in both men and women. This review also found that group-based interventions
were more effective, although the reviewed population was predominantly female.49
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Few interventions included a structured formal behaviour change programme although many included
elements of behaviour change, for example self-monitoring and goal setting. Trials conducted by Esposito
and colleagues,85 Khoo and colleagues87 and Morgan and colleagues89 included behavioural support as
part of a dietary-based intervention. The trials did not compare different types of behaviour change activity
and consequently it is impossible to assess whether or not one type of activity is most effective. The trial
by King and colleagues88 showed that behavioural support can be beneﬁcial for men during weight
maintenance, although this seemed to be more effective at reducing weight regain by encouraging men
to continue to engage in physical activity rather than restricting their dietary intake. The trial by Borg and
colleagues84 did not clearly demonstrate that the type of physical activity was important for weight
maintenance, as resistance training was not associated with signiﬁcantly less weight gain than walking,
and neither type of exercise was signiﬁcantly better than diet only for preventing weight gain.
Few reports gave details of the method of randomisation. It is therefore not possible to judge the success
of randomisation for these trials. Similarly, few authors used intention-to-treat analysis, choosing instead to
present data for completers only both at baseline and for ﬁnal outcome measurements. It is therefore
difﬁcult to judge the level of attrition bias in these studies. The methodological quality of future trials could
be improved by adopting an intention-to-treat approach, carrying out assiduous follow-up of participants
and providing a conservative estimate of results by assuming weight regain to baseline for those who drop
out. Reporting could also be improved by following the standards outlined in the Consolidated Standards
of Reporting Trials (CONSORT) statement.128,129 Similarly, few trials reported details concerning the equity
or sustainability of the considered interventions. Providers of the interventions were described at an
occupational level, for example nutritionist or physical activity trainer, but the sex of providers was not
reported. It is subsequently unclear from the included studies whether the sex of the person providing a
weight-loss intervention to men, either individually or in groups, is an important factor in the effectiveness
of that intervention.
Future trials should also gather information on patient-reported quality of life and clinical and economic
outcomes to assess the full value of an intervention other than for amount of weight lost. Future research
is also required to develop effective interventions to prevent men regaining weight in the long term
following successful weight loss.Review of randomised controlled trials of men and
women comparedThis systematic review was of RCTs of interventions in any setting for men and women who are obese
with a BMI of ≥ 30 kg/m2 (or overweight with a BMI of ≥ 28 kg/m2 and cardiac risk factors based on
orlistat guidance) in which the results are presented separately for men and women in the same trial.
We used trials including both men and women to look for differences in effectiveness.Number and type of studies
Twenty RCTs94–113 including both men and women, with six linked reports,120–125 were identiﬁed as eligible
for inclusion. Nine trials94,97–99,109–113 were conducted in the USA; six95,96,101,102,104,108 were conducted in
Finland and one was conducted in each of the following locations: Canada,106 Israel,107 Scandinavia,105
Sweden103 and the UK.100 The trial by Jolly and colleagues100 in the UK evaluated commercial and NHS
weight-loss services in primary care and the community. The study by Ross and colleagues106 was
conducted in a primary care setting in Canada. The remaining studies appeared to be conducted in
research settings.
Table 10 details the characteristics of the included reports. A very diverse range of interventions was tested
in the trials. The majority of trials investigated interventions for weight loss. Three trials investigated
different types of reducing diet or when to use such diets.103,107,113 Eight trials investigated a variety of
dietary, physical activity and behaviour change interventions compared with control/usual care51
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provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35interventions.97,99–101,104,108,110,111 The study by Volpe and colleagues109 compared a reducing diet, an
exercise programme or both together. One trial examined which type of behaviour change programme to
use.97 One trial examined the effect of modifying the home environment.94 The study by Jeffery and
colleagues evaluated the delivery of a programme by mail or by telephone.99 One study evaluated the
delivery of a programme by doctors or by nurses.102 Wing and colleagues112 investigated whether or not
weight loss was improved if a spouse also attended the programme. Two trials by Hakala and
colleagues95,96 examined the beneﬁt of an initial inpatient rehabilitation programme.
One trial105 solely investigated interventions for weight maintenance, comparing the effectiveness of
orlistat with the effectiveness of placebo treatment. The period of follow-up ranged from 1 to 6 years
(median 2 years). A trial published in 198498 included a weight-maintenance component in a subset of
participants following a weight reduction phase. Both phases of this trial investigated the effect of
ﬁnancial contracts on weight loss and maintenance.
Of the six reports linked to RCTs, ﬁve were identiﬁed as ancillary studies to main trials. These included
two studies examining spousal effects,120,121 one study examining the effects of weight loss on erectile
function in a subset of male participants,122 one study investigating differences in body image between
men and women123 and one study investigating the effects of weight-loss interventions on bone mineral
density.124 One report provided additional data for risk factors not included in the main trial report.125Characteristics of the men and women
Of the included reports we identiﬁed three large trials of weight-loss interventions for the prevention
or treatment of type 2 diabetes: the Diabetes Prevention Program (DPP);111 the Finnish Diabetes Prevention
Study (FDPS)104 and the Look AHEAD (Action for Health in Diabetes) trial.110 A further ﬁve trials targeted
participants with type 2 diabetes97,102,108,112,113 and two included some people with diabetes or impaired
glucose tolerance.105,107 In total, 12,934 men and women were enrolled in the trials, with the mean age
of participants ranging from 37 to 59 years (median 55 years). The highest reported BMI was 42.7 kg/m2
for men95 and 43.6 kg/m2 for women,95 whereas the lowest was 29.7 kg/m2 104 and 30.53 kg/m2 98
respectively. Only nine trials reported BMI by sex at baseline. In eight studies women had a higher BMI
than men,95,96,102,104,106,108,110,111 and in one study BMI was higher in men.98Attrition in men compared with women
Eight trials95,96,98,100,102,103,106,111 provided data that could be included in the analysis comparing the numbers
of men and women who completed the trials. In total, there were 3813 participants; 1197 were men and
2616 were women (Tables 11 and 12). The results shows that men were 11% (95% CI 8% to 14%,TABLE 11 Studies included in the analysis of attrition by sex
Study ID % men recruited
No. randomised No. completed
Men Women Men Women
Hakala 199395 33.3 20 40 18 35
Hakala 199496 30.0 18 42 13 30
Jeffery 198498 48.7 55 58 53 55
Lantz 2003103 25.8 86 248 35 82
Korhonen 1987102 50.0 40 40 38 33
Jolly 2011100 30.7 227 513 162 182
Ross 2012106 29.8 146 344 121 275
West 2008111 31.3 605 1331 416 889
Total 31.4 1197 2616 856 1581
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ABLE 12 Contingency table and results for studies included in the analysis of male and female attrition
Sex Completed study Did not complete study Total Proportion completing
Male 856 341 1197 0.72
Female 1581 1035 2616 0.60
Total 2437 1376 3813 0.64
Difference in proportion between men and women (95% CI) 0.11 (0.08 to 0.14), p < 0.001
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSTp < 0.001) more likely to complete the trial than women, suggesting men are highly motivated once
commencing weight loss.
Overview of types of outcomes reportedQuantitative outcomes
All trials reported either baseline and end weights or changes in weight by sex except for the FDPS,104
which reported incidence of diabetes by sex. Two studies reported waist circumference by sex106,109 and
two reported BMI by sex.106,108 Cardiovascular risk factors were reported by sex in ﬁve trials: two reported
HbA1c,97,108 three reported systolic and diastolic blood pressure,101,106,109 three reported triglycerides106,108,109
and three reported total and HDL cholesterol.106,108,109 LDL cholesterol was reported by Volpe and
colleagues109 and Ross and colleagues106 and fasting plasma glucose was reported by Vanninen
and colleagues108 and Ross and colleagues.106Process outcomes
Hakala96 evaluated inpatient rehabilitation and health centre weight-loss programmes. The only reported
difference by sex was that men in the health centre group were more likely to ﬁnd GP appointments
useful than women (63% of men vs. 23% of women). Both programmes met the expectations of
participants. Participants in the rehabilitation group considered counselling by a nutritionist, physiotherapist
and physician to be necessary and counselling from a social worker to be useful, although 62% wanted
more individual counselling from the nutritionist. The majority (72%) of the rehabilitation participants felt
that the 3-week inpatient period was satisfactory. The remaining 28% felt that it was too short. In
comparison, the majority (72%) of the health centre participants felt the longer 10-week course was too
short and 77% stated that they wanted more individual counselling with a greater emphasis on practical
physical activity and dietary advice. No data were provided by sex for process outcomes.
Similarly, all nurses delivering the 6-week weight reduction programme in the trial by Karvetti and
Hakala101 and the majority (58%) of the participants responding to the evaluation assessment (86%
response rate) felt that the weight-loss programme in this trial was too short. Most nurses suggested that
the programme should be extended to 10 weeks. The programme met the expectations of 66% of the
participants. The only reported difference by sex was that most men (80%) and just under half of the
women (42%) felt that six weight assessments during the intervention year were adequate. The remainder
would have preferred more frequent assessment. Group support was also reported as being important for
successful weight reduction.
Of the GPs participating in the trial conducted by Hakala,96 65% responded to the evaluation exercise.
Only 41% considered their role as a GP to be suitable for the follow-up of obese participants, with 47%
feeling that they were not suitable. Many felt that the task was uninteresting and useless, with only 35%
showing that they were motivated to support participants in their weight reduction efforts. Similarly, the
authors of the Lighten Up trial100 noted that GPs may have less faith in their ability to produce positive
weight change in obese participants. Participants in this trial also noted that difﬁculty arranging regular
appointment times with their general practice contributed to their failure to complete the full programme.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Commercial companies, on the other hand, were able to offer weekly meetings at the same time each
week. Neither trial reported differences by sex.Quality of the evidence
Risk of bias
The risk of bias assessment for the individual trials is shown in Appendix 10 (see Table 58). Figure 11
summarises the assessment.
Five trials99,100,104–106 were judged to have adequate sequence generation but this was unclear for the
majority of trials (14/20, 70%). Only one trial97 was judged as having a high risk for this item. Similarly,
only ﬁve trials97,99,100,104,106 demonstrated successful allocation concealment and were considered at low
risk for selection bias. Richelsen and colleagues105 compared orlistat therapy with placebo for weight
maintenance; therefore, blinding was possible in this trial, although it was unclear whether or not those
administering treatment were blinded to the nature of the interventions and whether participants were
unblinded by gastrointestinal effects or not. Blinding of participants or health-care providers was not
possible for any of the remaining trials. Four trials100,104,107,111 carried out blinding of outcome assessors.
This was unclear for the remaining trials.
In three trials, groups were treated differently apart from the interventions received. For the trial conducted
by Shai and colleagues,107 fewer men in the low-fat diet group participated in the ancillary substudy; in the
DPP trial111 the standard lifestyle group received a placebo tablet whereas the intensive lifestyle group
received no tablet; and in the trial conducted by Wing and colleagues113 the very low-calorie diet group
received physician monitoring, which was not given to the low calorie diet group. Although only four
trials95,96,101,111 were judged as being at high risk of attrition bias because of incomplete outcome data, the
risk of bias for this item was unclear in just under half of all trial reports (9/20; 45%).94,97–99,103,105,108,109,113
Only seven trials94,99,100,104,106,107,110 carried out a full intention-to-treat analysis and for three trials97,98,109 the
method of analysis was unclear. The remaining trials analysed data for trial completers/compliers only.
All trials were considered to be at low risk for selective reporting and only two trials were considered to
be at unclear risk of other bias. Jeffery and colleagues98 enrolled men from a previous weight-loss trial
conducted by the same authors. Gorin and colleagues94 provided free exercise equipment for use in the
home and reimbursed participants in the intervention group for home delivery of grocery items; the control
group received no similar ‘incentives’ or additional reason to feel obligated to complete the trial.0 20 40 60 80 100
Other bias
Selective reporting
Intention-to-treat analysis (attrition bias)
Incomplete outcome data (attrition bias)
Groups treated identically (performance bias)
Blinding of outcome assessment (detection bias)
Blinding of health-care providers (performance bias)
Blinding of participants (performance bias)
Allocation concealment (selection bias)
Sequence generation (selection bias)
Low
High
Unclear
FIGURE 11 Summary of risk of bias assessment of trials included in the systematic review of men and women.
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSAssessment of equity and sustainability
Trial-level results are detailed in Appendix 10 (see Table 59). Figure 12 summarises the equity assessment.
As with our review of men-only RCTs, the majority of equity items were not considered, were unclear or
were not reported by the trial authors. The trials mainly did not report on diversity, sustainability or political
context and did not describe partnerships. The majority of trials included a representative participant
spectrum with the exception of those conducted by Karvetti and Hakala,101 Jeffery and colleagues,98
Volpe and colleagues,109 and Gorin and colleagues,94 but none reported sociodemographic differences
between participants withdrawing or excluded and those continuing. Four trials were considered to
have occurred in settings that could have excluded speciﬁc population groups. The trials conducted by
Jeffery and colleagues98 and Wing and colleagues112 both required ﬁnancial deposits at trial entry, thus
potentially excluding less afﬂuent participants. Similarly, Jeffery and colleagues99 recruited participants
with private health-care insurance only. Shai and colleagues107 conducted their trial in a work setting with
on-site medical clinic facilities. Only two trials100,110 carried out ﬁdelity checks. Three trials reported
adverse harms.100,105,106 As discussed earlier, only three trials evaluated process outcomes.96,100,101 None
of the trial authors were considered to have conﬂicting interests although this was unclear for
ﬁve reports.95,101,103,105,106Assessment of effectiveness
An exercise programme compared with a low-fat reducing diet
Volpe and colleagues109 compared a supervised exercise programme, a low-fat reducing diet, and a
supervised exercise programme plus a low-fat reducing diet. The goal was for participants to lose
0.5–1.0 kg per week, although it is unclear whether this related to the dietary prescription alone or also
took account of the exercise programme. By 12 months the exercise group and the diet group had gained
weight. Men in the exercise group gained more weight than men in the diet group whereas the reverse
was true for women (Figure 13).
At 1 year, all groups showed little difference in changes to waist circumference. All groups showed a large
deterioration in HDL cholesterol and an increase in LDL cholesterol. Similarly, all groups showed increases
in triglycerides, with the exception of men in the diet group in which levels were lowered, although
changes were more modest. Both men and women in the diet group and men in the exercise group0 20 40 60 80 100
Harms/unintended effects
Author conflict
Referred partnerships
Political/organisational context
Sustainability
Providers reported
Process evaluation
Fidelity check
Diversity/disadvantage strategies
PROGRESS categories
Sociodemographic differences
Representativeness
Equity pointer
Yes
No
Unclear/not reported
FIGURE 12 Summary of equity assessment of trials included in the systematic review of men and women.
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSlowered their systolic and diastolic blood pressure, with men showing greater decreases than women. Both
types of blood pressure were raised for women in the exercise group, especially diastolic blood pressure.
The difference in diastolic pressure between women in the diet group and women in the exercise group
was signiﬁcant after 1 year (p = 0.01) (Table 13).A low-fat reducing diet plus an exercise programme compared with a
low-fat reducing diet
In the same trial109 a combination of a low-fat reducing diet and an exercise programme was compared
with the same diet but without the exercise programme. At 12 months, men in the diet and exercise
programme group gained less weight than men in the diet group. The protective effect of diet and
exercise was repeated for the women (Figure 14).
The low-fat reducing diet and exercise programme resulted in modest reductions in waist circumference.
Although both groups showed poorer LDL cholesterol levels, the diet and exercise group showed less
deterioration than the diet group for both sexes. Women in the diet and exercise group and men in both
groups reduced their triglyceride levels, with men in the combined group showing the greatest reduction.
Men in both groups reduced their systolic and diastolic blood pressure with the greatest reduction shown
in the diet and exercise group. Conversely, both diastolic and systolic blood pressure slightly increased in
women in this group, whereas diastolic and systolic blood pressure slightly decreased in women in the diet
group (Table 14).ABLE 13 Calculated mean change in risk factors for the exercise programme and low-fat reducing diet groups
fter 1 year
Outcome
Exercise programme Low-fat reducing diet
Men (n = 17) Women (n = 17) Men (n = 13) Women (n = 15)
Waist circumference (cm) –1.2 –3.9 –0.1 +0.9
Total cholesterol (mmol/l) –0.18 +0.03 +0.01 +0.26
LDL cholesterol (mmol/l) +0.37 +0.15 +0.21 +0.44
HDL cholesterol (mmol/l) –0.18 –0.13 –0.19 –0.24
Triglycerides (mmol/l) +0.07 +0.03 –0.06 +0.01
Systolic blood pressure (mmHg) –14.4 +3.0 –13.3 –1.5
Diastolic blood pressure (mmHg)a –7.9 +6.3a –9.5 –2.6
a Signiﬁcant difference vs. the low-fat reducing diet group (reported p = 0.01).T
aNIHR Journals Library www.journalslibrary.nihr.ac.uk
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ABLE 14 Calculated mean change in risk factors for the low-fat reducing diet plus exercise and the low-fat
educing diet only groups after 1 year
Outcome
Low-fat reducing diet and exercise
programme Low-fat reducing diet
Men (n = 14) Women (n = 14) Men (n = 13) Women (n = 15)
Waist circumference (cm) –1.9 –2.1 –0.1 +0.9
Total cholesterol (mmol/l) –0.04 –0.18 +0.01 +0.26
LDL cholesterol (mmol/l) +0.15 +0.10 +0.21 +0.44
HDL cholesterol (mmol/l) –0.13 –0.23 –0.19 –0.24
Triglycerides (mmol/l) –0.20 –0.16 –0.06 +0.01
Systolic blood pressure (mmHg) –15.6 +2.1 –13.3 –1.5
Diastolic blood pressure (mmHg) –12.3 +1.2 –9.5 –2.6
88
SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALST
rA low-fat reducing diet plus an exercise programme compared
with an exercise programme
The trial by Volpe and colleagues109 also compared diet plus exercise with exercise alone. The addition of a
diet to exercise again provided greater beneﬁts than exercise alone in terms of less weight gain for both
sexes, although the difference was statistically signiﬁcant for men only (p = 0.04) (Figure 15).
Modest reductions in waist circumference were also found for this comparison. LDL cholesterol levels in all
groups worsened. The decrease in triglyceride levels for the diet and exercise group was not repeated in
the exercise group, with both sexes showing increased levels. The combination of both diet and exercise
produced the greatest reduction for this outcome. Again, only men beneﬁted from a reduction in systolic
and diastolic blood pressure, with the greatest reduction occurring in the combined intervention group.
Both diastolic and systolic pressure were raised in women in both groups at 1 year (Table 15).NIHR Journals Library www.journalslibrary.nihr.ac.uk
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ABLE 15 Calculated mean change in risk factors for the low-fat reducing diet plus exercise and the exercise-only
roups after 1 year
Outcome
Low-fat reducing diet and exercise
programme Exercise programme
Men (n = 14) Women (n = 14) Men (n = 17) Women (n = 17)
Waist circumference (cm) –1.9 –2.1 –1.2 –3.9
Total cholesterol (mmol/l) –0.04 –0.18 –0.18 +0.03
LDL cholesterol (mmol/l) +0.15 +0.10 +0.37 +0.15
HDL cholesterol (mmol/l) –0.13 –0.23 –0.18 –0.13
Triglycerides (mmol/l) –0.20 –0.16 +0.07 +0.03
Systolic blood pressure (mmHg) –15.6 +2.1 –14.4 +3.0
Diastolic blood pressure (mmHg) –12.3 +1.2 –7.9 +6.3
90
SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALST
gA low-fat reducing diet with exercise advice compared with control
Vanninen and colleagues108 investigated a low-fat reducing diet and exercise advice compared with basic
conventional educational materials only. Details of the exact dietary prescription were not provided. All
participants in this trial were non-insulin-dependent type 2 diabetics. After 1 year men in the intervention
group had lost signiﬁcantly more weight than men in the control group (p = 0.04). Women in the
intervention group also lost more weight than women in the control group although the difference was
not signiﬁcant (Figure 16). It should be noted that women had a higher mean BMI than men at
baseline (34.2 and 33.4 kg/m2 for women vs. 30.1 and 31.1 kg/m2 for men for the control and intervention
groups respectively).
Men in the intervention group showed a greater improvement in total cholesterol, triglyceride and HbA1c
levels than men in the control group, although the control group had a greater improvement in HDL
cholesterol levels. Fasting plasma glucose levels increased for both groups of men but the control group
saw the greatest increase. No signiﬁcant differences between groups were reported for men (Table 16).
Women in the intervention group showed greater improvements than women in the control group for
total cholesterol and triglycerides and also for HDL cholesterol. The control group showed a greater
decrease in fasting plasma glucose levels, but the improvement in HbA1c was the same in both women’s
groups. However, women in the control group had higher HbA1c and fasting plasma glucose levels than
women in the intensiﬁed diet and exercise group at baseline (see Table 16). In a later report,125 the authors
report a continuing reduction in BMI for the intervention groups at 15 months, with some reduction also
seen in the control groups.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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ABLE 16 Calculated mean change in risk factors from baseline in the low-fat reducing diet and exercise advice and
ontrol groups after 1 year
Outcome
Time
(months)
Low-fat reducing diet
and exercise advice Control
Men
(n = 21)
Women
(n = 17)
Men
(n = 24)
Women
(n = 16)
Total cholesterol (mmol/l) 12 –0.3 0 +0.1 +0.2
HDL cholesterol (mmol/l) 12 +0.11 +0.12 +0.4 +0.04
Triglycerides (mmol/l) 12 –0.9 –0.1 0 +0.2
HbA1c (%) 12 –0.1 –0.9 +0.1 –0.9
Fasting plasma glucose (mmol/l) 12 +0.1 –0.6 +0.6 –1.3
SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALST
c92Diabetes incidence
The FDPS104 included participants at high risk of developing type 2 diabetes based on a classiﬁcation of
being overweight and having impaired glucose tolerance. Participants were randomised to receive an
individually tailored low-fat reducing diet plus an exercise programme to achieve 5% weight loss or to
receive general advice. After a median follow-up period of 4 years, the active intervention group showed
favourable results in reducing the incidence of diabetes. The incidence rate was 8.6 (95% CI 5.8 to 12.6)
per 100 person-years for men in the control group compared with 3.7 (95% CI 2.2 to 6.2) per 100
person-years in the intervention group. For women the incidence rate was 6.9 (95% CI 5.2 to 9.2) in the
control group and 4.3 (95% CI 3.0 to 6.2) in the intervention group. The hazard ratio for diabetes
incidence was 0.43 (95% CI 0.22 to 0.81) for men and 0.61 (95% CI 0.39 to 0.97) for women, with no
statistically signiﬁcant interaction between sex and intervention. Other risk factors were not reported by
sex in this study.A low-fat reducing diet plus behavioural therapy compared with control
Karvetti and Hakala101 investigated a low-fat reducing diet plus behavioural therapy delivered in the
primary health-care setting. The dietary prescription of 1200 kcal per day for weight reduction and
1800 kcal per day for maintenance was not reported to differ by sex. Participants in the
intervention group were supported by public health nurses with three lectures from a physician,
a psychologist and a physiotherapist. Participants were also given encouragement and support.
The control group received no instruction and was contacted for yearly assessment only. After 1 year both
men (–11.80 kg, 95% CI –16.86 to –6.74 kg) and women (–5.60 kg, 95% CI –8.74 to –4.57 kg) in the
intervention group had lost signiﬁcantly more weight than men and women in the control group
respectively (Figure 17).
Women in the intervention group showed a signiﬁcant reduction in systolic blood pressure compared with
women in the control group (reported p < 0.05) (Table 17). No other changes in risk factors were reported
as being statistically signiﬁcant between groups according to sex.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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ABLE 17 Calculated mean change in risk factors from baseline in the diet and behavioural therapy and control
roups after 1 year
Outcome
Diet and behavioural therapy Control
Men (n = 22) Women (n = 71) Men (n = 20) Women (n = 76)
Total cholesterol (mmol/l) +0.2 +0.2 +0.2 +0.3
HDL cholesterol (mmol/l) +0.25 +0.18 +0.02 +0.04
Systolic blood pressure (mmHg) 0 –6.00a –1.00 0
Diastolic blood pressure (mmHg) –7.00 –6.00 –5.00 –3.00
a Signiﬁcant difference vs. the control group (reported p < 0.05).
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gA low-fat reducing diet plus exercise advice, behavioural therapy and
home environment modification compared with a low-fat reducing
diet plus exercise advice and behavioural therapy only
The trial by Gorin and colleagues94 randomised overweight and obese participants and an overweight
household member, willing to act as a support partner, to a low-fat reducing diet with exercise advice
and behavioural therapy or to the same treatment package but with modiﬁcations made to the home
environment. Only participants received treatment in the standard programme whereas both participants
and partners received treatment in the modiﬁed programme. Most participant–partner pairs were spouses
or signiﬁcant others (77.2%), with the remainder being participant–adult child (17.4%), participant–other
relative (3.0%) and participant–roommate (2.5%) pairings. Modiﬁcations targeted physical and social
cues in the home. At 18 months, women in the modiﬁed programme lost signiﬁcantly more weight than
women in the standard programme [–8.1 kg (SD 1.1 kg) vs. –4.2 kg (SD 1.1 kg), reported p = 0.014].
However, men in the standard programme lost more weight than men in the modiﬁed programme
[–10.0 kg (SD 2.3 kg) vs. –4.6 kg (SD 2.2 kg)] although differences were not signiﬁcant (reported
p = 0.065). Partners in the modiﬁed programme lost more weight than partners in the standard
programme at 18 months, regardless of sex. The authors reported that sex did not moderate weight
regain for participants or partners, with men and women in both groups regaining weight at
equivalent rates.A low-fat reducing diet plus an exercise programme and behavioural therapy
Wing and colleagues112 randomised obese type 2 diabetic participants to receive a behavioural weight-loss
programme either with their obese spouse (together) or without their spouse (alone). All participants
received behavioural therapy consisting of stimulus control, problem solving, assertion, goal setting and
cognitive techniques. Participants were also advised to monitor calorie intake to between 1200 and
1500 kcal per day and to set stepwise goals for walking. Participants in the together group attended
with their spouses and both were targeted for weight loss. Participants in the alone group attended by
themselves with spouses attending assessment sessions only. The weight loss of participants treated alone
and together was not signiﬁcantly different after 1 year, although men lost more weight when treated
alone whereas women did better when treated together (Table 18). There was no evidence that marital
satisfaction affected weight loss. Spouses of both sexes lost more weight in the together group than in
the alone group (p < 0.05) but there were no differences between treatment groups for change in calorie
intake or exercise.NIHR Journals Library www.journalslibrary.nihr.ac.uk
ABLE 18 Effect of a behavioural weight-loss programme with/without spouse attendance on weight change
t 1 year
Outcome
Together Alone
Men (n = 8) Women (n = 12) Men (n = 10) Women (n = 13)
Weight loss at 1 year (kg) –1.25 –5.89 –7.25 –2.26
Note: Spouse weight-loss data not available by sex.
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35T
aThe Look AHEAD study110 recruited overweight or obese type 2 diabetics to a trial comparing an intensive
lifestyle intervention comprising a low-fat reducing diet, some meal replacements and exercise advice and
intensive behavioural therapy with diabetes support and education. The intensive lifestyle intervention was
designed to produce a minimum weight loss of 7% of initial body weight during the ﬁrst year, with dietary
instructions tailored to initial body weight.
Wadden and colleagues110 reported weight data by sex for the active intervention group. The men in this
group consistently lost more weight than the women at each annual assessment up to 4 years’ follow-up
(Table 19). The prescribed calorie intake was based on weight but it is not clear whether or not the calorie
intake also took account of sex. Attendance and treatment contacts were similar for men and women in
the ﬁrst 4 years.Effect on body image of a low-fat reducing diet with exercise advice
and behavioural therapy compared with control
Several ancillary studies have reported sex effects in the Look AHEAD study. Stewart and colleagues123
investigated changes in body image in men and women. The authors recruited participants from one
centre (Pennington Biomedical Research Centre, Los Angeles, CA, USA) and reported weight data by sex
for both groups at 1 year. Women in this study had a higher baseline BMI than men in both treatment
groups. Women in the intervention group had a slightly higher discrepancy between their current and their
ideal body size (body dissatisfaction) than men (20.9 vs. 19.6), whereas men in the control group were
slightly more dissatisﬁed than women with their body size (20.0 vs. 19.0). Both men and women in the
intervention group lost signiﬁcantly more weight than men and women in the control group respectively
(reported p < 0.001) (Figure 18). Both men and women in the intervention group showed a signiﬁcant
reduction in body image dissatisfaction compared with the control group after 1 year (p < 0.05 and
p < 0.01 respectively). Men in both the intervention group and the control group showed a greater
reduction in dissatisfaction than women [–8.1 (standard error 1.59) vs. –6.3 (standard error 0.94) for the
intervention group and –3.3 (standard error 1.66) vs. –2.3 (standard error 0.96) for the control group].TABLE 19 Mean weight change (kg) for an intensive lifestyle intervention by sex
Follow-up period (year) Men (n = 1044) Women (n = 1526)
1 –9.3 –8.1
2 –7.1 –5.9
3 –5.9 –4.6
4 –5.2 –4.4
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Effect on bone mineral density of a low-fat reducing diet with exercise
advice and behavioural therapy compared with control
In a separate substudy Schwartz and colleagues124 investigated the effect of the weight-loss intervention
on bone mineral density in participants from ﬁve of the Look AHEAD centres. Hip, spine and whole-body
dual-energy X-ray absorptiometry scans were obtained for 237 men and 405 women in the intervention
group and 246 men and 386 women in the control group. After 1 year, at the total hip the difference in
bone loss between the two treatment groups was signiﬁcantly greater for men (–1.48% intervention vs.
0.02% control) than for women (–1.44% intervention vs. –0.61% control, p = 0.04). The authors reported
that there was no evidence of an interaction by sex at the other bone sites.Effect on erectile dysfunction of a low-fat reducing dietwith exercise
advice and behavioural therapy compared with control
Wing and colleagues122 investigated the effect of weight loss on erectile function. Men with erectile
dysfunction (n = 153 in the intervention group and n = 150 in the control group) were recruited from ﬁve
of the 16 Look AHEAD centres. Sexual function was evaluated by self-reported completion of the IIEF.126
The IIEF is a validated scale of erectile function, with ﬁve domains, with scores ≤ 10 denoting severe
dysfunction, scores of 11–21 denoting moderate dysfunction, scores of 22–25 indicating mild dysfunction
and scores ≥ 26 indicating no dysfunction. After 1 year men in the intervention group showed a greater
weight change than men in the control group (Figure 19).
After adjusting for baseline differences in erectile function score, the authors reported an increase
(improvement) in erectile function of 1.3 (SD 4.7) with the intensive lifestyle intervention at 1 year
and 0.03 (SD 5.7) in the control group at 1 year (reported p = 0.06).
Using the cut-off values of ≤ 21 and ≥ 22 to denote worsening or improvement in erectile function,
respectively, the greater weight loss achieved by the intervention group did not produce a signiﬁcantly
greater improvement in erectile function in men with moderate or severe dysfunction compared with the
control group. For mild or no dysfunction, signiﬁcantly fewer men in the intervention group than in
the control group reported worsening of function (reported p < 0.001). The intervention group also
showed signiﬁcantly greater changes in HbA1c, systolic and diastolic blood pressure and HDL cholesterol
(all reported p≤ 0.01) (Table 20).Effect on spouses of a low-fat reducing diet with exercise advice and
behavioural therapy
Gorin and colleagues121 assessed the impact of the intervention and control treatments on the untreated
spouses of the Look AHEAD participants from three sites. There were no speciﬁc eligibility requirements for
spouses other than a willingness to participate in the research. Spouses were not formally involved in either
treatment group and were not expected to attend group meetings. Participants in the active intervention
group were taught ways to enhance social support to promote their weight-loss efforts (e.g. how to
communicate assertively with family members about desired food modiﬁcations). Participants in the control
group received no such training. As in the full trial, intensive lifestyle participants lost more weight than
control participants during the ﬁrst year [–9.9 kg (SD 7.6 kg) vs. –1.2 kg (SD 4.9 kg), reported p < 0.001].
After 1 year, spouses of the intensive lifestyle participants had a weight change of –2.4 kg (SD 4.5 kg)
compared with –0.2 kg (SD 3.3 kg) for spouses of control participants. The authors reported no effect by
sex or baseline weight of the spouse.97
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Robertson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
St
u
d
y 
o
r 
su
b
g
ro
u
p
W
in
g
 2
01
01
22
To
ta
l (
95
%
 C
I)
H
et
er
o
g
en
ei
ty
: n
o
t 
ap
p
lic
ab
le
Te
st
 f
o
r 
o
ve
ra
ll 
ef
fe
ct
: z
 =
 1
2.
32
 (
 p
 <
 0
.0
00
01
)
M
ea
n
– 1
1.
1
SD 9.
4
To
ta
l
15
3
15
3
M
ea
n
– 0
.7
SD 4.
5
To
ta
l
15
0
15
0
W
ei
g
h
t
10
0.
0%
10
0.
0%
– 1
0.
40
 (
– 1
2.
05
 t
o
 –
 8
.7
5)
–  1
0.
40
 (
– 1
2.
05
 t
o
 –
 8
.7
5)
D
ie
t 
w
it
h
 e
xe
rc
is
e 
an
d
 B
T
C
o
n
tr
o
l
M
ea
n
 d
if
fe
re
n
ce
IV
, fi
xe
d
, 9
5%
 C
I
M
ea
n
 d
if
fe
re
n
ce
IV
, fi
xe
d
, 9
5%
 C
I –
 2
0
– 1
0
0
10
20
Fa
vo
u
rs
 in
te
rv
en
ti
o
n
Fa
vo
u
rs
 c
o
n
tr
o
l
FI
G
U
R
E
19
Ef
fe
ct
o
f
a
lo
w
-f
at
re
d
u
ci
n
g
d
ie
t
w
it
h
ex
er
ci
se
ad
vi
ce
an
d
b
eh
av
io
u
ra
l
th
er
ap
y
vs
.
co
n
tr
o
l
o
n
w
ei
g
h
t
ch
an
g
e
(k
g
)
in
m
en
w
it
h
er
ec
ti
le
d
ys
fu
n
ct
io
n
.
98
NIHR Journals Library www.journalslibrary.nihr.ac.uk
SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALS
TABLE 20 Mean change in risk factors from baseline in the diet and exercise with behavioural therapy and control
groups after 1 year (men only)
Outcome
Diet and exercise with
behavioural therapy (n = 153) Control (n = 153)
Total cholesterol (mmol/l) –0.26 (n = 148) –0.22 (n = 144)
LDL cholesterol (mmol/l) –0.18 (n = 148) –0.14 (n = 144)
HDL cholesterol (mmol/l)a 0.09 (n = 148) –0.03 (n = 144)
Systolic blood pressure (mmHg)a –7.5 (SD 16.3) –1.5 (SD 14.9) (n = 150)
Diastolic blood pressure (mmHg)a –4.7 (SD 7.9) –1.0 (SD 7.6) (n = 150
HbA1c (%)
a
–0.7 (SD 1.0) –0.3 (SD 1.1) (n = 150)
a Between-group signiﬁcance reported as p≤ 0.01.
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35A low-fat reducing diet with an exercise programme and behavioural therapy
compared with placebo
The DPP111 randomised individuals at high risk of diabetes to an intensive low-fat reducing diet with an
exercise programme and behavioural therapy, metformin or placebo. For the purposes of this review, we
present data for the intensive intervention and placebo groups only. The aim of the intensive lifestyle
programme was to lose 7% of initial body weight and maintain this weight loss throughout the trial. The
calorie goals were calculated based on initial weight loss and a deﬁcit of 500–1000 kcal per day, together
with an increase in physical activity equivalent to 700 kcal per week. By 30 months, both sexes had lost
more weight in the intensive group than in the placebo group (reported p < 0.001).
The authors reported that, within the lifestyle treatment group, black women lost signiﬁcantly less weight
than all other race–sex groups (reported p < 0.01) with the exception of black men (Table 21). A higher
proportion of women than men were obese at baseline (74% vs. 59%) and a higher proportion of black
people than Hispanic and white people were obese at baseline (74% vs. 67% and 68% respectively).
Comparisons of different types of diet
Shai and colleagues107 investigated the effectiveness of a low-fat reducing diet (1500 kcal per day for
women, 1800 kcal per day for men), a Mediterranean diet with equivalent calories and a low carbohydrate
(20 g per day initially increasing to 120 g per day) non-restricted calorie diet in the Dietary Intervention
Randomized Controlled Trial (DIRECT). At the end of the 2-year trial, the only signiﬁcant difference was for
women in the Mediterranean reducing diet group, who lost signiﬁcantly more weight than women in the
low-fat reducing diet group (p = 0.01) (Figures 20–22).
Effect on Dietary Intervention Randomized Controlled Trial wives
Golan and colleagues120 conducted a parallel study describing the effect of the DIRECT dietary
interventions on 74 wives of men participating in the trial. The wives were not randomised to any
treatment group but were invited to attend the 90-minute support group meetings held every 2 months
for the DIRECT participants. The aim of the meetings was to update the wives about the principles of the
diet strategy to which their husbands had been randomised rather than treating the wives directly. At the
end of the trial, men whose wives had attended support meetings lost more weight than men who did
not have spousal support, both as an entire group and within each diet group (Figure 23).
Golan and colleagues120 investigated whether or not the intervention had any indirect inﬂuence on the
DIRECT wives, termed ‘halo’ effects by the authors (Figures 24–26). Differences in weight loss between
groups were statistically signiﬁcant between the low-carbohydrate diet and low-fat reducing diet groups
only (reported p < 0.05).99
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Wing and colleagues113 compared an intermittent very low-calorie diet (400–500 kcal per day) with a
low-calorie, low-fat diet (1000–1200 kcal per day) in a 1-year trial including participants with type 2
diabetes. Both groups also received behavioural therapy and exercise advice and deposited US$150, which
was refunded depending on compliance. Women in the very low-calorie diet group lost signiﬁcantly more
weight after 1 year than women in the low-calorie, low-fat diet group (14.1 kg vs. 8.6 kg, reported
p < 0.023) whereas men showed comparable weight loss in both treatment groups (15.4 kg and
15.5 kg respectively).An on-demand diet compared with a regularly repeated diet
After 16 weeks of a 450 kcal per day diet, Lantz and colleagues103 randomised participants to receive
either an on-demand very low-calorie diet (450 kcal per day) or a regularly repeated diet. After the initial
16 weeks, participants in the intermittent on-demand group followed a 500 kcal per day deﬁcit diet but
changed to the 450 kcal per day diet when their individual body weight reached a predetermined cut-off
level throughout the trial period. Participants in the regularly repeated group followed the same 500 kcal
per day deﬁcit diet but used the 450 kcal per day diet for a fortnight every third month.
At 2 years, men in the on-demand intermittent diet group showed signiﬁcantly more weight change than
men in the regularly repeated diet group (mean difference –10.50 kg, 95% CI –4.84 to –16.16 kg). There
was no signiﬁcant difference in weight loss between diets for women (mean difference 1.80 kg, 95% CI
5.23 to –1.63 kg) (Figure 27).
Types of behaviour change for weight loss
Heitzmann and colleagues97 randomised participants with type 2 diabetes to a behavioural, cognitive or
cognitive–behavioural therapy or a control group, who received muscle relaxation training and factual
diabetes information only. Participants in all groups received dietary advice from a registered nutritionist
and were given individual exercise advice. At 18 months across all intervention groups, it was reported that
men lost an average of 3.63 kg whereas women gained an average of 0.04 kg (Table 22). That men may
beneﬁt more from weight reduction programmes than women was shown by a borderline signiﬁcant
interaction (reported p = 0.057). Men also experienced a signiﬁcantly greater reduction in HbA1c than
women (reported p < 0.05) but this difference was not signiﬁcant between experimental groups. The
effects of the individual programmes by sex were not reported.105
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Robertson et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
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TABLE 22 Weight change (kg) for men and women in the behaviour change intervention groups and the control
group at 18 months
Intervention Men (n = 22 for all groups) Women (n = 24 for all groups)
Control +0.6 +1.4
Behavioural –4.2 –0.7
Cognitive –2.5 –1.5
Cognitive–behavioural –0.7 –2.0
Note: Data derived from graph format.
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35An intensive inpatient rehabilitation setting compared with a
community setting
Hakala and colleagues95,96 investigated the effectiveness of an intervention carried out in an initial inpatient
rehabilitation setting compared with an intervention carried out in a community setting for people who
were at least 50% overweight. The rehabilitation intervention included intensive behavioural and
educational group sessions along with a prescribed physical activity programme and occupational therapy,
as well as individual nutritionist (1200 kcal per day) and physician counselling. The community intervention
involved the same dietary intervention but included either individual physician counselling95 or group-based
counselling delivered in the health centre setting.96
In the earlier trial,95 men did better in the community setting than in the inpatient setting, possibly because
of more individual counselling, although differences were statistically signiﬁcant only for years 1 and 2
(p < 0.01). There were no signiﬁcant differences between groups for women (Figure 28).
In the later trial by Hakala and colleagues,96 a similar comparison was carried out between an intervention
in an initial intensive inpatient rehabilitation setting and an intervention in a community setting, delivered
in group format only. When both rehabilitation and community interventions were delivered to men in
groups, the rehabilitation setting produced favourable results, although differences were again statistically
signiﬁcant only over the ﬁrst 2 years (p = 0.02 and p = 0.04 respectively). For women, the rehabilitation
setting produced no signiﬁcant beneﬁt in weight loss over the community intervention for any time point
from 1 to 5 years (Figure 29).107
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSType of provider and tailoring for dietary interventionA tailored nurse intervention compared with a doctor-provided
leaflet for weight loss
Korhonen and colleagues102 randomised type 2 diabetic patients to receive care from either a doctor or a
specialist nurse to investigate the effect of provider and individual tailoring of a diet and weight reduction
intervention on achievement of weight loss. Participants randomised to the care of a doctor were given
general concise written information on diet and weight reduction with no further instruction thereafter.
Participants randomised to the care of the nurse were given individual assessments and tailored dietary
instruction. Nurse interventions were repeated at follow-up visits. At 12 months there were no signiﬁcant
differences between groups for either sex for weight change (Figure 30).
Commercial providers compared with NHS providers
The Lighten Up trial100 randomised participants to one of three weight-loss programmes run by commercial
companies (Weight Watchers, Slimming World and Rosemary Conley) or to one of three programmes
delivered through the NHS (NHS Size Down, a GP or a pharmacist) or to a choice group in which they
were able to choose one of the six programmes depending on their preference. For the control group
(minimal interventional) participants received vouchers for 12 free sessions at a council-run leisure centre.
All programmes lasted for 12 weeks and provided advice on exercise, but only the Rosemary Conley group
had an exercise class provided. The Weight Watchers and Rosemary Conley programmes tailor advice by
sex. The investigators did label some of the commercial groups as ‘male friendly’ so that men would know
that they would not be the only ones present. For the Rosemary Conley programme, a group walk was
available for people who did not want to undertake the group exercise. Women were more likely to
choose a commercial provider than men (81% vs. 47%). Men in the choice arm were more likely to
choose a NHS programme.
Statistically signiﬁcant weight loss at 1 year from baseline was found for all groups except for the general
practice and pharmacy groups (complete case analysis, baseline observation carried forward and last
observation carried forward). Only the Weight Watchers group was signiﬁcantly different from the control
group for men and women combined (adjusted mean difference –2.49 kg, 95% CI –4.15 kg to –0.83 kg).
The authors found no statistically signiﬁcant interaction between sex and weight-loss programme.
Further data supplied by the authors show signiﬁcant weight loss from baseline for women in the choice,
NHS Size Down, Rosemary Conley, Slimming World, Weight Watchers and control groups, for all methods
of analysis. For men, the NHS Size Down, Rosemary Conley and Weight Watchers programmes produced
signiﬁcant weight loss from baseline for all analyses. For men, the control and Slimming World
programmes also produced signiﬁcant weight loss from baseline, but only in the last observation carried
forward analysis (Table 23).
Telephone compared with mail advice and behaviour change techniques
Jeffery and colleagues99 compared the effectiveness of an intervention including weight reduction advice,
physical activity advice and behaviour change techniques delivered by telephone or mail. A control group
received usual care. Details of the dietary and exercise advice are unclear. Men in both the telephone
group and the mail group had lost signiﬁcantly more weight at 1 year than men in the control group
(p = 0.03). By contrast, there were no signiﬁcant differences between women in the telephone or mail
group and women in the control group. There were no signiﬁcant differences for either sex for the
telephone group or the mail group (Figures 31–33).NIHR Journals Library www.journalslibrary.nihr.ac.uk
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Physical activity advice, a healthy diet and behavioural therapy
compared with usual care
The Prevention and Reduction of Obesity Through Active Living (PROACTIVE) trial106 randomised
abdominally obese participants to receive an intervention offering physical activity and behavioural therapy
or to usual care. Participants in the intervention group received individually tailored counselling based on
motivational interviewing to provide the knowledge and skills to increase physical activity and adopt a
healthy diet and eating patterns. Calorie reduction was not explicitly mentioned. Participants receiving
usual care were given lifestyle advice for reducing obesity from their primary care physician following the
usual appointment schedule and counselling approach. After 2 years, men in the intervention group had
lost signiﬁcantly more weight and signiﬁcantly reduced their BMI and waist circumference compared with
men in the usual care group. Women in the intervention group signiﬁcantly reduced their waist
circumference compared with women in the usual care group after 1 year but the effect was lost by
2 years. There were no other signiﬁcant differences between groups (Figure 34 and Table 24).
Varying monetary contracts for weight loss
Jeffery and colleagues98 investigated the effect of ﬁnancial contracts on weight loss and weight
maintenance in men and women recruited from a previously identiﬁed population or people self-referred
through newspaper advertisements. All participants paid a US$150 deposit at the start of a 16-week
weight-loss phase consisting of nutrition, exercise and behaviour change technique education sessions.
Details of the dietary and exercise advice are unclear but the aim was to lose 2 lb (0.9 kg) per week.
Participants randomised to the control groups were refunded their entire deposit at the initial session.
Participants in the constant contract groups were refunded $30 for each successive group average weight
loss of 5 lb (2.27 kg) and participants in the increasing contract groups were refunded US$5, US$10,
US$20, US$40 and US$75 for successive 5-lb group weight losses. Following the weight-loss phase,
17 men and 25 women were randomised to receive either intensive or non-speciﬁc
weight-maintenance sessions.
Those enrolling in the maintenance phase paid a US$100 deposit, which was returned in US$25
increments for attendance at quarterly group sessions. Those not enrolling in the maintenance phase were
contacted at the 1-year follow-up assessment only. Table 25 details the weight loss for all participants at
1 year. Eleven participants gave a self-reported weight at this assessment. The trial authors added 5 lb to
these weights for their analyses. Two participants who were lost to follow-up were recorded as having lost
0 lb and three participants were excluded from the analyses.
The authors reported that weight loss at 1 year was not statistically associated with recruitment source,
contract type or sex. Analysis of percentage change in weight showed that women lost signiﬁcantly more
weight than men (reported p < 0.05). During weight maintenance it was reported that the only signiﬁcant
effect was for women in the intensive maintenance condition who outperformed men for this contract
type (reported p < 0.006).115
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TABLE 24 Mean change in risk factors and adverse events in the physical activity advice, healthy diet and
behavioural therapy group and the usual care group by sex (denominators unclear)
Outcome Sex Follow-up
Healthy diet,
physical activity and
behavioural therapy Usual care
BMI (kg/m2) Men 1 year –0.72 –0.23
18 months –0.50 +0.04
2 yearsa –0.56 +0.12
Women 1 year –0.93 –0.34
18 months –0.73 –0.49
2 years –0.50 –0.45
Waist circumference (cm) Men 1 year –2.9 –1.3
18 months –2.2 –0.5
2 yearsb –1.6 +0.1
Women 1 yearc –2.4 –0.8
18 months –1.6 –0.4
2 years –0.6 +0.3
Total cholesterol (mmol/l) Men 1 year –0.08 –0.13
18 months –0.14 –0.10
2 years –0.29 –0.24
Women 1 year +0.31 –0.11
18 months –0.28 –0.14
2 years +0.35 –0.30
HDL cholesterol (mmol/l) Men 1 year –0.06 –0.07
18 months –0.09 –0.13
2 years –0.20 –0.19
Women 1 year –0.14 –0.13
18 months –0.19 –0.18
2 years –0.27 –0.25
LDL cholesterol (mmol/l) Men 1 year +0.15 –0.004
18 months +0.13 +0.07
2 years +0.08 +0.03
Women 1 year –0.10 +0.07
18 months –0.01 +0.12
2 years +0.02 +0.04
Triglycerides (mmol/l) Men 1 year –0.38 –0.15
18 months –0.38 –0.13
2 years –0.35 –0.20
continued
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TABLE 24 Mean change in risk factors and adverse events in the physical activity advice, healthy diet and
behavioural therapy group and the usual care group by sex (denominators unclear) (continued )
Outcome Sex Follow-up
Healthy diet,
physical activity and
behavioural therapy Usual care
Women 1 year –0.17 –0.08
18 months –0.17 –0.16
2 years –0.19 –0.19
Systolic blood pressure (mmHg) Men 1 year –2.92 –3.46
18 months –0.99 –1.06
2 years –1.69 –0.31
Women 1 year –2.39 –1.43
18 months –0.89 –2.67
2 years –0.01 –0.70
Diastolic blood pressure (mmHg) Men 1 year –2.98 –2.53
18 months –1.81 –2.27
2 years –2.26 –0.88
Women 1 year –1.63 –1.02
18 months –1.32 –1.77
2 years –0.71 –0.61
Fasting plasma glucose (mmol/l) Men 1 year –0.12 +0.11
18 months +0.27 +0.05
2 years +0.07 +0.23
Women 1 year –0.06 +0.09
18 months +0.05 +0.22
2 years +0.09 +0.22
No. of musculoskeletal
adverse events
Men Total 96 96
Requiring physician visit 51 50
Requiring hospitalisation 2 2
Women Total 204 215
Requiring physician visit 124 110
Requiring hospitalisation 3 10
No. of potential cardiovascular
adverse events
Men Total 46 39
Requiring physician visit 36 29
Requiring hospitalisation 7 9
Women Total 69 98
Requiring physician visit 40 54
Requiring hospitalisation 2 9
a Between-group difference signiﬁcant at 2 years (reported p = 0.01).
b Between-group difference signiﬁcant at 2 years (reported p = 0.049).
c Between-group difference signiﬁcant at 1 year (reported p = 0.01).
118
NIHR Journals Library www.journalslibrary.nihr.ac.uk
SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALS
ABLE 25 Effect of ﬁnancial contracts on mean weight change after 1 year in a self-referred and population
ample of men and women
Sample Weight change (kg) n
Self-referred
Control Men –4.27 10
Women –9.21 9
Constant contract Men –4.44 7
Women –8.24 10
Increasing contract Men –6.63 11
Women –4.30 10
Population
Control Men –2.82 10
Women –2.71 11
Constant contract Men –5.43 9
Women –3.87 9
Increasing contract Men –8.93 8
Women –9.54 9
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35T
sOrlistat compared with placebo for weight maintenance
Richelsen and colleagues105 investigated the effect of orlistat in people with type 2 diabetes, impaired
fasting glucose or dyslipidaemia. Before randomisation, participants all initially lost at least 5% of their
body weight by following a very low-calorie diet of 600–800 kcal per day over an 8-week period.
Participants were then randomised to receive lifestyle counselling with either 120 mg of orlistat three times
daily or matching placebo capsules. Weight change from the start of the diet to 3 years, analysed using
the last observation carried forward for dropouts, was reported as signiﬁcantly greater for women in the
orlistat group than for women in the placebo group [–9.7 kg (–8.4%) vs. –6.3 kg (–5.3%), p < 0.02].
For men the difference between groups was not signiﬁcant [orlistat vs. placebo: –8.9 kg (–8.3%)
vs. –8.1 kg (–7.5%)].Comparison between weight loss in men and weight loss in© Queen’s Printer and Controller of HMSO 2014. This work was produced by Robertson et al. under the terms of a commissioning contract issued by the
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in profe
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reprodu
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of S
Park, Southampton SO16 7NS, UK.women across trials
For the analysis comparing weight loss between men and women a total of 11 studies had data
available,95,96,98,101,102,106,108–112 including a total of 5519 participants, 3493 women and 2026 men. Two
analyses were carried out comparing mean weight change and percentage weight loss between men and
women. Both analyses show that there were no signiﬁcant differences in weight change between men
and women recruited to these studies (Figures 35 and 36). However, few studies provided sufﬁcient data
to allow us to be sure that men and women were prescribed the same calorie deﬁcit. Whether men or
women adhere better to lifestyle prescription is unclear.119
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Discussion of the results from the review of trials with data for
men and women
We identiﬁed a modest number of trials reporting outcomes by sex, the majority of which recruited many
more women than men. The variety of different interventions, and the small size of many of the studies,
mean that conclusions about the best study design for men, and whether or not services should be
different for men and women, can only be tentative. Few of the trials considered truly comparable
interventions and, in most cases, data were unsuitable for pooling in a formal meta-analysis.
Our analyses of weight loss showed no signiﬁcant differences between men and women, although it
should be noted that this was based on only a handful of trials. Dietary and physical activity prescriptions
were rarely described well, with little evidence of allowances made for the greater body size and muscle
mass of obese men. Authors often did not report baseline weight or BMI by sex, reporting only weight
change data between the sexes at varying time points. This makes comparisons between men and women
problematic as men tend to be heavier with proportionately greater muscle mass than women and will
therefore lose more weight than women if prescribed the same calorie intake and if adherence is similar.
Only the DIRECT trial107 reported a more generous calorie allowance for men than for women with the
Look AHEAD trial110 reporting a 1200–1800 kcal per day diet depending on initial body weight. Similarly,
the Weight Watchers and Rosemary Conley programmes also take account of body size and sex for
calorie allowances.
From our results it is possible to conclude that interventions encompassing both diet and exercise
components are more successful in achieving weight loss and preventing weight gain than interventions
including diet or exercise only.109 Men outperformed women when they had to reduce their calorie intake
in response to body weight cues rather than following a very low-calorie diet at regular intervals.103
Regulating calorie intake by responding to one’s own body may offer a greater sense of personal control
over weight loss, which could be more important to men than to women. This could partly be explained
by evidence suggesting that physical vulnerability or health issues are often a key motivator for men,44 and
so evidence of increased body weight acted as a better motivator for the men in this trial. Alternatively, it
could be that this form of weight regulation was seen as less regimented or imposing by the men and was
therefore favoured because of the tendency for men to be reluctant to follow formal diet plans.44
There was no clear evidence that type of diet inﬂuenced long-term weight loss in men.107,113
Men have beneﬁted from training in behaviour change techniques alongside diet and physical activity
interventions.97,99,101,102,110,111 Although men performed well in terms of weight loss in group
settings,96,98,100,101,110 more favourable results were produced when individual support or tailored advice
was delivered to men as well as the group intervention. This personalising of the intervention could be
more important for men than for women.95,99,106 This may also offer men a greater sense of personal
control or men may have greater educational needs in terms of weight-loss reduction techniques than
women. Results from the Look AHEAD trial110 suggest that tailoring by ethnicity may be more important
for women than men for certain ethnic groups, although whether or not this is true for ethnic groups
outside the USA requires further investigation.
When group programmes are offered both sexes lost more weight in an intense rehabilitation setting than
in a community setting, with men in particular losing more weight in this setting.96 Support from a
spouse120 and learning how to enhance social support from family members121 may also be favourable for
men. Having a partner participate in a weight reduction programme also produces favourable weight-loss
results but this effect appears to be greater for women than for men.94,112 Gorin and colleagues94 suggest
that this may be explained in part by households in which women are more likely to be responsible for
food shopping and preparation. Having a partner who is following the same diet plan reduces the burden
of preparing additional meals and the likelihood of purchasing foods that are inconsistent with weight-loss121
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALSefforts. Men, on the other hand, may assume more responsibility for their own behaviour change if they
attend on their own. The authors admit that their interpretation is speculative and that other factors may
act as important moderators. When ‘traditional’ gender roles are less evident, programmes involving
participating partners could produce different results.
Altering weight reduction activities to be compatible with perceptions of feminine and masculine
behaviours also appears to be important for achieving successful results. In the Lighten up trial100 the
authors noted that, although men performed well in the programmes delivered by commercial companies,
fewer than half picked these programmes when the choice of provider was freely available. The authors
suggest that commercial companies may appear more female orientated. By contrast, NHS-delivered
programmes may be perceived by men as purely concerned with improving health rather than physical
appearance and may therefore appear more masculine in this regard. Men in the choice group had poorer
results than women in this group, which could reﬂect men’s greater educational needs. Of the NHS
programmes, the Size Down programme produced results that were comparable with those of some of
the commercial companies. Size Down was the only NHS programme to offer group sessions, again
suggesting a beneﬁt from group interactions.
Of the commercial programmes, men appeared to do best with Weight Watchers, but numbers of
participants were limited. A speciﬁc area of the Weight Watchers website is dedicated to men only. The
success of Weight Watchers may be in allowing men to feel that they are following a programme that is
targeted to their needs. Having the ﬂexibility to adapt programmes in this way may encourage greater
programme engagement among men. Unlike commercial companies, primary care may lack the resources
required to provide sufﬁcient support to patients to produce effective weight-loss results. Results from the
Hakala96 and Lighten Up100 trials also suggest that general practice staff may perceive themselves as
unsuitable for arranging weight-loss care for obese patients. Although the staff in the Lighten Up trial
received speciﬁc training, they were less experienced in a weight management role than providers of
commercial weight-loss programmes. This suggests that health service staff may beneﬁt from greater
education and training in weight loss if weight management services are to be delivered by the primary
health-care system in this way. Similarly, patients may be too inhibited to discuss problems experienced
with weight-loss techniques if they feel that they are constrained to the limited time available during a
GP consultation.
Our analyses of trial retention showed that men were signiﬁcantly more likely to complete a trial than
women. We are unable to comment on possible explanations for the differential dropout between men
and women from the available data. Nevertheless, this ﬁnding suggests that, although fewer men are
likely to join weight-loss programmes, once they do join they show the motivation and commitment to
‘stick with’ the programme. This highlights the importance of ﬁnding successful strategies to engage men
in weight-loss services and will be discussed further in Chapter 4.Overall summary from both reviews in this chapterWe summarise in the following sections the main points that have arisen from both reviews in
this chapter.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35General issues relating to methodology1. We identiﬁed very few randomised trials examining weight loss in men-only groups. Few mixed-sex
trials reported weight-loss outcomes by sex, and trials recruited much greater proportions of women.
Despite this sex bias, men were rarely consulted beforehand about the design of studies or asked their
views on the programmes that they undertook.
2. Male study participants tended to be middle-aged, white and not morbidly obese. Men from minority
groups were under-represented. Relatively few interventions involved men who were obese with
existing health problems, such as type 2 diabetes, cardiovascular disease or osteoarthritis. Few trials
presented data on changes in cardiovascular risk factors, or clinical outcomes.
3. Most of the interventions were not described in sufﬁcient detail such that they could be replicated. Few
studies reported conducting ﬁdelity checks for intervention delivery. Interventions tended to be intensive
in terms of time required from participants and those delivering the programme.
4. Providers of the interventions were described at an occupational level, for example nutritionist or
physical activity trainer, but the sex of providers was not reported. It is unclear from the included
studies whether or not the sex of the person providing a weight-loss intervention to men, either
individually or in groups, is an important factor in the effectiveness of that intervention.
5. There were particularly few studies that looked at the long-term maintenance of weight loss.
6. There were very few data on quality of life or clinical and economic outcomes to assess the full value of
an intervention.
7. Details of trial methodology were often inadequately reported, for example method of randomisation.
Reporting could also be improved by following the standards outlined in the CONSORT statement.128,129
Few authors presented data for the entire cohort (e.g. baseline observation carried forward,
last entry carried forward), choosing instead to present data for completers only both at baseline and
for ﬁnal outcome measurement. It is therefore difﬁcult to judge the level of attrition bias in
these studies. Similarly, few trials reported details concerning the equity or sustainability of the
considered interventions.Pointers for effective interventions
Although few trials were available, there are some pointers for factors that may contribute to effective
programmes for men:
1. The type of reducing diet, for example providing more protein, has not been shown so far to affect
long-term weight loss.83,87,91,107,113 However, intermittent periods of very low-calorie dieting, as
required, may be better than regular periods of such dieting.103
2. Men may do well if physical activity is part of a weight-loss programme and may be more likely to
respond to this than women.93,106,109 Men like using pedometers90 but weight loss is better with a
reducing diet than with physical activity alone, and better if both are provided.91,93,109 However, one
small trial did not ﬁnd that a physical activity programme and a reducing diet were better than the
diet alone.92
3. Behaviour change training improves long-term weight loss, and weight maintenance for men after a
physical activity programme.88,101
4. Health concerns could help motivate men. Intensive programmes with low-fat reducing diets and
physical activity with or without behaviour change training can reduce weight and improve erectile
dysfunction in men with and without type 2 diabetes,85,110,122 and prevent diabetes,104 although in
type 2 diabetes successful weight loss might increase the risk of osteoporosis.124
5. Once recruited, men appear less likely to drop out from programmes than women. Men may like less
monitoring than women.96 Telephone and mail support could be useful.99
6. The effect of support from partners to aid weight loss is inconsistent.94,112,120123
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SYSTEMATIC REVIEWS OF MEN-ONLY RANDOMISED CONTROLLED TRIALS7. Men may be particularly less likely to choose a commercial weight-loss programme than women.100
Health service programmes appear to be favoured by men with obesity.96,100 The comparative
effectiveness of NHS and commercial weight-loss programmes for men in the trial by Jolly and
colleagues100 is unclear.
8. Men do well in groups of men, but some individual tailoring of advice or counselling may also aid
weight loss.85,90,95,96 Too many weight-loss sessions may be counterproductive.101 Group ﬁnancial
contracts were associated with better weight loss than individual contracts, but the size of the
contract has not been found to be a signiﬁcant factor.86,98
9. Men like individualised, fact-based, ﬂexible and simple to understand information.90
10. Men are less likely than women to do well using orlistat to help long-term weight-loss maintenance.105
11. The beneﬁts of internet-based advice for men are presently unclear.89,90NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Chapter 4 Systematic review of UK interventions
with data for men or for men and women compared
In this chapter we provide the results of the systematic review of UK interventions for men with obesity,including any setting, study design or duration. This review also includes data from mixed-sex UK studies
in which data were provided separately for men and women.
This chapter also contains details of the systematic review of studies that speciﬁcally investigated increasing
the engagement of men with obesity services (i.e. increasing the take-up of services by men); no studies
ﬁtting the inclusion criteria for this review were found. However, information on engaging men with
services is available and discussed in the ﬁrst review in this chapter.Quantity of evidenceOur primary literature searches identiﬁed 2057 potentially relevant titles and abstracts (Figure 37). In
addition to this, we identiﬁed 20 potentially relevant reports from other sources listed in Appendix 1, such
as commercial organisations, professional organisations, and from grey literature. For our review of UK
studies of any design, we selected 140 reports for full-text assessment, of which we identiﬁed 15 eligible
reports of men-only studies33–35,138–149 (two of which were RCTs141,146). We also found 11 eligible
reports31,36,37,150–157 (including one linked report157) of mixed-sex studies in which the results were reported
by sex. Of these included reports, one was an abstract141 and four were poster presentations.148,151–153 The
remaining reports were full-text publications. Three of the full-text reports were written as evaluation
reports of public health initiatives139,147,149 and were not published in an academic journal. One other
mixed-sex UK RCT by Jolly and colleagues100 has already been discussed in Chapter 3 in the review of
interventions for men and women compared. No eligible reports were identiﬁed for inclusion in our review
of interventions to promote the engagement of men with weight-loss services.
Characteristics of included studies
Tables 26 and 27 detail the characteristics of the included studies. Of the men-only studies,
we identiﬁed two RCTs with follow-up periods of 12141 and 24 weeks146 and seven prospective cohort
studies33,138–140,142,147,149 with follow-up ranging from 6 weeks149 to 49 months.142 There were two
retrospective cohort studies that included follow-up periods of 10148 and 2434 weeks. Of the mixed-sex
reports, seven were retrospective cohort studies with follow-up periods ranging from 12 weeks150 to
24 months.31 We included two prospective cohort studies,31,155 which reported data for men at 6 weeks
and 12 months respectively.
Four reports were of studies using male-orientated sports settings to facilitate recruitment and intervention
delivery; two involved four Scottish Premier League (SPL) football clubs138,141 and two involved one Rugby
League club.139,149 Four reports were of interventions provided by commercial organisations34,148,154,156 and
ﬁve reports were of NHS referrals to commercial organisations.33,36,37,150,157 A further three reports151–153
were of a commercial computer package for use by health-care professionals in the NHS primary and
secondary care setting. Two studies were set in men’s health clinics run by NHS primary care142,147
and two were set in the workplace.140,146 One study was set in the NHS GP setting31 and one examined
the promotion of dietary carbohydrate intake in individuals in the community.155125
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Studies identified from primary
searches
n = 830 (n = 1227)
Excluded
n = 690 (n = 1223)
n = 86 excluded from UK interventions review
   n = 34 no data by sex
   n = 33 not UK
   n = 7 background
   n = 11 ineligible intervention
   n = 1 ineligible population
   n = 2 no relevant data
   n = 1 no unique data
Included
n = 26
n = 24 retrieved for other reviews
   n = 19 for qualitative review 
   n = 5 for RCTs of men and women 
n = 4 excluded from engagement review
   n = 3 not UK-based studies
   n = 1 not targeted at engagement
Selected for full-text screening
n = 140 (n = 4)
Studies identified from searches for
men-only RCTs, RCTs of men and
women and qualitative reviews and
from contact with experts and
commercial organisations
n = 20
FIGURE 37 Flow chart of the number of potentially relevant reports and the numbers of reports subsequently
included and excluded from the reviews of UK interventions and interventions to increase engagement
(numbers for engagement review are in parentheses).
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35In terms of the interventions, three studies provided dietary advice only.140,146,155 It was not clear
whether or not any advice on behaviour change was given in these studies. All of the remaining studies
discussed in this chapter provided dietary and exercise advice and behaviour change training, and four of
these also provided an exercise programme to attend.138,139,141,149 An exercise programme is also provided
in the Rosemary Conley Diet and Fitness Clubs, which was one of the interventions evaluated by Dixon
and colleagues.150Characteristics of the menA total of 11,426 men were allocated to an intervention and 8957 were included in the report analyses.
Men represented 11.7% of the population of mixed-sex studies (Table 28). The youngest reported
mean age for men was 39 years and the oldest was 61 years. The lowest reported mean BMI was
30.6 kg/m2 and the highest was 39.0 kg/m2. The lowest reported mean weight was 93.8 kg and the
highest was 126.5 kg.Overview of types of outcomes reportedAll studies reported either baseline and end weights or changes in weight. Nine studies provided details of
change in BMI33,34,36,139,142,146–148,157 and four reported changes in waist circumference.139,141,147,156 One study
reported changes in total cholesterol and blood pressure138 and one reported changes in total, LDL and
HDL cholesterol and triglycerides.146 Twelve studies gave details of percentage change in body
weight.34,36,138,140–142,147,151–154,156 Nine studies reported achieving 5 kg or 5% or 10% weight
loss.34,36,142,147,150–154
Six reports138,139,141,142,147,155 conducted a formal process evaluation.TABLE 28 Percentage of men recruited to mixed-sex studies included in the review of UK interventions
Study ID
No. of participants
% menMen Women All
Ross 200831 (Counterweight) 438 1468 1906 23.0
Dixon 2012150 150 907 1057 14.2
Kirk 2000155 6 16 22 27.3
Rolland 2013156 81 429 510 15.9
Johnson 2011154 (Nutracheck) 642 2979 3621 17.7
Evans 2011152 (ProHealthClinical, Hertfordshire)a 298 846 1144 26.0
Evans 2011151 (ProHealthClinical, Cambridgeshire)a 43 179 222 19.4
Evans 2012153 (ProHealthClinical)a 118 294 412 28.6
Stubbs 201136 (Slimming World) 3651 30,620 34,271 10.7
Ahern 201137 (Weight Watchers) 3074 26,252 29,326 10.5
Total 8501 63,990 72,491 11.7
a Attending at least four ProHealthClinical appointments.
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154Quality of the evidence
Risk of bias
The risk of bias assessment for the individual studies is shown in Appendix 12 (see Tables 60 and 61). Only
one full-text publication of an RCT146 was identiﬁed; this study was judged to be at high risk of bias for the
sequence generation, allocation concealment and blinding (participant and health-care provider) domains
of The Cochrane Collaboration’s risk of bias tool (see Appendix 12, Table 60).57 It was unclear whether or
not outcome assessors were blinded, all groups were treated identically and if the authors carried out
intention-to-treat analyses. The trial was, however, judged to be at low risk of bias for incomplete data.
The trial by Gray and colleagues141 was excluded from the risk of bias assessment as outcome data were
available only in abstract format.
The remaining 14 full-text publications were assessed using the ReBIP quality assessment tool for
non-randomised comparative and case series studies (see Appendix 12, Table 61). Figure 38 summarises
the risk of bias assessment for these studies. Items in italics are valid for comparative studies only.
The majority (57.1%) of studies included a representative participant sample. Rolland and colleagues156
analysed data for participants who had baseline and 12-week weight data only and Kirk and colleagues155
included only healthy overweight participants. Data were largely collected prospectively and interventions
were delivered by appropriate people (71.4% and 64.3% of studies respectively). All studies used valid
objective outcome measures but few (28.6%) included a sufﬁcient follow-up time (here considered to be
at least 1 year) to give meaningful information on the sustainability of weight loss. Just over half of the
studies (57.1%) provided information on participant dropouts. Many items were unclear because of
insufﬁcient reporting by study authors and it is therefore not possible to summarise the impact of these
biases on the overall body of evidence.
Assessment of equity and sustainability
We assessed 16 studies for equity and sustainability. Results for the individual studies are detailed in
Appendix 12 (see Table 62). Although the Football Fans in Training (FFIT) pilot RCT141 was excluded from0 20 40 60 80 100
Analyses adjusted for confounding factors
Important prognostic factors identified
Length of follow-up similar between comparison groups
Withdrawals likely to introduce bias
Information on non-respondents, dropouts
Follow-up long enough
Assessment of main outcomes blind
Objective outcome measures used
Important outcomes considered
Intervention delivered in an appropriate setting
Intervention delivered by experienced person
Intervention clearly defined
Groups comparable
Data collection undertaken prospectively
Selection of participants consecutive
Participants at similar point in disease progression
Inclusion/exclusion criteria clearly defined
Representative sample
Yes
No
Unclear/not
reported
N/A
FIGURE 38 Summary of risk of bias assessment of non-RCT studies included in the review of UK interventions.
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35the risk of bias assessment, details of the intervention and intervention delivery were made available to us
by the study authors (Kate Hunt, University of Glasgow, February 2012, personal communication). We
therefore included this study in our assessment, summarised in Figure 39. Just over half (56.3%) of the
studies were conducted in settings considered to target or exclude speciﬁc populations. Three studies
targeted a male sports fan base138,139,141,149 and two studies targeted participants in their workplace.140,146
Three studies of commercial providers34,154,156 were judged to have potentially excluded populations unable
to afford their subscription charges. None of the studies reported on sociodemographic differences
between participant dropouts and withdrawals, although many (56.3%) reported details for some
PROGRESS categories at baseline. Few (25.0%) considered sustainability or discussed their interventions in
political or other organisational contexts (31.2%). Four studies described partnerships between academic
and sporting institutions and the NHS138,139,141,149 and four described partnerships between commercial
organisations and the NHS.33,36,37,150
None of the studies indicated whether participants had experienced adverse harms as a result of the
interventions. The Slimming World studies34,36 had potential conﬂicts of interest as the study authors are
employed by Slimming World and the research was funded by the organisation. Conﬂict of interest was
less clear for the Rolland and colleagues’ LighterLife study,156 with some of the authors acting as
LighterLife consultants and research funding provided by LighterLife. Furthermore, although Johnson and
colleagues154 declared that they had no conﬂict of interest in their analysis of Nutracheck subscribers, the
data were supplied by a company representative who also commented on the study analysis. Conﬂict of
interest was also unclear in the study by Drummond and colleagues.140 Although the authors were
independent, the Carb Boosters snacks used in the study are manufactured by the study funder, the Sugar
Bureau. Similarly, the study by Leslie and colleagues146 included meat and no meat groups and was funded
by the Meat and Livestock Commission, and the study by Kirk and colleagues155 of breakfast cereal was
supported by the Kellogg Company of Great Britain. Other items were largely unclear because of
inadequate reporting issues.0 20 40 60 80 100
Harms/unintended effects
Author conflict
Referred partnerships
Political/organisational 
Sustainability
Providers reported
Process evaluation
Fidelity check
Diversity/disadvantage strategies
PROGRESS categories
Sociodemographic differences
Representativeness
Equity pointer
Yes
No
Unclear/not reported
FIGURE 39 Summary of the equity and sustainability assessment of trials included in the review of UK interventions.
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156Assessment of effectivenessBecause of the heterogeneity of the included studies, we did not attempt any quantitative synthesis
of the results. Instead, summary data from the included studies and a narrative overview of each study
are presented.Men-only programmes
Weight-loss programmes and the workplace
Two studies investigated the delivery of dietary interventions to promote weight loss in a male-orientated
workplace setting. The ﬁrst of these146 was conducted in a single petrochemical worksite in Glasgow over
a 24-week period. Men were randomised to receive either an individualised energy-deﬁcient diet or a
general low-calorie diet. Men in the energy-deﬁcient diet group received individualised energy
prescriptions calculated in accordance with their age, sex and body weight to produce a 600-kcal daily
energy deﬁciency. Men in the general diet group consumed 1500 kcal per day. The weight-loss phase of
the trial lasted 12 weeks. During weeks 12–24, diet and energy requirements were recalculated for weight
maintenance rather than weight loss. Within each group, men were also randomised to consume meat or
no meat. Men in the meat groups consumed red meat at least ﬁve times per week. Men in the non-meat
groups substituted red meat with ﬁsh, eggs and cheese. Intention-to-treat analyses showed no signiﬁcant
difference in weight loss between the energy-deﬁcient diet and the general low-calorie diet during the
weight-loss phase [–3.7 kg (SD 3.4 kg) vs. –3.9 kg (SD 3.5 kg) respectively, p = 0.78]. Differences between
groups for other risk factors were also non-signiﬁcant (Table 29). For those who completed the
programme, both groups signiﬁcantly gained weight during the weight-maintenance phase but the
difference between groups was not signiﬁcant [+0.9 kg (SD 2.0 kg) vs. +1.4 kg (SD 1.6 kg), p = 0.27].
Data for meat/non-meat participants were not reported by the original diet group. Meat consumption did
not signiﬁcantly affect weight loss or biochemistry. Average weight loss during the weight-loss phase for
those men who completed the meat and non-meat programmes was –4.2 kg (SD 3.7 kg) and –5.0 kg
(SD 3.2 kg) respectively. Again, both groups gained weight during the weight-maintenance phase [+0.9 kg
(SD 1.6 kg) vs. +1.4 kg (SD 2.0 kg)]. The study authors commented that weight loss was less than expected
and the dropout rate was signiﬁcantly greater in the general low-calorie diet group.
The study conducted by Drummond and colleagues140 aimed to recruit male and female taxi drivers, but
only men volunteered. Men followed a low-fat, high-carbohydrate (sugar-containing), energy-restricted
diet that was tailored to produce a daily energy deﬁcit of 600–700 kcal for each man over a 12-week
period. Men were also advised to consume specialist sugar-containing Carb Boosters snacks to prevent a
‘starve and binge’ dieting pattern. The study was funded by the Sugar Bureau. By 12 weeks both BMI and
weight were signiﬁcantly reduced (p < 0.05). The average weight loss in completers was –5.5 kg,TABLE 29 Mean (SD) change in risk factors at 12 weeks for those men who completed the energy-deﬁcient and
general low-calorie diets
Risk factor Energy-deﬁcient diet (n = 49) General low-calorie diet (n = 42)
Weight loss (kg) –4.3 (3.4) –5.0 (3.5)
Waist circumference (cm) –4.7 (3.4) –5.2 (3.4)
Total cholesterol (mmol/l) –0.20 (0.6) –0.34 (0.5)
LDL cholesterol (mmol/l) –0.09 (0.5) –0.20 (0.2)
HDL cholesterol (mmol/l) +0.005 (0.1) –0.02 (0.2)
Triglycerides (mmol/l) –0.2 (0.8) –0.2 (0.8)
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The men also perceived that their quality of life had increased over the 12-week period.Men’s health clinics
Two studies evaluated NHS-delivered, men-only weight management groups. The Bloke’s Weigh
programme147 was jointly developed by the NHS Angus Weight Management Project Facilitator and the
MACH4 (Male Checks for Health) Men’s Health Project to provide a weight management group to the
men of Arbroath, a town in Scotland that is recognised to have high levels of social deprivation. The men
met in a local church hall and received advice for following a low-fat diet and increasing levels of physical
activity over a 6-week period, extended to 10 weeks because of demand. Causes of weight gain, the role
of alcohol, self-monitoring and the beneﬁts of weight loss were also discussed. Four men also approached
the Men’s Health Project worker for a health check and advice outside the group environment; areas of
concern were weight and diet related but mental health issues were also raised. Twenty-three of the
38 participants attended the sessions regularly. Of these, four men gained weight but the other men
showed varying degrees of weight loss (15 men lost 1–6 kg and four men lost 7–11 kg). Reductions in BMI
and waist circumference were also achieved (Table 30).
McFarlane and colleagues147 conducted a process evaluation of the Bloke’s Weigh programme. Ten men
stated that they would have attended the programme in mixed-sex groups, nine stated that they would
not or probably would not have attended and one man stated that he would possibly have attended. The
authors reported that the majority of men enjoyed all sessions but that they would have preferred more
meetings over a longer time period and the inclusion of an exercise class. Some men stated that a 19:00TABLE 30 Bloke’s Weigh programme: 10-week outcomes
Outcome No. of men (n = 23)
Weight
Gain 4
Lost 1–6 kg 15
Lost 7–11 kg 4
BMI
Increase 5
Reduced by 2 kg/m2 14
Reduced by up to 4 kg/m2 4
% of baseline weight lost
Increase 4
≤ 5 14
6–10 3
11–15 2
Waist circumference
Increase 7
Lost ≤ 5 cm 7
Lost > 5 cm to ≤ 10 cm 8
Lost > 10 cm to ≤ 16 cm 1
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158start time would be more convenient than 18:00. Blood pressure measurements and relaxation/stress
management techniques were also recommended for future programmes.
Gray and colleagues142 evaluated a group-based weight management programme aimed at men in
the Camelon and Grangemouth areas of Scotland. Twelve weekly group sessions were held in local
community health clinics. The men were also given advice for following a low-fat reducing diet and
increasing physical activity with the aim of losing 0.5–1 kg per week. The psychology of behaviour change
and value of social support were also discussed. Men were also invited to join organised post-programme
meetings to facilitate long-term weight management. Men with a BMI of ≥ 35 kg/m2 were more likely to
enrol in the programme than those with a BMI of < 30 kg/m2. The majority of men who enrolled were
married and employed (both 73.5%). Almost half (47.9%) of the men came from households classed as
deprived according to the Scottish Index of Multiple Deprivation (see www.scotland.gov.uk/Topics/
Statistics/SIMD), but none was from an area classiﬁed in the most deprived quintile. In total, 80 men
completed the 12-week programme. The average weight loss was 5.0 kg (range –17.2 kg to +2.6 kg); the
average reduction in BMI was 1.3 kg/m2 (range –5.5 kg/m2 to +2.2 kg/m2); and the average reduction in
waist circumference was 7.5 cm (range –27.5 cm to +3.0 cm). At 12 weeks, 35.4% of completers had lost
≥ 5% of their body weight and 8.9% had lost ≥ 10%. Following programme completion, weight-loss
records were available for 20 men. These men were between 1 and 49 months post programme and had
maintained an average 3.7% weight loss compared with their baseline weight (range –32.6% to
+25.6%). In total, 14 men were lighter than their baseline weight, two were stable and four had gained
weight compared with their original starting weight. The men’s experiences of being in the programme
were evaluated using focus group interviews. The results of this evaluation are discussed in Chapter 6.Sports clubs
Four studies138,139,141,149 investigated the use of male-orientated sports clubs to deliver nutritional advice
and an exercise programme in men-only groups. The study by Brady and colleagues138 included male
season ticket holders at Glasgow Rangers and Celtic football clubs. Both clubs were part of the SPL at the
time of the study. Interested men were asked to provide details of their height, weight, general ﬁtness
level and approximate level of general health. Men were graded according to their BMI measurement and
those with the highest BMI were selected ﬁrst. A total of 20 men were invited to each club for the ﬁrst
programme cycle. There were two early withdrawals before the initial assessment but these places were
readily ﬁlled by others. The authors reported that almost all men underestimated their true weight and
overestimated their height. The men attended 10 weekly sessions lasting 2 hours at their respective club
stadiums. The ﬁrst hour covered discussion of health issues, with health lectures delivered by a physician.
Mediterranean-style low-fat dietary advice was delivered by research dietitians and nurses, with calorie
restriction when required. Emphasis was placed on changing lifestyles and adopting healthy behaviours
for the men and their families. The second hour consisted of exercise classes run by professional Rangers
and Celtic coaching staff. Heart rate monitors were used and the men were instructed to exercise at an
appropriate heart rate for 30 minutes three to four times a week. At the start of the programme only
six men could jog round the stadium football pitch without stopping (distance of around 350m). After the
10-week programme all of the men could complete one lap and some were able to complete multiple laps
without stopping. The programme attracted 100% attendance. Furthermore, some of the men arranged
to exercise in small groups after the programme ﬁnished. Others encouraged the setting up of exercise
programmes at their workplace. Data for 36 out of 40 men were available 15 months after the
programme ﬁnished (Table 31).
The study authors deliberately targeted their intervention at men who had a passion for their football club.
Participants ranged from manual workers and ofﬁce workers to a company director but all shared an
enthusiasm for their club. The authors reported that every man considered their participation in the
programme to be one of the most rewarding experiences of their lives.
Gray and colleagues141 delivered a similar intervention at two SPL clubs (Hearts and Kilmarnock) as part of
a pilot RCT lasting 12 weeks. Men were randomised either to receive the FFIT weight-loss programme orNIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 31 Mean change in outcomes at 15 months after programme cessation
Outcome Baseline
Mean change at
10 weeks (n = 40)
Mean change at 15 months
post baseline
Weight (kg) 95.0 –2.7 –3.8 (n = 36)
Total cholesterol (mmol/l) 5.66 –0.75 –0.49 (n = NR)
Systolic blood pressure (mmHg) 136.6 –2.5 NR
Diastolic blood pressure (mmHg) NR –1.0 NR
NR, not reported.
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(Hearts) but not in the smaller town-based club. As with the study by Brady and colleagues,138 men in
the FFIT programme attended 12 weekly sessions at their club training ground where they received
personalised dietary and healthy eating and behaviour change advice followed by structured exercise
classes. Men in the waiting list group were told that they would receive the FFIT programme 4 months
later. The majority of men were white (99%), married (71.8%) and in full-time employment (76.7%).
The authors reported that there were no baseline differences between the FFIT group and the waiting list
group (Dr Cindy Gray, University of Glasgow, October 2012, personal communication).
The FFIT men achieved signiﬁcant weight loss and a signiﬁcant reduction in waist circumference compared
with the waiting list men, who showed increases for both outcomes (Table 32). The FFIT men also reported
signiﬁcant improvements in self-esteem, quality of life (as measured by the SF-12) and physical activity and
healthy eating. These changes were also signiﬁcantly different from those in the waiting list group
(reported p = 0.001 to 0.048).
The attrition rate was reported as low, with 83.5% of the men completing the FFIT programme.
The authors reported that the men were very positive about their participation in the programme. The
afﬁliation with the football clubs was highlighted as being the main incentive as many men indicated that
they would not have attended a weight-loss programme in an alternative setting. The professional
coaching staff also gave positive feedback about their involvement with the programme.
Similar weight-loss programmes have been aimed at men in the rugby league setting. The Tackling Men’s
Health (TMH) initiative was developed out of a partnership between the Department of Health, Leeds
Rhinos Rugby League Club and Leeds Metropolitan University. The initiative was promoted in partnershipTABLE 32 Comparison of 12-week outcomes for the FFIT and comparison groups
Outcome
FFIT Waiting list
Baseline (n = 51) 12 weeks (n = 44) Baseline (n = 52) 12 weeks (n = 42)
Weight (kg), mean (SD) 107.6 (15.0) 101.6 (14.1) 107.5 (19.5) 106.2 (18.5)
% weight loss from baseline,
mean (SD)a
–4.6 (2.8) +0.6 (0.2)
Waist circumference (cm),
median (IQR)a
115.5
(111.5 to 124.6)
112.9
(106.7 to 120.2)
115.1
(107.4 to 121.7)
116.6
(108.8 to 121.6)
IQR, interquartile range.
a Between-group difference signiﬁcant (reported p < 0.001).
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160with male health-related projects, the Yorkshire Man Mini Manual (Men’s Health Forum) and Change4Life
(Cancer Research UK), and targeted men attending rugby matches at the Leeds Rhinos stadium with the
aim of improving various areas of health and well-being (e.g. mental health, diet and nutrition, exercise and
sexual health). TMH staff found it difﬁcult to recruit men to the weight-loss group, highlighting difﬁculties
in identifying men in a crowd of supporters as overweight without causing offence. The recruitment
strategy was therefore altered for the weight-loss group: men were contacted by the Leeds Rhinos club
through existing communication strategies and offered the opportunity to attend the weight-loss
programme at the club training ground. Group sessions were split between discussing diet, physical activity
and behaviour change and taking part in physical activity involving aerobic and muscle resistance training
exercises. The programme was run over a 6-week period during the 2009 rugby league season for a group
of seven men149 and was repeated over an 8-week period during the 2010 season for a group of 12 men
(10 completed the course).139 The main facilitator for the theory sessions was male but the intervention
was delivered by a mixed-sex team. The average weight loss for the 2009 and 2010 groups was –2.1 kg
(SD 3.3 kg) and –2.4 kg (SD 1.4 kg) respectively. Furthermore, data for the 2010 group showed an average
4.3-cm (SD 2.3 cm) reduction in waist circumference and an average BMI reduction of 0.8 kg/m2.
Men in the 2010 group139 gave their evaluation of the course. The key reasons that the 12 men gave for
joining the programme were the chance to use the club training facilities (ﬁve men); that the sessions were
held in the evening (four men); the accessible location (three men); and the men-only group (two men).
The men enjoyed the sessions, particularly the inclusion of physical activity exercises and the ability to
discuss sensitive issues in a male-only environment. The initiative also provided the opportunity to refer the
men to other local health initiatives and two men were referred to a specialist diabetes group.Commercial weight-loss providers
We identiﬁed seven reports of men-only weight-loss groups provided by commercial organisations: Weight
Watchers,33 Slimming World34 and LighterLife.35,143–145,148 Both Weight Watchers and Slimming World
delivered their standard programme in men-only groups. Men in the Weight Watchers report were
referred by their NHS health-care provider. Weight Watchers provide a dietary plan that allocates points to
certain foods whereas Slimming World allows unlimited consumption of low-calorie ‘free foods’ and a ‘no
hunger’ diet plan. A 30-minute exercise add-on class was provided to two-thirds of the Weight Watchers
groups. The Weight Watchers programme is designed to create a caloric deﬁcit for a healthy weight-loss
rate of up to 2 lb a week, taking into account an individual’s sex, age, height and current weight.
Slimming World does not differentiate by sex in its dietary prescription.
The LighterLife ‘Man Plan’ programme was aimed at men and participants were provided with a booklet
using male-friendly language and humour, using a football team analogy to describe the beneﬁts of
the programme. The LighterLife men abstained from conventional food and alcohol for 8 weeks and
consumed very low-calorie diet formula foods known as ‘Man Plan’ food packs (although the diet is the
same for men and women, irrespective of body weight). Abstinence from conventional food is reported by
the LighterLife authors as providing clarity around boundaries for food and drink consumption. Group
behaviour change work is also used to explore reasons for overeating and develop practical and
psychological strategies for future weight maintenance.
Men in the LighterLife, Weight Watchers and Slimming World reports were followed up for a period of 8,
12 and 24 weeks, respectively, although men in the Weight Watchers group were able to complete the
12 sessions over a longer time period if necessary. For the Slimming World programme, data were
analysed for men who had attended for at least 8 weeks.
LighterLife data were available at 8 weeks from ﬁve reports.35,143–145,148 Details are presented in Table 33.
The majority of men completed the Weight Watchers programme (63%, 39/62) and the majority achieved
a weight loss of ≥ 5% [77% of programme completers (30/39) and 52% of all participants (32/62)].33
Average weight loss for all men was –6.3 kg (SD 4.1 kg) and average BMI reduction was 2.1 kg/m2. TheNIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 33 Effect of the LighterLife diet on mean weight and BMI at 8 weeks
Study ID (number of men)
Mean start
weight (kg)
Mean start
BMI (kg/m2)
Mean weight
change (kg)
Mean BMI
change (kg/m2)
% weight
loss
Holt 2007145 (n = 1279) 121.5 38.5 –17.4 –5.5 14.3
Hallam Spencer 2008143 (n = 1000) 121.3 38.0 –17.5 –5.5 14.5
Salsbury 2009148 (n = 2200) 119.2 37.4 –14.8 –4.7 12.5
Hallam 2010144 (n = 950) 123.2 38.6 –19.5 –6.1 15.8
Hallam 201135 (n = 1006) 124.0 39.0 –19.4 –6.1 15.6
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35authors reported that the men were positive about the Weight Watchers programme and unanimously
preferred the men-only meetings.
Weight-loss data for the Slimming World programme for those men who had been members for at
least 24 weeks were available for 16 men only.34 These men lost an average of 13.2 kg (SD 3.6 kg)
representing an 11.4% (SD 4.2%) change in weight (69% achieved 10% weight loss and 31% achieved
at least 5% weight loss). At the point of data collection, the average BMI reduction was –3.4 kg/m2.
There were no signiﬁcant differences in weight loss between men employed in shift work and men
employed in non-shift work.Mixed-sex programmes
NHS primary care setting
We identiﬁed four reports of weight-loss programmes delivered in the NHS primary care setting.31,151–153
Three of these reports describe an evidence-based computer programme, ProHealthClinical. The
programme provides instant access to practical eating plans and strategies for increasing physical activity as
well as motivational information, such as behaviour change techniques, and tools for tracking patient
progress for health-care practitioners. The Counterweight programme offers patients a prescribed
energy-deﬁcient diet, behavioural therapy and advice for increasing physical activity.ProHealthClinical
ProHealthClinical is a computer toolbox of weight and behaviour modiﬁcation resources developed by
KasTech Ltd. KasTech Ltd is a private, non-NHS company that sells its product and training to health-care
professionals. ProHealthClinical provides a range of evidence-based weight and behaviour tools that
enhance the skills, knowledge and effectiveness of health-care and non-health-care practitioners providing
weight-loss advice to patients (e.g. a lifestyle goal-setting database, meal and snack plans, activity energy
expenditure information, progress graphs). Advice takes account of the age and sex of the patient. We
identiﬁed three studies of GP practices that purchased the programme and training from KasTech Ltd. The
ﬁrst of these evaluated ProHealthClinical in 26 GP practices and four leisure centres in NHS Hertfordshire
Primary Care Trust.152 Centres either offered dedicated weight-loss clinic sessions or integrated patients
into existing chronic illness clinics over six appointment sessions. Practitioners were encouraged to
discharge patients who were unmotivated to make lifestyle changes within the ﬁrst 4 weeks. The number
of men enrolling in the programme (26.7%) was reported to be higher than is usually seen for commercial
weight-loss programmes (10%). Of those attending ﬁve or more appointments, 26.7% (n = 246) were
male, the majority of whom lost weight (228/246, 92.7%). The average weight loss for men attending ﬁve
or more appointments was 5.1 kg (average 4.4% change from baseline weight) and 102 (41.5%) men
achieved weight loss of ≥ 5% of their baseline weight. For women attending ﬁve or more appointments,
the average weight loss was 3.9 kg and the average percentage weight loss was 4%, with 245 (36.2%)
losing ≥ 5% of their baseline weight.161
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162A similar evaluation of the programme was conducted in 20 GP practices in NHS Cambridgeshire Primary
Care Trust.151 Eight fortnightly workshops were held over 3 months. Dietitians and physical activity
instructors delivered four out of eight workshops to patients who worked together in small supportive
teams. Participants were also given practical 2-week lifestyle challenges, for example eating only fruit or
vegetable snacks. In total, 33 men and 123 women attended six or more workshops within 3 months.
The mean reduction in weight was 5.2 kg for men (mean 4.6% of baseline weight) and 3 kg for women
(mean 3.1% of baseline weight). The programme produced weight loss of ≥ 5% for 12/33 (36.4%) men
and 28/123 (22.8%) women.
In the third study, ProHealthClinical was used within a pilot weight management service, Weigh2Go,
commissioned by the Cambridgeshire Association to Commission Health (CATCH).153 Participants were
invited to attend six appointments over a 3-month time frame. Of those attending at least ﬁve
appointments, 118 (28.6%) were men and 112 (94.9%) lost weight. Mean weight loss was 5.4 kg and
mean per cent weight change was 4.7% for men; the equivalent ﬁgures for women were 4.1 kg and
4.2%. In total, 52 men (44.1%) and 96 (32.7%) women achieved ≥ 5% weight loss.
Table 34 provides a summary of the data from the various programmes using ProHealthClinical.
Counterweight
The Counterweight programme31 was delivered by specially trained GP practice nurses and health-care
assistants. Their role was to deliver education and advice through discussion and communication of
information and through the transfer of behaviour change skills and strategies. Participants were
prescribed a > 500 kcal per day energy-deﬁcit low-fat diet plan and aimed to achieve a weight-loss goal of
5–10% through individual or group goal-setting behaviour. The GP exercise referral scheme was also
offered to participants when this was available and appropriate for individuals. In total, 22 practices were
located in deprived areas of the UK, a further 22 were from intermediately deprived areas and 12 were
from afﬂuent areas; these practices contributed 36.4%, 29.5% and 34.2% of the total study population
respectively. The programme lasted twelve weeks. At 12 months, data for 171 (49%) men and 471 (32%)
women were available. Mean weight loss was –3.4 kg (SD 7.31 kg) for men. There was no signiﬁcant
difference in weight loss between the sexes [mean weight loss for women –2.8 kg (SD 6.38 kg)].Commercial weight-loss programmes
We identiﬁed two eligible studies of commercial weight-loss programmes: LighterLife156 and Nutracheck.154TABLE 34 Mean weight loss and per cent weight change for programmes using ProHealthClinical
Outcome Hertfordshire PCT Cambridgeshire PCT Weigh2Go
No. of appointments attended ≥ 5 ≥ 6 ≥ 5
Men
n 246 33 118
Weight loss (kg), mean (range) –5.1 (–17.3 to +4.1) –5.2 (–17.7 to +3.1) –5.4 (–18.4 to +2.7)
Weight change (%), mean (range) –4.4 (–12.5 to +2.6) –4.6 (–15.5 to +2.5) –4.7 (–14.8 to +2.3)
Women
n 677 123 294
Weight loss (kg), mean (range) –3.9 (–23.2 to +5.5) –3.0 (–19.7 to +1.6) –4.1 (–16.5 to +2.1)
Weight change (%), mean (range) –4.0 (–19.9 to +4.4) –3.1 (–16.6 to +2.0) –4.2 (–16.8 to +2.2)
PCT, primary care trust.
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women differed from a matched Caucasian group in their response to the LighterLife very low-calorie diet.
The standard programme was delivered to participants in single-sex groups. Outcomes at 12 weeks are
shown in Table 35. Asian men and Caucasian men lost a similar percentage of weight whereas Asian men
showed a greater reduction in mean waist circumference per kg of weight loss.
Nutracheck is a commercial internet-based weight-loss programme offering reducing diet and exercise
advice. Nutracheck offers personalised daily calorie and physical activity targets, online food and exercise
diaries that calculate calorie intake and energy expenditure, and access to an online social community
providing support and motivation. Johnson and Wardle154 carried out a retrospective analysis of
self-reported weight loss in men and women joining Nutracheck between July 2005 and November 2008.
During the study period the Nutracheck Men service was launched (April 2007). Men registering from this
time onwards were free to join either the male or the unisex version of the programme. Data were
available for 642 men and 2979 women with a mean follow-up period of 186.7 days (SD 192.6 days).
Average (mean) weight loss for the men was 5.6 kg (SD 6.5 kg), equivalent to 5.5% (SD 5.9%) of initial
weight. Just under half of the overweight or obese men (47.6%) achieved > 5% weight loss. For women,
average weight loss was less than for men [3.7 kg (SD 5.1 kg)], equivalent to 4.5% (SD 5.5%) of initial
weight. A smaller percentage of overweight or obese women also achieved 5% weight loss (40.7%).
Men remained registered for longer than women (187 vs. 170 days, reported p < 0.05) and made more
frequent diary entries (56% vs. 52% of daily entries, reported p < 0.05). Women posted more messages
on the online forum (35% vs. 19%, reported p < 0.001) although forum use was not a signiﬁcant
predictor of weight loss. It is unclear whether both the unisex and the Nutracheck Men forums were
included in the analysis.NHS referral to commercial weight-loss programmes
Four reports investigated NHS referral to commercial weight-loss programmes. Ahern and colleagues37
conducted an independent analysis of referral to Weight Watchers and Dixon and colleagues150 reported
on referral to Weight Watchers, Slimming World or Rosemary Conley Diet and Fitness Clubs. Stubbs and
colleagues36,157 reported on referral to Slimming World, although the research team was not independent
of the commercial provider. Participants in all studies were given vouchers for 12 free sessions with the
commercial provider. Participants in the study by Dixon and colleagues150 had a free choice of provider.
Vouchers for Weight Watchers cost the NHS £45 per participant.37 Vouchers for Slimming World were
funded by the NHS and subsidised by the commercial company.157
In the study by Ahern and colleagues37 some of the 12-week courses were repeat referrals for the same
participant. For those completing a ﬁrst referral course, median percentage weight change was greater in
men than in women (difference between men and women –0.54%, 95% CI –0.81% to –0.27%, reported
p < 0.001). For men and women completing their ﬁrst referral course, median weight change was –5.4 kg
[interquartile range (IQR) –7.8 to –3.1 kg)] representing 5.6% (IQR –8.1% to –3.2%) weight loss. DixonTABLE 35 Effect of the LighterLife very low-calorie diet on mean (SD) weight and waist circumference at 12 weeks
in Asian and Caucasian men
Outcome
Asian men
(n = 36)
Caucasian men
(n = 36)
Asian women
(n = 166)
Caucasian women
(n = 166)
Weight loss (kg) –21.4 (6.7) –24.4 (8.2) –14.5 (4.6) –19.3 (4.2)
Weight loss (%) 18.1 (4.0) 18.6 (7.3) 15.9 (5.0) 28.1 (7.3)
Change in waist circumference (cm) –20.6 (12.8) –16.1 (6.7) –15.9 (6.6) 18.9 (5.3)
Waist circumference change per kg
of weight loss (cm)
–1.05 (0.7) –0.71 (0.4) –1.19 (0.74) 1.00 (0.3)
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164and colleagues150 similarly reported that men were more likely to lose 5 kg than women (OR 0.66, 95% CI
0.46 to 0.96, reported p = 0.03). Fewer men in this report were referred by GPs to the scheme (n = 265,
18.5%). Men were also less likely to return their consent form and receive vouchers than women. There
was no difference in attendance and completion rates between sexes.
Stubbs and colleagues157 noted that men represented a greater proportion of their audit than the
proportion in the standard commercial Slimming World population (11% (n = 3651) vs. 6%). The mean
follow-up time was 9.2 weeks. Using the last observation carried forward, mean weight loss for men was
5.8 kg (SD 4.9 kg) or 4.9% (SD 4.0%) of initial weight, with a reduction in BMI of 1.8 kg/m2 (SD 1.6 kg/m2).
Weight loss was less for women: 3.8 kg (SD 3.5 kg) or 3.9% (SD 3.5%) of initial weight, with a reduction in
BMI of 1.4 kg/m2 (SD 1.3 kg/m2). Men did not attend a greater number of sessions but signiﬁcantly more
men than women were classed as completers (attended at least 10/12 sessions) (63.8% vs. 57.4%,
reported p < 0.001). More men lost 5% (46.3%) and 10% (10.6%) of their initial weight than women
(34.6% and 5.2% respectively) by the 12th session.
Some of the NHS trusts involved in the study by Stubbs and colleagues36 offered a second referral,
resulting in 4754 participants (575 men and 4179 women) having a 24-session referral period to Slimming
World.157 There was no signiﬁcant difference between men and women in the percentage classed as
completers (attended 20/24 sessions) (82.6% vs. 75.8% respectively). Men continued to lose signiﬁcantly
more weight than women (79.5% vs. 73.8% lost 5% of their weight at baseline and 44.3% vs. 36.4%
lost 10% of their weight by the 24th session). In the regression model, male sex was the second greatest
predictor of weight loss (reported p = 0.013) after percentage weight loss in the ﬁrst week (reported
p < 0.001). Men in both Slimming World studies were older (reported p < 0.001) and had a higher BMI
(p < 0.00136 and p = 0.032157) at baseline than women.Weight maintenance
One study examined the promotion of dietary carbohydrate for weight maintenance following an initial
energy reduction phase.155 In total, 29 employees of Queen Margaret University College, Edinburgh,
enrolled in the Kellogg’s-funded study and, of these, six men and 16 women completed the full 6-week
course. All were habitual breakfast eaters and four were regular smokers. For the ﬁrst 2 weeks participants
were asked to replace one main meal, lunch or dinner, with a 45-g serving of a Kellogg’s breakfast cereal
of the participant’s choice with 125ml semi-skimmed milk. Following the energy restriction phase, meal
replacement ended but participants were encouraged to eat breakfast cereals as snacks if desired.
Participants were also given individually tailored advice on increasing their carbohydrate intake and how to
consume at least ﬁve portions of fruit and vegetables per day. A participation fee of £75 was paid to
everyone completing the study. Of those completing the study, mean weight loss at 2 weeks was 1.6 kg
for men and 2.1 kg for women. At 6 weeks, overall mean weight loss was 0.8 kg in men and 2.3 kg in
women. It should be noted, however, that women had a slightly higher mean BMI than men at baseline
and only six men completed the full regime. In total, 19 of the 22 completers responded to an
acceptability feedback questionnaire administered at the end of the study, with 12 (63%) stating that they
had found the 2-week meal replacement regime easy to follow and 16 (84%) stating that they would use
this method for losing weight again. Only one woman who failed to maintain her initial weight loss gave a
negative response.Comparison between men-only and mixed-sex programmesFew of the identiﬁed reports of men-only and mixed-sex weight management programmes included similar
interventions or follow-up periods making comparisons between men-only and mixed-sex groups
problematic. Interventions were comparable for two of the commercial providers, Slimming World and
Weight Watchers, but differences in numbers of men recruited, follow-up and outcome reporting make
comparisons difﬁcult.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35DiscussionWe identiﬁed few studies for inclusion in the systematic review of studies of UK interventions with data
for men or for men and women compared and found no eligible studies for inclusion in our review of
interventions to promote male engagement with obesity services. The included studies were of moderate
quality with limited follow-up and variable reporting of outcomes. Few studies identiﬁed were comparable
in terms of interventions, timing of outcome assessment and participants recruited. Similarly, we were
unable to make comparisons between the effectiveness of men-only and mixed-sex programmes from the
available data. The results for this review should therefore be interpreted with caution because of the
limited evidence base from which they are drawn.
Only seven reports138,139,141,142,147–149 described tailoring intervention delivery to men. Strategies to promote
engagement included using male-friendly language, male humour, men-only groups and venues that
promoted camaraderie through shared sporting interests. These strategies were reported as being
highly successful in attracting and engaging men with programmes, although it should be noted that
very few men were recruited to these programmes and therefore robust conclusions cannot be drawn.
Nevertheless, the men gave positive evaluations of these interventions, describing them as enjoyable and
informative, and welcomed the opportunity to discuss sensitive issues in men-only groups. However, the
men-only setting did not appear to be the most important reason for attracting men to join a weight-loss
programme. Men particularly enjoyed interventions that were afﬁliated with their sports club, indicating
that this is a potentially useful setting for attracting certain types of men. Indeed, enthusiasm for their
chosen football or rugby team appeared to be the biggest driver for motivating men to join the weight-loss
programme. These programmes included a structured exercise programme with healthy eating advice,
which may suggest that men prefer to lose weight through exercise rather than through a programme
requiring adherence to a strict dietary regime. Holding group sessions in the evening was also described as
being useful for attendance.
Attrition rates for programmes designed for men tended to be low but programmes were short and
numbers of men recruited were low, with the exception of the LighterLife study148 (although the attrition
rate for this study is unknown). All other studies were of standard unisex programmes delivered in either
male-only groups33,34,140,146 or mixed-sex groups.31,36,37,150–157 As seen in our review of mixed-sex trials,
fewer men joined these programmes than women but more men completed them and men tended to
show a greater percentage weight loss than women. As some of the programmes required referral from
health service staff, we do not know whether or not referral patterns differed for men and women.
It should be noted that studies did not often report adjusting energy allowances for men and women.
However, Weight Watchers provide differing calorie allowances by sex37,150 and Nutracheck154 tailor daily
calorie targets in accordance with individual participants’ characteristics and chosen rate of weight loss.
Successful programmes generally included some element of individual tailoring, in the form of
individualised dietary allowances,33,37,140,154 exercise programmes138,141 and/or personalised feedback on
weight loss.142,154 However, the only study in which an individualised energy-deﬁcient diet and a general
low-calorie diet were compared showed no difference in weight loss between the two types of dietary
regime.146 Weight loss for the general diet group was less than expected and the attrition rate was
signiﬁcantly higher in this group than in the individualised diet group, although there were no differences
in reasons for withdrawal. This could indicate that men are more likely to adhere to a tailored diet even if
it does not produce better weight-loss results. This study also found that diet plans high in red meat were
no more beneﬁcial than diets in which meat was excluded.
The LighterLife148,156 very low-calorie formula food diet produced highly favourable results, especially in
waist reduction for Asian men, although it should be noted that follow-up details for these participants
were very limited. Longer-term results are required to understand whether or not weight loss achieved165
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166through replacement food diets is sustainable following reintroduction of normal food during
weight maintenance.
Programmes from commercial organisations36,37,154,157 produced results that were as good as those from
NHS programmes31,151–153 when these were delivered in mixed-sex settings, whether this was for privately
subscribing or NHS referral participants. When interventions were delivered in single-sex groups, however,
commercial providers33,34,148,150,156 outperformed NHS services, but data were very limited.142,147 This is in
keeping with the results of our reviews of RCTs, which highlighted the resource potential that commercial
companies have, enabling them to offer ﬂexible services to their participants compared with the NHS. In a
single-sex setting, commercial companies have further opportunities to tailor services for men whilst
offering them regular classes at times that can be compatible with work and family commitments. As
previously shown, men are, however, less likely to choose a commercial provider than they are to choose
a NHS programme. The NHS referral scheme may increase men’s engagement with commercial providers.
Most of the interventions involved group meetings. We lack data within this review to be able to compare
these interventions with interventions aimed at individuals but, in keeping with previous ﬁndings, it is
suggested that men lose more weight in a group setting in which individual advice as well as support and
motivation can be provided. As with our previous reviews, authors made little attempt to consult men in
the design of the interventions and few were successful in recruiting substantial numbers of men. Men
made up a very small proportion of participants recruited to mixed-sex studies, highlighting the problems
of engaging men in weight-loss programmes compared with women. As seen in the results of our review
of RCTs of men and women (Chapter 3), when men were recruited they were more likely than women
to regularly attend and complete programmes. This highlights the importance of engaging men with
weight-loss services. Future research should consult individual men or men’s health representatives during
intervention development with a view to improving male recruitment. Furthermore, outcome data should
be collected at sufﬁcient follow-up intervals to ensure that adequate information is obtained beyond
the immediate weight-loss periods and through the difﬁcult weight-maintenance phase. Study authors
could also improve outcome reporting by adhering to the CONSORT129 recommendations for scientiﬁc
reporting and presenting baseline and outcome data consistently by sex and intervention group with
clear reporting of numbers of participants enrolled, assigned, withdrawn (with reasons) and analysed.
Weight-loss data should be provided for all participants enrolled, preferably using both baseline
observation carried forward and last observation carried forward results for handling dropouts.
Information concerning energy prescription by sex would also be useful, to allow a direct comparison
of responses by sex.Overall summary
We summarise below the main points that have arisen from the review in this chapter.General issues relating to methodology1. We found no studies speciﬁcally examining how to improve men’s take-up of obesity services.
2. We identiﬁed very few randomised trials examining weight loss in men-only groups or weight loss by
sex in the UK. Mixed-sex studies had much lower proportions of men than women, especially in
commercial weight-loss programmes. Men were rarely consulted beforehand about the design of
studies or asked their views on the programmes that they undertook.
3. Male study participants tended to be middle-aged, white and not morbidly obese. Relatively few
interventions involved men who were obese and who were selected as a result of an existing health
problem such as type 2 diabetes, cardiovascular disease or osteoarthritis. Very few studies presented
data on changes in cardiovascular risk factors, clinical outcomes, quality of life or economic outcomes.
4. Most of the interventions were not described in sufﬁcient detail such that they could be replicated.
Few studies reported conducting ﬁdelity checks for intervention delivery.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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the person providing a weight-loss intervention to men is an important factor in the effectiveness of
that intervention.
6. Many studies were of short duration. Few authors presented data for the entire cohort (e.g. baseline
observation carried forward, last entry carried forward), choosing instead to present data for completers
only both at baseline and for ﬁnal outcome measurement. It is therefore difﬁcult to judge the level of
attrition bias in these studies. Similarly, few studies reported details concerning the equity or
sustainability of the considered interventions.Pointers for effective interventions
Although few studies were available, there are some pointers for factors that may contribute to effective
programmes for men:
1. Effective interventions in workplaces and with sports fans in sporting venues were able to recruit men,
although the scale of these interventions was limited. Although a suitable place and time may aid
recruitment, it may also exclude those for whom these are not relevant. Interventions with football fans
have had low dropout rates and shown very positive responses from participants, with signiﬁcant
improvements in self-esteem and quality of life. The opportunity to improve physical ﬁtness and discuss
issues in a male-only environment was valued.
2. The type of reducing diet followed has not been shown so far to affect weight loss.140,146
3. Weight-loss programmes speciﬁcally for men delivered through the NHS142,147 have so far been small,
with limited follow-up. Feedback was generally positive; however, not all participants felt that men-only
programmes were needed.
4. Weight Watchers, Slimming World and LighterLife have provided men-only weight-loss groups.
LighterLife tailored its programme for men but the extent to which tailoring was carried out by Weight
Watchers and Slimming World was unclear. For the Weight Watchers programme, men lost more
weight in the men-only groups than in the mixed-sex groups. Short-term data show that all of these
programmes were effective in terms of weight loss, and they were probably more effective than the
men-only NHS programmes; however, data are very limited.
5. Short-term data also show that men do well in the mixed-sex LighterLife and Nutracheck online
commercial programmes.
6. Data show that weight-loss programmes delivered in NHS primary care are also effective
(ProHealthClinical and Counterweight) and show that more men join these programmes than
commercial mixed-sex weight-loss programmes. The Counterweight study provides much longer
follow-up data than the ProHealthClinical studies.
7. NHS referrals have been investigated in the trial by Jolly and colleagues and also for Weight Watchers,
Slimming World and Rosemary Conley. The proportions of men attending such programmes are higher
than for non-referral schemes.
8. It appears that men may lose more weight than women with the ProHealthClinical, LighterLife,
Nutracheck, Weight Watchers and Slimming World programmes. However, not all providers prescribed
a calorie deﬁcit that took account of sex.167
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evaluations
This chapter, evaluating the cost-effectiveness of interventions for obesity in men, consists of three mainsections, namely (1) a brief outline and explanation of the principles and methods of the economic
evaluation of health-care programmes; (2) the methods of the systematic review process; and (3) the
results of the systematic review, including summary results and quality assessment of the included studies.
The chapter concludes with a discussion of the results, leading to broad conclusions and recommendations
for the conduct of future economic evaluations of obesity interventions in a male subpopulation.Principles of economic evaluationThe need for economic evaluation of health-care programmes (drugs, interventions, medical devices,
diagnostic tools, etc.) is driven by the fact that national health budgets are a scarce resource. Budget limits
mean that trade-offs between health-care interventions need to be made. The allocation of resources to
one intervention or clinical area means that we are forgoing an opportunity to spend these resources on
an alternative health-care programme. This economic concept is commonly referred to as opportunity cost,
that is, the highest-valued alternative forgone as a result of a spending allocation decision. Economic
evaluation is essentially the comparative analysis of alternative courses of action in terms of both their
costs (resource use) and their effectiveness (health effects). It is a method of providing decision-makers
with the tools and information necessary to make the allocation decision in a way that maximises beneﬁt
and reduces opportunity costs.
There are four main methods of economic evaluation, each of which is summarised brieﬂy in Table 36.
The measurement of costs is similar across all economic evaluation frameworks. Good studies would
be expected to consider the direct costs of an intervention together with the costs of downstream
complications, such as cardiovascular events, stroke, diabetes and other health conditions related to the
clinical area of interest (in the context of this review we are interested in obesity-related complications). Of
the four economic evaluation frameworks outlined, the most simplistic is cost-minimisation analysis, which
would essentially lead a decision-maker to adopt the least costly intervention. Cost–beneﬁt analysis could
be considered the broadest measure of evaluation, accounting for individual preferences and broad
outcomes measures that go beyond health outcomes. The wider the measure of beneﬁt used, the more
likely the analysis framework is to consider the effects that are of greatest importance to individuals.
Cost–utility analysis [cost per quality-adjusted life-year (QALY) gained] and cost-effectiveness analysis
(usually cost per life-year gained) are the most commonly used frameworks of economic evaluation.
Cost–utility analysis is the approach to decision-making recommended by NICE.161 QALYs represent a
combination of the quality and length of additional life-years attributable to an intervention in one
measure. For example, a value of 6 QALYs could mean 6 years in full health or 12 years in half of full
health [i.e. 12 life-years gained (LYG) but with a quality of life of 0.5 on a scale from 0 to 1].
For the purposes of this review, the two frameworks used in the included studies are cost-effectiveness
analysis and cost–utility analysis.
The concept of economic evaluation and speciﬁcally the comparative analysis of the differences between
costs and beneﬁts (incremental costs and incremental beneﬁts) across treatment groups can be
summarised on the cost-effectiveness plane (Figure 40).169
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ABLE 36 Methods of economic evaluation
Economic evaluation method Outcomes measured as:
Cost-minimisation analysis Not applicable; outcomes are assumed equal for all options, hence decisions are
made based on the least costly intervention
Cost-effectiveness analysis Outcomes are measured in their natural units (e.g. LYG or kg lost)
Cost–utility analysis Outcomes are measured as QALYs
Cost–beneﬁt analysis Costs and outcomes are measured in monetary terms (beneﬁt often measured
as willingness to pay)
SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS
170TIntervention
is less
effective
Intervention
is more
effective
Intervention is more costly
NW quadrant
Intervention is dominated
(More costly and less effective)
Intervention is less costly
NE quadrant
(Consideration of ICER)
Additional cost per unit gain
in benefit
SW quadrant
(Consideration of ICER)
Incremental cost savings per
unit reduction in benefit
SE quadrant
Intervention is dominant
(Less costly and more effective)
FIGURE 40 Cost-effectiveness plane of measures of economic costs and benefits. NE, north-east; NW, north-west;
SE, south-east; SW, south-west.The results of an analysis could be seen to ﬁt onto one of four quadrants in the cost-effectiveness
plane, namely:
1. North-west (NW) quadrant – the intervention under consideration is more costly and less effective
than the comparator; therefore, the new intervention is dominated and should not be accepted.
2. South-east (SE) quadrant – the intervention under consideration is less costly and more effective
than the comparator; therefore, the new intervention is dominant and should be accepted by
a decision-maker.
3. South-west (SW) quadrant – the intervention is less costly but also less effective. In this case, a
decision-maker would need to weigh up the potential cost savings against the loss in beneﬁt, with a
decision being required about the amount of savings that would be needed before a decision-maker
could allow a unit loss of beneﬁt to occur.
4. North-east (NE) quadrant – the intervention is more costly and more effective. A decision is required
about how much we are willing to pay to achieve an additional single unit of beneﬁt.
The decision rule for the NW and SE quadrants is clear because one treatment dominates (either the
comparator or the experimental treatment is less costly and more effective). For the NE and SW quadrants
a judgement is required whether the more effective treatment is worth the additional cost (or whether the
cost savings are worth the potential loss in QALYs). To inform decision-making in these scenarios,
information is provided in terms of the incremental cost-effectiveness ratio (ICER), which is essentially theNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35difference in costs between the two treatments under consideration divided by the difference in beneﬁts.
This allows us to calculate the cost per unit change in beneﬁt. In the context of a cost–utility analysis,
an intervention might typically be acceptable to a decision-maker if the additional cost of achieving an
additional QALY is < £20,000–30,000 per QALY gained. Although NICE does not operate a threshold
value of willingness to pay (WTP) for a QALY gain per se, it typically recommends interventions with a cost
per QALY gained within this range. However, exceptions to this broad guideline exist. It is not clear what
one might consider a typically acceptable value of WTP for a gain in life-years. However, generally
speaking, the higher the ICER the greater the health-care expenditure required to achieve a unit gain
in beneﬁt and hence the less likely an intervention is to be considered cost-effective. Assuming that
additional LYG are in full health, one could reasonably assume a similar decision rule to that mentioned
for QALYs.
The results of the studies included in our systematic review will be described and discussed in the context
of the cost-effectiveness plane and will include a discussion about which strategies for the management of
obesity in men may be acceptable to health-care decision-makers. This process is, however, complicated
by the heterogeneity of the included studies, the range of country settings and the uncertainty created
through inﬂation and alternative values of currencies’ purchasing power (purchasing power parity indices).
The reader should therefore exercise caution in terms of any comparative conclusions across studies and
should instead focus and assess each study on its own individual merits.Systematic review of cost-effectiveness studies
Aims
To report the costs, outcomes and cost-effectiveness results of alternative strategies for the management
of obesity in adult men.Methods
Search strategy
Studies that reported both costs and outcomes of alternative strategies for weight loss, providing a distinct
and interpretable focus on strategies for the management of male obesity, were identiﬁed. This included
studies alongside RCTs as well as de novo decision-analytical models. An extensive electronic search was
carried out to identify reports of relevant published and ongoing studies as well as grey literature. A highly
sensitive search strategy using both appropriate subject headings and text word terms to identify reports
on costs and weight-loss strategies for the management of male obesity was used (see Appendix 1).
The following databases were searched:
l MEDLINE (1946 to January 2012)
l MEDLINE-In-Process & Other Non-Indexed Citations (19 January 2012)
l EMBASE (1974 to January 2012)
l HMIC (1979 to January 2012)
l NHS EED
l CEA Registry
l RePEc.
No language restrictions were imposed on the search; however, the search was limited to studies
published post 1990 in societies relevant to the UK setting.171
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172Eligibility and inclusion criteria for studies
Studies that compared both costs and outcomes for interventions for the management of obesity in adult
men were included. Studies were excluded if they did not attempt to relate cost to outcome data.
Methodological papers, papers that review economic evaluations (although their reference lists were
checked for additional papers to include), discursive analysis of costs/beneﬁts, partial evaluation studies
such as cost analysis, efﬁcacy or effectiveness evaluations and cost of treatment/burden of illness papers
were all excluded.
Studies included men with a mean or median age of ≥ 16 years, with no upper age limit. Studies
particularly examining men with obesity related to psychotropic medication or a diagnosed eating disorder
or with learning disabilities were excluded.
A range of interventions were deemed suitable for inclusion in our review, namely orlistat (but not
sibutramine or rimonabant, which no longer have UK licences), diet, physical activity, behaviour change
techniques or combinations of any of these. Complementary therapy (e.g. acupuncture), non-diet products
promoted for weight loss available solely over the counter or bariatric surgery were not included for
evaluation. Weight loss or weight gain prevention after weight loss needed to be explicitly stated as the main
goal of the intervention undergoing economic evaluation. Studies examining a combination of interventions,
for example smoking cessation and weight loss, at the same time were not included in the review.Data extraction strategy
Data extraction was undertaken by the project health economist. Data extraction forms were checked by a
second member of the review team for consistency and accuracy. The data extraction process focused on
two key areas: (1) the results of the economic evaluations in terms of estimates of costs and effects and
(2) the methods used to derive the results. Detailed data extraction forms for each study are reported in
Appendix 13.Data synthesis
Because of the heterogeneity of the studies retrieved, we did not attempt any quantitative synthesis of the
included studies. Instead, summary data from the included studies and a narrative overview of each study
are presented. When incremental costs, incremental effects or ICERs have not been reported, when
possible we have undertaken these calculations, based on data included in the studies. The aim of the
narrative is to identify common results across broad intervention groups. Common strengths and
weaknesses across the studies are identiﬁed and used to develop recommendations for future economic
evaluation studies of weight-loss interventions for men.Results
Number of studies retrieved from the searches
Details of study identiﬁcation are provided in Figure 41.
Using the search strategy outlined in Appendix 1 a total of 1502 titles and abstracts were identiﬁed as
being potentially relevant to our research question. These studies were screened by a project review team
member to assess their relevance to the study question, focusing on economic evaluations of interventions
for weight management in obese men. Of those initial 1502 screened titles and abstracts, a total of 79
were deemed potentially relevant and/or required further evaluation to assess their eligibility for inclusion
and were read in full. On reading all full-text papers, a total of ﬁve studies162–166 were deemed to ﬁt with
our inclusion criteria and were formally included in the review and quality assessment process. In addition,
our searches retrieved one further methodological paper167 reporting a value of information analysis
alongside one of our included studies. We also retrieved one clinical guideline from NICE53 that assessed
the cost-effectiveness of orlistat for use in the UK. The guideline brieﬂy discussed male-speciﬁc issues
and conducted some brief modelling that showed potentially differential results for male and female
subgroups. The additionally retrieved methodological study and clinical guideline have not been dataNIHR Journals Library www.journalslibrary.nihr.ac.uk
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FIGURE 41 Flow chart for identification of studies.
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35extracted or formally quality assessed; however, they are discussed in the results section of this review as
they address important policy and methodological questions, especially in relation to developing a future
research agenda for obesity-related weight management.
Full and detailed data extraction forms for each included study as well as completed quality assessment
checklists, based on Phillips and colleagues,168 are presented in Appendix 13.Description and characteristics of the included studies
Of the ﬁve studies that were deemed eligible for inclusion in the review, three162,163,165 assessed lifestyle
interventions including components of physical activity, dietary advice, professional counselling and group
behavioural modiﬁcations. The remaining two studies164,166 evaluated the cost-effectiveness of orlistat
(a pharmaceutical agent to aid weight loss). The ﬁrst evaluated orlistat in addition to standard diabetes
management.166 The second evaluated orlistat in addition to a lifestyle intervention.164 The comparator
group for both studies included a placebo drug, prescribed for the same frequency and duration as orlistat.
All studies reported results for male subgroups; however, only one study163 reported results for a wholly
male group of participants. Another study166 reported results for adults; however, because of the nature of
the baseline data, it could be assumed that the results were most relevant to a very speciﬁc subgroup of
the population (age 52 years, male).
Studies were conducted in a variety of countries, including Italy,164 Switzerland,162 Denmark,165 Australia163
and the USA.166 None of the included studies was UK speciﬁc.173
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174Description of the interventions included in the review
Lifestyle interventions
Of the ﬁve included studies, three162,163,165 evaluated lifestyle interventions/behavioural modiﬁcation
interventions with the aim of reducing participant weight. Because of the heterogeneity of the
interventions, it is not possible to make comparisons across the studies.
Segal and colleagues163 evaluated a range of alternative programmes in different population groups in
Australia for the prevention of type 2 diabetes. A total of six programmes were evaluated in different
settings. For the purposes of this review, however, only one programme reported results for a male
population. Programme IV consisted of a group behavioural modiﬁcation for men based on an
empowerment philosophy, involving ﬁve to six group sessions, with the aim of reducing waist size through
dietary change and increased physical activity, with no further details reported. We were unable to retrieve
additional information regarding the detailed methods and results for the male-speciﬁc programme IV.
Alternative interventions evaluated ranged from diet and counselling to media campaigns to surgery. No
results were presented for male-speciﬁc subgroups other than for programme IV detailed here.
Olsen and colleagues165 assessed the role of alternative health-care professionals in the delivery of
nutritional advice to obese patients, to stimulate weight loss and reduce the risks of ischaemic heart
disease and death. The study compared two health professionals providing advice (GP or dietitian) with no
active intervention. Although both interventions delivered dietary advice, there were important differences
in the content of the interventions. GP counselling delivered over 12 months (one consultation for
30 minutes and a further ﬁve consultations of 12 minutes each) included the provision of general lifestyle
advice, commercially available written information and leaﬂets on healthy diet. The dietitian-provided
advice focused on the principles of good nutrition, including restricting total dietary energy, reducing
fat intake and advice on a cholesterol-lowering diet. Six consultations were delivered over 12 months
(one 60-minute consultation and ﬁve 30-minute consultations). Results were presented for male speciﬁc
subgroups of the population.
Galani and colleagues162 estimated the long-term health and economic consequences of preventing and
treating obesity with lifestyle interventions in an overweight and obese population subgroup. The lifestyle
intervention was the same for both overweight and obese subgroups and was compared against a
standard of care deemed to be appropriate and reﬂective of participants’ BMI. The intervention consisted
of regular physical activity advice (to undertake at least 30 minutes of moderate physical activity daily) and
detailed dietary recommendations (adapted from the FDPS).132 Recommendations were to limit intake of
fat to < 30% of energy consumed and of saturated fat to < 10% and to increase ﬁbre to at least 15 g per
1000 kcal. Participants attended regular supervised exercise sessions and dietitian consultations over
3 years of follow-up. The intervention was compared with different standards of care for overweight and
obese population groups. Overweight participants received no active intervention. Obese patients received
basic dietary counselling and physical exercise sessions over the 3-year follow-up period. The study also
evaluated cost-effectiveness for a borderline obese group to assess any important transitions to obesity and
how these might impact on the cost-effectiveness outcomes.Orlistat
A further two studies included in our review evaluated the use of orlistat in combination with lifestyle
interventions for the prevention of type 2 diabetes.
Maetzel and colleagues166 evaluated the cost-effectiveness of 120mg of orlistat taken three times daily for
1 year in addition to standard treatment for type 2 diabetes, including pharmacotherapy (e.g. metformin)
and weight management in the form of dietary and physical activity advice. This was compared over an
11-year time horizon with adherence to standard treatment guidelines alone. The evaluation thus
compared an intervention group who received orlistat and adhered to treatment guidelines in year 1
followed by 10 years of adherence to guidelines with a comparator group who received 11 years ofNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35adherence to treatment guidelines alone. The intervention was delivered in a US health-care setting.
Detailed information on the components of standard treatment guidelines were not available by treatment
group; however, it can be assumed that there are no incremental differences attributable to this.
The second orlistat study164 involved a cost–utility analysis over a 10-year time horizon, which evaluated
the longer-term economic impact of the use of orlistat plus a lifestyle intervention compared with a
lifestyle intervention alone in Italian obese patients through the long-term projection of XENical in the
Prevention of Diabetes in Obese Subjects (XENDOS) study results.169 The intervention consisted of 120mg
of orlistat three times a day over 4 years in addition to the lifestyle intervention compared with the lifestyle
intervention plus a similarly delivered placebo drug. The lifestyle intervention, common to both arms of the
study, involved patients being prescribed a low-fat reducing diet and physical activity advice.
Both studies were quite similar in terms of the research question addressed (i.e. both evaluated the
cost-effectiveness of orlistat over a similar time period); however, the baseline data sources were different.
Maetzel and colleagues166 relied on the UK Prospective Diabetes Study (UKPDS)170 for input data and
Iannazzo and colleagues164 relied on the XENDOS RCT.169 Both studies reported results for a male
subgroup of the modelled population. However, in the study by Maetzel and colleagues166 it was indirectly
assumed that the results were most relevant to men because cardiovascular risk factors were calculated
based on UKPDS data,170 which references a 52-year-old man. The data from Iannazzo and colleagues,164
on the other hand, are directly linked to the XENDOS trial data,169 with extrapolations based on
sex-speciﬁc data from the trial. There were key differences in the assumptions regarding maintenance
of treatment effect and weight loss. Maetzel and colleagues166 focused on HbA1c levels, and tested
two scenarios, one in which the treatment effect was maintained for only 1 year and the other in which
the treatment effect persisted for 3 years. Iannazzo and colleagues164 assumed, based on data from the
XENDOS study,169 that weight returned to baseline levels after 4 years of treatment. NICE has also issued
guidance for the use of orlistat in the management of obesity.53 The guidance issued by NICE is
summarised in the following section.
Table 37 presents summary information with regard to the intervention type, reference population
modelled and characteristics for all ﬁve of the included studies.
National Institute for Health and Care Excellence guidance
The National Institute for Health and Care Excellence in the UK has issued clinical guideline no. 43 (CG43)
on obesity.53 CG43 replaced previous NICE guidelines for individual therapies for the management of
obesity, namely orlistat (technology appraisal no. 22, TA22),172 sibutramine (TA31)173 and surgery for
morbid obesity (TA46).174 The last TA is outwith the scope of our review and is not discussed further.
In addition, following the suspension of the marketing authorisation for sibutramine (Reductil, Abbott
Laboratories) by the Medicines and Healthcare products Regulatory Agency (MHRA) in January 2010,170,175
NICE recommendations were updated to refer health-care professionals to the MHRA advice and its
previous recommendation for the use of sibutramine was withdrawn.
The discussion in this section therefore focuses on NICE guidance for orlistat. The original guidance was
developed in 2000 as part of TA22,172 informed by an independent review group report.176 However,
this report did not present sex-speciﬁc results and so was not included in our review. Guidance was
subsequently developed in 2006 (CG43), with the development of a comprehensive guideline document
for the management of obesity.53 The review was subsequently updated in December 2011.177 In terms of
the health economic content and cost-effectiveness case in the review, the guideline development team
conducted a large systematic review of options for the treatment of obesity, which included orlistat and
lifestyle interventions. However, few studies were found and none was reported to refer to a male
subgroup of the population. Therefore, no sex-speciﬁc cost-effectiveness analyses were reported for
orlistat or for lifestyle interventions for the management of male obesity.175
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178Additional modelling work was therefore undertaken to estimate sex-speciﬁc quality-of-life weights to
inform QALY calculations and for use in subsequent economic modelling exercises. Data from Macran178
were used to estimate quality-of-life weights for ﬁve BMI ranges. Data from Ara and Brennan’s submission
to NICE,179 quoted in CG43,53 were used to estimate weight based on BMI for male and female
subgroups, given the average height of a typical man and typical woman. Weight-loss ﬁgures were
ascribed to central values of each range and a linear trend between midpoints was assumed. Taking this
midpoint of each BMI range, weight loss and utility gain178 were synthesised into utility gained per kg lost
for men and women. Expected quality of life values were estimated for each 0.1 increment of BMI. A
diabetes disutility value of 0.8661 was identiﬁed from the literature and assumed.3 Sex-speciﬁc QALY and
cost per QALY sensitivity analyses were presented based on available effectiveness (weight loss) and cost
data for orlistat. Detailed costings were not presented within the analysis. The modelled sensitivity analysis
presented indicates little or no sex-speciﬁc difference in cost-effectiveness of 12 months’ treatment with
orlistat, with ICERs for both male and female subgroups well below a commonly acceptable WTP of
£20,000 per QALY gained.
Differences between male and female subgroups appear to be more pronounced when comparing
longer-term treatment (48 months) with current practice of 12 months’ treatment. The base-case analysis
reports a higher cost per QALY for men (£29,089) than women (£26,917). Within this analysis, in a male
subgroup, the data suggest that the greater the initial BMI, the more cost-effective orlistat is, with an ICER
of £29,920 when BMI is 38 kg/m2, increasing to £33,134 when initial BMI is 30 kg/m2. The converse
appears to be true for women, with an ICER of £30,155 for an initial BMI of 38 kg/m2 and an ICER of
£23,982 for an initial BMI of 30 kg/m2. The results show that for the comparison between 48 months of
treatment and 12 months of treatment, cost-effectiveness of orlistat is dependent on a number of factors,
including sex, baseline BMI, weight trend without orlistat and weight regain after treatment
discontinuation. The conclusion of the evaluation was that NICE could not recommend 48 months of
treatment with orlistat, given the uncertainty in the ICER presented.
Work by Foxcroft180 and referenced by NICE53 evaluates both the European Medicines Agency (EMA)181,182
and NICE guidelines172 for the use of orlistat. These guidelines recommend different continuation rules for
treatment with orlistat. The original NICE guidelines172 (TA22, updated as part of CG4353) recommend
continuation only if patients achieve 5% weight loss at 3 months and 10% weight loss at 6 months.
The EMA criterion181,182 is slightly more relaxed than that used by NICE, requiring only a minimum of 5%
weight loss at 3 months to justify continuation of treatment. Results from the Foxcroft study180 were not
reported separately for male and female subgroups. However, for all adults, the results suggest that
adoption of the EMA criterion for the continuation of orlistat would result in a lower ICER than that
obtained using the NICE guideline criterion. The cost per QALY was £24,400 (range £10,900–77,200) and
£19,000 (range £8800–57,800) for the NICE and EMA criteria respectively. The study recommended that
future economic evaluations of the cost-effectiveness of orlistat should consider the use of the EMA
criterion. The most recent review of the NICE guidelines177 considered the Foxcroft analysis and the
less restrictive EMA criterion. The NICE update to the guidance found that, although there was some
evidence to support removal of the requirement that at least 10% of body weight is lost by 6 months
for continuation of treatment, there are equally reasons for the criterion to remain unchanged.
Methodological uncertainty in the estimation approach to QALY gains led NICE to conclude that
adoption of wider EMA-based criterion was not recommended at this time.Quality of the included studies
Model structure
All studies included in the review were based on models with a common goal of extrapolating short-term
outcomes, such as weight loss, to longer-term health beneﬁts, either in terms of survival (LYG) or a
combination of survival and quality of life (QALYs). All studies reported incremental costs and incremental
beneﬁts, for which formal cost-effectiveness analyses were undertaken. For the purposes of assessing
the quality of the modelling studies in this review, particular attention was given to model parameterNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35estimation and the methods by which short-term outcomes were extrapolated over a longer-term horizon,
accounting for downstream health-care costs and patient health outcomes. Included studies were quality
assessed using the criteria of Phillips and colleagues.168 These criteria provide a platform to quality assess
studies based on best practice methods for the conduct of decision modelling studies for use in health-care
decision-making. Detailed quality assessment checklists for each of the included studies are presented in
Appendix 13 for information.
All included studies used modelling techniques of varying degrees of complexity and sophistication to
synthesise cost and effectiveness outcomes. All studies measured cost-effectiveness using some form of
extrapolation of lifetime mortality and disease risk. Four out of the ﬁve included studies estimated their
results using Markov models to extrapolate weight loss and disease risk to longer-term outcomes.162–164,166
Two out of the four Markov models measured outcomes in terms of incremental cost per QALY gained,
combining measures of additional life-years with quality-of-life weights applied to disease states in the
model.162,164 The remaining two Markov models163,166 did not report any utility values and hence outcomes
were based on survival estimates alone, with the economic evaluation presented as cost per life-year
gained163 and cost per event-free/diabetes-free life-year gained.166 The remaining study165 was based on a
Cox regression model using time to event modelling, adjusted for baseline risk factors, to estimate survival
associated with treatment. The model predicted life-years and LYG without ischaemic heart disease. Given
that the obesity-related health complications are likely to occur into the future, it is important that the
dynamic nature of progression between disease states is adequately modelled. For this reason it could be
argued that Markov modelling was the most appropriate method to synthesise the dynamic cost and
effect relationships for obesity-related disease pathways. Further, Markov models, because of their design,
are more appropriate to estimate the impact of more dynamic state transitions associated with alternative
courses of disease progression. The models are, however, only as good as the data used to generate the
state transitions and there is a trade-off between the level of sophistication of the models and the data
available to populate them.Selection of interventions considered
Only one of the included studies explicitly discussed or justiﬁed the intervention strategies compared.163
However, given the wide variation in possible interventions (both pharmaceutical and lifestyle related), the
interventions compared in each study appear to be appropriate, given the decision problem and stated
objective of the respective analyses. Segal and colleagues163 conducted a systematic review to determine
the most appropriate programmes to compare in a cost-effectiveness framework. Although the review was
systematic and six programmes were ultimately evaluated, it was difﬁcult to draw comparisons across
programmes given the heterogeneity of the populations and programmes evaluated. For the purposes of
this review, our discussion pertaining to this study relates only to the male-speciﬁc group behavioural
intervention (programme IV).163Incorporation of data into economic models
All studies clearly described the methods used to incorporate data into their models and sources were
mainly derived from the literature. Although a broad spectrum of literature appears to have been
considered for the majority of included studies, literature searches were none the less ad hoc and there
was no evidence of systematic literature searching to identify key model parameters. Justiﬁcation for
the use of data is generally poor with little discussion of choices between key data sources. When
meta-analyses of treatment effects were carried out there was little information provided on the data
synthesis methods used and so quality assessment was not possible. Only one study brieﬂy described the
model used to synthesise data as a random-effects meta-analysis.162 Nevertheless, the data included in
the studies were well referenced and data sources were clear for the most part.179
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180Cost data in the models
Four162–164,166 of the ﬁve studies considered costs over an extended time horizon. The remaining study165
did not extrapolate costs beyond the cost of the intervention and so failed to account for any downstream
costs associated with obesity-related complications. This is an important part of the disease process and
limits the value of the study results. The costing perspective was described in all studies. Two studies stated
that a societal perspective was used;162,164 however, explicit data relating to a societal perspective, beyond
health service resource use, were not detailed in the studies. It appears that, given the data included, these
studies would more accurately be described as using a health services or health services and personal
perspective. One explanation for this could be a lack of consistency in the deﬁnition of perspectives across
countries. Some countries might consider publicly provided health care to be provided from a societal
perspective. It is important that perspective is clearly deﬁned for all studies. Intervention costs were
included for all studies; however, detailed calculations were not presented in all studies, rendering it
difﬁcult to quality assess the costing methods in general. Costs were incorporated for downstream health
events in all but one study;165 however, again this information was reported with varying degrees of
completeness and detail. It is imperative that economic evaluation studies include detailed unit costs of
interventions, follow-up costs of obesity-related complications and a synthesis of these two cost aspects to
generate total cost estimates. It should in theory be possible to reproduce results given the data provided
in a study; however, this was not the case in the studies retrieved for this review.
The costing year was explicitly reported in four studies;162,163,165,166 however, it was also possible to source
the costing year indirectly for the ﬁfth study through the appropriate references.164 A range of currency
data was reported, with only one study163 converting currency to international dollars. Galani and
colleagues162 also converted data to study year euros. Many different currencies and costing years meant
that a comparison of the results is subject to considerable uncertainty because of the wide variations in
exchange and inﬂation rates over time. Discount rates applied to costs were clearly detailed for all studies
that measured longer-term horizon costs (four162–164,166 out of ﬁve included studies). The ﬁfth study165
considered costs over a 1-year time horizon only and thus discounting of costs was not necessary. The
impact of uncertainty surrounding discount rates was tested in sensitivity analyses, with two162,166 of the
ﬁve studies reporting cost-effectiveness results associated with varying discount rates. Iannazzo and
colleagues164 reported discount rates but did not test assumptions regarding their impact in sensitivity
analysis. As Olsen did not consider long-term costs, discounting was considered only for outcome data.165
The ﬁnal study did not report any sensitivity analyses for the male-speciﬁc programme within the study.163Effectiveness, treatment outcomes and linking of evidence
Effectiveness data used for the studies relate to a linked evidence approach. For the majority of studies,
the goal was weight loss. For the most part, however, model inputs were predicted based on clinical
outcomes such as lipid levels, systolic blood pressure and HbA1c levels and taken from published sources,
with the link between weight loss and these outcomes less clear. One study164 used Framingham risk
equations183 to determine relative risks of cardiovascular events. These were then linked, using a
combination of the literature and modelling exercises, to ﬁnal health outcomes and complications
(e.g. diabetes, stroke, myocardial infarction). This has been completed to varying degrees of complexity
and it is not always clear whether male-speciﬁc data are used for the model inputs. In terms of the
effectiveness of the interventions for weight loss, only one162 of the ﬁve studies explicitly reported
weight-loss data, despite this being an outcome of importance to the study questions. Instead, studies
relied on cardiovascular risk data at a population level, based on weight-loss data from randomised trials,
as model inputs.
Galani and colleagues162 estimated weight loss on the basis of a meta-analysis of randomised trials and
used Framingham risk equations together with national Swiss data to estimate cardiovascular risk factors
and mortality. Methods for the meta-analysis were not clearly reported and it was not possible to quality
assess this aspect. Assumptions regarding weight loss were clearly documented and weight loss was
maintained over 6 years, with linear regain over 4 years. Therefore, after 10 years it was assumed that
weight had returned to baseline levels. This assumption was validated against the FDPS;132 however,NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35alternative assumptions were not explored in sensitivity analysis. Although mortality and cardiovascular risk
factors are based on sex-speciﬁc data and these are extrapolated to ﬁnal outcomes, it is not clear whether
these were applied to sex-speciﬁc weight-loss data or not.
The remaining studies did not report weight loss per se, despite this being an implied goal of the studies in
all but one case.165 Olsen and colleagues165 used a combination of clinical data, including risk factors of
age, sex and BMI score, to establish the lifetime mortality risk. It was assumed that the effects of the
intervention would be continued over the lifetime of follow-up, an assumption that the authors
acknowledge as a key limitation of the study. Despite this, no alternative sensitivity analyses were
presented to test the impact of this assumption on cost-effectiveness outcomes.
The model developed by Iannazzo and colleagues164 was based on the extrapolation of results from the
XENDOS RCT.169 Data from the trial were used to predict diabetes incidence and forecast blood pressure
and cholesterol variation. The impact on cardiovascular disease was described using Framingham risk
equations. Although no other studies were considered, and no data synthesis was undertaken, the
randomised and blinded nature of the XENDOS data is likely to ensure that rigorous estimates were used
in the model. Methods of data extrapolation were clearly described and were sex speciﬁc; however, the
use of Framingham equations, which do not explicitly include BMI as a risk parameter, mean that the
model was not sufﬁciently sensitive to changes in weight and BMI. However, data from the original
XENDOS trial,169 which did measure weight gain and maintenance, showed that weight returned to almost
baseline levels at 4 years’ follow-up.
Maetzel and colleagues166 also did not directly report weight loss in their study. However, weight loss was
an important goal of the study. Instead, weight loss impacted on HbA1c scores, which were reported and
linked to relative cardiovascular risk reductions. Data from four placebo-controlled trials were used to
conduct meta-analyses to synthesise outcomes in terms of HbA1c levels. However, details of the data
synthesis methods used were not provided and the quality of the analysis methods was not critiqued
within the study. Methods of extrapolation of treatment effects over an extended time horizon were
clearly described and it was assumed that patients receiving orlistat would experience weight loss over
1 year of therapy, after which weight regain would be linear over 3 years and weight would then match
that of the placebo group. This assumption was tested in sensitivity analysis and was found to have an
impact on cost-effectiveness results.
In general, data syntheses for treatment effects were documented but methods were poorly reported.
It was not clear whether or not separate weight-loss parameters were included for men and women;
however, cardiovascular risk inputs to the model were sex speciﬁc. The link between weight loss and
cardiovascular outcomes was poorly addressed and this adds uncertainty to the cost-effectiveness results.
Although results were often clearly reported separately for male and female subgroups, it would also be
useful to see input parameters (including weight-loss data, cardiovascular risks and health state utilities)
reported by sex subgroup. This would give a clear picture of how sex-speciﬁc inputs were used in the
model and would facilitate the hypothetical/theoretical reproduction of the results by sex subgroup.
Assumptions regarding maintenance of weight loss were well described in the orlistat studies.162,166
However, one of the lifestyle intervention studies165 does not deal explicitly with this issue and appears to
assume that the treatment effect is continuous based on initial or transient improvement in cardiovascular
health parameters. This is a strong assumption and likely inappropriate in the context of the research
question addressed. No sensitivity analyses were explored.Utilities and quality-adjusted life-years
Only two studies reported results in terms of QALYs.162,164 Although details of mortality risk and hence
life-years were clearly described across the studies, methods of utility estimation were not. Utility estimates
were taken from the literature, were sourced adequately and were clearly referenced. However, the
methods used to derive those utilities were not clearly described (e.g. standard gamble, time trade-off,
visual analogue scale or discrete choice experiments or other methods). The estimation method for utilities181
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assessment of this part of the studies. However, neither of the two studies that estimated QALYs provided
in-depth descriptions of the utility estimation methods. There was no discussion of different options
for utility estimation or of any impact that these would have had on the overall results. This is a key
methodological limitation of these otherwise well-conducted and methodologically appropriate studies.Sensitivity analyses
All studies attempted some form of sensitivity analysis, mainly focusing on issues of parameter uncertainty.
However, none addressed all four types of uncertainty (structural uncertainty, methodological uncertainty,
heterogeneity and parameter uncertainty).
Two of the included studies addressed structural uncertainty. Segal and colleagues163 calculated both gross
costs (intervention programme delivery costs only) and net costs (programme delivery costs less any
downstream future costs to health services) in their analysis. Maetzel and colleagues166 explored the
impact of alternative assumptions regarding weight regain and duration of treatment effect. This was
the only study to consider this important issue and, as expected, the results were found to be sensitive to
this assumption.
Methodological uncertainty was generally well addressed. However differences in results, arising from
varying discount rates were explicitly presented in only two162,166 of the ﬁve studies. Although Segal and
colleagues163 reported sensitivity analysis of discount rates for one individual programme, this was not
differences in results for the male-speciﬁc programme, and so the impact of alternative discount rates on
this programme was not clear. Iannazzo and colleagues164 recalculated the cost-estimates assuming that
the Italian NHS and not the patient paid for orlistat. Olsen and colleagues 165 addressed methodological
uncertainty in terms of alternative costing assumptions and by inclusion of people’s own use of time in
sensitivity analysis.
Heterogeneity in the study results was well accounted for across studies, with four out of ﬁve studies
reporting results for key subgroups (e.g. impaired glucose tolerance, age, sex). All studies apart from that
by Maetzel and colleagues166 reported male and female subgroup results separately; in the study by
Maetzel and colleagues166 the base-case model results were speciﬁc to a male subgroup. Subgroup
analyses conducted were appropriate to the study question and were generally clearly reported and
interpreted. When multivariable sensitivity analyses were conducted, the results were not always reported
separately for male and female subgroups. Sensitivity analyses tended to focus on base-case results for all
patients and not individual subgroups. This renders it difﬁcult to interpret any impact that sensitivity
analyses may have had on sex-speciﬁc cost-effectiveness estimates.
Parameter uncertainty was explored in four out of ﬁve studies, the exception being the study by Olsen
and colleagues.165 Most sensitivity analyses were conducted as simplistic one-way analyses (changing
one parameter at a time); however, this does not account for the joint dependence of one parameter on
another or, indeed, the dependence of one parameter on sex-speciﬁc subgroups. However, some two-way
deterministic analyses (varying the values of two parameters at the same time) were conducted by Maetzel
and colleagues166 and Galani and colleagues.162 Sensitivity analyses undertaken were clearly described and
justiﬁed across the studies. Results were presented in a fair and balanced way and the impact of the
sensitivity analyses was appropriately discussed. In one study,163 comprehensive sensitivity analyses were
presented for some programmes but not for the programme relevant to a male subgroup.
Three studies162,164,166 conducted extensive probabilistic analysis. Results were presented in the form of
cost-effectiveness acceptability curves (CEACs) and scatterplots to illustrate uncertainty. However, in only
one of the studies were uncertainty illustrations presented separately for male and female subgroups.162
Maetzel and colleagues166 also conducted probabilistic sensitivity analysis with an extensive range of clinical
outcome parameters. The inclusion of cost parameters was less clear. Results were again illustrated in the
form of CEACs. Bootstrapping analyses were plotted on a comparative graph of costs and effects from theNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Cox regression models used in the study by Olsen and colleagues165 and these illustrated the uncertainty
and wide variability in the ICERs presented.Consistency and validation of the results
The mathematical logic behind the models was tested in only one study, that by Iannazzo and
colleagues,164 with the convergence and stability of the model being tested. Multiple chains were run and
both visual and statistical tests were used to test the model’s reliability. Counterintuitive results were found
in one study,162 with cost-effectiveness in a borderline obese group being greater than in an overweight
group and poorer than in an obese group. These results were acknowledged and discussed, with
justiﬁcation provided in the article. Four162,164–166 out of ﬁve studies discussed the results in the context of
other literature in the ﬁeld and comparisons were made with the results of similar studies when
appropriate. No in-depth discussion of other studies was presented by Segal and colleagues.163Summary
Studies were of variable methodological quality but many were appropriate to and compliant with best
practice guidelines at the time of their publication. There are some common themes and issues that could
be addressed to improve future economic evaluations of men’s health interventions to induce weight loss:
1. Improving the reporting of sources used to inform utility weights and also the methods used within
source studies to derive those weights (e.g. standard gamble, time trade-off, visual analogue scale or
discrete choice experiments).
2. Reporting of costs (both intervention and subsequent costs of complications) in detail, with appropriate
references, in a manner that would facilitate the theoretical reproduction of the study results.
3. Downstream costs to health services associated with the differential risk of signiﬁcant health-care
events should be incorporated in economic models as standard.
4. Assumptions should be clearly deﬁned and highlighted in the published articles. It should be clear to
the reader what assumptions have been used, especially regarding maintenance of weight loss and
continuation of treatment effect. These should be comprehensively tested in structural
sensitivity analyses.
5. Methods used to model the effect of weight loss on future obesity-related disease should be
comprehensively explained. Where a number of potential data sources exists, choices regarding which
source to use should be clearly outlined and any potential variation explored in deterministic or
probabilistic sensitivity analysis.
6. Speciﬁcally for interventions relating to men, data inputs for the model should be clearly detailed on a
sex-speciﬁc basis. When data for all sexes have been used and applied to male and female subgroups
separately, this should be acknowledged and highlighted as a potential limitation.
By addressing these points it would be possible to greatly improve the quality of studies in the area of
men’s health in general and in the area of the treatment of male obesity in particular. These points are
based on issues arising from the studies included in the review; however, it is acknowledged that the
estimation of results separately for male and female subgroups was not the primary goal of the included
studies and so sensitivity analyses were not all presented separately for sex-speciﬁc subgroups.
A summary of the quality assessment checklists is presented in Table 38. Detailed comments on individual
studies are presented in the detailed quality assessment checklists in Appendix 13.183
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188Summary of the results of the included studies
As described in Table 37, three studies focused on lifestyle interventions and two on orlistat. The included
studies were, in most cases, broadly similar in terms of patient populations; however, there was wide
heterogeneity in terms of the concomitant lifestyle intervention and control group accompanying orlistat
treatment. Data were not reported in sufﬁcient detail across studies to assess common outcome measures
and the study designs were not sufﬁciently homogeneous to draw any comparative conclusions across
studies. When appropriate, incremental costs, incremental effects and ICERs have been calculated based
on data provided within the studies. Because of the wide variation in reported currencies and costing
years, we have inﬂated costs from the study publication dates to 2012 values using appropriate inﬂation
indices for each individual country. Inﬂation rates were sourced from Eurostat184 (EU and US data) and rate
inﬂation sources185 (Australian historical data). Costs were then converted to common 2012 UK pounds
using purchasing power parity indices provided by the Organisation for Economic Co-operation and
Development.186 The purpose of this exercise is not to facilitate a direct comparison between studies but
rather to assess them all in a common currency and year of valuation, to aide understanding
of the results.
Despite the heterogeneity of the study results we can nonetheless comment on individual study results and
interpret these in the context of the decision problem, the objective of the analysis, the structure of the
model and the outcome measures reported. Summary cost-effectiveness results are presented in Table 39,
with more detailed information on each study available from the data extraction forms included in
Appendix 13. In this table the key base-case results are presented. In studies in which the base-case
analysis was concluded using a cost–utility and cost-effectiveness analysis framework, the former is
reported. Results refer to male-only subgroup analysis unless otherwise stated.
Lifestyle interventions
In relation to the lifestyle intervention studies, Segal and colleagues163 found the group behavioural
intervention for men to be cost-effective for both the mixed glucose tolerance subgroup (presumed
to be a mix of normal glucose tolerance, impaired glucose tolerance and type 2 diabetes) and the impaired
glucose tolerance subgroup. Although the intervention was found to be cost-effective for both groups,
the estimates of ICER were slightly lower for the impaired glucose tolerance subgroup, indicating
potentially greater value for money associated with intervening with those at greatest risk. The male-speciﬁc
programme was on average less costly and more effective and was thus dominant over the comparator
treatment of no routine intervention. The sensitivity analyses showed that the conclusions were robust to
plausible variation in the treatment success rate. Despite a lack of detailed information available for the
male-speciﬁc programme, the results indicated that a group behavioural modiﬁcation intervention may be
a cost-effective use of health-care resources. Preventative measures in type 2 diabetes thus showed the
potential to be either cost saving or highly cost-effective. However, the authors ﬂagged an urgent need for
research in the area of diabetes prevention, especially in terms of quality-of-life outcomes. Despite this
recommendation being made in 1998, there is still little robust evidence regarding the impact of weight
loss on quality of life and cardiovascular risk events within an economic evaluation framework for
overweight and obese men.
Olsen and colleagues165 found that GP counselling was more cost-effective than dietitian counselling for
encouraging weight loss. The authors concluded that GP counselling is cost-effective, but that the
differences are probably the result of GPs offering extra advice beyond the dietary/nutritional counselling
prescribed in the protocol. The authors concluded that, despite the lack of data from their study to support
dietitian counselling, the role of the dietitian should not be discounted, especially given health-care
provider constraints in practice.
Galani and colleagues162 conducted a cost–utility analysis and found that a lifestyle intervention was
highly cost-effective, with ICERs well below those typically considered good value for money for health
gains. ICERs were dominant for a male subgroup including those who were borderline obese, with
the intervention being less costly and more effective than the comparator. Results for other groupsNIHR Journals Library www.journalslibrary.nihr.ac.uk
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35(overweight and obese) were also associated with ICERs of < 2000 CHF (Swiss francs) or £1000 (year 2012)
per QALY gained. Given usual values of WTP for a QALY gained considered by decision-makers, the
intervention evaluated was highly cost-effective. The results remained robust to sensitivity analyses for the
male population subgroup, adding strength to the cost-effectiveness conclusions drawn by the authors.
The authors recommend that pan-European research in the area should be a priority.
In summary, based on the data presented in this review, there is some evidence to suggest that lifestyle
interventions could be a highly cost-effective use of resources in terms of encouraging weight loss and
improving health outcomes in overweight and obese men. However, because of the many assumptions
made and the heterogeneity of the studies, it is not possible to synthesise a robust comparison of these
interventions regarding cost-effectiveness.Orlistat
Two studies evaluating orlistat for obesity presented data of relevance to a male subgroup of the
population. The ﬁrst164 reported a cost–utility analysis of orlistat in combination with a lifestyle intervention
compared with a lifestyle intervention alone. The base-case ICER was €74,290 (£69,427, year 2012), well
above a level of WTP for a QALY gain that would typically be accepted as cost-effective. Although
sensitivity analyses were not available for a male-speciﬁc subgroup, sensitivity analyses were conducted for
the wider group of all sexes combined. There was signiﬁcant uncertainty in the presented ICERs, with the
results being particularly sensitive to the level of risk of developing diabetes. Therefore, the authors
concluded that, if the drug was targeted at a high-risk group (i.e. impaired glucose tolerance), the
treatment had an estimated ICER of €10,160 (year 2007) per QALY gained, equivalent to approximately
£9500 (year 2012), indicating that the drug was likely to be cost-effective if targeted at the highest-risk
subgroups of the population. Although data were not presented, it is likely that the conclusion on
cost-effectiveness in those at greatest risk also holds true for men.
The second study,166 carried out in the USA, reported costs per event-free LYG. In the base-case analysis it
appeared that the drug was an appropriate addition to standard guideline treatment for diabetes, resulting
in weight loss. The ﬁndings suggest that the use of orlistat was cost-effective in the management of
overweight and obese patients with diabetes in the USA. The results of the study are not presented
separately for male and female subgroups but could be considered representative of a 52-year-old man,
based on the relative risk calculations for cardiovascular events used in the model. Although the authors
suggested that the intervention may be cost-effective in a US setting, it was not clear whether results would
be transferable to a UK setting. There was some uncertainty in the estimates of cost-effectiveness and the
results were particularly sensitive to the assumed duration of treatment effect. The greater the duration of
beneﬁt, the more likely the drug was to be cost-effective. Observational data to support long-term use of
orlistat in this population are needed to validate the results of the study and further studies are required to
reproduce the results in male subgroups of different ages in the UK population.
In summary, there is some evidence to suggest that orlistat is a cost-effective add-on to lifestyle
interventions in male overweight and obese patients, with a greater likelihood of cost-effectiveness if the
drug is targeted towards those at greatest risk of diabetes.Summary
There is evidence of mixed quality and strength which suggests that lifestyle interventions are cost-effective
at reducing weight and improving future health gains. There is also some evidence that orlistat may be
cost-effective as an add-on to lifestyle interventions if targeted at the subgroups at greatest risk. Despite
these promising results, strong assumptions were made in the studies regarding the continuation of
treatment effects and the similarity of weight-loss success across male and female subgroups. There were
no clear indications of large differences in cost-effectiveness outputs across studies between male-speciﬁc
subgroups and their female counterparts.191
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192DiscussionWe conducted a systematic search of the literature for studies that assessed the cost-effectiveness of a
range of interventions for the treatment of male obesity. To our knowledge, this is the only systematic
review of the cost-effectiveness of weight-loss interventions speciﬁc to a male subgroup of the population.
However, we were unable to ﬁnd any studies that speciﬁcally set out to model the cost-effectiveness of
obesity interventions in men. In total, ﬁve studies reporting male-speciﬁc subgroup analyses were deemed
relevant for inclusion (three evaluating lifestyle interventions and two evaluating orlistat). Of the included
studies, one described a male-speciﬁc intervention programme, among others;163 however, only limited
details of the particular intervention are provided. A second study166 was modelled on risk factors for a
52-year-old man (from the UKPDS170); however, male-speciﬁc weight-loss data were not explicitly included
in the model. The fact that only subgroup analyses are reported renders it difﬁcult to quality assess the
included studies in terms of sex-speciﬁc model inputs. The remaining three studies simply presented male
subgroup analyses.
There is an indication in the included studies that lifestyle interventions appear to be highly cost-effective
and that orlistat has the potential to be cost-effective when prescribed to those at greatest risk of
complications of type 2 diabetes. However, it is important to interpret the studies in this review in light of
their methodological quality and limitations.
First, as discussed, the studies were not designed to determine cost-effectiveness for a male-only subgroup
of the population. The male-speciﬁc results presented were instead subgroup analyses of the main studies.
It is unclear in a number of studies how sex-speciﬁc data were used to populate the economic models.
Although results are presented for male subgroups, the use of non-sex-speciﬁc baseline data inputs for the
models is likely to reduce the ability to show any male/female differences in the cost-effectiveness results.
Second, strong assumptions were made across the studies with regard to the continuation of treatment
effects and weight-loss maintenance over time, with no clear consensus about how these assumptions
have been incorporated into the economic models. Studies that assumed maintenance of incremental
weight loss over time for the experimental group are likely to bias the analysis greatly in favour of the
experimental intervention. There is great uncertainty, for example, with regard to the continuation of the
treatment effect for orlistat. One study166 investigated this and found substantial variation in the ICER
depending on the assumptions used in the model. Although it is accepted that there is a lack of evidence
with regard to the continuation of the treatment effect, it is imperative that this aspect is adequately and
comprehensively tested in sensitivity analyses to explore the impact of uncertainty in the model parameters
on the ﬁnal results. This will allow decision-makers to decide what level of uncertainty they are willing to
accept when making recommendations regarding the provision of various treatments or interventions.
Third, the models have been developed with varying degrees of modelling sophistication and complexity.
Although four studies included Markov decision-analytic models, the level of complexity and the number
of potentially important health states included varied greatly across the studies, from only three in one
study to eight in another. It is important that best practice guidelines and detailed clinical expertise are
sought when developing economic models for weight-loss interventions, both in men speciﬁcally and in
all population groups more generally. The inconsistency across studies in terms of model structure and
health states modelled means that results are likely to differ substantially across studies, and common
comparisons cannot be made. For example, studies that consider downstream costs of diabetic
complications are more likely to accurately reﬂect the dynamics of the disease pathway than those that
do not. This coupled with the fact that outcome measures are not consistent across the studies (some
reporting cost per life-year gained, others cost per event-free life-year gained and others QALYs) renders it
difﬁcult to disentangle any real trends across the studies.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Fourth, only two of the included models presented detailed cost–utility analyses with dynamic modelling of
the treatment pathway and reported results in terms of costs per QALY gained. Cost–utility analyses are
recommended by NICE for the evaluation of health-care interventions and have been used previously in
numerous cardiovascular and diabetic modelling studies. The use of QALYs as the estimate of choice is
important as QALYs measure both the mortality aspect and the quality-of-life aspect of the chronic
complications of obesity. However, although methodologically robust, the two studies that reported costs
per QALY gained were not designed to answer a male-speciﬁc question.
Fifth, broader measures of beneﬁt, which go beyond the QALY measure and value attributes of an
intervention beyond health outcomes, are more likely to capture issues of importance to the patients
themselves. One suggestion for future health research in this area could be the use of cost–beneﬁt
analyses and discrete choice experiments to evaluate the processes and attributes of care that patients,
and indeed taxpayers, feel are of greatest value. This would extend the measure of beneﬁt considered
beyond quality of life to include a range of attributes of importance.
Finally, the use of older studies with outdated unit costs across different countries and with different
control treatments and subtle differences in the interventions delivered renders broad comparisons across
studies difﬁcult. The lack of evidence is further complicated by the lack of generalisability of the studies to
the UK setting. Although we have endeavoured to generate UK estimates where possible based on
inﬂationary and purchasing power parity assumptions, such an approach generates uncertainty in itself.
It is therefore our conclusion that, on the basis of the retrieved literature, there is insufﬁcient evidence
available to make clear recommendations regarding the cost-effectiveness of interventions or treatments
for male obesity. There is also insufﬁcient evidence to recommend different treatment strategies for male
and female subgroups on the grounds of cost-effectiveness.Overall summary of the cost-effectiveness review
The key conclusions from the review of cost-effectiveness studies are summarised below:
1. There were no studies evaluating the cost-effectiveness of weight reduction interventions exclusively in
an overweight and obese male population.
2. Five studies of weight-loss interventions for male and female participants evaluated the
cost-effectiveness of the interventions in male subgroups.
3. The evidence suggests that lifestyle interventions combining low-fat, usually calorie-reducing dietary
advice and physical activity are likely to be cost-effective; however, the interventions were poorly
described in some studies.
4. There is some evidence suggesting that orlistat may be cost-effective in addition to lifestyle
interventions, especially when targeted at those with or at greatest risk of developing type 2 diabetes
(e.g. those individuals who have impaired glucose tolerance).
5. None of the studies presented clearly differing conclusions for male and female subgroups and there is
insufﬁcient evidence to say whether this is because of a real similarity in the groups or the result of
methodological complications with regard to sex-speciﬁc inputs to the economic models.
6. Studies were of varying methodological quality, especially with regard to modelling methods and
assumptions over the continuation of the treatment effect (i.e. the modelling of maintenance of weight
loss over a longer time period) and the modelled link between weight loss and ﬁnal health outcomes.
7. The methodological variability and study heterogeneity, with many key differences across studies,
including differences in comparators, interventions, costing methodology, model sophistication, primary
economic analysis outcomes and country of study, make it difﬁcult to assess the factors that are of
greatest importance in determining cost-effectiveness.
8. Therefore, on the basis of the evidence summarised in the review and the lack of generalisability to a
UK setting, it is impossible to draw clear conclusions on the cost-effectiveness of alternative
interventions for the treatment of male obesity.193
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194Future research recommendations
There is an urgent need for UK male-speciﬁc economic evaluations to assess the value for money of
alternative weight reduction strategies in a UK decision-making context. Such studies should systematically
consider the available evidence on acceptability, effectiveness, costs and cost-effectiveness of alternative
interventions. The following are key requirements for future research:
1. The development of decision-analytical models that model a dynamic disease pathway, using
sex-speciﬁc model inputs to determine the key drivers of cost-effectiveness in weight-loss interventions
for obese men and what, if any, differences exist in terms of cost-effectiveness across sex subgroups.
2. In terms of the parameters of greatest importance, a study conducted by Galani and colleagues167
alongside one of our included studies162 indicated that, based on expected value of information
analysis, if further research were to be commissioned it should focus on the effectiveness of lifestyle
interventions for cardiovascular risk factors and quality of life of overweight and obese people.
3. An important consideration for future research will be to explore and improve modelling methods to
link the effect of weight loss to overall disease risk. Some of our included studies seemed to suggest
that small and even transient weight loss may have an impact on future disease risk and therefore
could have an important impact on long-term effectiveness and cost-effectiveness outcomes.
4. Future studies should focus on assumptions surrounding the maintenance of weight loss over time,
rigorously testing the impact of assumptions on cost-effectiveness outcomes through comprehensive
sensitivity analyses.
5. It is important for future research to use a broad measure of beneﬁt and to involve service users in the
decision-making process, focusing on the interventional processes and associated outcomes of care that
are of greatest importance to individuals to effectively and cost-effectively moderate behaviour.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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research and mixed-method synthesis of data
from men
This chapter is organised into themes based on a logic model (Figure 42) that emerged by applying acombined realist and socioecological approach (for methods see Chapter 2). Study characteristics
presents a narrative description of the studies that were included in this review. Social, cultural and
environmental influences on obesity in men highlights the wider social, cultural, economic and political
macro-level themes that have been implicated as predisposing men to gain weight in the ﬁrst place.
Engagement with weight management programmes focuses on men’s engagement with weight
management programmes and implementing programme advice within their everyday lives. First, themes
that relate to the role and inﬂuence of relationships and interactions with family, friends and peers, and
various settings like the workplace, home and sports facilities are discussed. We focus on the time period
before joining a formal weight management programme to understand factors that motivate men to want
to lose weight and decide to engage. In The weight management programme, the themes that relate to
men’s perspectives of the relevance and utility of weight-loss programmes and their experiences acquired
during their journey through the processes and components delivered as part of weight-loss interventions
and how this relates to programme adherence are discussed. The impact and consequences of weight-loss
programmes discusses men’s perspectives on the outcomes achieved after they have completed a weight
management programme and the consequences for men, their families and their friends. For each theme
the qualitative ﬁndings are linked to randomised and non-randomised intervention studies aimed at obese
men. These ﬁndings are then integrated with relevant quantitative systematic review ﬁndings (see Chapters
3 and 4). Finally, we draw on the wider qualitative literature on aspects of obesity in men. Our analysis is
supported by ﬁrst-order quotations from men with relevant characteristics included in the studies. Author
interpretations of primary qualitative data have been described as second-order constructs or second-order
themes39 and, ﬁnally, third-order interpretations are made as a research team. The chapter ﬁnishes with
the quality assessment carried out during the data extraction process (see Quality assessment of qualitative
studies linked to interventions).
Study characteristics
The primary searches identiﬁed 5209 references of which 407 were selected for full-text screening. In
addition, 29 studies were identiﬁed from other sources, such as commercial organisations and contact with
experts. Of these 436 studies, 22 met the inclusion criteria.44,46,49,89,142,149,187–202 Figure 43 provides details of
study identiﬁcation (see Appendix 15 for the data extraction form).
We included 13 studies linked to interventions46,49,89,142,149,187–194 and nine studies not linked to
interventions.44,195–202 With regard to the studies linked to interventions, ﬁve studies46,89,187–189 were linked
to RCTs and the remaining eight49,142,149,190–194 were linked to non-randomised studies.
Four of the included studies linked to interventions46,142,149,189 were linked to studies included in
the quantitative reviews in this report and these ﬁndings are reported in Chapters 3 and 4. Eight
studies46,49,89,142,149,189,191,193 were linked to interventions that were open to men only. Of these eight, the
studies by Gray and colleagues142 and Leishman193 were linked to the same group-based programme (the
Camelon model147), which was delivered in men’s health clinics in Scotland, whereas the studies by White
and colleagues49 and Harrison191 were linked to the Health of Men workplace-based weight management
programme that was delivered in England in a group format. The study by Witty and White149 was linked
to a group-based intervention that was delivered at Leeds Rhinos Rugby League Club in England.139
The studies by Morgan and colleagues89,189 were linked to the SHED-IT trial,189 which was an individual195
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35website-based weight management programme delivered in Australia. The study by Hunt and colleagues46
was linked to the group-based FFIT intervention delivered at senior Scottish football club stadiums.141
The remaining ﬁve studies were linked to interventions that were open to both men and women. The
study by Gallagher and colleagues187 was linked to a group-based intervention delivered in Australia,203
that by Mallyon and colleagues188 was linked to an individual-based intervention delivered in Australia,204
and the study by Abildso and colleagues190 was linked to a group-based insurance-sponsored weight
management scheme delivered in the USA.205 The study by Kim and colleagues192 reported on a
faith-based group weight management programme delivered within a rural African American community,
whereas the study by Ogden and Sidhu194 analysed the experiences of individuals taking the medication
orlistat for weight loss in England.
Each of the nine studies not linked to interventions was UK based and collected primary data from a
male-only sample. These studies drew on the views, attitudes and perceptions of men who taken part in
formal weight management programmes and interventions or who had attempted to reduce or manage
their weight in other ways. De Souza and Ciclitira195 interviewed men to investigate their views on health
and body image. In addition, Gillon196 examined how men talk about body weight. The study by Gough
and Conner44 provided an account of meanings that men attach to food and the links between food and
health. Gough and Flanders197 conducted research with men who were active members of the gay ‘bear’
community, which is a homosexual subculture in which excess weight is considered sexually attractive.
McCullagh198 interviewed long-distance lorry drivers to inform the development of appropriate health
education strategies to encourage them to be health aware, access services and attain a healthier lifestyle.
One study by Monaghan199 investigated attitudes to obesity and ill health, disease and disease risk and
another study by Monaghan200 discussed justiﬁcations for levels of body mass that are in the overweight or
obese range. A third study by Monaghan201 explored men’s talk about physical activity, weight, health and
slimming. Finally, the study by Weaver and colleagues202 investigated how men understand obesity and its
relation to the risk of diabetes.Social, cultural and environmental inﬂuences on obesity in menMost included studies took a predominantly individualistic approach to the factors that may inﬂuence
weight gain, rather than a more ecological and environmental approach. References to issues in the wider
environment that may act to increase the propensity for men to be obese were identiﬁed in four45,48,141,148
of the 13 included studies linked to interventions and six43,190,193,197,198,201 of the nine studies that were not
linked to interventions.
Two distinct subthemes emerged from the data: Sociostructural determinants of obesity and Obesity and
deprivation. No quantitative data from the other systematic reviews were found to support or disconﬁrm
these themes.Sociostructural determinants of obesity
White and colleagues49 referred to structural changes in society that may predispose individuals to gain
weight. They presented this in a second-order construct as a dichotomy between (1) the fecklessness of
three-quarters of men in the UK, which the authors thought was unlikely, and (2) vulnerability because
of structural changes in the wider society.
No participant quotes were found to indicate that men were thinking about wider society-level
determinants of their behaviour when discussing factors that helped or hindered weight-loss attempts.
Indeed, it is evident from the data presented in the remainder of this chapter that those issues were
almost entirely absent from men’s conceptualisation of the problem, with an emerging prevalent theme of
personal responsibility more obviously apparent. White and colleagues49 did not reference speciﬁc
examples of sociostructural issues that may inﬂuence the increasing prevalence of obesity in the UK.197
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198However, previous research206 has demonstrated that individuals may interact with environments on many
levels in activity-related settings such as the workplace, home, school and the neighbourhood that can be
and are inﬂuenced by structural factors in the macro environment such as government policy, education
and health systems.
Some studies in this review suggested that the role that environment plays in inﬂuencing behaviours
helped some researchers decide where to locate the delivery of weight management programmes. For
example, the Health of Men programme, as described by Harrison191 and White and colleagues,49 was
located in the workplace, with the rationale that it was more convenient to access than non-workplace
settings. Two other studies were located in sports facilities,46,149 with the rationale that these environments
were congruous to male identities and therefore more appealing to men than interventions in more formal
clinical settings. Targeting a population through a special interest setting was apparent in the study by Kim
and colleagues,192 who located their faith-based weight management intervention in a (predominantly)
African American church. The Camelon model142,193 was located in a more formal health-care setting,
namely a men’s health clinic. However, in contrast to the other studies mentioned here, the authors
emphasised the utility of a group-based setting for men (over the physical location of the intervention) in
allowing men to raise sensitive issues that may otherwise be embarrassing to discuss.142 The remaining
studies188,190,194 were not clear about the setting where the intervention took place.
Participants in two studies191,194 made reference to environmental factors relating to work that they
believed played a part in the onset of their obesity. A 43-year-old white participant in Ogden and Sidhu’s
study194 on the experiences of taking orlistat for weight management stated that his static job played a
part in his obesity. This man talked about knowing that he ate far too much of the wrong things, naming
bacon, eggs, sausages, chips, meat and bread.
The repeated use of ‘I’ by this participant (in his account of this issue) suggested a strong sense of intrinsic
personal responsibility with regard to his engagement in behaviours that he perceived had led to his
obesity. Nevertheless, reference to external determinants of behaviour (considered beyond the control of
the individual) that had contributed to a person’s weight gain was observed in the study by Harrison,191
linked to the Health of Men workplace-based intervention. Here a participant described how working
irregular hours away from home played a role in his gaining weight:NIHRWhen you work away from home you have no one to prepare nutritious food for you, you live off
takeaways, kebabs, pub meals and have a few pints
Mark, age 34 years, p.70191The reference to ‘you’ as opposed to ‘I’ may thus be viewed as absolving oneself from blame. Finally, a
47-year-old participant quoted by Ogden and Sidhu194 attributed his obesity to his home environment,
family behaviour in relation to food availability, ﬁnishing his children’s food and his personal coping
strategy of turning to food for comfort to improve his general sense of well-being.
These examples illustrate the complexity of the interactions between the individual men’s intrinsic and
extrinsic motivation to change and the environmental barriers to and facilitators of instigating and sustaining
change. Such interactions, which operate between the macro, meso and micro levels described in ecological
models of behaviour, pervade the themes that are presented in the subsequent sections of this chapter.
Referring to the wider qualitative literature on obesity in men, reference is made to the concept of the
obesogenic environment. This has been deﬁned as:The sum of influences that the surroundings, opportunities, or conditions of life have on promoting
obesity in individuals or populations
p. 56465Journals Library www.journalslibrary.nihr.ac.uk
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Leeder207 have argued that sociostructural factors have played a very powerful role in creating toxic
environmental conditions that make it very difﬁcult for individuals to maintain a healthy weight. They
point to relatively recent but radical changes in food supply (in terms of the price and availability of food),
transport and urban design (especially walkability) as well as commercial pressures to overconsume food
and engage in less than optimal levels of physical activity as key drivers of the obesity problem.
The importance of the sociostructural determinants of obesity as a theme that contrasts with the obesity as
individual responsibility standpoint was supported in ﬁve of the studies not linked to weight management
interventions.44,197,198,201,202 For example, Weaver and colleagues202 provided direct quotes from men
regarding sociostructural determinants of keeping ﬁt and eating healthily. These quotes, related to press
and government health promotion messages, such as eating ﬁve portions of fruit or vegetables a day, and
food labelling, indicated that some men were conscious of the sociocultural and economic aspects of their
lives that encourage weight gain.202
However, government public health messages were described in another study44 as an intrusive health
lobby, which can prompt resistance and a will to reclaim eating as personal choice. A quote provided to
support this referred to all enjoyable food being bad for you, something which the 47-year-old respondent
argued was not the case two decades ago when you could eat what you liked.
Nevertheless, another participant, in the study by Weaver and colleagues,202 appeared to show that
government-driven health messages are heeded by some:© Que
Health
provid
addres
Park, SThere is always fresh fruit in the house . . . I try and keep away from microwave meals . . . we don’t
eat a lot of fried food you know, if everything is done, it would be grilled or it would be boiled
Jack, age 34 years, p. 4202The use of pronouns is interesting, as the impersonal ‘there is always fresh fruit’ represents a detachment
from the actual buying or eating of the fruit but also a recognition of the importance of healthy food
being always available as a facilitator to healthy behaviour.
The men in McCullagh’s study198 on long-distance lorry drivers also frequently attributed their
self-perceived poor diet and low levels of exercise to their obesogenic work environment. They recognised
that driving long hours leads to weight gain, with some expressing regrets about gaining a licence. In
particular, the drivers lamented the lack of healthy food available at roadside catering establishments in
the UK:The food offered in transport cafes is appalling. The breakfasts have names like ‘Belly Buster’ or
‘Heart Attack’
No individual characteristics provided, p. 5198The theme pertaining to perceptions of obesogenic environments was also conﬁrmed in Monaghan’s199
ﬁeld diary, written when observing male members of a slimming club. One excerpt covered the difﬁculties
that men encounter in resisting the temptations of the garage shop when ﬁlling up their cars, as well as
vending machines at work, with a discussion of strategies of how to avoid these temptations.Obesity and deprivation
Links between obesity and deprivation were highlighted in the Camelon men’s health clinic group-based
intervention of Gray and colleagues,142 who stated in a second-order construct that obesity is linked to
socioeconomic status through poorer men eating less well, with the incidence of obesity increasing with
deprivation and lower levels of education.199
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200This was supported by author text in ﬁve of the non-intervention studies,193,197,198,201,202 in which the
relationship between obesity and health inequalities was discussed. For example, Weaver and colleagues202
investigated how men understand obesity and its relation to the risk of diabetes. They concluded that
lower social class men were more at risk of obesity and its related diseases, but that they were also a
hard-to-reach group for health promotion.
In addition, De Souza and Ciclitira195 referenced ﬁndings from the literature which suggested that people
with lower levels of education and wealth are at a greater risk of obesity and as a result have a lower life
expectancy.195,208 In addition, De Souza and Ciclitira state that, although people of higher socioeconomic
status report higher levels of perceived overweight, they have been found to be more likely to monitor
their weight closely, more likely to try to lose weight and more likely to report higher levels of physical
activity.195,209 Furthermore, De Souza and Ciclitira195 cite evidence that men of lower socioeconomic status
were less likely than women to have knowledge of healthy eating and that the lower a man’s social class
or education level the lower the level of such knowledge.
A debate emerges concerning the relative appropriateness of framing obesity discourses according to
gender, health or wider macro sociostructural and socioeconomic perspectives. De Souza and Ciclitira195
argue that an appreciation of socioeconomic factors and education, rather than gender differences, is
important when investigating the causes of obesity.
However, Monaghan199 argues that focusing the obesity debate on the perceived unhealthiest individuals
occupying lower socioeconomic strata is unhelpful. Monaghan refers to victim blaming, a term generated
by the orthodox medicalised view of obesity, whereby obese people from lower social class backgrounds
are regarded as being in poor health because of their obesity. Moreover, they are forced into pursuing
individualised solutions that, in themselves, may be physiologically or psychologically harmful. It is argued
that one of the consequences of the focus on obesity is that it legitimates and perpetuates a society in
which many people are dissatisﬁed with their bodies.
The study by Weaver and colleagues202 also provided direct quotes from men indicating that economic
factors constrained their choices for healthy eating and exercise. For example, men described the high cost
of membership of clubs and gyms, or the fact that healthy food, especially fruit and vegetables, is more
expensive than food high in sugar. Similar economic issues were raised by long-distance lorry drivers in the
context of work, with an example given in the study by McCullagh198 of a apple costing an expensive 60p.Engagement with weight management programmesDespite the increasing prevalence of male obesity in the UK, and the existence of well-established links
between obesity and poor health, men are less likely than women to participate in weight-loss
programmes.142,210 The reasons for this lack of participation are not well understood as little research has
been carried out to identify the barriers to and facilitators of the participation and engagement of men in
weight-loss programmes.189 This section discusses themes that have been found to affect men’s
engagement with programmes and programme advice, in particular considering the lead-up to
participating in a weight-loss programme. These themes relate to the role and inﬂuence of programme
settings and interactions with family, friends and peers and in particular refer to the initial motivation to
lose weight, factors that attract men to participate in interventions, the importance of location and setting
in acting as a ‘hook’ to engage men to join weight management programmes and the inﬂuence of
partners, family and friends on men’s engagement with weight management programmes.Initial motivation to lose weight
Men may pay less attention to their weight than women and may therefore be less likely to attempt
weight loss than women.41,42 However, little is known about the types of issues that motivate men to
either join a formal programme or try to lose weight independently. Leishman193 reported that a diagnosisNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35and label of obesity came as a substantial jolt to men attending the group-based Camelon programme in
Scotland, who had not previously thought of themselves as being problematically overweight. This
realisation appeared to increase their motivation and commitment to embark on a process of trying to lose
weight. For example, a 42-year-old man expected that tests would show that he was a bit overweight but
ﬁnding out that he was obese hit him very hard. When the facts were staring him in the face he felt
motivated to act.193
Another participant from the study by Leishman193 referred to how men who are big can be normalised
within some environmental settings such as the workplace. The authors suggested that presenting
information on weight visually can potentially provide the jolt needed to increase motivation. The use of
charts to display clinical measurements in relation to norms links to the theme discussed later around
men’s preference for more scientiﬁc and technological representations of obesity. One 38-year-old man
was shocked to be labelled obese because in his workplace most of his colleagues were big, suggesting
that obesity and being overweight was a previously unacknowledged social network norm for him:© Que
Health
provid
addres
Park, SMy size just seemed normal. When the girl (assessing nurse) showed me the chart I was really
shocked to see that I was clinically obese. If it had showed me as being fat it wouldn’t have got to
me as much and I probably wouldn’t have done anything about it.
p. 79193The obesity diagnosis bringing about the motivation to act (as opposed to being labelled fat) is also
highlighted in the study by Gray and colleagues,142 which was linked to the Camelon programme,
delivered to men in groups in a health clinic setting in Scotland. In this study men experienced
dissatisfaction with their body image only when they were labelled as obese. In contrast, it was reported
that men whose BMI was in the overweight range (< 30 kg/m2) were less likely to enrol in the Camelon
model’s weight management programme. Gray and colleagues142 therefore contended that contemporary
social norms that place emphasis on the idea that men should be bigger and stronger than women have
perhaps inﬂuenced men’s perceptions of an ideal weight as being in the overweight range.
Concerns regarding health issues that may be worsened by obesity and the concomitant fear and anxiety
related to a medical diagnosis or event, or the realisation of how ageing with obesity affects health, can
also motivate obese men to lose weight. For example, a 44-year-old participant in the study by Morgan
and colleagues89 reported having had a recent health scare and realising that he was not getting any
younger, which motivated him to act.
Motivation seemed to increase particularly if a hospital admission was reported, with accounts of medical
procedures interpreted as serious or life threatening involving mechanical deﬁciencies in the heart or
breathing, as detailed by Ogden and Sidhu194 investigating the experiences of individuals taking the
medication orlistat for weight loss in England. Typically, men would attend their GP surgery and be
referred for tests, which showed that their health was far worse than they had envisaged, and this
diagnosis/realisation triggered them to do something. As one 43-year-old (of white ethnic origin) in the
study explained:It got to the stage that I knew I was going to die and that was the turning point. I knew
I was going to die unless I did something about it. And then I just got into gear and it turned me
right around
p. 548194A similar picture was seen in the study by Gallagher and colleagues:Having a heart attack really scared me. I just wanted to feel better, see my kids grow up, and be more
in control. I had tried so many things, but being in hospital really brought me to my senses
John, age 38 years187201
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202In addition, the study by White and colleagues49 (which is linked to the Health of Men workplace-based
weight management programme delivered in a group format in England) found that some overweight
participants who felt unhealthy, as opposed to actually being diagnosed with a health problem, were
motivated to lose weight.
A desire to improve personal health was also highlighted in the quantitative evidence base. In our review
of men-only trials (see Chapter 3), emphasising the link between weight loss and improved erectile
dysfunction85,122 produced very favourable reductions in body weight. Similarly, men who participated in
the Bloke’s Weigh programme147 expressed concerns over mental health issues in addition to concerns
about weight and diet (see Chapter 4). The greater take-up of commercial weight-loss programmes by
men referred from general practice than from self-referral, as seen in Chapter 4, also suggests the
importance of health issues for motivation.
In the study by Morgan and colleagues189 linked to the web-based SHED-IT trial, a concern over physical
appearance was also described as a motivator to take part in a weight-loss programme for younger men in
particular. However, the only quote provided to support this is from a middle-aged man who, whilst
looking at himself in a mirror, compared his appearance unfavourably to that of his father.
These themes pertaining to the initial motivation to lose weight were largely supported in the studies not
linked to weight management interventions. For example, the study by De Souza and Ciclitira195 conﬁrmed
the theme that men were likely to be motivated to lose weight for health reasons, which they distinguish
from their perceptions about why women attempt to lose weight (for appearances). One 54-year-old man
reiterated that women were more likely to want to lose weight to ﬁt into their clothes for reasons of vanity
and that men were more likely to want to lose weight for medical reasons. Another 45-year-old man in
the same study agreed that women’s weight loss was driven by vanity.
Similarly, the study by Gough and Conner44 reported that men were initially motivated to lose weight for
health reasons, for example after being diagnosed with diabetes, or when health professionals advised a
diet to lower cholesterol.
The study by De Souza and Ciclitira195 also found that for gay men weight management was thought of
as a way to improve appearance. For example, a 33-year-old participant talked about slimness as being
something that was socially prized within the gay community and another man of the same age talked
about withdrawing from the gay scene as he no longer thought himself attractive enough because of
weight gain.
However, evidence from participants self-identifying as gay ‘bears’ in the study by Gough and Flanders197
refuted the notion that being labelled as obese provides motivation to lose weight. In this particular gay
subculture, obese bodies are the norm and are viewed as desirable and healthy. A 39-year-old man
explains how the bear community encourages him to be ‘meaty’, with a BMI in the overweight to obese
range. Moreover, the bear community had an immense appeal to him as he felt that he had gained more
friends since increasing his BMI.Factors that attract men to participate in interventions
It has been argued that the failure of programmes to recognise gender issues in weight management may
have a part to play in the apparent lack of enthusiasm that men have for joining weight management
programmes.210 Several studies demonstrated how being able to undertake weight-loss activities in a
male-only environment was appealing for some men. In the study from Australia by Morgan and
colleagues189 a 21-year-old participant explained that he was attracted to the male-only aspect of
the programme.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35This was also found in the study linked to the group-based Camelon programme, delivered in a health
clinic setting in Scotland, with Gray and colleagues142 quoting a man as saying that he would not attend
any intervention with female participants.
However, other research211 has found that male-only features of interventions were less important to most
men. Instead, the opportunity to receive a second opinion was more important. In addition, a 19-year-old
participant in the study by Morgan and colleagues189 stated that the website-based programme with individual
advice sounded achievable and this was more important than the male-only aspect of the intervention.
A non-intervention study195 provided evidence to support the view that not all men prefer male-only
weight management environments. One 40-year-old man, who was the only man in a slimming club,
appreciated the support that he got from his fellow club members. He was also helped by the fact that he
was the manager of 20 women, half of whom attended slimming clubs, leading to a competition at work
to lose weight, with him reporting that he had beaten them all.
An example of how the delivery of an intervention can engage men is provided by several studies through
the use of humour or banter.46,49,142,149,189,191,193 For example, a nurse in Witty and White’s study149 noted
the sensitive communication issues that arise in identifying obesity and inviting men to join a group.
A light-hearted approach with the use of banter was important when attempting to approach and
encourage overweight or obese men to take part in a study, to lessen the chance of causing offence.
Morgan and colleagues189 explained how humour was deployed in the SHED-IT website-based weight
management programme to aid participation and engagement. Comical language and imagery (such as
the picture of a beer glass) were used in the programme’s promotional materials to attract men and get
across the message that the internet-based programme allowed treats such as beer. This was said to be
particularly successful with regard to recruitment; a 29-year-old man said he saw the glass of beer and
signed up immediately.189
A further reason why men were attracted to take part in the Camelon programme was the knowledge
that the programme had been successful for other men. This is illustrated by one participant who had
been persuaded to join because he had heard that the groups worked well and were a good laugh.193
The theme of humour is considered again in the following section (see The weight management
programme) when the nature of the interactions within weight-loss programmes are reported.
Engagement is also inﬂuenced by perceptions of what the weight management programme will involve.
Two of the included studies141,192 indicated that men would be disinclined to undertake any forms of strict
dieting. For example, a participant in Leishman’s study193 linked to the Camelon programme delivered in a
group format in health clinics in Scotland, explained his feelings of apprehension at joining if strict dieting
was involved, as a diet that makes one starve is not appealing. However, the man was pleasantly surprised
that Camelon was more of an education programme about healthy eating and exercise not a strict diet.
In fact, at ﬁrst he thought that it would not work as he felt that he was eating the same volume of food,
with just more vegetables and fruit.
The absence of an extreme dietary regime appeared to be instrumental in attracting men to participate in
several studies.142,189 Gray and colleagues142 found that men had joined the group-based Camelon
programme as it was marketed as not involving dieting. However, no participant quotations are given to
support this ﬁnding.The importance of location and setting as a ‘hook’ to engage men
The location and setting of certain programmes acted as an important element to attract men to
participate in them. In the study by Hunt and colleagues46 the intervention was located within SPL football
club stadiums and targeted obese supporters. The aim of weight loss therefore becomes congruent203
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204with a strong personal commitment to being a football supporter. Our interpretation is that associating
long-standing loyalty, commitment and pleasure attained from collectively supporting a football team
(still predominantly a male activity) with challenging men’s lifestyles to encourage behaviour change,
such as losing weight, could hypothetically increase the likelihood of ‘contagious motivation’ whereby
motivation for turning up to support the team either consciously or subconsciously transfers to motivation
to lose weight with fellow team supporters. To support this interpretation, a participant emphasised having
been a lifelong football supporter and the status that being part of an intervention with his club gave him
in his circle of friends and how this was an incentive to engage with the intervention and lose weight.46
Hunt and colleagues46 contended that the setting acted as a ‘hook’ and an additional incentive to attract
men to participate in weight-loss activities, which they had felt unable to do in other contexts. The football
context conﬁrmed the men’s male identities and made them feel comfortable. Our interpretation is that
the football club setting facilitated enrolment into a cohesive group of men with shared characteristics
(overweight team supporters) who partook in a task-orientated group to lose weight according to key
criteria for delivering health improvement groups.212 Similarly, Witty and White149 studied a weight-loss
programme that was set in a rugby stadium. Certain men seemed more inclined to attend a weight
management programme located in such a setting, which might be because of a reduction in men’s
anxiety in this setting. One respondent commented that he would recommend this programme to his
friends and that he found it more comfortable than traditional health services, because some men
still have:NIHRAnxiety or apprehension about consulting a health professional in a building that is very clearly a
health oriented building so I think that the opportunity to be able to access some form of health
service in an environment that I would imagine feels far less threatening.
Age 35–44 years, p. 25149The sense of well-being and pleasure associated with attending a football or rugby game contrasts with
the anxiety and fear that can be experienced when attending a programme in a health setting. Indeed, a
participant in the study by Gallagher and colleagues187 appeared to display a degree of distrust towards
health professionals and a lack of conﬁdence that they could offer effective solutions for his problems.
It may be that juxtaposing a challenging task such as weight loss with an activity that increases well-being
might help to overcome some of the emotional barriers such as anxiety and fear that could impact on
enrolment and engagement with interventions delivered in a health setting.
In Chapter 4 we discussed how Brady and colleagues138 deliberately targeted men who had a shared
passion for their football club. The trial attracted limited numbers of men from varying socioeconomic
backgrounds but all stated that they found the experience highly rewarding.
White and colleagues49 reported on men’s experiences of a weight-loss intervention based in the
workplace, which again appeared to act as an attractor for several of the men who took part.
A 54-year-old participant stated that being able to attend an intervention during work hours provided the
motivation to attempt weight loss, which is something he would not have attempted in the evening.
White and colleagues49 stated that the convenience of having the programme in the workplace played
a key part in attracting men; however, they also highlighted that male participation in work-based
programmes is to some extent dependent on the creation of a positive environment within the
organisation to provide the right climate for the initiative to work. In addition, one aspect that links these
three separate contexts (football stadium, rugby stadium, work environment) is that they ﬁt well with
masculine identities. Hunt and colleagues46 noted that, when a context is congruent with masculine ideals
and not challenging, attempts at engaging in weight loss and health improvement activities are more
palatable for men.Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Influence of partners, family and friends on men’s participation with
weight management programmes
The concept of hegemonic masculinity refers to a culturally normative ideal of male behaviour and is used
by Mallyon and colleagues188 to refer to the ways that men think about and do manliness, and speciﬁcally
as a construct that is the opposite of femininity. In the study by Mallyon and colleagues,188 which is
linked to a RCT from Australia, men who engaged in hegemonic masculinity received appropriate dieting
support from (female) partners in terms of the preparation of food, which helped them stick to a weight
management programme, whereas those less engaged in hegemonic masculinity were more likely to take
control of their own dieting practices. Mallyon and colleagues188 explain that men who engage in
hegemonic masculinity view dieting as a feminine activity that is about looking slim and pretty, which is
linked to vanity. Thus, hegemonically masculine men will look for ways to distance themselves from
dieting. For example, a participant who was described by the authors as being more engaged in
hegemonic masculinity explained his female partner’s role in his dieting. His wife cooked for him and he
acknowledged that his wife did it all for him.188
The role that female partners play in the preparation of food is also evident in other studies. Leishman193
provided an example in which a man undertaking the Camelon programme set a SMART goal (speciﬁc,
measurable, achievable, realistic and time limited) for his weight loss in which the importance of his
partner’s cooking was illustrated. Instead of having biscuits whilst waiting for his partner to cook for him,
he removed himself from that temptation by leaving the house to take the dog for a walk.
Contradictory results were found for the role of female partners in men’s weight loss in our quantitative
reviews of men and women94,112,120 (see Chapter 3). It is not possible to comment on any causal link
between quality of female partner support and weight loss for these studies, but differences could
highlight the importance of positive and negative inﬂuences of signiﬁcant others on weight-loss efforts.
The study by Mallyon and colleagues,188 which was linked to a RCT of an intervention delivered individually
in Australia, also provided an example of a family member having a negative effect on a man’s
engagement with a weight management programme. A quotation described how the man’s mother
thought that he was becoming gaunt and too skinny and his perception that her solution to everything
was to provide excessive amounts of food, which he blamed for his obesity. Some men undertaking
weight management programmes reported having difﬁculties if they needed to reject their mother’s
cooking (which might include large portions or high-calorie food) for dietary reasons, fearing that any
rejection would be perceived as a form of insult, which would damage the mother–son relationship.188
Mallyon and colleagues188 found that being less engaged in hegemonic masculinity could leave a man’s
adherence to dieting plans more vulnerable to social sabotage, which in turn could act as a deterrent to
adherence. In particular, the encouragement of male peers who were not dieting was found to be an
important issue in that, if male peers respond in a way that is perceived by the male dieter to be negative,
motivation to stick to a programme may diminish. Choosing against the expected social norm is
challenging, for example it was suggested that ordering a healthy meal at a restaurant would often be
questioned by male friends.188 Another participant’s motivation to adhere to a diet was tested and reduced
when he ate diet food while his friends ate normal food.188
Mallyon and colleagues188 suggested that in this context the diet functions as a barrier to normal
socialising with friends. Similar issues were presented by Kim and colleagues192 (linked to a faith-based
group weight management programme delivered within a rural African American community) with a205
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206participant explaining that peer pressure to consume unhealthy food affected his ability to adhere to
eating healthily, commenting on how strong you have to be to resist peer pressure:NIHR‘Man, you better get up from here – nobody want that food you’re eating. You know, eat something
that’s good for you.’ And it may, if you’re not strong enough, you gonna say, ‘Well, hey, maybe I’ll try
a piece’
Age 45 years, p. 641192Unlike the facilitating inﬂuence of cohesive group settings such as sports clubs or the workplace on the
engagement of men in weight management interventions, the inﬂuence of groups such as family and
friends can serve as either a facilitator of or a barrier to engagement with weight management
programmes and/or the prescribed advice forthcoming from such programmes. One of the studies not
linked to a weight management intervention provided evidence to conﬁrm the crucial role of partners in
weight-loss attempts, suggesting that sudden jolts relating to opportune moments or particularly symbolic
or important situations, as described earlier for health, can be the trigger for behaviour change for men:I realized for some time that I was overweight, and I wasn’t as fit as I should be, and the jolt was
my wife saying she’s not going on holiday sitting on a coach with a fat man on half a seat you know
Age 52 years, p. 799195On the other hand, it was found that partners of the homosexual men in the study could be very
unsupportive of weight-loss attempts, because weight loss made the man more attractive to others.195
Gough and Flanders197 provided a new theme on the inﬂuence of families, partners and friends,
demonstrating that the gay ‘bear’ community actively encourages men to reject established advice on
appropriate BMI levels in order to remain obese, which is seen as sexually attractive. The bear community
acts as a social milieu in which these men are empowered to reject the advice of health professionals
and feel, comfortable and desired in their obese state. This acceptance (of their overweight status)
was valued by some participants over and above the value they place on their personal physical health.
A 39-year-old man weighing 20 stone who developed type 2 diabetes as a consequence of being obese
downplayed obesity as being manageable and claimed to be more active, because of stopping smoking,
than when he was lighter. He was more comfortable being obese.The weight management programmeThis section presents and discusses themes that inﬂuence and shape men’s perspectives and experiences
when participating in weight management programmes. The content, format and delivery processes of
weight management programmes are considered, as well as how these relate to the individual, biological
and social determinants of health and well-being. The following themes are presented: men and diets,
alcohol and obesity, men and physical activity and understanding interactions within a weight
management programme. It should be noted that a degree of overlap was observed with the themes
relating to engagement described in the previous section. The demarcation of themes is presented here as
a dynamic rather than categorical process.Men and diets
As noted earlier, men may be more inclined to avoid what is perceived as the feminised realm of dieting,
in which women are often viewed as the experts.51 In addition, poor-tasting diets that emphasise smaller
portions are also hypothesised as a reason why men may distance themselves from dieting.44 However,
little is known about the subjective experiences of dieting men188 or the meanings that men attach to
food,51 or indeed their experiences and understanding of food.44 The approach in the Camelon weight
management programme was to de-emphasise the role of dieting and weight loss and emphasise a
personalised approach that accounts for individual needs, to make men feel in control of their weight loss.Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Gray and colleagues142 reported that this personalised approach gained the approval of some participants
who had taken part in the Camelon programme.
Evidence from Gallagher and colleagues187 also appears to support the idea that a personalised approach
is more appealing to men. Quotes from this study in which the intervention was delivered in a group
format without an individualised component show that men can ﬁnd a one size ﬁts all approach
confusing. Calorie counting was seen as needing time, which one 58-year-old man perceived as a barrier.
Another found it hard to put all of the components of losing weight together – what to eat, how to
exercise – and found that it could be too much, with a recommendation to break down the information,
implying a need to simplify the messages and reduce the burden.
The ﬁnding that individualised programmes are preferable to men is substantiated from the quantitative
evidence as successful programmes generally included some element of individual tailoring, either
in the form of individualised dietary allowances or advice and/or personalised feedback or support
(see Chapter 3).88,90,96,99,100,106,110,142,154,213
A similar de-emphasis on the role of extreme dieting was employed in the SHED-IT internet-based study,189
which some men compared positively with imposed crash diets elsewhere.
The SHED-IT programme also encouraged participants to enjoy some treats in moderation, such as beer
and junk food, which was welcomed by participants. One man (age 35 years) used a variant of the
expression ‘have one’s cake and eat it’ when referring to having your beer and losing weight.
A 21-year-old highlighted that:© Que
Health
provid
addres
Park, SThe most enjoyable aspect [of the SHED-IT programme] was the fact that it allows for those days
where you know, if you have a **** day at work you can just go and have a few beers afterwards
and not feel ****house for it
p. E245, quote as in the original189A 50-year-old participant quoted by Morgan and colleagues189 stated that an appealing aspect of the
SHED-IT programme was that he did not have to make any signiﬁcant alterations to his diet, whereas
a 19-year-old participant in the same study welcomed the fact that SHED-IT gave him choices and thus
facilitated personal control.
Therefore, men from three studies appeared to welcome aspects of programmes that placed less emphasis
on strict dieting and emphasised personal control over which foods they consumed. This appears to
support the notion that men are reluctant to diet and are attracted to engage in and adhere to
programmes that appear realistic and can feasibly be assimilated into their lives.Alcohol and obesity
According to Gray and colleagues142 alcohol may pose a particular problem for men in relation to weight
gain and thus alcohol intake should be managed when attempting weight loss. An alcohol awareness
component was built into the Camelon programme, with the role of alcohol in weight gain considered
and each participant setting SMART goals to decrease alcohol intake. However, there were no participant
quotes in the study by Gray and colleagues142 to shed light on any issues that men may have had with
alcohol in relation to their weight. One other study191 provided participant data on alcohol and obesity.
Here, a causal link between alcohol consumption and increased appetite is proposed. For example, one
34-year-old man suggested that after a few beers he lowered his defences and ate more. He would have
a few cans of beer most nights and put his feet up to watch television and he commented that with the
drinking his diet also deteriorated.
Several of the non-intervention studies provided evidence to both conﬁrm and (in one case) refute our
other ﬁndings on diet and alcohol. For example, the study by De Souza and Ciclitira195 conﬁrmed that men207
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208disliked the restrictiveness of strict dieting and having their alcohol intake limited, especially in social
situations. This was argued by the authors rather than being obviously evident from the data presented
from the men themselves. For example, the authors stated that a feature of maleness was avoiding
activities that could be construed as feminine, such as having a soft drink or following a diet.195
However, De Souza and Ciclitira195 also explained that the men in this study may have been atypical as
they admitted after several interviews to multiple weight-loss attempts in the past, including crash diets
such as the Cambridge diet or SlimFast, and described the difﬁculties that they had experienced in
maintaining weight loss. The authors argued that this could be the primary reason why they ﬁnally decided
to use a formal weight-loss programme, with the support of their partners, with it being perceived as
including a legitimate and sensible diet.
The study by Monaghan199 conﬁrmed that men undertaking weight management programmes prefer a
system in which they can still enjoy treats, which meet the programme goals but can undermine a healthy
diet. One of the participants described a point-based system based on energy-dense foods used by a
commercial slimming club. The man explained how he can still enjoy some chocolate, crisps and a bottle
of vodka at the end of the working week, yet stay within his weekly maximum points.Men and physical activity
The included qualitative studies contained very little on the views of men about physical activity. Most
data were provided by just one of the included studies46 linked to the group-based FFIT trial delivered in
Scotland at the stadiums of Scottish football clubs.
It is suggested that men may view physical activity in different ways from women, especially with regard to
using physical activity to become stronger, ﬁtter and healthier,47 and also in how they use pedometers for
self-monitoring.46 Men have also been posited to be more likely to use physical exercise than dieting to
control their weight.46,142
The use of pedometers in the men-only FFIT programme appeared to act as a key motivator for many
interviewees.46 In particular, the pedometer appeared to be useful in encouraging men to meet
prespeciﬁed individualised activity targets. One quote suggested that a man was competing with himself,
for example to reach his daily target of recommended steps, and that he changed his perception of
walking as a mode of travel:NIHRI’m walking places I’d just never have dreamed of walking
p. 6146In addition, a 72-year-old participant in the study by Gallagher and colleagues187 (linked to a group-based
RCT delivered in Australia) also felt that using a pedometer helped to facilitate weight loss by allowing him
to keep track and understand how much physical activity he undertook each day.
However, the perception of walking as enjoyable was not universal amongst participants. For example, one
man who wore his pedometer all the time still did not ﬁnd walking as attractive as attending the gym,46
and another participant in the same study had got bored with the lack of variety in walking routes.
That men like engaging in physical activity is supported by our review of the quantitative evidence
(see Chapter 4). Men were also more likely to be successful in their weight-loss efforts if they included
some element of physical activity in their weight-loss programme, but only if this was combined with some
form of dietary regime106,109 (see Chapter 3). In our review of men-only RCTs (Chapter 3), the trial by
Patrick and colleagues90 reported that pedometers were enjoyed by the men for their novelty and
assistance with self-monitoring of their behaviour. The men in this trial were randomised to receive a
low-fat diet with behavioural therapy and exercise advice or general health advice only. It should be noted
that, although the intervention group initially lost more weight, by 12 months the differences were notJournals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35statistically signiﬁcant, indicating that, although men may enjoy using pedometers, their usefulness in
losing weight may vary depending on the overall weight-loss programme. Alternatively, it may be the case
that the fun aspect of using pedometers declines with repeated use, which may negatively impact on
walking behaviour.
With the above in mind, the studies not linked to weight management interventions also displayed limited
data on men’s physical activity preferences. The study by Weaver and colleagues202 provided data that
conﬁrmed men’s enjoyment of exercise; their participants spoke of experiencing various immediate
beneﬁts, such as being more alert or being less stiff.
Nevertheless, pain as a limiting factor for exercise was raised as a new theme by Weaver and colleagues.202
Many men particularly described having knee pain, which had a debilitating effect on their ability to
exercise. Interestingly, different causal relationships were proposed between knee pain, exercise and
obesity. Some men thought that their exercise regime had caused the knee pain, which in turn resulted in
weight gain. Weaver and colleagues202 weighed up the available evidence and suggested that taking
exercise is unlikely to cause osteoarthritis (unless perhaps in top footballers) and that obesity is clearly
linked with long-term knee problems. They concluded that men need to be educated about the impact of
weight on their knees and about weight loss as a means to prevent knee problems.Understanding interactions within a weight management programme
The data pertaining to interactions within the weight management programme were diverse. Within this
theme we provide ﬁve further subheadings: group-based programmes and social support, promoting
engagement and the use of humour, scientiﬁc appeal, accountability and adherence, and goal setting.Group-based programmes and social support
Several studies highlighted the importance of group-based weight management programmes. Proponents
of this approach argued that it facilitated peer or social support amongst people with similar health
problems. This was observed in the study by Leishman,193 which was linked to the group-based Camelon
programme, delivered in men’s health clinics in Scotland. Here, men praised the support that they got
from each other and valued the ability to talk to other men on a similar programme.
In addition, a 34-year-old participant in the study by Harrison191 was surprised at how supportive his work
colleagues were of him taking part in the Health of Men work-based programme, something he had not
expected. Nevertheless, the study by Morgan and colleagues89 found that men undertaking an individually
based weight management programme that was internet based would have preferred more contact with
the instructor as opposed to peer support, but no participant quotes were provided to support this
assertion. However, it is difﬁcult to know how generalisable this ﬁnding is to interventions not delivered
over the internet.
Indeed, the study by Leishman193 emphasised the importance of support offered by health professionals
delivering weight management interventions to help men to stay conﬁdent about their ability to lose
weight and to stay motivated to do so. Leishman193 argued that men should be encouraged to focus less
on ideal body weight, which if using the BMI classiﬁcation would involve losing large (and unrealistic)
amounts of weight. Leishman193 argued that this would be unachievable for many men and instead
recommended that men should be directed towards smaller, more realistic weight-loss goals of 5–10%,
which still have many direct health beneﬁts and seem more achievable.
Other authors suggested that group-based programmes can be logistically difﬁcult with regard to
scheduling meetings and are therefore impractical for time-poor men who already consider time a barrier
to engagement with physical activity.190
Although our quantitative data85,86,90,95,96 supported the assertion that group-based programmes produce
beneﬁcial results (see Chapter 3), men may be less inclined to join these types of programmes depending209
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210on their perception of the weight-loss provider, setting or gender mix.100 Group-based weight
management programmes have been stated to produce more weight loss than individual programmes,
even for those who expressed a preference for individual treatment.121,214 Leishman’s study193 linked to the
group-based Camelon programme delivered in a Scottish health-care setting147 noted that factors such as
group competitiveness and team spirit can motivate men to meet their goals, whereas the potential for
group camaraderie to facilitate the sharing of information, tips and humorous banter can help men to
meet weight-loss targets and reduce attrition.215Promoting engagement and the use of humour
In Engagement with weight management programmes, describing the importance of location and setting
as a ‘hook’ to engage men, the role of humour in attracting men to programmes was mentioned. The
included studies also found that humour and banter had a valuable function in building positive
relationships between group members and promoting adherence to a programme once engaged. For
example, a participant quoted in the study by Gray and colleagues142 (linked to the group-based Camelon
programme delivered to men in health clinics in Scotland) explained how the camaraderie and enjoyable
conversation in the group made men want to come back the following week. Similarly, a participant in the
study by Leishman193 enjoyed and was helped by the atmosphere, laughter and support from men who
were all there for the same reason.
Of the non-intervention studies, Gillon196 conﬁrmed that humour was used by men when discussing issues
related to weight and was often useful. One participant’s quote discussed how being a rugby player in his
youth and being very active had helped him maintain a steady body weight, despite the fact that he
tended to eat lots.
The experience of a team atmosphere, with men in similar situations attempting to achieve similar goals,
was also found to play a part in the perception that group-based programmes were preferred. This
connects with the earlier discussion in which we identiﬁed the value of employing cohesive, task-oriented
groups for men engaging in a process of weight management. For example, a participant in a study that
was linked to the Camelon programme delivered to men in groups in a health clinic setting perceived that
being with men who were in the same situation as himself made him realise that he was not alone.142
In addition, the importance of sharing commonalities (i.e. being a rugby fan and being overweight)
with fellow participants was also valued by a participant in the group-based programme at a rugby club
described in the study by Witty and White.149
However, in our quantitative review of UK studies, half of the men (10/20, 50%) attending the Bloke’s
Weigh programme147 stated that they would have attended a mixed-gender programme and in the Leeds
Rhinos study139 the male-only environment was the least important reason for joining the programme
(see Chapter 4).
Nevertheless, a participant in the study by Morgan and colleagues189 explained that the male-only feature
of the SHED-IT programme was important in that it helped to facilitate engagement in male-oriented
banter that for him would have been curtailed in a mixed-sex environment.
Several authors offered views on why they believed that interventions for men should be different from
those for women; however, these assertions were unsupported by participant quotes. For example,
Gray and colleagues142 argue in their study linked to the Camelon programme that the association
between femininity and dieting may act as a major barrier for men:NIHRHowever, the current evaluation suggests that the perceived focus on the ‘feminine domain’ of
dieting within the commercial sector may also act as a significant barrier to men
p. 78Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Mallyon and colleagues188 also contended in their study linked to an individually delivered intervention in
Australia that male weight management programmes should be framed in such a way that they do not
threaten masculine identities, but also conceded that more research in this area was required.Scientific appeal
Mallyon and colleagues188 suggested that it might be possible to enhance the attractiveness of weight
management programmes for men by emphasising their scientiﬁc appeal. This, they contended, can help
to draw attention away from associations of dieting with feminine weakness. Furthermore, Mallyon and
colleagues188 stated that emphasis on the scientiﬁc nature of a weight management programme can
empower dieting men to resist social sabotage by (often well-meaning) friends and family if they try and
entice them to eat like a real man.Accountability and adherence
Adherence is a decisive factor in predicting success for participants undertaking weight management
programmes.216 With this in mind, the included studies detailed various methods to help participants stick
to the programmes in terms of being accountable to oneself and having to account for food choices to
others within the programmes. One such method involved creating ways to promote self-monitoring and
accountability for participants. For example, the study by Abildso and colleagues,190 which was linked to a
group-based insurance-sponsored weight management scheme delivered in the USA, encouraged
participants to use a daily food log that was checked by programme staff. The accountability that came
with staff reviewing the food logs was stated to be central to successful participant weight loss, and
statistical analyses revealed that these food logs were more frequently completed by those who lost a
large amount of weight than by those who lost a moderate amount of weight. The following participant
extract supports this:© Que
Health
provid
addres
Park, SWhat really helped me was having somebody go over the food log every day. That was the big thing;
just having staff talk about things I was eating, choices I was making, maybe making a few little
suggestions – that was really very helpful.
No individual characteristics provided, p. 286190Accountability for one’s own actions whilst undertaking a weight-loss programme was also a factor that
promoted adherence in the study linked to the SHED-IT website-based programme delivered in
Australia.189 Men felt accountable by keeping track through the weekly weigh-ins.
Morgan and colleagues189 also reported a similar approach to awareness and self-monitoring of food
intake to promote adherence. As outlined in Chapter 3, participants were randomised to either a
weight-loss information-only group or to a group who received weight-loss information, use of
a weight-loss website and individualised support from programme staff. Both groups received a
weight-loss handbook that detailed a simple energy in/energy out equation, allowing participants to keep
a record of their energy intake balance. Morgan and colleagues189 stated that this was mentioned as a
source of satisfaction and acted as a mechanism that participants used to control their weight. With this in
mind, sticking to the mathematical equation was found to aid initial weight loss, which facilitated further
adherence. For example, a 43-year-old man was quoted as noticing that his energy count was directly
related to weight, with this knowledge acting as a motivating factor. Similarly, two younger participants
preferred the regular counting routines in contrast to less concrete aspects of support. The 21-year old had
used some support early on to get going and the 19-year-old seemed to prefer the calorie counting and
spoke quite derogatively about the ineffective support.
That men welcome simple, fact-based instruction as part of their weight-loss programme is supported by
the reported preferences of men who participated in focus groups during the intervention development
stage of the trial conducted by Patrick and colleagues90 (see Chapter 3).211
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212The internet users in the programme reported by Morgan and colleagues89 were also asked to submit food
(and exercise) logs to receive feedback from programme staff, in a similar approach to that successfully
employed in the study by Abildso and colleagues.190 One man was quoted as saying that the website
format alone was sufﬁcient to maintain adherence and self-discipline. He described how he did not
need or want someone telling him what to do; he had the knowledge and the website provided him
with accountability.89 This acknowledges the intrinsic motivation that is required to engage in
such programmes.
In the Nutracheck study154 (see Chapter 4) men made more frequent diary entries than women, suggesting
that they prefer this type of self-monitoring activity. However, in the study by Morgan and colleagues,89
non-compliers found that keeping a food diary was overly time-consuming and thus operated as a barrier
to successful adherence:NIHRIt was just constantly having to get to a computer everyday and spend 10/20 min on there trying to
plug in everything I ate was a bit tough
No individual characteristics provided89A further complaint of non-adherers to this internet programme pertained to a lack of face-to-face contact
with programme staff, which was stated to act as a barrier to adherence. Certain participants felt that
small group meetings or lectures would have given a more human touch to the project, facilitated peer
support and helped maintain focus and motivation.Goal setting
A further way in which participants were encouraged to stick to programmes was by setting weight-loss
goals. For example, a participant in the study by White and colleagues49 linked to the Health of Men
group-based programme delivered in the workplace described how setting easy weight-loss goals and
anticipating the satisfaction of achieving the 1- or 2-stone weight loss 1 year later helped his adherence
and motivation. However, this quote also highlights that there may be a mismatch between participants’
expectations about goals and the targets that are found in the weight-loss literature. The published
literature suggests goal-setting targets that are much lower than the targets stated by individuals wishing
to lose weight. For example, the quantitative systematic reviews in this report have demonstrated that
weight loss of 2 stone (13 kg) after 1 year was rarely achieved (see Chapters 3 and 4).
Other studies described the use of innovative methods to demonstrate achieved weight loss to men and to
help men stick to a weight management programme. The study by Gray and colleagues142 linked to the
group-based Camelon programme delivered in Scotland explained how sandbags were used to give men
tangible physical evidence of their weight loss at the midway point of the programme. A participant in the
study by Leishman193 (which also investigated men’s experiences of the Camelon programme) explained
how proud he was when he held the bag of sand and its weight and the motivational effect that this had
on him at the half-way stage of the programme.
Mallyon and colleagues188 examined before and after body scans of men who participated in their trial.
The ability of men to compare scan images showing differences in body shape/weight was stated to help
them stick to the diet and to be a motivational factor for losing weight.The impact and consequences of weight-loss programmesSeveral studies included data from participants reﬂecting retrospectively on their participation in weight
management programmes and the consequences of participating. These reﬂections centred on the
following issues: how programmes impact on partners and family members, the downside for men of
losing weight, improvements in health and fears of relapse when programmes end.Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35How programmes impact on partners and family members
Within the included studies there were many reported reﬂections on how aspects of programme activities
indirectly impacted on the family members of participants. For example, the Camelon group-based
programme delivered in men’s health clinics in Scotland142,193 appeared to have a positive impact on the
partners/family of participants. To investigate indirect effects of the programme on female partners, Gray
and colleagues142 conducted a focus group with female partners of men taking part in the programme.
This focus group research indicated that many of the female partners had been inﬂuenced by the men’s
engagement with the programme. Indeed, some women had followed the programme alongside their
male partner, whereas others stated that their family (including children) were snacking less, taking more
exercise and eating more fruit and vegetables. Some women observed that their male partner’s
involvement in the Camelon programme had made them think more about what they were eating.142
In addition, a participant in the study by Leishman193 suggested that the Camelon programme had a
positive inﬂuence on both his own and his female partner’s eating habits, for example they ate smaller
portions and fewer unhealthy snacks. Similar indirect effects on close family members of the SHED-IT
website programme were found in the study by Morgan and colleagues,189 who described a 36-year-old
speaking of his whole family now eating healthier home-cooked food and fewer takeaway meals.
A 40-year-old man referred to his wife walking every morning, something she did not do before he got
involved in the SHED-IT programme.
A further effect of weight management programmes on partners and family members was observed in
the study by Gallagher and colleagues187 that was linked to a group-based intervention in Australia.
It was inferred that nutritional knowledge gained by men through undertaking a weight management
programme can be passed on to their children. This was supported by a quote from a man who stated
that he was actively teaching his 13-year-old son the right things to eat so that he could make informed
choices regarding his weight.The downside for men of losing weight
Gray and colleagues142 found that men attending the Camelon group-based programme felt dissatisﬁed
with their weight only when they were labelled as obese, for example one 15-stone man was quoted as
saying that if he lost too much weight he would probably start looking ill. This sentiment regarding weight
loss was found to be universal amongst the men interviewed by Gray and colleagues,142 meaning that, for
these men, being in the overweight range represented an ideal weight and they did not want to become
too thin.
In a second-order construct, Gray and colleagues142 suggested that this phenomenon arises from social
norms with regard to the construction of the ideal male. This dictates that men should be bigger and
stronger than women, referring to the ideal male bodybuilder’s body. They concluded that such ideal
overweight body images may render health promotion interventions to lose weight ineffective.
With regard to the non-intervention studies the study by Gough and Flanders,197 which conducted
research with men who were active members of the gay ‘bear’ community, conﬁrmed the view that losing
too much weight can result in a perceived unhealthy appearance. A 37-year-old man explained that
losing weight as a gay man could be associated with being human immunodeﬁciency virus positive. When
he lost weight he felt uncomfortable, lost conﬁdence and stopped going out to meet people and he
recalled how losing weight made him feel unhappy and lonely. Furthermore, Gough and Flanders197
quoted a 44-year-old man who did not want to adhere to a perfect BMI because:© Que
Health
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Park, SI want to be around 16 stone, my GP wants me to be 12.5 stone, if I was 12.5 stone, I’d look like I’d
been incinerated, something out of Jason and the Argonauts, like the skeletons walking around
p. 248197213
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214These statements suggest that men from a range of backgrounds are keen to avoid looking too thin. The
study by De Souza and Ciclitira195 also found that gay men may be put off losing too much weight in case
it threatens their relationship with their partner. In addition, Monaghan199 noted in his ﬁeld diary that
some men expressed anxieties about the potential adverse health impacts of rapid weight loss and crash
diets, with some agreeing that men need to lose weight gradually to give their bodies a chance to adapt
and to stabilise the effects on the heart, kidneys and muscles.Improvements in health
The studies by Abildso and colleagues190 (linked to a group-based insurance-sponsored weight
management scheme delivered in the USA) and Hunt and colleagues46 (linked to the group-based FFIT
trial delivered at the stadiums of Scottish football clubs) reported that many participants experienced
beneﬁts to health beyond weight loss after participating in the programmes. Examples of such health
beneﬁts included improved sleep, decreased pain, improved blood pressure, improved cholesterol levels,
loss of leg neuralgia and a decrease in headaches associated with coming off some of the medications
taken for conditions related to obesity.46,190
In addition, there were accounts of how physical ﬁtness had improved as a consequence of a weight-loss
programme, with positive consequences for health, with some being quoted as having a more positive
mindset, feeling younger or being able to walk up stairs again.46 Feelings of subjective well-being induced
by greater ﬁtness levels were also found in the study by Harrison,191 who quoted men who were proud of
their physical achievements in the gym.
These accounts of improved perceptions of health and well-being are positively reinforcing for both
adhering to the programme and sustaining behaviour change after the programme has ended. They
illustrate the sense of achievement and motivation resulting from success.Fears of relapse when programmes end
The study by White and colleagues,49 which was linked to a workplace-based weight management
programme delivered in England in a group format, described how concern was expressed that the group
might gradually stop meeting after the programme ended, which would perhaps impact on adherence to
the messages of the programme after it ended. In particular, a participant expressed doubts about group
members continuing to walk without the group support, in the context of busy working lives. Three- to
6-monthly group reunions were seen as a good idea to review progress. Popping into a group to be
weighed or have blood pressure checked was perceived as more likely.49
This notion that some men would like to continue meeting up with their group after the programme had
ﬁnished is mentioned further in the study by White and colleagues.49 A Health of Men support worker
expressed surprise and noted that men had initiated a poster on a board to document participants’
weights, with continued regular weighing perceived as important, particularly if the men did not have
scales at home. Sustained access to equipment and a dietitian were also considered important; however,
concern was expressed about the lack of capacity to sustain ongoing weekly meetings.
The need for more sustained interventions was therefore evident, but this received little attention in the
studies that we identiﬁed.ConclusionsThe key ﬁndings from this chapter are detailed in the following sections.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Social, cultural and environmental influences on obesity in men1. Men made very little reference to wider social determinants of their behaviour and instead focused on
their motivation and own agency to overcome (or attempt to overcome) those secular macro-level
changes that have encouraged the overconsumption of energy-dense foods and constrained or reduced
opportunities to be physically active.
2. The role that the environment plays in inﬂuencing behaviours helped some researchers decide where to
locate the delivery of weight management programmes. For example, the programme described by
Harrison191 and White and colleagues49 was located in the workplace, with the rationale that it was
more convenient to access than a programme in a non-workplace setting.
3. The importance of the theme of sociostructural determinants of obesity in contrast to the obesity as
individual responsibility standpoint is supported in four of the studies not linked to weight
management interventions.Engagement with weight management programmes1. The main reasons that men gave as their primary motivation for losing weight were a diagnosis
of obesity, health scares, particularly if hospitalisation was involved, and a desire to improve
personal appearance.
2. From the participant data available we did not establish whether or not male-only weight-loss
environments were more attractive to men. Data were presented that did indicate that men felt more
comfortable in these settings; however, we also observed that a male-only setting was not consistently
considered to be an issue that would attract men to participate.
3. The use of humour in promotional materials for weight management programmes
(e.g. comical language and imagery, such as a picture of a beer glass) attracted men. In addition,
the knowledge that programmes had been successful for other men increased the likelihood that
men would participate.
4. Men were reluctant to undertake any forms of strict dieting as part of a weight management
programme.
5. Men appeared to prefer community or workplace settings for interventions over hospital or other
health-care settings.
6. The pivotal role of female partners emerged as an important aspect of successful weight-loss attempts.
7. Motivation to stick to a programme may diminish if family members and male peers who are not
dieting respond in a negative way to men who diet.
8. The included qualitative studies contained very little information on the views of men on physical
activity. However, the data indicated that the use of pedometers appeared to act as a key motivator
for men. In particular, pedometers appeared to be useful in encouraging men to meet prespeciﬁed
individualised activity targets.The weight management programme1. Group-based weight management programmes were found to facilitate peer or social support amongst
people with similar health problems, despite the fact that some men were initially reluctant to take part
in a group programme.
2. However, group-based programmes can be logistically difﬁcult with regard to scheduling meetings and
therefore impractical for time-poor men who already consider time a barrier to engagement with
physical activity.190
3. The included studies found that humour, banter and camaraderie had a valuable function in
building positive relationships between group members and promoting adherence to programmes
once engaged.
4. Men found that being accountable to themselves and having to account for food choices to others
within the programme facilitated adherence.215
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2165. A further way in which participants were encouraged to stick to programmes was by setting
weight-loss goals.The impact and consequences of weight-loss programmes1. The weight management activities of men were found to have had an indirectly positive impact on
family members in terms of improved nutrition and increased physical activity levels.
2. Men from a range of backgrounds were keen to avoid looking too thin.
3. Men experienced beneﬁts to health beyond weight loss after participating in the programmes.
4. In the case of group-based programmes, concern was expressed that groups may gradually stop
meeting after the programmes ended and this might impact negatively on adherence to the messages
of the programmes. The need for more sustained interventions was evident.What is missing from the qualitative data?1. Experiences and perspectives of men from black or ethnic minority backgrounds, low-income or
unemployed men and rural and/or remote-dwelling men.
2. Although we have a little insight into gay men’s perspectives and experiences of weight-loss attempts
from the non-intervention studies, these insights are missing from the intervention literature.
3. Qualitative studies that target mixed samples of men and women need to make gender evident in the
reporting of data to provide a clearer gender picture in relation to the results.Quality assessment of qualitative studies linked
to interventionsOur quality assessment covered the following ﬁve items: aims and methods, sample details, reﬂexivity,
ethics and general criteria.Aims and methods
Seven studies45,87,141,148,186,188,189 stated an explicit aim of the research with one stating a research
objective.49 Another stated both an explicit aim and an objective,194 whereas four studies188,191–193 did not
state any explicit aim (or objective). In addition, just two studies188,189 stated explicit research questions in
the text and only three188,192,194 were clear about the theoretical perspective underpinning the research. In
terms of describing the theoretical perspective underpinning the intervention that the qualitative study was
linked to, three studies46,89,192 provided this information. All studies provided an account of the qualitative
methods that were used to gather data and all but two studies191,193 provided in-depth accounts of the
chosen procedure for data analysis.Sample details
Only two studies149,193 failed to provide a clear statement pertaining to sample size. In terms of sample
characteristics, just three188,189,191 of the male-only studies provided this information. Of the mixed-sample
studies, only that by Ogden and Sidhu194 provided sample characteristics clearly by gender, with those by
Abildso and colleagues,190 Gallagher and colleagues187 and Kim and colleagues192 providing sample
characteristics but not by gender. In addition, nine46,89,142,187–190,192,194 of the studies provided a clear
description of the sample selection process. Seven46,89,142,187,189,190,192 of the 13 studies provided clear details
of sample inclusion and exclusion criteria.Reflexivity
Reﬂexivity is a credibility-adding concept that is central to robust qualitative research. It refers to the
qualitative researcher’s engagement with self-critique and self-appraisal throughout the research and
explains how his or her own experience has or has not inﬂuenced the stages of the research process
(Koch and Harrington217 cited in Dowling218). We were therefore interested in investigating whether or notNIHR Journals Library www.journalslibrary.nihr.ac.uk
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the included studies detailing the ways in which the work was limited, only the study by Morgan and
colleagues189 considered the role that the researchers may have played in inﬂuencing the ﬁndings. For
example, they drew attention to the fact that, as the researchers and research staff conducted the
interviews; this may have led to some socially desirable responses from respondents.Ethics
We further assessed whether or not the studies linked to interventions provided any details regarding
ethical issues such as obtaining approval for the study from an institutional ethics board. Only
three191,193,194 of the included studies did not refer to any ethical issues in the text.General criteria
The ﬁnal section of the quality assessment investigated more general aspects of quality in the studies
linked to interventions. First, we asked whether or not the ﬁndings were adequately supported by the
data. We found that six studies49,89,188,189,192,194 stated second-order ﬁndings that were unsupported by
participant data in the study text. However, it should be noted that this issue may occur because of
stringent publication word limits. We further investigated whether or not there was the potential for
charisma effects in the research regarding the inﬂuence of the study principal investigator or a member of
the research team. We suggest that there may have been the potential for such a phenomenon to occur in
the studies reporting qualitative data from the SHED-IT internet-based trial from Australia. How the
intervention is delivered and the qualitative data are collected may inﬂuence how feedback on the
programme was reported by certain participants, in that favourable responses may have been given. For
example, in the study by Morgan and colleagues89 the authors state that the men would have preferred
more contact with the instructor rather than peer support (p. 147). However, it is unclear whether or not
the principal investigator is the actor referred to by the term ‘instructor’. This would seem to infer that the
instructor has a positive motivational inﬂuence on the men, which will most probably affect the ability of
the programme to be effectively replicated elsewhere if the same charismatic inﬂuence is absent.
Finally, we addressed any other issues relating to the quality of the studies that were not covered by the
previous items of the quality appraisal tool. In total, ﬁve studies89,187,189,190,192 had issues that we considered
were important when interpreting the data. For example, the studies by Abildso and colleagues190 and
Gallagher and colleagues187 did not address the possibility that men and women may require different
things from a weight-loss programme to successfully lose weight. In addition, the faith-based programme
detailed by Kim and colleagues192 lasted for just 8 weeks, which may have been too short a time.
Furthermore, the studies by Morgan and colleagues89,189 linked to the internet-based SHED-IT trial are
limited in that only the most successful participants in terms of losing weight were interviewed. Thus, the
data presented suffer from bias as the less successful participants and those who may not have actually
liked the programme were not interviewed.217
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In this chapter we very brieﬂy summarise our ﬁndings and current policies and guidelines relating tomen’s health and obesity before discussing the ﬁndings from all of the reviews in detail, following our
evidence synthesis logic model (see Chapter 6). Our ﬁndings should be interpreted with the knowledge
that the evidence base, particularly in the UK setting, is currently limited in the quality and number of
studies and mainly reﬂects white, middle-class, middle-aged men. Few UK studies had long-term data
available. Our results may not necessarily be applicable to all men. Some of our ﬁndings may also be
applicable to women, but our reviews were not designed to answer questions on weight-loss programmes
for women. We had difﬁculties retrieving studies and it is possible that the studies that we found had
more promising results than those we were not able to access.Summary of ﬁndings and policy implicationsThere were some consistent ﬁndings across the systematic reviews that may help with the formation of
policies to increase men’s uptake of and continuation with weight-loss programmes. Health issues were
important intrinsic (because of increased levels of concern) and extrinsic (prompting advice from others)
motivators to engage in programmes and change behaviour. Although health service staff can help
motivate change, setting programmes in the health service may be far less attractive than using settings,
such as a football stadium, that provide long-term social support and an ambience (e.g. humour and
banter) that appeals to men.
Physical activity has more appeal for men than women as a means of weight control (although physical
activity on its own is unlikely to result in much weight loss). Dieting, particularly strict dieting, is seen as
a feminine activity. Thus, although reducing diets are needed for greater weight loss, strict diets seem
unpopular and terms such as ‘healthier eating’ (which allows for treats such as alcohol) and ‘portion
control’ seem to be more appealing to men.
Men may have particular difﬁculties perceiving that they or others are overweight or obese, because of
the desirability of muscularity and the masculinity of a large body size. Obesity can be conceptualised as a
predominantly female issue around image, a viewpoint perhaps reinforced by the greater attendance of
women at weight-loss programmes.
A consistent ﬁnding was the lack of consultation with men when developing or evaluating interventions,
with very little qualitative research, which is surprising as men are under-represented in almost all
weight-loss interventions. NICE3 and SIGN52 also have not provided speciﬁc guidance for men for the
prevention and treatment of obesity. However, our data show that, once committed, men are less likely to
withdraw from programmes and might experience relatively more weight loss than women. Therefore, a
focus only on lack of engagement with programmes can underestimate the beneﬁts of existing programmes.
The need for men’s health strategies in member states has been highlighted by a European Commission
report,219 which called for policy, research and practice to be developed speciﬁcally for men, whose health
may be even more disadvantaged by deprivation. The Republic of Ireland has a national men’s health
policy, which has increased the focus on men’s health and community settings targeting disadvantaged
men, but the countries of the UK do not.220 In the UK the Equality Act 2010221 (applicable to England,
Scotland and Wales) has improved men’s health.222 The introduction of Gender Equality Duty in 2007
placed a legal obligation on the NHS and public bodies to take account of the speciﬁc needs of men and
women in these countries.222
The Men’s Health Forum in England and Wales has been given ‘strategic partner’ status by the
Department of Health.222 The Men’s Health Forum in Scotland also works closely with the Scottish219
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220government. For example, in 2005 the Scottish government provided funding to support community-based
partnerships in developing Well Men’s Services, funding 16 pilots across seven health boards in Scotland,
targeting disadvantaged areas.211 Northern Ireland bases its equality obligations upon Section 75 of the
1998 Northern Ireland Act.223
The Men’s Health Forum in England and Wales convened a conference about men and weight issues in
2005 with 23 health and social policy researchers. The outcomes of this conference were subsequently
published in a book entitled Hazardous Waist: Tackling Male Weight Problems.54 The need to focus on
male-sensitive approaches to weight-loss issues was apparent then and was encompassed by the
publication of The HGV Man Manual,224 designed in the format of the Haynes car maintenance manuals.
However, in the UK, initiatives speciﬁcally to help obese men, particularly from disadvantaged groups, lose
weight, both within the NHS and outside the NHS, are still relatively few in number, with few evaluations
available. The NHS Health Trainer Service aims to promote behaviour change in socially disadvantaged
people in England and Wales. The most recent study225 showed that only 21% of clients were men,
although 69% were from the two most deprived quintiles.
The ﬁndings from our systematic reviews were limited by the relatively low numbers of included studies.
This was especially the case with regard to data from the UK. It is also important to consider that men are
not a homogeneous group. We had even fewer data or no data at all on men from deprived, unemployed,
ethnic minority, younger age, disabled, gay, bisexual, transgender, rural and other minority groups.Discussion of the results from the systematic reviews
How are men motivated to lose weight and to participate in weight
management programmes?
We found that men were signiﬁcantly less likely to drop out of weight-loss programmes than women, and
there was some evidence to suggest that they might lose relatively more weight than women. Morishko
and colleagues30 undertook a systematic review of predictors of dropout in weight-loss interventions and
reported narrative ﬁndings that sex was not associated with attrition. However, their review did not focus
on RCTs only and there was no statistical synthesis of the results. Our results suggest that men may be
harder to engage than women, but then show great commitment, emphasising the need to improve
engagement without diminishing commitment.
The evidence from the qualitative studies suggests that middle-aged men were attracted to lose weight
once they perceived that they had a problem with their health (particularly a health scare or
hospitalisation), and were diagnosed as obese by a health professional or labelled with the term ‘obese’,
and/or their weight was shown to them on a chart by a health professional.44,187,189,193–195 Feeling
unhealthy was also a motivator.49 These ﬁndings could reﬂect the predominantly white, middle-class and
middle-aged men recruited, who were conscious of their mortality, or suffering from some form of chronic
condition that they believed, or had been told, might be ameliorated by weight loss. GP referral to a
commercial organisation increased the proportion of men taking part compared with self-referral, again
suggesting that for some men concerns about their health and health professionals’ advice acted as
motivators to engage in a weight-loss programme. However, qualitative research in the UK reports that
GPs think that obesity management is not within their professional domain, even if patients would like
them to take responsibility for their weight problems.226 Contacts with primary care can provide ‘teachable
moments’,227 which are opportunities to motivate people to change unhealthy behaviours and
opportunities for referral or signposting to available services. ‘Teachable moments’ might be of particular
beneﬁt to men from disadvantaged backgrounds, providing that they are in contact with health services
already. Offers of health screening, such as checking cholesterol or blood pressure, including checks
provided outside health service premises, may also be a way of engaging with obese men. We also found
that ‘jolts’ from a partner195 and word of mouth recommendations193 could also help with motivation to
lose weight and engage with services.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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obese men. Programmes with low-fat reducing diets and/or physical activity, with or without behaviour
change training, improved erectile dysfunction in men with and without type 2 diabetes85,110,122 and
prevented diabetes,104 although in type 2 diabetes successful weight loss might increase the risk of
osteoporosis.124 These health beneﬁts could also help motivate men, for example the potential beneﬁt on
erectile dysfunction is probably not well known to men. Qualitative research also showed beneﬁts for men,
including taking fewer medications, decreased morbidity, increased mobility, such as the ability to tie
shoelaces,190 increased physical ﬁtness46,191 and improvement in outcomes not traditionally associated with
obesity, such as a reduction in headaches.
The desire to improve personal appearance was an important motivator to lose weight in men too, such as
the recognition by one man that he was starting to look like his obese father.189 However, male social
norms and expectations about body size mean that men, in contrast to women, may express a desire to
gain weight rather than lose it, as a means of living up to bodily ideals emphasising strength and size.228
The term ‘bigorexia’ has been used to describe large muscular men who do not wish to look small.195
It was clear from our review that men from a range of backgrounds were keen to avoid looking too
thin.142 The importance of appearance as a motivator was also evidenced from the very small gay sample.
We also found evidence that the so-called gay ‘bear’ subculture celebrated and encouraged men to take
on a large body size.197
We found that interventions in community (particularly associated with Premier League football or rugby
clubs) or workplace settings were acceptable and attractive to male supporters and preferable to
interventions in hospital or health-care settings. The sense of well-being and pleasure associated with
attending a football or rugby game contrasts with the anxiety and fear149 that can be experienced when
attending a programme in a health-care setting.187 Interventions situated in sporting contexts46,138,149 may
provide men with a strong sense of afﬁliation and belonging, bolstering male identities and masculine
social capital. Our interpretation is that associating long-standing loyalty, commitment and pleasure
attained from collectively supporting a football team (still predominantly a male activity) while challenging
men’s lifestyles to encourage behaviour change, such as losing weight, could hypothetically increase the
likelihood of ‘contagious motivation’ amongst fans. The club setting for the programme, with the kudos of
club privileges such as access to team coaches, changing facilities and club tops, seems to reinforce a
connection between being a club supporter and losing weight, and appears to ﬁt the theory of associative
coherence.229 The motivation for being a long-standing team supporter could either consciously or
subconsciously become associated with the motivation to lose weight with fellow team supporters. The
National Institute for Health Research-funded FFIT trial is evaluating the long-term weight outcomes in a
weight-loss programme delivered through SPL football clubs.230
However, the reach of programmes delivered through sporting venues is not clear, both among the club
supporters and among obese men generally. Sporting venues may not be the most promising point of
contact for the majority of obese men. Workplaces offer another opportunity to engage men49 and have
the potential to inﬂuence productivity and absenteeism.231 Clubs in workplaces and for supporters will not
reach those who are unemployed or unable to afford the cost of attending sporting events. Venues that
are associated with male identities outside the NHS need to be selected to deliver programmes that could
reach and engage these disadvantaged groups, such as barbers, pubs and road service stations.232,233
Careful use of humour in promotional materials in weight management programmes, such as comical
language and imagery (e.g. a picture of a beer glass189), attracted men. However, these should be piloted
ﬁrst as humour has the potential to backﬁre if issues are seen to be trivialised (Paula Carroll, Men’s Health
Forum Ireland, 4 December 2012, personal communication).221
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222What makes weight-loss programmes more effective for men?
Reducing diets and alcohol
There was clear evidence from the randomised trials that reducing diets, particularly low-fat reducing diets,
were effective for men and were the most important component of any weight-loss intervention. We were
unable to establish that the nutrient (such as providing more protein) or calorie content (provided that
there is a prescribed calorie deﬁcit) of the reducing diets inﬂuenced the amount of weight lost long term
by men.83,87,91,107,113,140,146 Men did not want to undergo strict or extreme diets142,189,193,195,199 and it may be
that using ‘healthier eating’ terms can be used to promote reducing diets to men.193 The ability to have
some alcohol and food treats was also valued.89,199 However, intermittent periods of very low-calorie
dieting, as required, may be better than regular periods of such dieting.103
Men reported valuing the scientiﬁc appeal of the energy intake and calorie expenditure equation and liked
having the ability to monitor their calorie intake.188,189Physical activity interventions
Men do well if physical activity is part of a weight-loss programme and they may be more likely to respond
to such a programme than women.93,106,109 However, weight loss was better with a reducing diet than
with physical activity alone, and better still if both were provided,91,93,109 although one small trial did not
ﬁnd that a physical activity programme and reducing diet were better than the diet alone.92 We found very
little qualitative data from men themselves on physical activity interventions.
The success of the interventions in football clubs and rugby clubs, with their focus on physical activity,
reinforces the importance of this aspect for men’s weight-loss programmes. However, pain and
comorbidities may be limitations.202 Men reported that they liked using pedometers.46,90,187 NICE234
presently recommends that pedometers are used only as part of a package that includes monitoring,
feedback and support to set realistic goals (whereby the number of steps taken is gradually increased).
Walking as a means to exercise was not universally liked and some men preferred the gym.46 A preference
for the more technological aspects of diets and physical activity, both in the content of the interventions
and in the monitoring processes, was evident.Helping to change behaviour
There were few RCTs that speciﬁcally examined whether or which behaviour change strategies were
effective for men; those that did demonstrated improved long-term weight loss and maintenance.88,101
Descriptions of the interventions were often limited with regard to the techniques used. NICE235
recommends that interventions at the individual level contain easy steps that can be taken over time such
as learning coping strategies, goal setting and sharing these goals, and planning for social situations that
might undermine changes. More recently, Greaves and colleagues236 undertook a systematic review of
reviews of intervention components that increased effectiveness for changing diet and levels of physical
activity. They found that engaging social support, increased contact frequency and using a cluster of
self-regulatory behaviour change techniques (e.g. goal setting, prompting self-monitoring, providing
feedback, review of goals) increased effectiveness.
With regard to self-monitoring and feedback, the accountability that came with staff reviewing food logs
was stated to be central to successful participant weight loss,190 and statistical analyses revealed that these
food logs were more frequently completed by those who lost a large amount of weight than by those
who lost a moderate amount of weight. Morgan and colleagues189 found that participants liked
the accountability of weigh-ins. Computer-linked monitoring was reported to help but also to be
time-consuming, with a lack of personal contact.189 Men may prefer less monitoring than women.96
Telephone and mail support could be useful.99NIHR Journals Library www.journalslibrary.nihr.ac.uk
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delivered in UK health services were often of short, ﬁxed duration, perhaps reﬂecting the constrained
spending on health care.Social support within the programme
Group and individual support
In a systematic review of male inclusion in RCTs, Pagoto and colleagues29 found a trend towards lower
representation of men in group (24%) than in individual (29%) or mail/e-mail/internet programmes
(34%). The male/female mix of the groups was not speciﬁed. We also found that men were considerably
under-represented in commercial weight-loss groups when both men and women were eligible
to participate.
We found that men do well in groups of men but that individual tailoring of fact-based,
simple-to-understand advice or counselling was wanted too.49,85,90,95,96,142,187 Jeffery and colleagues86
also found that group monetary contracts were more effective for weight loss than individual monetary
contracts for men.
Some men clearly wished to attend a men-only group142,189 whereas for others this was not considered
important.189,195 It could be deduced that being able to identify with the other individuals attending the
programme, rather than just men only, is the issue (although these are more likely to be other men).191,193
Group-based weight management programmes were found to facilitate peer or social support amongst
people with similar health problems, despite the fact that some men were initially reluctant to take part in
a group programme.
De Souza and Ciclitira195 suggested that men were happy to attend mixed slimming classes as they
received support and were ‘cheered on’ by their fellow female slimmers. The authors talked about the
‘competitive’ aspect of this being attractive to men.
Groups provided camaraderie, and the spontaneous humour and banter was important to
men.46,49,142,149,189,191,193,196 These features are used in the FFIT trial, in which the Facebook page is engaging
participants in banter and support (Kate Hunt, University of Glasgow, 6 February 2012, personal
communication). Men also reported that being accountable to themselves and having to account for food
choices to others within a programme facilitated programme adherence.190
There are many factors to consider when designing group-based programmes.212 Although groups may
require fewer resources, group-based programmes can be logistically difﬁcult with regard to scheduling
meetings and may therefore be impractical for time-poor men, who already consider time a barrier to
engagement with physical activity.190
In the case of group-based programmes, concern was expressed that groups may gradually stop meeting
after programmes have ended and this may impact negatively on adherence to the messages of the
programmes.49 This anxiety has also been seen with smoking cessation groups (Flora Douglas, University of
Aberdeen, 12 March 2013, personal communication). On the other hand, too many weight-loss group
sessions may be counterproductive.101Commercial organisations
Commercial weight-loss organisations36,37,154,157 were effective at producing weight loss in men, producing
results that were as good as those in NHS programmes31,151–153 when delivered in mixed-sex settings. Men
are much less likely to enrol in mixed-sex programmes run by these organisations than women,100 but
some men-only groups and websites are available. When interventions were delivered to single-sex
groups,33,34,148,150,156 commercial providers appeared to outperform single-sex NHS services,142,147 but data
were very limited. Referral by GPs to commercial providers can improve the low take-up by men, but223
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224health service programmes appear to be favoured by men, despite the fact that we also found that health
service settings appear to provoke fear and anxiety amongst men.96,100 The comparative effectiveness of
NHS and commercial weight-loss programmes for men in the long-term randomised UK trial by Jolly and
colleagues100 was unclear.Family and friends
In the trials that we reviewed, the effect of support from partners to aid weight loss was
inconsistent.94,112,120 Partners can have a pivotal role in successful weight-loss attempts,188,193 providing
support for those choosing against the expected social norms.188,192 However, the inﬂuence of family
members and peers who respond in a negative way can be very detrimental to men’s efforts to lose
weight. Men reported not wishing to offend mothers and mothers-in-law intent on ‘feeding them up’.188
Gay partners may not be happy with their partners losing weight, which they can perceive as making them
more attractive to others.195 Conﬂict over attempts to lose weight arose especially when the giving and
receiving of food was regarded as a means of maintaining communication and relationships with family
members.237,238 Comments from family and friends on weight, body size or image or programme
participation can either motivate or demotivate behaviour change.
There were no family-based interventions that ﬁt any of the inclusion criteria for our reviews, but there
was good evidence that men’s participation in weight-loss programmes had beneﬁcial effects on the
weight of other members of the family.89,112,121,142,187,193 The Healthy Dads, Healthy Kids study from
Australia evaluated the effect of primary school children attending some of the weight-loss sessions
intended for adult men.239 After 6 months men had an impressive weight loss of 7.6 kg (baseline
observation carried forward), with a signiﬁcant improvement in the physical activity levels and dietary
intake of their children.Orlistat
We found that men are less likely than women to do well using orlistat to help long-term weight-loss
maintenance.105 Again, this might reﬂect men’s lesser interest in dieting.
There was some evidence to suggest that orlistat was a cost-effective add-on to lifestyle interventions in
male overweight and obese patients, with a greater likelihood of cost-effectiveness if the drug was
targeted towards those at greatest risk of diabetes.164,166 NICE and EMA both recommend the use of
orlistat for the treatment of obesity in the UK and Europe respectively. Thresholds of weight loss required
to justify continued treatment with the drug differ across the regulatory bodies. The original NICE
guidelines172 recommend continuation of treatment only if subjects achieve 5% weight loss at
3 months and 10% at 6 months. The original181 and updated182 EMA criteria are slightly more relaxed
than those used by NICE, requiring only a minimum of 5% weight loss at 3 months to justify continuation
of treatment.Innovations
There was some evidence that men found technology and innovations appealing in their weight-loss
programmes, for example using sandbags to demonstrate the weight that had been lost193 or using body
scans to show changes in body composition.188 These tangible props with objective measures to support
programmes, for example pedometers, could reduce the need for men to discuss their feelings.Do men state who they believe to be the best person/persons to
deliver the intervention?
We found no clear evidence that the sex or profession of the person delivering the intervention affected
men’s outcomes. The only evidence came from an economic evaluation of a study from Denmark by Olsen
and colleagues,165 which was not eligible for any of our other reviews. This found that men did better with
lifestyle counselling from their GP than with the same number of longer sessions with a dietitian who
focused on nutritional counselling. The opposite was the case for women. The sex of the GPs andNIHR Journals Library www.journalslibrary.nihr.ac.uk
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inﬂuence of the person providing the counselling.
There is evidence that important differences in training, skills and the personal experience of weight-loss
advisors may inﬂuence engagement with group-based programmes, although whether advisors were men
or women was not examined.240 In the UK, men appear to be more likely to raise weight problems with
primary care nurses than with their GPs.241
Research by Dutton and colleagues242,243 in the USA found that physicians had target BMIs that were
signiﬁcantly lower for obese women than for obese men. Obese women themselves were signiﬁcantly
more likely to endorse unrealistic weight-loss goals than obese men, but female physicians recommended
more reasonable goals than male physicians for both male and female patients.Social, cultural and environmental influences on obesity in men
Normative understandings of masculinity are often associated with risky behaviours (e.g. drinking,
smoking, late health care seeking) even after social class is accounted for.244 Men’s reluctance to seek help
is often explained through theories of masculinity.245–247 Theories of masculinity rest on the concept of
‘hegemonic’ or dominant masculinity248 and, in debates on health-related help-seeking, hegemonic
masculinity is thought to create patterns of behaviour that are based on resisting contact with formal
services to emphasise self-sufﬁciency and robustness. However, the notion of hegemonic masculinity
as the dominant force in health-related decision-making has been criticised. Some have suggested that
masculinity has become abstracted and consequently divorced from studying the actual practices of
men.249 Masculinity, it is argued, interconnects with other factors such as social class, age and
ethnicity245,246 and, accordingly, from this perspective, it is impossible to pull men out of the social
structures in which they are located. Other factors such as social stratiﬁcation or age are considered
more important than gender.250 One of the theoretical implications of envisaging masculinity as an
external pressure is that men are conceptualised as ‘slaves’ to hegemonic discourses. Unfortunately,
this perspective has led to ‘men’ being constructed as a universal category.251
The desire for muscularity could make it harder for men than women to identify that they are overweight.2
Although BMI tends to be used more than waist circumference in risk prediction and the NHS, waist
circumference might be a better measurement for raising awareness of weight issues amongst men,
and less susceptible to conﬂicts over muscularity. There is continuing debate about the health risks of
being overweight with a BMI of ≥ 25 kg/m2 and < 30 kg/m2 as opposed to being obese with a BMI
of ≥ 30 kg/m2.15 An evidence synthesis of health risks according to BMI and waist circumference for men
and women by age group would be useful to direct policy.
In our qualitative research synthesis men made very little reference to wider social determinants of their
behaviour and instead focused on their motivation and own agency to overcome (or attempt to overcome)
those secular macro-level changes that had encouraged the overconsumption of energy-dense foods and
constrained or reduced opportunities to be physically active. This could reﬂect the inﬂuence of the intrusive
health lobby.44
We would reiterate the importance of environmental inﬂuences on men’s weight,191,194,198,199 as
exempliﬁed by the Foresight report.5 Egger and Swinburn252 have long drawn attention to the
environmental determinants of obesogenic behaviours. More recently, De Vogli and colleagues253 have
found a clear link between economic globalisation, income inequality and BMI in high-income countries.
The role that the environment plays in inﬂuencing behaviours helped some researchers to decide where to
locate the delivery of weight management programmes. For example, the programme described by
Harrison191 and White and colleagues49 was located in the workplace, with the rationale that it was more
convenient to access than non-workplace settings, thus removing a barrier to engagement.225
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DISCUSSION
226Finally, the cost of attending exercise facilities or purchasing healthier food is a deterrent to making
lifestyle changes.198,202Findings from the systematic review of economic evaluationsThe review of cost-effectiveness studies has revealed a real paucity of evidence on the cost-effectiveness of
interventions to tackle male obesity. No studies were conducted in a UK setting and there was much
heterogeneity across the ﬁve studies included in our review, with studies being of variable methodological
quality. The evidence suggested that GP counselling may be more cost-effective than dietitian counselling
(although more detailed), again suggesting that an emphasis on diet is a turn-off for male participants.165
It is interesting that this study showed that women tended to do better with the dietitian than their male
counterparts. Segal and collegaues163 investigated a group lifestyle intervention for men but reported only
limited data and did not fully describe the intervention evaluated. Evidence suggested that this group
intervention was cost-effective. Galani and colleagues162 conducted a high-quality economic modelling
study, showing that a lifestyle intervention was highly cost-effective, although further work would be
required to demonstrate the viability of such an intervention in a UK male population. Orlistat was found
to be a cost-effective addition to a lifestyle intervention, but only when targeted at those men with
greatest risk of developing type 2 diabetes.
Further information is required to generate more speciﬁc evidence on the cost-effectiveness of orlistat in
a UK context and also which prescribing guidelines (NICE or EMA) offer the greatest patient beneﬁt and
value for money to the NHS.
Although the studies included in our review provide information on the potential cost-effectiveness of
different interventions for weight loss, the results should be interpreted in light of their variable
methodological quality, their relevance to a UK health-care setting, the assumptions regarding
maintenance of weight loss over time and the applicability of model inputs to a male subgroup of the
population. We conclude that, on the basis of the retrieved literature, there is insufﬁcient evidence
available to make clear recommendations regarding the cost-effectiveness of interventions or treatments
for male obesity, nor is there any evidence to recommend for or against different treatment strategies for
male and female subgroups on the grounds of cost-effectiveness. It is imperative that future clinical studies
should be accompanied by high-quality economic evaluations.Limitations of our researchWe had difﬁculty identifying the evidence bases for the reviews included here. Current indexing by
databases makes searching for male-/female-related issues and qualitative research very challenging.
Finding unpublished evaluations of UK studies was even more challenging. Thus, it is likely that we will
have missed some of the evidence base. Evaluations with more favourable results are more likely to have
been found. Only one of the long-term randomised trials100 came from the UK, so the generalisability of
the trial evidence could be limited. Furthermore, no long-term randomised trial provided qualitative and
health economic data. In fact, qualitative and quantitative evidence often did not come from the same
study. However, the ﬁndings were mostly consistent across the randomised trials, non-randomised
interventions and qualitative evidence. If resources had allowed we would also have liked to explore the
evidence from a systematic review of surveys of men’s views on obesity and weight loss.
The evidence base for black or ethnic minority men, men with low incomes or who are unemployed, men
living in rural and/or remote areas or men with a gay, bisexual or transgender background was almost
completely absent. It will be important to study how programmes can be readily adapted to encompass
these groups.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Our reviews focused on weight-loss interventions for men who were obese. Prevention of obesity in men
should also be a focus for research and health care.Other evidence and resourcesOne previous systematic review by Young and colleagues56 has examined the effectiveness of male-only
weight-loss and maintenance interventions. Included studies were of any duration or study design, and
studies with men with comorbidities were excluded. There is little overlap between our reviews and
Young’s review. Young and colleagues56 found that younger age, more frequent contact (three or more
contacts per month), a prescribed energy restriction and group face-to-face delivery were associated with
improved effectiveness. However, older men are more likely to have not been included in their review
because of the presence of comorbidities. A systematic review of workplace physical activity interventions
for men has also highlighted the need to speciﬁcally target men in the development of interventions.254
Our ﬁndings would not disagree with these reviews.
There are resources available to help people to engage men and to design and provide services to help
obese men lose weight.54,224,255–260 These resources emphasise the need for commitment, training and
adequate long-term resources for services.
There are also resources available to aid with the conduct and reporting of high-quality randomised trials
and economic modelling exercises. Glick and colleagues261 have published detailed guidelines that provide
a step-by-step guide to carrying out pragmatic economic evaluations alongside randomised trials. Perhaps
of more relevance to obesity-related conditions is the requirement for high-quality modelling studies
projecting disease progress, costs and beneﬁts over a longer time horizon, including the impact on patient
health and risk of future obesity-related complications. A series of seven papers published by the
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) provides guidance on
decision-analytical modelling in drug trials,262–268 and Briggs and colleagues269 provide a good grounding in
and discussion of the methods of decision modelling and should be used to inform best practice methods
for conducting cost-effectiveness analyses of obesity-related interventions.227
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Chapter 8 ConclusionsImplications for health care1. Weight reduction for men is best achieved and maintained with the combination of a reducing
diet, physical activity advice or a physical activity programme and behaviour change techniques
(e.g. self-monitoring, goal setting, prompting self-monitoring, providing feedback, review of goals).
These key components differ from those for women in that men prefer more factual information on
how to lose weight and more emphasis on providing physical activity programmes. Weight-loss
programmes can prevent type 2 diabetes and improve cardiovascular risk factors and erectile
dysfunction, self-esteem and quality of life in men.
2. For some men the opportunity to attend men-only groups may enhance intervention effectiveness.
Individual tailoring and feedback may also be features of more effective services.
3. Weight-loss programmes for men may be better provided in social settings, such as sports clubs and
workplaces, which may be more successful at engaging men than health service settings. Innovative
means of delivering services are needed for hard-to-reach groups, such as those men who do not see
their weight status as a problem, younger men, unemployed men and those living in remote and
rural locations.Recommendations for research
General recommendations1. Research is needed to examine the effectiveness and cost-effectiveness of new approaches to engaging
men with weight-loss services and the best design for those services.
2. Men (and women) are a heterogeneous group. Rigorous methods are needed to test more complex
interventions in recognition of the fact that simple interventions testing a few components are unlikely
to motivate all men. Men should be consulted on how to optimise engagement and make interventions
more user-friendly, and services need to be formally evaluated. The experiences and perspectives of
men (and women) who are black and from ethnic minority backgrounds, who are unemployed and on
low incomes, who are gay, bisexual and transgender and who are from rural and/or remote locations
need to be addressed. Rigorous feasibility studies and piloting with service user input at all stages is
required before undertaking deﬁnitive RCTs.
3. Health concerns, which may prompt contact with health service staff, motivate men to address their
obesity. Research is required to examine the most effective brief interventions delivered at these pivotal
health service encounters when an obesity-related diagnosis is made.
4. Although there are many published evaluations of weight-loss interventions, the lack of data on
participation and outcome by sex and gender suggests that sex and gender are not considered
important issues. It is essential to report these data in weight-loss programmes, including the
proportions of disadvantaged and minority group participants.
5. The inﬂuence of the sex of providers and gatekeepers on engagement in, and outcomes from,
weight-loss services should be examined. In addition, the importance of personal experience of weight
problems in those delivering weight management programmes requires exploration.
6. Clearer reporting of all aspects of interventions, including psychological and ecological theories and
behaviour change techniques, is needed to develop the evidence base and allow others to
replicate interventions.
7. Systematic reviews should examine the quantitative and qualitative evidence base for the management
of obesity in women, whose needs will differ from those of men.229
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CONCLUSIONS
2308. Research is needed on programmes that aim to tackle more than one health-related behaviour at once
(such as harmful drinking and obesity), the implementation of such services and their reach in
underserved groups of men.Quantitative research1. We found relatively few long-term RCTs and there were even fewer UK studies that provided outcome
data for men of more than a few months’ follow-up. As was clear from our reviews, men would value
longer-term support and there is a need to provide longer-term outcome data (at least 1 year of
follow-up). There is also a need to look speciﬁcally at ways of enhancing the maintenance of long-term
weight loss. The majority of the programmes did not make a distinction between support for the initial
weight loss and a different or modiﬁed programme to help maintain that weight loss.
2. Although weight loss was the primary aim of the programmes that we reviewed, it is also essential to
study the impact of weight-loss programmes, with adequate statistical power, on the prevention and
treatment of comorbidities and on quality of life. We recommend that data are collected on
cardiovascular risk factors to allow the modelling of impacts on cardiovascular disease, or that the direct
effects of weight loss are presented for clinical conditions, for example type 2 diabetes and erectile
dysfunction. Our data suggest that weight-loss programmes in the right social setting can improve
well-being; thus, quality-of-life data should also be collected.
3. An evidence synthesis of health risks according to BMI and waist circumference by sex and age group is
needed to direct policy.
4. Although the written reports of RCTs have improved over time, there is still a need for trials to improve
the reporting of methods and reporting of the items recommended by the CONSORT statement
(e.g. sequence generation, allocation concealment) and provide the items for the Campbell & Cochrane
Equity Methods Group checklist, to assess the impact on disadvantaged groups and the sustainability
of interventions. Intervention studies that are not RCTs also need to report these items when relevant.
Process evaluations and ﬁdelity checks are needed in trials.
5. Identifying reports of sex-speciﬁc studies, or reports in which data are reported separately for men and
women, is challenging because of suboptimal indexing in databases. Sex-speciﬁc index terms are a
feature of the controlled vocabularies of several major databases but they are underutilised. Consistent,
reliable indexing is needed to facilitate more efﬁcient literature searching.
6. Identifying studies in a UK setting is problematic. Within electronic databases, indexing with
country names could be used more frequently to enable efﬁcient identiﬁcation of studies set in a
particular country.
7. There is no consensus yet on reporting weight-loss results in intervention studies, in which dropouts
almost inevitably occur. Providing data for completers only, as was the case in many of the studies
reviewed here, will inevitably provide optimistic results. Similarly, using the last observation carried
forward for dropouts is also likely to provide results indicating better than actually achieved weight loss.
Baseline observation carried forward results are likely to provide the worst case scenario, with the last
observation carried forward results between these and the complete case results. Researchers and
programme providers should attempt to establish body weight at the end of follow-up, even if only
self-reported. Complete case, baseline observation carried forward and last observation carried forward
results should be provided to allow comparisons between weight-loss programmes.Health economics1. UK cost-effectiveness studies in men are needed.
2. Improvements are needed in the reporting of methods for the estimation of utility weights and the
methods used to derive them (e.g. standard gamble, time trade-off, visual analogue scale or discrete
choice experiments).
3. Costs (both intervention and subsequent costs of complications) should be reported in detail,
with appropriate references, in a manner that would facilitate the theoretical reproduction of the
study results.NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 354. Costs and outcomes should be measured over the appropriate time horizon to include the downstream
impact on health service utilisation and quality of life. Best practice decision-analytical methods should
be used to model the future impact of weight-loss interventions on disease areas such as diabetes and
coronary heart disease. The time horizon of the model should be sufﬁcient to capture all differences
between study groups and future costs and outcomes should be discounted to present values using
appropriate discount rates relative to the study country.
5. Assumptions used for modelling studies should be clearly deﬁned and highlighted. It should be clear to
the reader the assumptions that have been used, especially with regard to maintenance of weight loss
and continuation of treatment effect. These assumptions should be comprehensively tested in structural
sensitivity analyses.
6. Methods used to model the effect of weight loss on future obesity-related disease should be
comprehensively explained, with choices for sources of data clearly outlined and any potential variation
explored in deterministic or probabilistic sensitivity analysis.
7. Speciﬁcally for interventions relating to men, data inputs for models should be clearly detailed for men.
When data for men and women have been assumed and applied to male and female subgroups
separately, this should be acknowledged and highlighted as a potential limitation.Qualitative and mixed-methods research1. Qualitative research with men is needed to inform all aspects of intervention design, including the
identiﬁcation of new intervention settings, optimal recruitment processes, reasons for attrition and how
processes might minimise attrition. Process evaluations of intervention studies are needed to seek
feedback on the marketing, content and delivery of interventions and how the macro, meso and micro
contexts interact with the intervention.
2. We require a better understanding of the barriers to, and facilitators of, the decision to lose weight and
subsequent weight maintenance.
3. Integrating qualitative and quantitative research methods both in systematic reviews and in the design
and delivery of complex intervention trials is needed to better understand how men can effectively
lose weight and sustain weight loss and how the health service can best deliver services that help them
to succeed.
4. There were indications in this research that men may be maintaining relationships with family
members by accepting food offerings that may be contraindicated when following a weight-loss/
weight-maintenance diet. In addition, given the ﬁnding about men’s desire for ﬂexibility and treats
within weight-loss diets, more research is needed to understand men’s personal food systems and
values to understand how different groups of men value and act on the different dimensions that have
been found to be instrumental in food choice decision-making. Having a better understanding of these
issues may help with the design of future interventions that take account of, or help men ﬁnd ways
of dealing with unintended social sabotage that comes from not wanting to offend mothers,
mothers-in-law, girlfriends or boyfriends, etc.
5. The feasibility and acceptability of interventions delivered to families should be explored.
6. There is a need to understand the public perceptions of men who are not yet overweight or obese
(to the extent that they have taken action on it) or suffering from a weight-related health condition, to
understand how men who have not yet ‘problematised’ obesity and overweight can be engaged in
taking action to prevent their weight becoming a problem (i.e. needing medical intervention and
incurring costs to the NHS).
7. With regard to qualitative research recommendations associated with qualitative evidence synthesis, in
primary research papers there is a need to reduce the instances in papers in which second-order author
interpretations are unsupported by ﬁrst-order evidence. Participant details attached to quotes when
reporting qualitative research should provide details of the sex of the respondent.
8. Reports of qualitative research are indexed inadequately in electronic databases. Despite the primary
searches for the review of qualitative studies yielding a large number of results, only ﬁve studies were
found from the databases for this review. Electronic databases need to index qualitative research as a
publication type.231
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randomised controlled trials of men and womenMEDLINE (1948 to 18 May 2012), MEDLINE In-Process & Other Non-Indexed
Citations (18 May 2012) and EMBASE (1980 to 2012 Week 20)
Ovid multiﬁle search: http://shibboleth.ovid.com/
1. obesity/
2. (obesity adj2 (morbid or diabet$)).tw.
3. obesity, morbid/ use prmz
4. morbid obesity/ use emez
5. obes$.tw.
6. weight loss/ use prmz
7. weight reduction/ use emez
8. (weight adj1 (los$ or reduc$ or maint$ or control)).tw.
9. (diet adj5 weight).tw.
10. overweight.tw.
11. or/1-10
12. exp clinical trial/
13. Randomized Controlled Trials as Topic/
14. randomized controlled trial.pt.
15. controlled clinical trial.pt.
16. randomi?ed.ab.
17. randomization/ use emez
18. placebo.ab.
19. drug therapy.fs.
20. randomly.ab.
21. trial.ab.
22. groups.ab.
23. or/12-22
24. exp animals/ not humans/
25. 23 not 24
26. 11 and 25
27. (letter or editorial or comment or note).pt.
28. 26 not 27
29. limit 28 to (“all infant (birth to 23 months)” or “all child (0 to 18 years)” or “newborn infant (birth to
1 month)” or “infant (1 to 23 months)” or “preschool child (2 to 5 years)” or “child (6 to 12 years)”
or “adolescent (13 to 18 years)”)
30. limit 28 to (embryo or infant or child or preschool child <1 to 6 years> or school child <7 to 12 years>
or adolescent <13 to 17 years>)
31. 28 not 29
32. 28 not 30
33. 31 or 32
34. limit 33 to yr=”2001 – current”253
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APPENDIX 1
254Cumulative Index to Nursing and Allied Health Literature (1981 to May 2012)
http://search.ebscohost.com
1. (MH “Obesity+”)
2. (MH “Abdominal Fat”)
3. (MH “Body Mass Index”) OR (MH “Body Weight+”)
4. TX Obes* n2 morbid*
5. TX Obes* n2 diabet*
6. TX overweight or obes*
7. TX obes* n3 abdom*
8. TX fat n3 abdom*
9. (S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8)
10. (MH “Weight Loss”)
11. (MH “Diet, Reducing”) OR (MH “Weight Control”) OR (MH “Weight Reduction Programs”) OR
(MH “Diet, Fat-Restricted”)
12. TX weight n1 los*
13. TX weight n1 reduc*
14. TX weight n1 maint*
15. TX weight n1 control*
16. TX weight n5 diet
17. TX diet n2 restrict*
18. TX calorie* n3 restrict*
19. TX low n1 calorie
20. (S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19)
21. (MH “Clinical Trials+”)
22. PT randomized controlled trial OR PT clinical trial
23. TX trial* or random* or placebo*
24. S21 or S22 or S23
25. S9 and S20 and S24
26. (MH “Animals+”)
27. S25 not S26
28. PT pamphlet or letter or comment or commentary or editorial
29. S27 not S28
30. S27 not S28 Limiters – Exclude MEDLINE records; Age Groups: Fetus, Conception to Birth, Infant,
Newborn: birth-1 month, Infant: 1–23 months, Child, Preschool: 2–5 years, Child: 6–12 years,
Adolescent: 13–18 years
31. S29 not S30 Limiters – Published Date from: 20010101–20121231; Exclude MEDLINE recordsPsycINFO (1806 to May 2012)
http://search.ebscohost.com
1. DE “Obesity”
2. DE “Body Weight” OR DE “Overweight” OR DE “Obesity”
3. DE “Body Fat”
4. DE “Body Mass Index”
5. TX Obes* n2 morbid*
6. TX Obes* n2 diabet*
7. TX overweight or obes*
8. TX obes* n3 abdom*
9. TX fat n3 abdom*
10. S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9
11. DE “Weight Loss" OR DE “Weight Control”
12. DE “Dietary Restraint”NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 3513. TX weight n1 los*
14. TX weight n1 reduc*
15. TX weight n1 maint*
16. TX weight n1 control*
17. TX weight n5 diet
18. TX diet n2 restrict*
19. TX calorie* n3 restrict*
20. S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or S19
21. DE “Clinical Trials”
22. TX trial* or random* or placebo*
23. S21 or S22
24. S10 and S20 and S23 Limiters – Age Groups: Childhood (birth–12 yrs), Neonatal (birth–1 mo),
Infancy (2–23 mo), Preschool Age (2–5 yrs), School Age (6–12 yrs), Adolescence (13–17 yrs)
25. ( S10 and S20 and S23 ) NOT S24
26. PZ pamphlet or letter or comment or commentary or editorial
27. S25 not S26 Limiters – Publication Year from: 2001–2012Cochrane Central Register of Controlled Trials (The Cochrane Library,
Issue 5, 2012)
www.thecochranelibrary.com
1. MeSH descriptor Obesity explode tree 3
2. MeSH descriptor Weight Loss, this term only
3. (obesity near/2 (morbid or diabet*)):ti or (obesity near/2 (morbid or diabet*)):ab
4. (overweight or obes*):ti or (overweight or obes*):ab
5. (#1 OR #2 OR #3 OR #4)
6. (#5), from 2001 to 2012Cochrane Database of Systematic Reviews (The Cochrane Library,
Issue 5, 2012)
www.thecochranelibrary.com
1. MeSH descriptor Obesity explode tree 3
2. MeSH descriptor Weight Loss, this term only
3. (obesity near/2 (morbid or diabet*)):ti or (obesity near/2 (morbid or diabet*)):ab
4. (overweight or obes*):ti or (overweight or obes*):ab
5. (#1 OR #2 OR #3 OR #4)
6. (#5), from 2001 to 2012Database of Abstracts of Reviews of Effects, NHS Economic Evaluation
Database and Health Technology Assessment database (May 2012)
Centre for Reviews and Dissemination: www.crd.york.ac.uk
1. MeSH DESCRIPTOR weight loss
2. MeSH DESCRIPTOR obesity
3. MeSH DESCRIPTOR obesity, morbid
4. (obesity adj2 (morbid or diabet*))
5. (overweight or obes*):TI
6. #1 OR #2 OR #3 OR #4 OR #5
7. FROM 2001 TO 2012
8. #6 AND #7255
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256Trials
ClinicalTrials.gov
www.clinicaltrials.govCenterWatch
www.centerwatch.comControlled Trials
www.controlledtrials.com/mrctInternational Clinical Trials Registry
http://apps.who.int/trialsearch/Review of UK interventions
MEDLINE (1948 to 17 July 2012), MEDLINE In-Process & Other Non-Indexed
Citations (17 July 2012) and EMBASE (1980 to 2012 Week 29)
Ovid multiﬁle search: http://shibboleth.ovid.com/
1. *obesity/
2. obesity hypoventilation syndrome/
3. abdominal obesity/ use emez
4. morbid obesity/ use emez
5. diabetic obesity/ use emez
6. obesity, abdominal/ use prmz
7. obesity, morbid/ use prmz
8. (overweight or obes$).ti.
9. (obes$ adj1 (morbid or diabet$ or abdom$ or central)).tw.
10. or/1–9
11. *weight loss/ use prmz
12. *weight reduction/ use emez
13. (weight adj1 (los$ or reduc$ or maint$ or control or manag*)).tw.
14. (reduc$ adj2 (waist adj3 (ratio or circumference))).tw.
15. (reduc$ adj2 (bmi or body mass index)).tw.
16. (obesity adj1 manag*).tw.
17. (anti obesity or antiobesity).tw.
18. or/11–16
19. comparative study/ use prmz
20. follow-up studies/ use prmz
21. time factors/ use prmz
22. Treatment outcome/ use emez
23. major clinical study/ use emez
24. controlled study/ use emez
25. clinical trial/ use emez
26. (chang$ or evaluat$ or reviewed or baseline).tw.
27. ((prospective$ or retrospective$) adj1 (study or studies)).tw.
28. (cohort$ or case series).tw.
29. ((compare$ or compara$) adj1 (study or studies)).tw.
30. or/19–29
31. 10 and 18 and 30NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 3532. limit 31 to (“all infant (birth to 23 months)” or “all child (0 to 18 years)” or “newborn infant (birth to
1 month)” or “infant (1 to 23 months)” or “preschool child (2 to 5 years)” or “child (6 to 12 years)”
or “adolescent (13 to 18 years)”)
33. 31 not 32
34. limit 31 to (embryo or infant or child or preschool child <1 to 6 years> or school child <7 to 12 years>
or adolescent <13 to 17 years>)
35. 31 not 34
36. 33 or 35
37. exp animals/ not humans/
38. exp nonhuman/ not human/
39. 37 or 38
40. 36 not 39
41. (letter or editorial or comment or note or review or Video-Audio Media).pt.
42. 40 not 41
43. exp great britain/ use prmz
44. united kingdom/ use emez
45. (united kingdom or uk or britain or scotland or england or wales or northern ireland or british or irish
or scottish or welsh or english).tw.
46. (United kingdom or uk or Britain or scotland or England or wales or Ireland or London or Birmingham
or Leeds or Glasgow or Shefﬁeld or Bradford or Edinburgh or Liverpool or Manchester or Bristol or
Wakeﬁeld or Cardiff or Coventry or Nottingham or Leicester or Sunderland or Belfast or Newcastle
upon Tyne or Brighton or Hull or Plymouth or Stoke-on-Trent or Wolverhampton or Derby or Swansea
or Southampton or Salford or Aberdeen or Westminster or Portsmouth or York or Peterborough or
Dundee or Lancaster or Oxford or Newport or Preston or Norwich or Chester or Cambridge or
Salisbury or Exeter or Gloucester or Lisburn or Chichester or Winchester or Londonderry or Carlisle or
Worcester or Bath or Durham or Lincoln or Hereford or Armagh or Inverness or Stirling or Canterbury
or Lichﬁeld or Newry or Ripon or Bangor or Truro or Ely or Wells).ad.
47. (United kingdom or uk or Britain or scotland or England or wales or Ireland or London or Birmingham
or Leeds or Glasgow or Shefﬁeld or Bradford or Edinburgh or Liverpool or Manchester or Bristol or
Wakeﬁeld or Cardiff or Coventry or Nottingham or Leicester or Sunderland or Belfast or Newcastle
upon Tyne or Brighton or Hull or Plymouth or Stoke-on-Trent or Wolverhampton or Derby or Swansea
or Southampton or Salford or Aberdeen or Westminster or Portsmouth or York or Peterborough or
Dundee or Lancaster or Oxford or Newport or Preston or Norwich or Chester or Cambridge or
Salisbury or Exeter or Gloucester or Lisburn or Chichester or Winchester or Londonderry or Carlisle or
Worcester or Bath or Durham or Lincoln or Hereford or Armagh or Inverness or Stirling or Canterbury
or Lichﬁeld or Newry or Ripon or Bangor or Truro or Ely or Wells).in.
48. or/43–47
49. 42 and 48
50. male/
51. (men or male or males).tw.
52. or/50–51
53. 49 and 52
54. (female not male).tw.
55. (women not men).tw.
56. 53 not (54 or 55)257
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258PsycINFO (1806 to July 2012)
http://search.ebscohost.com
1. DE “Obesity”
2. TX Obes* n2 morbid*
3. TX Obes* n2 diabet*
4. TX overweight or obes*
5. TX obes* n3 abdom*
6. TX central n3 obes*
7. S1 or S2 or S3 or S4 or S5 or S6
8. DE “Weight Loss”
9. DE “Weight Control”
10. TX weight n1 los*
11. TX weight n1 reduc*
12. TX weight n1 maint*
13. TX weight n1 control*
14. TX reduc* n2 bmi
15. TX reduc* n2 body mass index
16. TX reduc* n2 waist circumference
17. S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16
18. AF United kingdom or uk or Britain or scotland or England or wales or Ireland or London or
Birmingham or Leeds or Glasgow or Shefﬁeld or Bradford or Edinburgh or Liverpool or Manchester or
Bristol or Wakeﬁeld or Cardiff or Coventry or Nottingham or Leicester or Sunderland or Belfast or
Newcastle upon Tyne or Brighton or Hull or Plymouth or Stoke-on-Trent or Wolverhampton or Derby
or Swansea or Southampton or Salford or Aberdeen or Westminster or Portsmouth or York or
Peterborough or Dundee or Lancaster or Oxford or Newport or Preston or Norwich or Chester or
Cambridge or Salisbury or Exeter or Gloucester or Lisburn or Chichester or Winchester or Londonderry
or Carlisle or Worcester or Bath or Durham or Lincoln or Hereford or Armagh or Inverness or Stirling
or Canterbury or Lichﬁeld or Newry or Ripon or Bangor or Truro or Ely or Wells
19. TX women NOT TX men
20. TX female not TX male
21. ( TX child* or TX adolescen* ) NOT TX adult*Social Sciences Citation Index (1970 to July 2012) and Conference Proceedings
Citation Index – Social Science & Humanities (1990 to July 2012)
www.webofknowledge.com
1. TS=(obes* or overweight)
2. TS=(obes* near/2 morbid*)
3. TS=(obes* near/2 diabet*)
4. TS=(obes* near/2 central)
5. TS=(obes* near/2 abdom*)
6. #5 OR #4 OR #3 OR #2 OR #1
7. TS=(weight near/1 los*)
8. TS=(weight near/1 reduc* )
9. TS=(weight near/1 maint*)
10. TS=(weight near/1 control*)
11. TS=(weight near/1 manag*)
12. TS=(reduc* near/2 bmi)
13. TS=(reduc* SAME (body mass index))
14. TS=(reduc* SAME (waist circumference))
15. TS= (obesity near/1 manag*)
16. TS=(antiobesity or anti obesity or anti-obesity)NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 3517. #16 OR #15 OR 14 OR #13 OR #12 OR #11 OR #10 OR #9 OR #8 OR #7
18. AD=(United kingdom or uk or Britain or scotland or England or wales or Ireland or London or
Birmingham or Leeds or Glasgow or Shefﬁeld or Bradford or Edinburgh or Liverpool or Manchester or
Bristol or Wakeﬁeld or Cardiff or Coventry or Nottingham or Leicester or Sunderland or Belfast or
Newcastle upon Tyne or Brighton or Hull or Plymouth or Stoke-on-Trent or Wolverhampton or Derby
or Swansea or Southampton or Salford or Aberdeen or Westminster or Portsmouth or York or
Peterborough or Dundee or Lancaster or Oxford or Newport or Preston or Norwich or Chester or
Cambridge or Salisbury or Exeter or Gloucester or Lisburn or Chichester or Winchester or Londonderry
or Carlisle or Worcester or Bath or Durham or Lincoln or Hereford or Armagh or Inverness or Stirling
or Canterbury or Lichﬁeld or Newry or Ripon or Bangor or Truro or Ely or Wells)
19. #6 and #14 and #15
20. TS=(female not male)
21. TS=(women not men)
22. TS=((child* or adolescen* or teenage* or infant*) not adult*)
23. #16 NOT #17
24. #20 NOT #18
25. #21 NOT #19Review of engagement
MEDLINE (1948 to 25 July 2012), MEDLINE In-Process & Other Non-Indexed
Citations (25 July 2012) and EMBASE (1980 to 2012 Week 30)
Ovid multiﬁle search: http://shibboleth.ovid.com/
1. *obesity/
2. obesity hypoventilation syndrome/
3. abdominal obesity/ use emez
4. morbid obesity/ use emez
5. diabetic obesity/ use emez
6. obesity, abdominal/ use prmz
7. obesity, morbid/ use prmz
8. (overweight or obes$).ti.
9. (obes$ adj1 (morbid or diabet$ or abdom$ or central)).tw.
10. *weight loss/
11. *weight reduction/ use emez
12. (weight adj1 (los$ or reduc$ or maint$ or control or manag$)).tw.
13. (reduc$ adj2 (waist adj3 (ratio or circumference))).tw.
14. (reduc$ adj2 (bmi or body mass index)).tw.
15. (anti obesity or antiobesity).tw.
16. (obesity adj1 manag$).tw.
17. or/1–16
18. *”patient acceptance of health care”/ or *patient compliance/ or *medication adherence/ or *patient
participation/ or exp *patient satisfaction/ or treatment refusal/
19. exp health promotion/
20. exp patient attitude/
21. *patient dropouts/ use prmz
22. exp patient compliance/
23. exp Consumer Participation/
24. (uptake or retention or retain or engag$ or particip$ or motivat$ or encourag$ or attrition or dropout
or promot$ or recruit$ or involv$).tw.
25. or/18-24
26. ((male or men?) adj3 (uptake or retention or retain or engag$ or particip$ or motivat$ or encourag$
or attrition or dropout or promot$ or recruit$ or involv$)).tw.259
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26027. ((service$ or program$ or scheme$ or initiative$ or intervention$ or diet$) adj3 ((uptake or retention or
retain or engag$ or particip$ or motivat$ or encourag$ or attrition or dropout or promot$ or recruit$
or involv$) adj3 (male or men?))).tw.
28. ((uptake or retention or retain or engag$ or particip$ or motivat$ or encourag$ or attrition or dropout
or promot$ or recruit$ or involv$) adj3 (men? or male) adj3 ((obesity adj1 manag$) or (weight adj1
(los$ or reduc$ or maint$ or control or manag$)) or (overweight or obes$))).tw.
29. 25 and 28
30. 17 and 26
31. 17 and 27
32. or/29–31
33. limit 32 to (embryo or infant or child or preschool child <1 to 6 years> or school child <7 to 12 years>
or adolescent <13 to 17 years>)
34. 32 not 33
35. limit 32 to (“all infant (birth to 23 months)” or “all child (0 to 18 years)” or “newborn infant (birth to
1 month)” or “infant (1 to 23 months)” or “preschool child (2 to 5 years)” or “child (6 to 12 years)”
or “adolescent (13 to 18 years)”)
36. 32 not 35
37. 34 or 36
38. exp animals/ not humans/
39. 37 not 38
40. (female not male).tw.
41. (women not men).tw.
42. 39 not (40 or 41)PsycINFO (1806 to July 2012)
http://search.ebscohost.com
1. DE “Obesity”
2. DE “Overweight”
3. DE “Weight Loss”
4. DE “Weight Control”
5. TX Obes* n2 morbid*
6. TX Obes* n2 diabet*
7. TX overweight or obes*
8. TX obes* n3 abdom*
9. TX central n3 obes*
10. TX weight n1 los*
11. TX weight n1 reduc*
12. TX weight n1 maint*
13. TX weight n1 control*
14. TX reduc* n2 bmi
15. TX reduc* n2 body mass index
16. TX reduc* n2 waist circumference
17. TX obesity n1 manag*
18. TX anti#obesity
19. (S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16
or S17 or S18)
20. DE “Treatment Compliance” OR DE “Client Participation” OR DE “Treatment Barriers” OR DE
“Treatment Dropouts” OR DE “Treatment Refusal”
21. DE ”Client Attitudes” OR DE ”Client Satisfaction”
22. TX (uptake or retention or retain or engag* or particip* or motivat* or encourag* or attrition or
dropout* or promot* or recruit* or involv*)
23. S20 or S21 or S22NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 3524. ( TX (uptake or retention or retain or engag* or particip* or motivat* or encourag* or attrition or
dropout* or promot* or recruit* or involv*) ) N3 ( TX (male or men#) )
25. ( TX (uptake or retention or retain or engag* or particip* or motivat* or encourag* or attrition or
dropout* or promot* or recruit* or involv*) ) N3 ( TX (male or men#) ) N3 ( TX (service* or program*
or scheme* or initiative* or intervention* or diet*) )
26. ( TX (uptake or retention or retain or engag* or particip* or motivat* or encourag* or attrition or
dropout* or promot* or recruit* or involv*) ) N3 ( TX (male or men#) ) N3 (S1 or S2 or S3 or S4 or S5
or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18)
27. S23 and S26
28. S19 and S25
29. S19 and S24
30. S27 or S28 or S29
31. TX women NOT TX men
32. TX female not TX male
33. S30 NOT S31
34. S33 NOT S32
35. ( TX child* or TX adolescen* ) NOT TX adult*
36. S34 NOT S35Cumulative Index to Nursing and Allied Health Literature (1981 to July 2012)
http://search.ebscohost.com
1. (MH “Obesity+”)
2. (MH “Body Mass Index”) OR (MH “Body Weight+”)
3. TX Obes* n2 morbid*
4. TX Obes* n2 diabet*
5. TX overweight or obes*
6. TX obes* n3 abdom*
7. TX fat n3 abdom*
8. (MH “Weight Loss”)
9. TX weight n1 los*
10. TX weight n1 reduc*
11. TX weight n1 maint*
12. TX weight n1 control*
13. TX weight n1 manag*
14. TX reduc* n2 bmi
15. TX reduc* n2 body mass index
16. TX reduc* n2 waist circumference
17. TX obesity n1 manag*
18. TX anti#obesity
19. S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16
or S17 or S18
20. (MH “Patient Compliance+”) OR (MH “Treatment Refusal”)
21. (MH “Research Dropouts”) OR (MH “Patient Dropouts”)
22. (MH “Consumer Participation”)
23. (MH “Patient Attitudes”)
24. TX (uptake or retention or retain or engag* or particip* or motivat* or encourag* or attrition or
dropout* or promot* or recruit* or involv*)
25. S20 or S21 or S22 or S23 or S24
26. ( TX (uptake or retention or retain or engag* or particip* or motivat* or encourag* or attrition or
dropout* or promot* or recruit* or involv*) ) N3 ( TX (male or men#) )261
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26227. ( TX (uptake or retention or retain or engag* or particip* or motivat* or encourag* or attrition or
dropout* or promot* or recruit* or involv*) ) N3 ( TX (male or men#) ) N3 ( TX (service* or program*
or scheme* or initiative* or intervention* or diet*) )
28. ( TX (uptake or retention or retain or engag* or particip* or motivat* or encourag* or attrition or
dropout* or promot* or recruit* or involv*) ) N3 ( TX (male or men#) ) N3 S19
29. S25 and S28
30. S19 and S27
31. S19 and S26
32. S29 or S30 or S31
33. TX women NOT TX men
34. TX female not TX male
35. S32 not S33
36. S35 not S34
37. ( TX child* or TX adolescen* ) NOT TX adult*
38. S36 NOT S37Applied Social Sciences Index and Abstracts (1987 to July 2012)
http://www.csa.com/
(((uptake or retention or retain or engag* or particip* or motivat* or encourag* or attrition or dropout* or
promot* or recruit* or involv*) within 3 (male or males or men or men's)) within 3 ((obes* or overweight
or (obes* within 2 control*)) or ((obes* within 2 central) or (obes* within 2 abdom) or (obes* within 2
manag*)) or ((weight within 2 manag*) or (weight within 1 control*) or (weight within 1 los*)) or ((weight
within 1 reduc*) or (weight within 1 maint*) or (reduc* within 2 bmi)) or ((reduc* within 2 body mass
index) or (reduc* within 5 circumference))))
Or
(((obes* or overweight or (obes* within 2 control*)) or ((obes* within 2 central) or (obes* within 2 abdom)
or (obes* within 2 manag*)) or ((weight within 2 manag*) or (weight within 1 control*) or (weight within
1 los*)) or ((weight within 1 reduc*) or (weight within 1 maint*) or (reduc* within 2 bmi)) or ((reduc*
within 2 body mass index) or (reduc* within 5 circumference))) And ((uptake or retention or retain or
engag* or particip* or motivat* or encourag* or attrition or dropout* or promot* or recruit* or involv*)
within 3 (male or males or men or men's)))
Or
(((obes* or overweight or (obes* within 2 control*)) or ((obes* within 2 central) or (obes* within 2 abdom)
or (obes* within 2 manag*)) or ((weight within 2 manag*) or (weight within 1 control*) or (weight within
1 los*)) or ((weight within 1 reduc*) or (weight within 1 maint*) or (reduc* within 2 bmi)) or ((reduc*
within 2 body mass index) or (reduc* within 5 circumference))) And (((uptake or retention or retain or
engag* or particip* or motivat* or encourag* or attrition or dropout* or promot* or recruit* or involv*)
within 3 (male or males or men or men's)) within 3 (service* or program* or scheme* or initiative* or
intervention* or diet*)))NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Review of qualitative evidence
MEDLINE (1948 to 30 July 2012), MEDLINE In-Process & Other Non-Indexed
Citations (30 July 2012) and EMBASE (1980 to 2012 Week 31)
Ovid multiﬁle search: http://shibboleth.ovid.com/
1. qualitative research/
2. exp questionnaires/ use prmz
3. exp questionnaire/ use oemezd
4. exp interviews as topic/ use prmz
5. exp interview/ use oemezd
6. (qualitative or interview$ or focus group$ or questionnaire$ or survey$).tw.
7. (ethno$ or grounded or thematic or interpretive or narrative or realist$ or meta stud$ or experience?).tw.
8. or/1-7
9. *obesity/
10. obesity hypoventilation syndrome/
11. abdominal obesity/ use oemezd
12. morbid obesity/ use oemezd
13. diabetic obesity/ use oemezd
14. obesity, abdominal/ use prmz
15. obesity, morbid/ use prmz
16. (overweight or obes$).ti.
17. (obes$ adj1 (morbid or diabet$ or abdom$ or central)).tw.
18. or/9–17
19. *weight loss/
20. *weight reduction/ use oemezd
21. (weight adj1 (los$ or reduc$ or maint$ or control or manag$)).tw.
22. (reduc$ adj2 (waist adj3 (ratio or circumference))).tw.
23. (reduc$ adj2 (bmi or body mass index)).tw.
24. anti obesity.tw.
25. (obesity adj1 manag$).tw.
26. or/19–25
27. 8 and 18 and 26
28. limit 27 to (“all infant (birth to 23 months)” or “all child (0 to 18 years)” or “newborn infant (birth to
1 month)” or “infant (1 to 23 months)” or “preschool child (2 to 5 years)” or “child (6 to 12 years)”
or “adolescent (13 to 18 years)”)
29. 27 not 28
30. limit 27 to (embryo or infant or child or preschool child <1 to 6 years> or school child <7 to 12 years>
or adolescent <13 to 17 years>)
31. 27 not 30
32. 29 or 31
33. (female not male).tw.
34. (women not men).tw.
35. 33 or 34
36. 32 not 35
37. or/19-21,24-25
38. 8 and 37
39. (men or male or males).tw.
40. 38 and 39
41. 36 not 40
42. exp animals/ not humans/
43. remove duplicates from 36263
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26444. limit 43 to yr=”2012 -Current”
45. (20111$ or 2012$).ed. use prmz
46. (20114$ or 20115$ or 2012$).em. use oemezd
47. 43 and 45
48. 43 and 46
49. 44 or 47 or 48Cumulative Index to Nursing and Allied Health Literature (1981 to July 2012)
http://search.ebscohost.com
Search 1:
1. (MH “Obesity”) OR (MH “Obesity, Morbid”)
2. TX Obes* n2 morbid*
3. TX Obes* n2 diabet*
4. TX overweight or obes*
5. TX obes* n3 abdom*
6. TX central n3 obes*
7. S1 or S2 or S3 or S4 or S5 or S6
8. (MH “Weight Loss”)
9. (MH “Weight Control”)
10. TX weight n1 los*
11. TX weight n1 reduc*
12. TX weight n1 maint*
13. TX weight n1 control*
14. TX reduc* n2 bmi
15. TX reduc* n2 body mass index
16. TX reduc* n2 waist circumference
17. S8 or S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16
18. (MH “Qualitative Studies+”)
19. (MH “Interviews+”)
20. (MH “Narratives”)
21. (MH “Projective Techniques+”)
22. (MH “Questionnaires+”)
23. (MH “Focus Groups”)
24. TX qualitative or interview* or focus group* or questionnaire* or survey* or ethno* or grounded or
thematic or interpretive or narrative or realist* or meta stud*
25. S18 or S19 or S20 or S21 or S22 or S23 or S24
26. S7 and S17 and S25
27. TX female not male
28. TX women not men
29. S27 or S28
30. S26 not S29
31. ( (MH “Child+”) OR (MH “Infant+”) ) NOT (MH “Adult+”)
32. S30 not S31
Search 2:
1. (MH “Qualitative Studies+”)
2. (MH “Interviews+”)
3. (MH “Narratives”)
4. (MH “Projective Techniques+”)
5. (MH “Questionnaires+”)NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 356. (MH “Focus Groups”)
7. TX qualitative or interview* or focus group* or questionnaire* or survey* or ethno* or grounded or
thematic or interpretive or narrative or realist* or meta stud*
8. S1 or S2 or S3 or S4 or S5 or S6 or S7
9. (MH “Weight Loss”)
10. (MH “Weight Control”)
11. TX weight n1 los*
12. TX weight n1 reduc*
13. TX weight n1 maint*
14. TX weight n1 control*
15. TX weight n1 manag*
16. TX obesity n1 manag*
17. TX anti#obesity
18. S9 or S10 or S11 or S12 or S13 or S14 or S15 or S16 or S17
19. TX men or male or males
20. S8 and S18 and S19
21. ( (MH “Child+”) OR (MH “Infant+”) ) NOT (MH “Adult+”)
22. S20 not S21 Exclude MEDLINE records Published Date from: 19900101-20121231Social Sciences Citation Index (1970 to July 2012) and Conference Proceedings
Citation Index – Social Science & Humanities (1990 to July 2012)
www.webofknowledge.com
Search 1:
1. TS=(obes* or overweight)
2. TS=(obes* near/2 morbid*)
3. TS=(obes* near/2 diabet*)
4. TS=(obes* near/2 central)
5. TS=(obes* near/2 abdom*)
6. #5 OR #4 OR #3 OR #2 OR #1
7. TS=(weight near/1 los*)
8. TS=(weight near/1 reduc* )
9. TS=(weight near/1 maint*)
10. TS=(weight near/1 control*)
11. TS=(reduc* near/2 bmi)
12. TS=(reduc* SAME (body mass index))
13. TS=(reduc* SAME (waist circumference))
14. #13 OR #12 OR #11 OR #10 OR #9 OR #8 OR #7
15. TS=(qualitative or survey* or questionnaire* or focus group* or interview* or ethno* or grounded
theory or interpretive or narrative or realist* or meta stud*)
16. #15 AND #14 AND #6
17. TS=(female not male)
18. TS=(women not men)
19. #18 OR #17
20. #16 not #19
21. TS=((child* or adolescen* or teenage* or infant*) not adult*)
22. #20 not #21265
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266Search 2:
1. TS=(qualitative or survey* or questionnaire* or focus group* or interview* or ethno* or grounded
theory or interpretive or narrative or realist* or meta stud*)
2. TS=(weight near/1 los*)
3. TS=(weight near/1 reduc* )
4. TS=(weight near/1 maint*)
5. TS=(weight near/1 control*)
6. TS=(weight near/1 manag*)
7. TS=(anti-obesity or anti obesity or antiobesity)
8. TS=(obesity near/1 manag*)
9. #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2
10. TS=(male or males or men)
11. #10 AND #9 AND #1PsycINFO (1806 to July 2012)
http://search.ebscohost.com
Search 1:
1. DE “Obesity”
2. TX Obes* n2 morbid*
3. TX Obes* n2 diabet*
4. TX overweight or obes*
5. TX obes* n3 abdom*
6. TX central n3 obes*
7. S6 or S5 or S4 or S3 or S2 or S1
8. DE “Weight Loss”
9. DE “Weight Control”
10. TX weight n1 los*
11. TX weight n1 reduc*
12. TX weight n1 maint*
13. TX weight n1 control*
14. TX reduc* n2 bmi
15. TX reduc* n2 body mass index
16. TX reduc* n2 waist circumference
17. S16 or S15 or S14 or S13 or S12 or S11 or S10 or S9 or S8
18. TX qualitative or interview* or focus group* or questionnaire* or survey* or ethno* or grounded or
thematic or interpretive or narrative or realist* or meta stud*
19. DE “Questionnaires” OR DE “Surveys” OR DE “Consumer Surveys” OR DE “Mail Surveys” OR DE
“Telephone Surveys” OR DE “Questionnaires” OR DE “General Health Questionnaire” OR DE
“Qualitative Research” OR DE "Grounded Theory” OR DE “Ethnography” OR DE “Narratives” OR DE
“Projective Techniques” OR DE “Holtzman Inkblot Technique” OR DE “Projective Personality
Measures”
20. S19 or S19
21. S7 and S17 and S20
22. TX female NOT TX male
23. TX women NOT TX men
24. S21 not S22
25. S24 not S23
26. ( TX child* or TX adolescen* ) NOT TX adult*
27. S25 NOT S26NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Search 2:
1. DE “Questionnaires” OR DE “Surveys” OR DE “Consumer Surveys” OR DE “Mail Surveys” OR DE
“Telephone Surveys” OR DE “Questionnaires” OR DE “General Health Questionnaire” OR DE
“Qualitative Research” OR DE “Grounded Theory” OR DE “Ethnography” OR DE “Narratives” OR DE
“Projective Techniques” OR DE “Holtzman Inkblot Technique” OR DE “Projective Personality
Measures”
2. TX qualitative or interview* or focus group* or questionnaire* or survey* or ethno* or grounded or
thematic or interpretive or narrative or realist* or meta stud*
3. S1 or S2
4. DE “Weight Loss”
5. DE “Weight Control”
6. TX weight n1 los*
7. TX weight n1 reduc*
8. TX weight n1 maint*
9. TX weight n1 control*
10. TX weight n1 manag*
11. TX obesity n1 manag*
12. TX anti#obesity
13. S4 or S5 or S6 or S7 or S8 or S9 or S10 or S11 or S12
14. TX men or male or males
15. S3 and S13 and S14 Publication Year from: 1990-2012Education Resources Information Center (1966 to July 2012)
http://search.proquest.com
(((cabs(weight near/1 los*)) OR (cabs(weight near/1 reduc*) or cabs(weight near/1 maint*))) OR (cabs
(weight near/1 control*) or cabs(reduc* near/2 bmi))) OR ((cabs(reduc* near/2 body mass index) or cabs
(reduc* near/2 waist circumference))) AND (((cabs(obes*)) OR (cabs(overweight) or cabs(obes* near/2
morbid*))) OR (cabs(obes* near/2 diabet*) or cabs(obes* near/2 central))) OR ((cabs(obes* near/2 abdom*)
or cabs(fat near/2 abdom)))Education Resources Information Center (1966 to July 2012)
http://www.csa.com/
((DE=((qualitative research) or (qualitative methods) or interviews) or DE=((cognitive interviews) or (exit
interviews) or (ﬁtness for interview)) or DE=((focus group interviews) or (semistructured interviews) or
(structured interviews)) or DE=((structured behavioural interviews) or (structured clinical interviews) or
(videotaped interviews)) or DE=(questionnaires or (mail surveys) or (multiple choice questionnaires))
or DE=(polls or (exit polls) or (opinion polls)) or DE=(semistructured questionnaires)) or((qualitative or
interview* or questionnaire*) or (survey* or ethno* or grounded) or (thematic or interpretive or narrative)
or (realist* or (meta stud*)))) and (((weight within 1 los*) or (weight within 1 control*) or (weight within 1
reduc*)) or ((weight within 1 maint*) or (weight within 1 manag*) or (obesity within 1 manag*) or
(anti*obesity))) and(men or males or male)
1990–2012267
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268Applied Social Sciences Index and Abstracts (1987 to July 2012)
http://www.csa.com/
Search 1:
1. obes* or overweight
2. ((obes* within 2 morbid*) or (obes* within 2 diabet*) or (obes* within 2 control*)) or ((obes* within 2
central) or (obes* within 2 abdom))
3. #1 or #2
4. ((weight within 1 los*) or (weight within 1 control*) or (weight within 1 reduc*)) or ((weight within 1
maint*) or (reduc* within 2 bmi) or (reduc* within 2 body mass index)) or (reduc* within 5
circumference))
5. (DE=((qualitative research) or (qualitative methods) or interviews) or DE=((cognitive interviews) or (exit
interviews) or (ﬁtness for interview)) or DE=((focus group interviews) or (semistructured interviews) or
(structured interviews)) or DE=((structured behavioural interviews) or (structured clinical interviews)
or (videotaped interviews)) or DE=(questionnaires or (mail surveys) or (multiple choice questionnaires))
or DE=(polls or (exit polls) or (opinion polls)) or DE=(semistructured questionnaires)) or((qualitative or
interview* or questionnaire*) or (survey* or ethno* or grounded) or (thematic or interpretive or
narrative) or (realist* or (meta stud*)))
6. #3 and #4 and #5
Search 2:
((DE=((qualitative research) or (qualitative methods) or interviews) or DE=((cognitive interviews) or (exit
interviews) or (ﬁtness for interview)) or DE=((focus group interviews) or (semistructured interviews) or
(structured interviews)) or DE=((structured behavioural interviews) or (structured clinical interviews) or
(videotaped interviews)) or DE=(questionnaires or (mail surveys) or (multiple choice questionnaires)) or
DE=(polls or (exit polls) or (opinion polls)) or DE=(semistructured questionnaires)) or((qualitative or
interview* or questionnaire*) or (survey* or ethno* or grounded) or (thematic or interpretive or narrative)
or (realist* or (meta stud*)))) and(((weight within 1 los*) or (weight within 1 control*) or (weight within 1
reduc*)) or ((weight within 1 maint*) or (weight within 1 manag*) or (obesity within 1 manag*) or
(anti*obesity))) and(men or males or male)
1990–2012Anthropology Plus (1957 to July 2012)
http://ﬁrstsearch.oclc.org
Search 1:
(kw: overweight or kw: obes*) or (kw: obes* n2 morbid*) or (kw: obes* n2 abdomin*) or (kw: obes* n2
diabet*) or (kw: obes* n2 central) and ((kw: weight n2 los*) or (kw: weight n2 reduc*) or (kw: weight n2
control*))
Search 2:
(kw: weight n2 los*) or (kw: weight n2 reduc*) or (kw: weight n2 control*) or (kw: weight n2 manag*) or
(kw: obesity n2 manag*) or (kw: anti and kw: obesity) or (kw: anti-obesity) or (kw: antiobesity)NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35British Nursing Index (1994 to July 2012)
Ovid multiﬁle search: http://shibboleth.ovid.com/
1. obesity/
2. (overweight or obes$).ti.
3. (obes$ adj1 (morbid or diabet$ or abdom$ or central)).tw.
4. or/1-3
5. research methods/ or “interviews and interviewing”/
6. (qualitative or interview$ or focus group$ or questionnaire$ or survey$).tw.
7. (ethno$ or grounded or thematic or interpretive or narrative or realist$ or meta stud$ or experience$).
tw.
8. or/5–7
9. (female not male).tw.
10. (women not men).tw.
11. 9 or 10
12. (child$ or adolescent$ or infant$).tw,hw.
13. 4 and 8
14. 13 not 11
15. 14 not 12Websites consulted
Picker Institute
http://pickerinstitute.orgJoanna Briggs Institute
www.joannabriggs.edu.au/Men’s Health Forum
www.menshealthforum.org.uk/Association for the Study of Obesity
www.aso.org.uk/fatmanslim.com
www.fatmanslim.comCost-effectiveness searchesMEDLINE (1946 to 19 January 2012), MEDLINE In-Process & Other
Non-Indexed Citations (19 January 2012) and EMBASE (1974 to
2012 Week 02)
Ovid multiﬁle search: http://shibboleth.ovid.com/
1. exp “costs and cost analysis”/
2. cost-beneﬁt analysis/
3. quality-adjusted life years/
4. economics,pharmaceutical/
5. exp budgets/
6. exp models, economic/
7. exp decision theory/
8. monte carlo method/269
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2709. markov chains/
10. exp health status indicators/
11. cost$.ti.
12. (cost$ adj2 (effective$ or utilit$ or beneﬁt$ or minimis$)).ab.
13. economic$ model$.tw.
14. (economic$ or pharmacoeconomic$ or pharmaco-economic$).tw.
15. (price$ or pricing).tw.
16. (ﬁnancial or ﬁnance or ﬁnances or ﬁnanced).tw.
17. ((value adj2 money) or monetary).tw.
18. markov$.tw.
19. monte carlo.tw.
20. (decision$ adj2 (tree? or analy$ or model$)).tw.
21. (standard adj1 gamble).tw.
22. trade off.tw.
23. or/1–22
24. *obesity/
25. *overweight/
26. obesity, morbid/ use prmz
27. morbid obesity/ use oemez
28. (obes$ or overweight).tw.
29. weight loss/ use prmz
30. weight reduction/ use oemez
31. (weight adj1 (los$ or reduc$ or maint$ or control or manag$)).tw.
32. (obesity adj1 management).tw.
33. (anti obesity or antiobesity).tw.
34. or/24–32
35. (men or male or males).tw.
36. *obesity/ec
37. *overweight/ec
38. or/36-37
39. (women not men).tw.
40. (female not male).tw.
41. 38 not (39 or 40)
42. 23 and 34 and 35
43. 41 or 42
44. exp animals/ not humans/
45. 43 not 44
46. (rat or rats).tw.
47. 45 not 46
48. limit 47 to (“all infant (birth to 23 months)” or “all child (0 to 18 years)” or “all adult (19 plus years)”
or “newborn infant (birth to 1 month)” or “infant (1 to 23 months)” or “preschool child (2 to 5
years)” or “child (6 to 12 years)” or “adolescent (13 to 18 years)”)
49. limit 47 to (embryo or infant or child or preschool child <1 to 6 years> or school child <7 to 12 years>
or adolescent <13 to 17 years>)
50. 47 not 48
51. 47 not 49
52. 50 or 51
53. limit 52 to yr=”2009 -Current”
54. remove duplicates from 53
55. (letter or editorial or comment or note).pt.
56. 54 not 55NIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35NHS Economic Evaluation Database (January 2012)
Centre for Reviews and Dissemination: www.crd.york.ac.uk
1. MeSH DESCRIPTOR Obesity EXPLODE ALL TREES
2. MeSH DESCRIPTOR weight loss
3. MeSH DESCRIPTOR obesity
4. MeSH DESCRIPTOR obesity, morbid
5. (obesity adj2 (morbid or diabet*))
6. (overweight or obes*):TI
7. #2 OR #3 OR #4 OR #5 OR #6
8. IN NHSEED FROM 1990 TO 2012
9. #7 AND #8Health Management Information Consortium (1979 to November 2011)
http://ovidsp.uk.ovid.com/
1. exp obesity/
2. weight loss/
3. (overweight or obes$).tw.
4. (weight adj1 (los$ or reduc$ or maint$ or control or manag$)).tw.
5. (obesity adj1 management).tw.
6. (anti obesity or antiobesity).tw.
7. or/1-6
8. exp “cost effectiveness”/
9. exp economic evaluation/
10. “cost beneﬁt analysis”/
11. monte carlo methods/
12. cost$.tw.
13. ((value adj2 money) or monetary).tw.
14. quality adjusted life years/
15. economic$ model$.tw.
16. (decision$ adj2 (tree? or analy$ or model$)).tw.
17. (standard adj1 gamble).tw.
18. trade off.tw.
19. or/8–18
20. 7 and 19
21. limit 20 to yr=”1990 -Current”
22. (female not male).tw
23. (women not men).tw
24. 21 not (22 or 23)Cost-Effectiveness Analysis Registry (January 2012)
https://research.tufts-nemc.org/cear4/SearchingtheCEARegistry/SearchtheCEARegistry.aspx
obesity OR weight loss OR overweightResearch Papers in Economics (January 2012)
http://ideas.repec.org/
obesity or overweight or weight loss271
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APPENDIX 1
272List of professional and commercial organisations contactedAssociation for the Study of Obesity
Boots Pharmacy
British Dietetic Association
Cambridge Weight Plan
Counterweight
Diet Chef
Dietitians in Obesity Management
fatmanslim
Go Lower
Jenny Craig
LighterLife
Men’s Health Forums of England and Wales, Scotland, and Ireland
Motivation
Nestlé
Online Slimming Club
ProHealthClinical
Rosemary Conley
Rotherham Institute for Obesity
Scottish Slimmers
Slimming World
Sure Slim
The Lose-It Coach
Trim Up Shape Down
Weight Care
Weight Medics
Weight WatchersNIHR Journals Library www.journalslibrary.nihr.ac.uk
DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Appendix 2 Data extraction form (reviews of
clinical effectiveness)
Version 2 October 2011
Included in systematic review number
Trial author and date
First author institution
Study ID of any linked reports
Reference Manager number
Extracted by
Checked by
Location/setting
Period of study and duration of follow-up
Method of recruitment and sampling
Yes No
Details (include whether single or multicentre,
prospective/retrospective, etc.)
RCT design?
Yes No
Details (include whether single or multicentre,
prospective/retrospective, etc.)
Quasi-RCT design?
Yes No
Details (include whether single or multicentre,
prospective/retrospective, etc.)
Other study design?
Yes No Details
Pretreatment phase?
Yes No Details
Subgroup analysis?
Yes No Details
Groups comparable at baseline?
Participants’ general description (e.g. cardiac risk factors, etc.):
Targeted particularly at: men Y/N, diabetics Y/N, impaired glucose tolerance Y/N, impaired fasting glucose Y/N,
glycaemia Y/N, hypertensive Y/N, hyperlipidaemia Y/N
Inclusion criteria Exclusion criteria
Notes
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TABLE 40 Details of interventions
Control group Treatment 1 Treatment 2 Treatment 3 Treatment 4
Type of intervention
Individual/group/both
Couple/family
Lifestyle/drug/both
Behaviour change
(and underlying theory)
Description of intervention
(include length of meeting,
duration, etc.)
Timing of active intervention
Duration
Number of times contacted
Frequency of contact
Maximum length
of follow-up
Health professional
involvement (role, timing)
Other details of care
TABLE 41 Study population baseline characteristics: men (record details for female participants on a separate page)
Baseline
characteristics Control Treatment 1 Treatment 2 Treatment 3 Treatment 4 Overall
Number of men enrolled
Number randomised
(RCTs only)
Age (mean/median,
SD/range)
Social class
Ethnic group
Smoking status
Weight (kg)
Height (m)
Reported BMI (kg/m2)
(mean/median,
SD/range)
Calculated BMI (kg/m2)
Waist circumference
(give units)
APPENDIX 2
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TABLE 42 Study population baseline characteristics: men (record details for female participants on a separate page)
Baseline characteristics Control Treatment 1 Treatment 2 Treatment 3 Treatment 4 Overall
Total cholesterol
(give units)
LDL cholesterol
(give units)
HDL cholesterol
(give units)
Triglycerides (give units)
Systolic blood pressure
(mmHg)
Diastolic blood pressure
(mmHg)
HbA1c (%)
Fasting plasma glucose
(give units)
Erectile dysfunction
(specify measure and
whether validated or not)
Quality of life
Generic
(specify measure)
Disease speciﬁc
(specify measure)
Other (specify)
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TABLE 43 Participant ﬂow for weight data only: men (record details for female participants on a separate page)
Control Treatment 1 Treatment 2 Treatment 3 Treatment 4 Overall
Number eligible
Number assigned/selected to
each group
Number withdrawn/lost to
follow-up (with reasons)
Number present for weight
at time =
Number withdrawn/lost to
follow-up (with reasons)
Number present for weight
at time =
Number withdrawn/lost to
follow-up (with reasons)
Number present for weight
at time =
Number withdrawn/lost to
follow-up (with reasons)
Number assessed at end of
study, with details
Number completed at end
of study
% dropout at end of study
Number dead at end of study
Period of active intervention
Maximum period of follow-up
TABLE 44 Outcomes: men (record details for female participants on a separate page)
Outcome Statistics
Timing
(e.g. 1 year,
18 months,
2 years)
Control
(n/N = )
Treatment
1 (n/N = )
Treatment
2 (n/N = )
Treatment
3 (n/N = )
Treatment
4 (n/N = )
Weight (kg)
Height (m)
BMI (kg/m2)
% ideal body
weight
Waist
circumference
(give units)
Total cholesterol
(give units)
LDL cholesterol
(give units)
HDL cholesterol
(give units)
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TABLE 45 Outcomes: men (record details for female participants on a separate page)
Outcome Statistics
Timing
(e.g. 1 year,
18 months,
2 years)
Control
(n/N = )
Treatment 1
(n/N = )
Treatment 2
(n/N = )
Treatment 3
(n/N = )
Treatment 4
(n/N = )
Triglycerides
(give units)
Systolic blood
pressure (mmHg)
Diastolic blood
pressure (mmHg)
HbA1c (%)
Fasting plasma
glucose
(give units)
Erectile dysfunction
(specify measure
and whether
validated or not)
TABLE 46 Outcomes: men (record details for female participants on a separate page)
Outcome Statistics
Timing
(e.g. 1 year,
18 months,
2 years)
Control
(n/N = )
Treatment 1
(n/N = )
Treatment 2
(n/N = )
Treatment 3
(n/N = )
Treatment 4
(n/N = )
Quality of life
Generic
(specify measure)
Disease speciﬁc
(specify measure)
Other (specify)
Deaths
Morbidity
Adverse events
Compliance
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ABLE 47 Study population baseline characteristics: women
APPENDIX 2
278TBaseline characteristics Control Treatment 1 Treatment 2 Treatment 3 Treatment 4 Overall
Number of women
enrolled
Number randomised
(RCTs only)
Age (mean/median,
SD/range)
Social class
Ethnic group
Smoking status
Weight (kg)
Height (m)
Reported BMI (kg/m2)
(mean/median, SD/range)
Calculated BMI (kg/m2)
Waist circumference
(give units)
TABLE 48 Study population baseline characteristics: women
Baseline characteristics Control Treatment 1 Treatment 2 Treatment 3 Treatment 4 Overall
Total cholesterol
(give units)
LDL cholesterol
(give units)
HDL cholesterol
(give units)
Triglycerides
(give units)
Systolic blood pressure
(mmHg)
Diastolic blood pressure
(mmHg)
HbA1c (%)
Fasting plasma glucose
(give units)
Quality of life
Generic
(specify measure)
Disease speciﬁc
(specify measure)
Other (specify)
NIHR Journals Library www.journalslibrary.nihr.ac.uk
TABLE 49 Participant ﬂow for weight data only: women
Baseline characteristics Control Treatment 1 Treatment 2 Treatment 3 Treatment 4 Overall
Number eligible
Number assigned/selected
to each group
Number withdrawn/lost
to follow-up (with
reasons)
Number present for
weight at time =
Number withdrawn/lost
to follow-up (with
reasons)
Number present for
weight at time =
Number withdrawn/lost
to follow-up (with
reasons)
Number present for
weight at time =
Number withdrawn/lost
to follow-up (with
reasons)
Number assessed at end
of study, with details
Number completed at
end of study
% dropout at end
of study
Number dead at end
of study
Period of active
intervention
Maximum period
of follow-up
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TABLE 51 Outcomes: women
Outcome
Statistics
and who
measured
Timing
(e.g. 1 year,
18 months,
2 years)
Control
(n/N =)
Treatment 1
(n/N =)
Treatment 2
(n/N =)
Treatment 3
(n/N =)
Treatment 4
(n/N =)
Triglycerides
(give units)
Systolic blood
pressure (mmHg)
Diastolic blood
pressure (mmHg)
HbA1c (%)
Fasting plasma
glucose (give units)
TABLE 50 Outcomes: women
Outcome
Statistics
and who
measured
Timing
(e.g. 1 year,
18 months,
2 years)
Control
(n/N =)
Treatment 1
(n/N =)
Treatment 2
(n/N =)
Treatment 3
(n/N =)
Treatment 4
(n/N =)
Weight (kg)
Height (m)
BMI (kg/m2)
% ideal body
weight
Waist
circumference
(give units)
Total cholesterol
(give units)
LDL cholesterol
(give units)
HDL cholesterol
(give units)
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TABLE 53 Economic analysis
Timing
(e.g. 1 year,
18 months,
2 years) Control Treatment 1 Treatment 2 Treatment 3 Treatment 4
Measure of health
beneﬁts used in the
economic analysis
Direct costs
Indirect costs
Currency
Statistical analysis
of quantities/costs
Sensitivity analysis
Estimated beneﬁts
used in the economic
evaluation
Costs results
Synthesis of costs
and beneﬁts
Authors’ conclusions
TABLE 52 Outcomes: women
Outcome
Statistics
and who
measured
Timing
(e.g. 1 year,
18 months,
2 years)
Control
(n/N =)
Treatment 1
(n/N =)
Treatment 2
(n/N =)
Treatment 3
(n/N =)
Treatment 4
(n/N =)
Quality of life
Generic
(specify measure)
Disease speciﬁc
(specify measure)
Other (specify)
Deaths
Morbidity
Adverse events
Compliance
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TABLE 54 Engagement
Formally
evaluated
(Y/N) Control Treatment 1 Treatment 2 Treatment 3 Treatment 4
Explicit strategies used to
promote recruitment
Explicit strategies used to
promote attendance/
compliance or weight loss
Explicit strategies used to
promote attendance/
compliance/weight
maintenance
Sex of programme
facilitator and health-care
professionals reported
(give details)
Programme environment
Use of technology
APPENDIX 2
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randomised controlled trials and randomised
controlled trials of men and women compared)
RCT quality assessment form, version 1, January 2012
Study ID: Reviewer initials: Date:Question
Judgement
(L = low,
U = unclear,
H = high) A description that
explains how the
judgement was reachedL U H
Potential for selection bias at trial entry (quality of random allocation concealment)
1. Was allocation adequately concealed?
l Low = good attempt at concealment; method should not allow
disclosure of assignment (telephone randomisation, third-party
involvement in allocation procedure, etc.)
l Unclear = states concealment but no description given
l High = concealed (open random numbers tables or quasi-randomised,
e.g. day of week, date of birth, alternation) or an attempt at
concealment but real chance of disclosure of assignment before
formal entry (envelopes without third-party involvement, random
numbers table but procedures not described)
2. Was random sequence generation adequately generated?
(selection bias)
l Low = adequate, e.g. random numbers table, use of computer
random number generator, shufﬂing cards or envelopes
l Unclear = insufﬁcient information to permit judgement of low or high
l High = inadequate, e.g. use of alternation, case record numbers, birth
dates, date of admission
Potential for bias around time of treatment or during outcome assessment (blinding) (performance and
detection bias)
3. Were participants ‘blind’ to treatment status?
l Low = action taken to blind participants to treatment likely to be
effective (e.g. placebo)
l Unclear = blinding stated but no description given
l High = attempt at blinding participants to intervention but reason to
think it may not have been successful (e.g. placebo smells different),
no mention of blinding or not blinded
4. Were health-care providers ‘blind’ to treatment status?
(performance bias)
l Low, unclear or high as in Q3
5. Were outcome assessors ‘blind’ to treatment status? (detection bias)
l Low, unclear or high as in Q3
6. Were the groups treated identically other than for the named
interventions? (performance bias)
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Question
Judgement
(L = low,
U = unclear,
H = high) A description that
explains how the
judgement was reachedL U H
Incomplete outcome data: potential for selection bias in analysis (attrition bias)
7. Was there a description of withdrawals, dropouts and those lost
to follow-up?
l Low = states numbers and reasons for withdrawals, no missing data,
missing data balanced across intervention groups, missing data
unlikely to impact on important effect size, appropriate imputation
methods used
l Unclear = states numbers of withdrawals only (no reason given) or
insufﬁcient reporting
l High = states withdrawals but no number given or not mentioned,
missing data unbalanced, missing data likely to be clinically relevant,
inappropriate imputation used
8. Was the analysis on an intention-to-treat basis (or is it possible to do
so on available data)? i.e. (A) Are results reported for everyone who
entered the trial?, (B) are participants analysed in the groups they were
originally allocated to? If low for both, intention-to-treat analysis has
been performed
9. Are reports of the study free of the suggestion of selective
outcome reporting?
l Low = the study protocol is available and all prespeciﬁed outcomes
have been reported; or the study protocol is not available but it is
clear that the published report includes all of the study’s prespeciﬁed
outcomes and all expected outcomes
l Unclear = insufﬁcient information
l High = not all of the study’s prespeciﬁed primary outcomes
have been reported; one or more primary outcome is reported
using measurements, analysis methods or subsets of the data
(e.g. subscales) that were not prespeciﬁed; one or more reported
primary outcome was not prespeciﬁed (unless clear justiﬁcation for
their reporting is provided, such as an unexpected adverse effect);
one or more outcome of interest in the review is reported
incompletely so that it cannot be entered in a meta-analysis; the
study report fails to include results for a key outcome that would be
expected to have been reported for such a study
10. Was the study apparently free of other bias that could put it at a high
risk of bias? (validity, topic/design speciﬁc)
l Low = appears to be free of other bias
l Unclear = insufﬁcient information
l High = the study had a potential source of bias relating to the speciﬁc
study design used; the study stopped early because of some
data-dependent process; or the study had an extreme baseline
imbalance in any factor that is strongly related to the outcome, etc.
APPENDIX 3
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Procedures quality assessment form (review of UK
interventions and engagement)Checklist for quality assessment of non-randomised studies
(comparative and cohort studies)Version 1, August 2012
Items speciﬁc to comparative studies are in italics
Assessor initial: Date evaluated: Study ID:Criteria Yes No Unclear Comments
1. Were participants a representative sample selected from a relevant
patient population, e.g. randomly selected from those seeking
treatment despite age, duration of disease, primary or secondary
disease and severity of disease?
2. Were the inclusion/exclusion criteria for participants clearly described?
3. Were participants entering the study at a similar point in their disease
progression, i.e. severity of disease?
4. Was the selection of patients consecutive?
5. Was data collection undertaken prospectively?
6. Were the groups comparable on demographic characteristics and
clinical features?
7. Was the intervention (and comparison) clearly deﬁned?
8. Was the intervention undertaken by someone experienced at
performing the procedure?a
9. Were the staff, place and facilities where the patients were treated
appropriate for performing the procedure? (e.g. access to back-up
facilities in hospital or special clinic)
10. Were any of the important outcomes considered, i.e. weight, clinical
effectiveness, cost-effectiveness?
11. Were objective (valid and reliable) outcome measures used, including
satisfaction scale?
12. Was the assessment of the main outcomes blind?
13. Was follow-up long enough (≥ 1 year) to detect important effects on
outcomes of interest?
14. Was information provided on non-respondents, dropouts?b
15. Did the withdrawals/dropouts have similar characteristics to those of
participants who completed the study and were they therefore unlikely
to cause bias?c
continued285
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Criteria Yes No Unclear Comments
APPENDIX 4
28616. Was the length of follow-up similar between comparison groups?
17. Were the important prognostic factors identiﬁed, e.g. age, duration of
disease, disease severity?d
18. Were the analyses adjusted for confounding factors?
The same form was adapted to assess the quality of case series by removing questions 6, 12, 16 and 18.
a ‘Yes’ if the practitioner had received training on conducting the procedure or had conducted the same kind of procedure
before, i.e. no learning curve.
b ‘No’ if participants were selected from those whose follow-up records were available (retrospective).
c ‘Yes’ if no withdrawals/dropouts; ‘no’ if dropout rate was = 30% or there was differential dropout, e.g. those having the
most severe disease died during follow-up but the death was not due to the treatment.
d ‘Yes’ if two or more than two factors were identiﬁed.
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Group equity checklist (reviews of clinical effectiveness)Item Yes No Unclear Not reported Notes
Equity pointer: social context of the study, e.g. was the study
conducted in a particular setting that might target/exclude
speciﬁc populations?
Representativeness of sample: are participants in the study
likely to be representative of the target population?
Sociodemographic differences between withdrawals
and exclusions?
PROGRESS categories reported at baseline (indicate letters of
those reported: place of residence, race, occupation, gender,
religion, education and literacy, socioeconomic status,
social capital)
Did the intervention include strategies to address
diversity/disadvantage?
Was there a ﬁdelity check?
Were process measures taken?
Providers (who, number, education/training in intervention
delivery, ethnicity, etc., if potentially relevant to acceptance
and uptake by participants)
Was sustainability discussed by the authors? Was it a
consideration in study development?
Do the authors describe any political or organisational context?
Were any partnerships described?
Potential for author conﬂict, i.e. evidence that author or data
collectors would beneﬁt if results favoured the intervention
under study or the control?
Were outcomes relating to harms/unintended effects of the
intervention described?
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clinical effectivenessIntroductionThe following provides an equation for deriving the SD for the change in weight from baseline given the
absolute value of the mean change in weight from baseline, as used in our previous systematic review.23MethodSummary statistics were provided from a series of trials representing 62 trial–treatment combinations of
which four had no data. A linear regression was made of the SD of the mean change on the absolute
mean change for weight.ResultsOf the 58 trial–treatment combinations, 43 reported both the mean change and the standard error of the
mean change in body weight from baseline to the end of the ﬁrst treatment phase whereas eight reported
only the mean and seven reported neither. The plot of SD by the absolute value of the mean change
(Figure 44) shows two points for which both the absolute mean and the SD of the mean are close to zero;
both were excluded from the linear regression, giving n = 41. The linear regression was also repeated
with observation 13, which was inﬂuential, excluded, to see whether or not the regression coefﬁcients
changed (Table 55).
Discussion
The results from the two linear regressions were similar. Diagnostic plots (not shown) suggested that the
regression could be improved by allowing for the increase in variation of the SD with increasing mean;
however, this is unlikely to change the results.ConclusionWhen the mean change in weight from baseline (mean) is known but its SD is unknown then the SD of
the mean change can be derived using the following equation:
SD in kg ¼ 5.915þ 0.283absolute ðmeanÞ in kg ð1Þ289
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FIGURE 44 Scatterplot of the SD of the mean change in weight by the absolute mean change in weight.
Observation 13 is labelled.
TABLE 55 Summary statistics and the equations for the predicted values of the SDs of the two linear regressions
n R2 Constant Slope
41 53.7% SD = 5.915 + 0.283 × abs(mean)
40 63.4% SD = 5.694 + 0.328 × abs(mean)
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men-only randomised controlled trialsBenassi-Evans 2010Benassi-Evans B, Clifton PM, Noakes M, Keogh JB, Fenech M. High protein–high red meat versus high
carbohydrate weight loss diets do not differ in effect on genome stability and cell death in lymphocytes of
overweight men. Mutagenesis 2009;24:271–7.Borg 2002Borg P, Kukkonen-Harjula K, Fogelholm M, Pasanen M. Effects of walking or resistance training on weight
loss maintenance in obese, middle-aged men: a randomized trial. Int J Obes 2002;26:676–83.Secondary publication
Kukkonen-Harjula KT, Borg PT, Nenonen AM, Fogelholm MG. Effects of a weight maintenance program
with or without exercise on the metabolic syndrome: a randomized trial in obese men. Prev Med
2005;41:784–90.Esposito 2004Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D’Andrea F, et al. Effect of lifestyle changes on
erectile dysfunction in obese men. JAMA 2004;291:2978–84.Jeffery 1983Jeffery RW, Gerber WM, Rosenthal BS, Lindquist RA. Monetary contracts in weight control: effectiveness of
group and individual contracts of varying size. J Consult Clin Psychol 1983;51:242–8.Secondary publications
Jeffery RW, Bjornson-Benson WM, Rosenthal BS, Lindquist RA, Johnson SL. Behavioral treatment of obesity
with monetary contracting: two-year follow-up. Addict Behav 1984;9:311–13.
Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor
Intervention Trial Research Group. JAMA 1982;248:1465–77.Khoo 2011Khoo J, Piantadosi C, Duncan R, Worthley SG, Jenkins A, Noakes M, et al. Comparing effects of a
low-energy diet and a high-protein low-fat diet on sexual and endothelial function, urinary tract
symptoms, and inﬂammation in obese diabetic men. J Sex Med 2011;8:2868–75.291
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TABLE 58 Risk of bias assessment for individual studies included in the review of RCTs of men and
women compared
Item
Gorin
201394
Hakala
199395
Hakala
199496
Heitzmann
198797
Jeffery
198498
Jeffery
200399
Jolly
2011100
Karvetti
1992101
Korhonen
1987102
Sequence generation
(selection bias)
? ? ? ✗ ? ✓ ✓ ? ?
Allocation
concealment (selection
bias)
? ? ? ✓ ? ✓ ✓ ? ?
Blinding of participants
(performance bias)
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Blinding of
health-care providers
(performance bias)
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Blinding of outcome
assessment
(detection bias)
? ? ? ? ? ? ✓ ? ?
Groups treated
identically
(performance bias)
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Incomplete outcome
data (attrition bias)
? ✗ ✗ ? ? ? ✓ ✗ ✓
Intention to treat
(attrition bias)
✓ ✗ ✗ ? ? ✓ ✓ ✗ ✗
Selective reporting
(reporting bias)
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Other bias ? ✓ ✓ ✓ ? ✓ ✓ ? ?
✓, low risk of bias; ✗, high risk of bias; ?, unclear risk of bias.
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Lantz
2003103
Lindstrom
2008104
Richelsen
2007105
Ross
2012106
Shai
2008107
Vannine n
1992108
Volpe
2008109
Wadden
2011110
West
2008111
Wing
1991112
Wing
1994113
? ✓ ✓ ✓ ? ? ? ? ? ? ?
? ✓ ? ✓ ? ? ? ? ? ? ?
✗ ✗ ✓ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
✗ ✗ ? ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
? ✓ ? ? ✓ ? ? ? ✓ ? ?
✓ ✓ ✓ ✓ ✗ ✓ ✓ ✓ ✗ ✓ ✗
? ✓ ? ✓ ✓ ? ? ✓ ✗ ✓ ?
✗ ✓ ✗ ✓ ✓ ✗ ? ✓ ✗ ✗ ✗
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
? ✓ ? ✓ ? ✓ ✓ ✓ ✓ ? ✓
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TABLE 59 Equity and sustainability assessment for individual studies included in the review of RCTs of men and
women compared
Item
Gorin
201394
Hakala
199395
Hakala
199496
Heitzman
198797
Jeffery
198498
Jeffery
200399
Jolly
2011100
Karvetti
1992101
Korhonen
1987102
Equity pointer: social
context of the study,
e.g. was the study
conducted in a
particular setting that
might target/exclude
speciﬁc populations?
✗ ? ? ✗ ✓ ✓ ✗ ? ✗
Representativeness of
the sample: are
participants in the
study likely to be
representative of the
target population?
✗ ? ✓ ✓ ✗ ✓ ✓ ✗ ✓
Sociodemographic
differences between
withdrawals and
exclusions?
✓ ? ? ? ? ? ? ? ?
PROGRESS categories
reported at baseline
(indicate letters of
those reported: place
of residence, race,
occupation, gender,
religion, education and
literacy, socioeconomic
status, social capital)
✓ ? ? ✓ ? ✓ ✓ ✓ ✓
Did the intervention
include strategies to
address diversity/
disadvantage?
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗
Was there a ﬁdelity
check?
✗ ? ? ✗ ✗ ✗ ✓ ? ✗
Were process measures
taken?
✗ ✗ ✗ ✗ ✗ ✗ ✓ ✓ ✗
Details of intervention
providers given
✓ ✓ ✓ ? ? ✓ ✓ ✓ ✓
Sustainability of the
intervention discussed?
✗ ? ? ? ? ? ✓ ? ?
Authors described any
political/organisational
context?
✗ ✗ ✗ ? ? ? ✗ ✗ ?
Were any partnerships
described?
✗ ✗ ✗ ? ? ? ✓ ✗ ?
Was there potential for
author conﬂict
✗ ? ? ? ? ? ✗ ? ?
Harms/unintended
effects of the
intervention described?
? ✗ ✗ ? ? ? ✓ ✗ ?
✓ =, yes; ✗ =, no; ? =, unclear/not reported.
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Lindstrom
2008104
Lantz
2003103
Richelsen
2007105
Ross
2012106
Shai
2008107
Vannine n
1992108
Volpe
2008109
Wadden
2011110
West
2008111
Wing
1991112
Wing
1994113
? ✗ ✗ ✗ ✓ ✗ ✗ ✗ ✗ ✓ ?
✓ ✓ ? ✓ ✓ ✓ ✗ ✓ ✓ ✓ ✓
? ? ? ? ? ? ? ✗ ? ? ?
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
✗ ✗ ✗ ✗ ✗ ✗ ✗ ✓ ? ✗ ✗
✗ ✗ ? ✗ ✗ ? ? ✓ ? ? ✗
✗ ✗ ? ✗ ✗ ? ? ✗ ? ? ✗
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ? ✓
? ? ? ? ? ? ? ? ? ? ✗
? ? ? ✗ ? ? ? ? ? ? ✗
? ? ? ✗ ? ? ? ? ? ? ✗
? ? ? ? ✗ ✗ ✗ ✗ ? ? ?
✗ ? ✓ ✓ ? ✗ ? ? ? ? ?
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individual studies: review of UK interventionsTABLE 60 Risk of bias assessment for individual RCTs included in the review of UK interventions
Item Leslie 2002146
Sequence generation (selection bias) ✗
Allocation concealment (selection bias) ✗
Blinding of participants (performance bias) ✗
Blinding of health-care providers (performance bias) ✗
Blinding of outcome assessment (detection bias) ?
Groups treated identically (performance bias) ?
Incomplete outcome data (attrition bias) ✓
Intention to treat (attrition bias) ?
Selective reporting (reporting bias) ✓
Other bias ?
✓, low risk of bias; ✗, high risk of bias; ?, unclear risk of bias.
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Galani 2007162Title: Modelling the lifetime costs and health effects of lifestyle intervention in the prevention and treatment of obesity
in Switzerland
Study charateristics
Country of study Switzerland
Setting Primary care
Research question/objective To quantify the lifetime health and economic consequences of
preventing and treating obesity with a lifestyle intervention in
Switzerland
Study design (model/RCT) Markov model
Inclusion criteria For the economic model inclusion criteria were overweight and obese
by Swiss standards; minimum age 25 years; ages modelled 25, 35,
45 and 55 years. In the economic model, subjects have a BMI of
27 kg/m2 (overweight group) or 33 kg/m2 (obese group)
Exclusion criteria None speciﬁed
Intervention Overweight and obese subjects received the same lifestyle intervention
of regular physical activity and low-fat reducing diet, including diets
rich in fruit and vegetables (adapted from the FDPS171). Detailed
dietary recommendations, including limiting intake of fat to < 30% of
energy consumed and saturated fat to < 10% and increasing ﬁbre to
at least 15 g per 1000 kcal as well as advice about speciﬁc food types.
Also asked to undertake moderate exercise for at least 30 minutes per
day. Participants attended dietitian and supervised exercise sessions
over the 3 years: seven dietitian visits in the ﬁrst year with four visits
per year thereafter over the remaining 2 years; four exercise sessions
per month in the ﬁrst year and two sessions per month thereafter in
each subsequent year for a total of 3 years
Control/comparison Overweight subjects: no active intervention. Obese subjects: basic
dietary counselling (three visits to the dietitian in year 1 and one visit
per year thereafter) and physical exercise sessions (two sessions per
month for the ﬁrst year and one session per month thereafter)
Methods: costing
Perspective Societal perspective stated
Currency Swiss francs, converted to euros in the analysis
Currency year of reporting All costs were updated to year 2006 using the consumer price index
Discount rate for costs 3%
Other costing information The inclusion of indirect costs was not entirely clear, except that they
were derived from the literature
Methods: outcome measures
Primary economic evaluation outcome LYG and QALYs
Discount rate for outcomes 3%
Time horizon over which outcomes
were assessed
60 years, to a maximum age of 85 years
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Methods: modelling
Type of model used Markov decision model
Size of model cohort 10,000
Model time horizon 60 years (for a 25-year-old) or to a maximum age of 85 years
Health states modelled A total of seven health states were modelled: (1) overweight/
obese (overweight or obese and free of complications);
(2) hypertension (overweight or obese and BP > 140/90mmHg);
(3) hypercholesterolaemia (overweight or obese and total serum
cholesterol ≥ 6.2mmol/l); (4) diabetes (overweight or obese and type
2 diabetes: fasting glucose at least 7.8mmol/l or 2-hour glucose at
least 11.1mmol/l); (5) stroke (overweight or obese and developed
stroke); (6) coronary heart disease (overweight or obese and
developed coronary heart disease); (7) death
Methods: economic evaluations alongside RCTs
Age group NA
Sex breakdown NA
Period of intervention NA
Period of follow-up NA
n randomised to intervention NA
n randomised to control NA
Data completeness intervention NA
Data completeness control NA
Results, base-case costs: deterministic model analysis results
Intervention costs (male only) Total cost data from the base-case model were not reported in detail.
Unit costs (CHF) included were:
Comparator group costs (male only) Cost of delivering the control arm of the study estimated as 573 CHF.
No further details regarding total comparative costs reported
Incremental costs (male only) Total incremental costs (CHF) were reported as follows (Incremental
data refer to long-term costs and effects per person per year.):
Lifestyle intervention 1268
Standard care obese 573
Hypertension 1653
Type 2 diabetes 2890
Hypercholesterolaemia 1245
Coronary heart disease 6242
Stroke 11,495
Weight category 0% discounting 3% discounting
Overweight +156 +405
Borderline obese –260 –6
Obese –70 +127
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Results, base-case primary economic outcome: deterministic model analysis results
Intervention group outcomes (male only) NR
Comparator group outcomes (male only) Individual results by intervention/control group not explicitly reported
Incremental outcomes (male only)
Results, primary economic analysis
Incremental results are as follows (all of these
results are based on probabilistic analysis)
Weight category 0% discounting 3% discounting
Life-years (intervention – control)
Overweight +0.03 +0.01
Borderline obese +0.03 +0.01
Obese +0.02 +0.01
QALYs (intervention – control)
Overweight +0.29 +0.25
Borderline obese +0.32 +0.28
Obese +0.33 +0.29
Weight
category
Age
(years) 0% discounting 3% discounting
ICERs (cost per life-year gained) (costs reported in CHF)
Overweight 25 –2840 (D) 34,291
35 3006 30,934
45 3054 24,473
55 2787 17,149
Borderline
obese
25 –19,496 (D) –14,886 (D)
35 –14,196 (D) –52,927 (D)
45 –14,158 (D) –9595 (D)
55 –13,282 (D) –10,417 (D)
Obese 25 –12,657 (D) 58
35 –7373 (D) 5580
45 –8912 (D) 185
55 –8048 (D) –1745 (D)
ICERs (cost per QALY gained) (costs reported in CHF)
Overweight 25 –374 (D) 1854
35 395 2014
45 324 1457
55 237 914
Borderline
obese
25 –2560 (D) –781 (D)
35 –283 (D) –331 (D)
45 –1373 (D) –523 (D)
55 –1027 (D) –508 (D)
Obese 25 –1453 (D) 3
35 395 276
45 –741 (D) 9
55 –502 (D) –69 (D)
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Results, secondary analysis (1)
No other secondary analyses reported
Results, sensitivity analysis (1)
No other deterministic sensitivity analyses reported
Results, subgroup analyses (1)
No other subgroup analyses reported beyond those reported in the tables above
Uncertainty
Probabilistic analysis undertaken? Yes
Results reported for male subgroup? Yes
Distribution for costs Normal (intervention costs); gamma (costs of obesity complications)
Parameter a NR
Parameter b NR
Distribution for utilities Beta
Parameter a NR
Parameter b NR
Distribution for other Normal (cardiovascular risk scores)
Parameter a NR
Parameter b NR
Results illustrated using (e.g. CEAC, scatter plot) CEACs and scatter plots of the cost-effectiveness plane; scatter plot of
cost-effectiveness results was not presented for a male-only subgroup
Key results of PSA (mean estimates of ICER) See above
Probability of cost-effectiveness Men and women together: Overweight 5%, borderline obese 78%,
obese 47% at WTP = 0 CHF; overweight 35%, borderline obese 99%,
obese 92% at WTP = 1000 CHF
Men only, borderline obese patients reported only (estimated from
the graphs presented): Male age 25 years 70%, male age 35 years
57%, male age 45 years 68%, male age 55 years 72% at
WTP = 0 CHF; male age 25 years 93%, male age 35 years 92%, male
age 45 years 96%, male age 55 years 98% at WTP = 1000 CHF
Results are on average (according to the graph) better for men than
for women in terms of cost-effectiveness, especially for young men
compared with young women. Results for borderline obese male and
female subgroups, 3% discount rate
Other methodological issues
Expected value of perfect information (EVPI)
analysis undertaken?
No – a related study provides value of information analysis167
Type NA
Results NA
Conclusions of EVPI analysis/recommendations
for future research
NA – no EVPI analysis conducted as part of this study
Study strengths The separate analysis of the borderline obese group allows the
researchers to study the transition from overweight to obesity
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Study limitations (as identiﬁed by authors) (1) The availability of additional Swiss-speciﬁc data would have
improved the model (e.g. epidemiological data such as the correlation
between BMI and risk of complications, obesity-related mortality and
changes in utility for weight loss have not been recorded for Swiss
populations); (2) future work should account for other complications
of obesity such as metabolic syndrome, colorectal cancer, gall bladder
disease, sleep apnoea and depression; (3) this study does not account
for the impact of smoking as a risk factor for disease, although it has
been documented that obese smokers have an increased risk of
mortality; (4) the costs of obesity are estimated using secondary
sources (the cost of stroke in this study is very high, although this was
conﬁrmed through a number of cost-of-illness studies)
Conclusions
Key issues noted with regard to sex: (1) the average LYG using the lifestyle intervention compared with standard care in
overweight, borderline obese and moderately obese patients were between 0.02 and 0.05 for men and women; (2) the
average QALYs gained using the lifestyle intervention compared with usual care are greater for men than for women: 0.29
vs. 0.27 (overweight); 0.32 vs. 0.29 (borderline obese); 0.33 vs. 0.29 (morbidly obese) respectively; (3) incremental costs
tended to be slightly lower for men than for women; (4) for overweight subjects, the ICER tended to favour younger (age
25 years) and older (age 85 years) men, with ICERs consistently but only marginally favourable in comparison to the female
group (this was consistent across weight groups); (5) the intervention is highly cost-effective for all subgroups of age and
sex with ICERs often dominant and always falling below 2014 CHF per QALY (men) and 6286 CHF per QALY (women)
The key study conclusion was that lifestyle interventions are cost-effective for the long-term prevention and treatment
of obesity
Recommendations for future research
There is a need for pan-European research into the cost-effectiveness of interventions to tackle obesity
D, dominant; NA, not applicable; NR, not reported; PSA, probabilistic sensitivity analysis.
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354Iannazzo 2008164Title: Economic evaluation of treatment with orlistat in Italian obese patients
Study characteristics
Country of study Italy
Study setting Not reported, presumably primary care
Research question/objective To evaluate the economic impact of the use of orlistat plus a lifestyle
intervention compared with the lifestyle intervention alone in Italian
obese patients through the long-term projection of XENDOS study
results169
Study design (model/RCT) Bayesian probabilistic Markov model extrapolating the ﬁndings of the
XENDOS study169
Inclusion criteria XENDOS study: BMI ≥ 30 kg/m2; Italian obese patients,
age 30–60 years (modelled cohort age ≥ 35 years)
Age (SD): 57.5 (13.3) years (men only); 47.7% male, 52.3% female
(Institute for Statistics data)
Exclusion criteria None explicitly reported in this study, although the main study report
will include exclusion criteria
Intervention Orlistat (120mg three times a day over 4 years) + lifestyle intervention.
The lifestyle intervention consisted of a prescribed calorie-lowering
diet with 30% of calories from fat and no more than 300mg of
cholesterol per day. Also encouraged to walk at least an extra 1 km
per day
Control/comparison Lifestyle intervention as described above in combination with a
placebo drug given three times per day over 4 years
Methods: costing
Perspective Societal perspective considered as orlistat is not available on the Italian
NHS
Currency Euros
Currency year of reporting Not reported although assumed to be 2007 from reference list
Discount rate for costs 3.5%
Methods: outcome measures
Primary economic evaluation outcome QALYs
Discount rate for outcomes 3.5%
Time horizon over which outcomes were
assessed
10 years (4 years of treatment and 6 years of follow-up); cycle length
was 1 year
Methods: modelling
Type of model used Bayesian probabilistic Markov model derived using random
distributions from a Monte Carlo simulation
Size of model cohort 30,000 iterations and excluding the ﬁrst 15,000 to ensure the
convergence of the two Bayesian ﬁtting models.
Model time horizon 10 years
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Health states modelled/model description Health states modelled: (1) obese; (2) diabetes; (3) death. The Markov
model included two Bayesian statistical models ﬁtted to the outcomes
from the XENDOS data:169 (1) to predict diabetes incidence; (2) to
forecast blood pressure and cholesterol changes from baseline
(cardiovascular risk parameters). Mortality – transition to the death
state in the model estimated using cardiovascular disease mortality
Framingham risk equations and non-cardiovascular disease mortality.
Utility for obese state extrapolated from the literature. Disutilities were
associated with the risk of major cardiovascular events
Methods, economic evaluations alongside RCTs: XENDOS RCT data169 (baseline data for model)
Age group 30–60 years, mean 43 years
Sex breakdown XENDOS: NR; Italian population: 47.7% (men), 52.3% (women)
Period of intervention 4 years
Period of follow-up 4 years only (no additional follow-up in the RCT, hence the need
for a model)
n randomised to intervention NR in the modelling study
n randomised to control NR in the modelling study
n randomised total NR in the modelling study
Data completeness intervention NR in the modelling study
Data completeness control NR in the modelling study
Results, base-case costs
Intervention group costs (95% CI) Men only: NR; men and women: €15,530 (€3342 to €117,000)
Comparator group costs (95% CI) Men only: NR; men and women: €12,580 (€51 to €116,600)
Incremental costs (95% CI) Men only: +€2931 (€383 to €3351); men and women:
+€2948 (€369 to €3353)
Results, base-case primary economic outcome (QALYs)
Intervention group outcomes (95% CI) Men only: NR; men and women: 6.13 (2.44 to 8.718)
Comparator group outcomes (95% CI) Men only: NR; men and women: 6.084 (2.417 to 8.666)
Incremental outcomes (95% CI) Men only: +0.046 (0.018 to 0.074); men and women: +0.046 (0.017
to 0.076)
Results, base-case results
Incremental costs (95% CI) Men only: +€2931 (€383 to €3351); men and women:
+€2948 (€369 to €3353)
Incremental outcomes (95% CI) Men only: +0.046 (0.018 to 0.074); men and women:
+0.046 (0.017 to 0.076)
ICER (95% CI) Men only: €74,290 (€8408 to €179,600); men and women: €75,310
(€7613 to €180,600)
Results, subgroup analysis (1): impaired glucose tolerance
Incremental costs (95% CI) Men only: NR; men and women: +€2237 (–€5601 to €3239)
Incremental outcomes (95% CI) Men only: NR; men and women: +0.123 (0.048 to 0.199)
ICER (95% CI) Men only: NR; men and women: €21,230 (dominant to €62,050)
Results, subgroup analysis (2): age < 60 years
Incremental costs (95% CI) Men only: NR; men and women: +€2933 (–€312 to €3355)
Incremental outcomes (95% CI) Men only: NR; men and women: +0.043 (0.017 to 0.072)
ICER (95% CI) Men only: NR; men and women: €79,110 (dominant to €194,500)
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Results, subgroup analysis (3): age ≥ 60 years
Incremental costs (95% CI) Men only: NR; men and women: +€2918 (€895 to €3327)
Incremental outcomes (95% CI) Men only: NR; men and women: +0.048 (0.019 to 0.077)
ICER (95% CI) Men only: NR; men and women: €70,720 (€18,090 to €162,900)
Results, sensitivity analysis (1): orlistat is given to every obese patient and the NHS pays an estimated ex-factory
price for it
Incremental costs (95% CI) Men only: NR; men and women: NR
Incremental outcomes (95% CI) Men only: NR; men and women: NR
ICER (95% CI) Men only: NR; men and women: €42,300 (dominant to €108,700)
Results, sensitivity analysis (2): orlistat is given only to obese patients with impaired glucose tolerance
Incremental costs (95% CI) Men only: NR; men and women: NR
Incremental outcomes (95% CI) Men only: NR; men and women: NR
ICER (95% CI) Men only: NR; men and women: €10,160 (dominant to €38,760)
Uncertainty
Probabilistic analysis undertaken? Yes
Results reported for male subgroup? No – results reported only for men and women together
Probabilistic distributions used in the model:
Results illustrated using (e.g. CEAC, scatter plot) CEACs and scatter plots used to illustrate the data; however, none of
the illustrations are presented separately for a male subgroup
Key results of PSA (mean estimates of ICER) NR
Probability of cost-effectiveness Base case: ∼15% at €45,000 per QALY gained; scenario 2 (impaired
glucose tolerance only subgroup): 99.2% at €45,000 per QALY
gained
Other methodological issues
Expected value of perfect information (EVPI)
analysis undertaken?
No
Type NA
Results: NA
Conclusions of EVPI analysis/recommendations
for future research
NA
Distribution for Distribution
Costs per patient per year (DIA) Gamma
Cost per case (diabetes) Normal
Cost per case (control) Normal
Utilities, obese state (male) Beta
Disutilities (DIA) Beta
Disutilities (myocardial infarction) Beta
Disutilities (stroke) Beta
Non-cardiovascular disease mortality OB (male) Gamma
Non-cardiovascular disease mortality DIA (male) Gamma
DIA, obese patients with diabetes; OB, obese patients
without diabetes.
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Study strengths (1) The authors use a novel modelling approach, based on detailed
clinical data from the XENDOS trial;169 (2) the modelling includes
Monte Carlo simulation within a probabilistic sensitivity analysis to
address uncertainty; (3) integrated WinBUGS modelling – linking
posterior distributions of each modelled parameter within a
probabilistic framework; (4) the modelling process follows best
practice ISPOR guidelines
Study limitations (1) The cost of diabetes – to make a more accurate estimate a
submodel to represent the dynamics of diabetes progression,
complications and related costs would probably have been necessary;
(2) the costs of the lifestyle intervention have not been included; this
would impact on the budget but not on the incremental results for
the economic evaluation given that the resource use was assumed to
be equal across the randomised groups; (3) the model has a lack of
predictive power for estimating cardiovascular risk impacts based on
weight loss – the effects of orlistat were therefore lower than initially
expected; (4) the model simulates cardiovascular disease risk
parameters independently (e.g. blood pressure and cholesterol risk);
however, these risk parameters could be cross-linked, resulting in a
higher overall risk than that modelled; (5) Framingham equations are
intrinsically conservative for the estimation of cardiovascular risks and
the relationships between risk and weight reduction
Conclusions
If orlistat treatment is targeted at patients at high risk of developing diabetes, this treatment has an estimated cost–utility
ratio of about €10,160 per QALY and is therefore highly cost-effective at usual threshold values of the maximum WTP for a
QALY gain. There appears to be little or no difference between a male-only subgroup and both sexes (men and women
considered together). However, this could be because the model is insensitive to links between weight loss and
cardiovascular disease outcomes and therefore any potential differences by sex at the weight-loss stage might be missed
using the model
Recommendations for future research
None explicitly made
DIA, obese patients with diabetes; OB, obese patients without diabetes; NA, not applicable; NR, not reported;
PSA, probabilistic sensitivity analysis.
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358Maetzel 2003166Title: Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus
Study characteristics
Country of study USA
Research question/objective To evaluate the cost-effectiveness of orlistat in addition to standard
type 2 diabetes treatment in the treatment of overweight and obese
people with diabetes (type 2) in a US-based health-care setting
Study design (model/RCT) Markov state transition model
Inclusion criteria Not speciﬁcally stated but the model refers to overweight and obese
patients with type 2 diabetes mellitus
Exclusion criteria None stated
Study setting US health-care setting. Not explicitly stated whether secondary or
primary care delivery
Intervention 11 years of standard diabetes therapy (ATG) + treatment with
orlistat (120mg three times per day for the ﬁrst year), i.e. year 1
(orlistat + ATG), years 2–11 (ATG only). ATG = standard
pharmacotherapy for type 2 diabetes (e.g. metformin) and
weight management (diet and physical activity)
Control/comparison 11 years of therapy with ATG
Methods: costing
Perspective US health-care provider
Currency US dollars
Currency year of reporting All costs inﬂated to 2001 US dollars using appropriate component of
the consumer price index
Discount rate for costs 3%
Other costing information Costs included in the analysis were for (1) study drugs (orlistat,
metformin, sulphonylurea and insulin) and (2) management of
complications (included a variety of cost categories depending on the
complication). Drug costs came from the National Prescription Audit.
Costs were reported as costs for one-time treatment and follow-up
for the speciﬁc complication considered in the model. Assumptions
are described and justiﬁed
Methods: outcome measures
Primary economic evaluation outcome Incremental cost per event-free life-year gained
Discount rate for outcomes 3%
Time horizon over which outcomes
were assessed
11 years
ATG, adherence to guidelines.
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Methods: modelling
Type of model used Markov state transition model
Size of model cohort 100,000 were simulated and run through the model
Model time horizon 11 years
Health states modelled (1) fatal or non-fatal myocardial infarction; (2) fatal or non-fatal
stroke; (3) fatal or non-fatal microvascular disease; (4) amputation or
death from peripheral vascular disease; (5) heart failure; (6) cataract
extraction; (7) no complication
Methods: economic evaluations alongside RCTs
Age group: NA
Sex breakdown NA
Period of intervention NA
Period of follow-up NA
n randomised to intervention NA
n randomised to control NA
Data completeness intervention NA
Data completeness control NA
Results, primary economic analysis and sensitivity analysis
Discount
rate (%)
Incremental costs
[(ATG+orlistat) vs. ATG] (US$)a
Incremental outcome
[(ATG + orlistat) vs. ATG]a ICER (US$)a
Mean updated HbA1c (3-year
persistence of effect)b
3 +1122 +0.135 8327
0 +1099 +0.162 6791
5 +1136 +0.12 9462
Raw annual HbA1c (1-year
persistence of effect)c
3 +1352 +0.057 23,574
0 +1365 +0.065 20,899
5 +1348 +0.052 25,827
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Uncertainty
Probabilistic analysis undertaken? Yes. PSA was applied by sampling from the CIs for clinical and cost
outcomes (n = 1000 samples). Distributions were not speciﬁed for the
parameters but sampling was more frequent around mean estimates
Results reported for male subgroup? Results are based on the UKPDS170 and are therefore based on speciﬁc
risk factors for a 52-year-old male referent group
Distribution for costs Not speciﬁed
Parameter a Not speciﬁed
Parameter b Not speciﬁed
Distribution for utilities Not speciﬁed
Parameter a Not speciﬁed
Parameter b Not speciﬁed
Distribution for other Not speciﬁed
Parameter a Not speciﬁed
Parameter b Not speciﬁed
Results illustrated using (e.g. CEAC, scatterplot) CEACs
Key results of PSA (including probability of
cost-effectiveness)
Sensitivity analysis for the base case (i.e. mean imputed HbA1c – 3-year
persistence of effect) showed that 95% of cost-effectiveness ratios fell
under a threshold of slightly less than US$20 000 per event-free
life-year gained. For the raw annual HbA1c (1-year persistence scenario),
95% of the cost-effectiveness ratios fell below a threshold of
US$68,000 per event-free life-year gained. By studying graphically
presented data it appears that the probability of cost-effectiveness is
∼30% for a 1-year persistence of effect and > 95% for a 3-year
persistence of effect at a WTP of US$20,000 per event-free life-year
gained; and ∼80–90% for a 1-year persistence of effect and > 95% for
a 3-year persistence of effect at a WTP of US$50,000 per event-free
life-year gained. Overall, it is clear that less beneﬁt is achieved with a
shorter persistence of orlistat effect (maintenance of weight-loss effect)
Conclusions of sensitivity analysis Use of raw annual HbA1c but 3-year persistence of effect led to an
ICER of US$21,962 per event-free life-year gained, which is higher
than the ICER observed using mean updated HbA1c. The assumption
of 0% and 5% discounting led to ICERs of US$6791 and US$9462
per event-free life-year gained respectively
Conclusions of subgroup analysis Main subgroup analysis undertaken was based on raw/imputed
(1–3-year persistence) HbA1c levels, showing as expected that a longer
persistence of effect yields greater beneﬁts and is more cost-effective
Conclusions drawn from PSA Longer persistence of effect (mean imputed HbA1c) is more likely to be
cost-effective than 1-year persistence of effect (raw data)
Other methodological issues
Expected value of perfect information (EVPI)
analysis undertaken?
No
Type NA
Results NA
Conclusions of EVPI analysis/recommendations
for future research
NA
Study strengths (as identiﬁed by authors) Results were based on the combined experience of orlistat
from four RCTs of 1 years’ duration in obese adult patients with
type 2 diabetes
APPENDIX 13
360
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Study limitations (as identiﬁed by authors) (1) The results are likely to be conservative as the authors did not
account for a reduction in lipid parameters or blood pressure and their
effect on other known conditions that were not modelled; (2) the
costs included for treating congestive heart failure were likely too low,
representing only one episode of inpatient care; (3) the results are
limited by the short-term nature of the supporting clinical trials;
(4) there is limited evidence supporting the efﬁcacy of orlistat beyond
treatment duration; (5) it is not known how long it takes for body
weight to return to baseline levels; (6) the long-term clinical impact
of even a transient reduction in HbA1c or body weight is unknown;
(7) relative risk reductions used in the model are sourced from the
UKPDS170 and as such are applicable to a cohort of 52-year-old men
only; (8) quality of life measures were not reported in the
supporting clinical trials, preventing a full-scale cost–utility
(cost per QALY) analysis
Key author conclusions
Orlistat complements traditional type 2 diabetes medication by causing weight loss. The ﬁndings suggest that orlistat is a
cost-effective therapy in the management of overweight and obese patients with type 2 diabetes in the USA
Recommendations for future research
Observational data to support long-term use of orlistat in this population are needed to validate the results of the study
NA, not applicable; PSA, probabilistic sensitivity analysis.
Bold text indicates base-case rate of discounting.
a ICER values reported directly from the study; incremental data are calculated based on available study data and are
subject to rounding errors.
b Mean updated HbA1c: average annual HbA1c of the patient over all years in the UKPDS.170
c Raw annual HbA1c: raw data taken directly from the UKPDS,170 representing a 1-year snapshot in time.
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362Olsen 2005165Title: Cost-effectiveness of nutritional counseling for obese patients and patients at risk of ischemic heart disease
Study characteristics
Country of study Denmark (not directly stated but assumed)
Study setting Primary care (GP/dietitian clinics)
Research question/objective To compare the costs and effects (in terms of LYG) of nutritional
counselling provided by a GP or a dietitian
Study design (model/RCT) Randomised study used to inform costs and a Cox regression model
used to estimate LYG
Inclusion criteria RCT inclusion criteria included BMI ≥ 30 kg/m2, waist circumference
> 102 cm (male) or > 88 cm (female), dyslipidaemia, type 2 diabetes
Exclusion criteria None reported
Intervention GPs were randomised to deliver nutritional counselling or to refer to a
dietitian
GP counselling: Initial counselling session of 30 minutes plus ﬁve
follow-on sessions of 12 minutes each over a 12-month period.
Counselling consisted of general lifestyle advice and the delivery of
commercially available information on a healthy diet
Dietitian referrals: Dietitian provided individual counselling based on
indication from referral, dietary history and routine. Focus was on
principles of good nutrition, food shopping, cooking methods, meal
planning and exercise. Recommendations included reduction of fat
component of diet and/or a cholesterol-lowering diet. Initial
counseling session of 1 hour plus ﬁve follow-up sessions of
30 minutes each
Control/comparison Both interventions (GP and dietitian) were compared against ‘do
nothing’ (no active intervention). This was based on assumption,
rather than a randomised ‘do nothing’ arm
Methods: costing
Perspective Health services perspective. Patient perspective considered as a
sensitivity analysis. Article methods section indicates a societal
perspective may also have been considered but no results are reported
Currency Danish kroner
Currency year of reporting 2001
Discount rate for costs No discounting as time horizon was 1 year
Other costing information Direct intervention costs (time spent with dietitian and GP), patients’
use of time and potential changed consumption of medicine because
of intervention were all considered. Long-term costs were not
considered
Methods: outcome measures
Primary economic outcome measure LYG and LYG without ischaemic heart disease
Discount rate for outcomes 5%
Time horizon for outcomes Time to event of death, model run up to 80 years of age. Time
horizon was therefore 80 years minus current age
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Methods: modelling
Type of model used Cox regression model for LYG/survival; non-parametric bootstrapping
used to estimate CIs
Size of model cohort NA
Model time horizon 80 years of age – current age of the modelled participant
Health states modelled/model description Primary modelled outcomes were LYG and LYG without ischaemic
heart disease, so the main health states modelled were survival and
death. The risk factors included in the model were sex, cholesterol
(including HDL), systolic blood pressure, smoking, BMI, diabetes,
familial predisposition and previous heart disease. Two Danish
population studies (n = 11,765) were used to estimate the risk scores
in the model and nine RCTs were used to estimate the effect of the
intervention. The Cox regressions described time to event (i.e. death)
based on these risk factors and an underlying survival function,
adjusting for current age. For each included patient, the prognostic
index, absolute risk of dying by the 80th year and absolute risk of
ischaemic heart disease and survival were estimated before and after
the intervention to estimate LYG. Therefore, the comparator group
was essentially no intervention as it was assumed that the prognostic
index remained unchanged without intervention
Methods: economic evaluations alongside RCTs
Age group NR
Sex breakdown Results available for men = 121/401 (70/243 dietitian, 51/158 GP)
Period of intervention 1 year
Period of follow-up Costs over 1 year, life-years long term using Cox regression model
n randomised to intervention 1 (dietitian) Total randomised: n = 503; n = 312 randomised to dietitian, full data
available for n = 243 (n = 70 male)
n randomised to intervention 2 (GP) Total randomised: n = 503; n = 191 randomised to GP, full data
available for n = 158 (n = 51 male)
Data completeness intervention 1 (dietitian) Life-years estimated for men: 243/312
Data completeness intervention 2 (GP) Life-years estimated for men: 158/191
Results, base-case costs (results based on LYG)
Intervention group costs (men only) (range) Dietitian: 1684 DKK (720–2971 DKK); GP: 774 DKK (416–818 DKK)
Comparator group costs (men only) Essentially do nothing, cost 0 DKK
Incremental costs (men only) (range) Dietitian: 1684 DKK (720–2971 DKK); GP: 774 DKK (416–818 DKK)
Results, base-case primary economic outcome
Outcomes measure used LYG
Discount rate used 5%
Intervention group outcomes (men only)
(95% CI)
Dietitian: ΔLYG: 0.0002 (–0.053 to 0.0531); GP: ΔLYG: 0.1210
(0.0424 to 0.1997)
Comparator group outcomes (men only) Essentially do nothing (ΔLYG = 0)
Incremental outcomes (men only) (95% CI) Dietitian: ΔLYG: 0.0002 (–0.053 to 0.0531); GP: ΔLYG: 0.1210
(0.0424 to 0.1997)
Results, base-case analysis (LYG)
Incremental costs (men only) (range) Dietitian: 1684 DKK (720–2971 DKK); GP: 774 DKK (416–818 DKK)
Incremental outcomes (men only) (95% CI) Diet: ΔLYG: 0.0002 (–0.053 to 0.0531); GP: ΔLYG: 0.1210
(0.0424 to 0.1997)
ICER (men only) (95% CI) Dietitian: NR, calculated as 8,420,000 DKK (NR); GP: 6399 DKK
(bias-corrected 95% CI 3911 DKK to 16,787 DKK)
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Results, secondary analysis (1): outcomes measured as LYG without ischaemic heart disease
Incremental costs (men only) (range) Dietitian: 1684 DKK (720–2971 DKK); GP: 770 DKK (416–818 DKK)
Incremental outcomes (men only) (95% CI) Dietitian: 0.0630 (–0.0140 to 0.1400); GP: 0.2376 (0.1015 to 0.3737)
ICER (men only) Dietitian: NR, calculated as 26,730 DKK (bias-corrected 95% CI NR);
GP: 3240 DKK (bias-corrected 95% CI 2069 DKK to 6841 DKK)
Results, sensitivity analysis (1): costs and ICERs calculated based on the estimated use of GP time (identical time
estimates for dietitians and GPs)
Incremental costs (men only) (95% CI) Dietitian: 541 DKK (NR); GP: 774 DKK (NR)
Incremental outcomes (men only) (95% CI) Dietitian: 0.0002 (–0.0530 to 0.0531); GP: 0.1210 (0.0424 to 0.1997)
ICER (men only) (95% CI) Dietitian: 2,705,000 DKK (NR); GP: 6399 DKK (NR)
Results, sensitivity analysis (2): costs and ICERs calculated based on registered use of dietitian time (identical time
estimates for dietitians and GPs)
Incremental costs (men only) (95% CI) Dietitian: 1231 DKK (NR); GP: 2278 DKK (NR)
Incremental outcomes (men only) (95% CI) Dietitian: 0.0002 (–0.0530 to 0.0531); GP: 0.1210 (0.0424 to 0.1997)
ICER (men only) (95% CI) Dietitian: NR, calculated as 6,155,000 DKK (NR); GP: 18,821 DKK (NR)
Results, sensitivity analysis (3): base-case analysis – outcomes measured as LYG and reported for men and
women together
Incremental costs (men and women) (range) Dietitian: 1642 DKK (720–3204 DKK); GP: 755 DKK (416–818 DKK)
Incremental outcomes (men and women)
(95% CI)
Dietitian: 0.0274 (0.0013 to 0.0534); GP: 0.0919 (0.0569 to 0.1269)
ICER (men and women) Dietitian: 59,987 DKK (bias-corrected 95% CI 30,545 DKK to
996,368 DKK); GP: 8213 DKK (bias-corrected 95% CI 5910 DKK
to 12,850 DKK)
Results, sensitivity analysis (4): outcomes measured as LYG without ischaemic heart disease and reported for men
and women together
Incremental costs (men and women) (range) Dietitian: 1642 DKK (720–3204 DKK); GP: 751 DKK (416–818 DKK)
Incremental outcomes (men and women)
(95% CI)
Dietitian: 0.0700 (0.0388 to 0.1011); GP: 0.1608 (0.1054 to 0.2162)
ICER (men and women) Dietitian: 23,469 DKK (bias-corrected 95% CI 16,223 DKK to
41,912 DKK); GP: 4670 DKK (bias-corrected 95% CI 3480 DKK
to 6905 DKK)
Results, sensitivity analysis (5): costs and ICERs calculated based on the estimated use of GP time (identical time
estimates for dietitians and GPs); outcomes measured as LYG and reported for men and women together
Incremental costs (men and women) (range) Dietitian: 533 DKK (NR); GP: 755 DKK (NR)
Incremental outcomes (men and women)
(95% CI)
Dietitian: 0.0274 (0.0013 to 0.0534); GP: 0.0919 (0.0569 to 0.1269)
ICER (men and women) (95% CI) Dietitian: 19,472 DKK (NR); GP: 8213 DKK (NR)
Results, sensitivity analysis (6): costs and ICERs calculated based on the estimated use of dietitian time (identical
time estimates for dietitians and GPs); outcomes measured as LYG and reported for men and women together
Incremental costs (men and women) (range) Dietitian: 1204 DKK (NR); GP: 2209 DKK (NR)
Incremental outcomes (men and women)
(95% CI)
Dietitian: 0.0274 (0.0013 to 0.0534); GP: 0.0919 (0.0569 to 0.1269)
ICER (men and women) Dietitian: 43,987 DKK (NR); GP: 24,037 DKK (NR)
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Uncertainty
Probabilistic analysis undertaken? NA – bootstrapped estimates used to describe uncertainty in the
cost–effect pairs
Results reported for male subgroup? No
Distribution for costs NA
Parameter a NA
Parameter b NA
Distribution for utilities NA
Parameter a NA
Parameter b NA
Distribution for other NA
Parameter a NA
Parameter b NA
Results illustrated using (e.g. CEAC, scatterplot) CEACs and scatterplots of 10,000 bootstrapped iterations
Key results of PSA Probability of cost-effectiveness: Dietitian ∼0% and GP ∼100%
at a WTP of 25,000 DKK per life-year gained; dietitian ∼80% and
GP ∼100% at a WTP of 100,000 DKK per life-year gained
Conclusions of sensitivity analysis GP counselling tends to be more cost-effective. Using identical time
estimates for dietitian and GP counselling services resulted in lower
intervention costs for the dietitian group; however, GP counselling
was still more cost-effective. Male participants tended to have a lower
ICER for GP counselling and female participants tended to have a
lower ICER for dietitian counselling
Conclusions of subgroup analysis Information based on subgroups showed that, in general, ICERs were
lower when the outcome measured was LYG without ischaemic heart
disease, that is, the cost of gaining 1 extra life-year without ischaemic
heart disease was lower than the cost of gaining 1 extra life-year. The
GP group tended to be more cost-effective here also, especially for
the male subgroup
Conclusions drawn from PSA The probability of acceptance of GP counselling would be much
greater than the probability of acceptance of dietitian counselling.
Further, there was much greater statistical uncertainty for the dietitian
group than the GP group
Other methodological issues
Expected value of perfect information (EVPI)
analysis undertaken?
No
Type NA
Results NA
Conclusions of EVPI analysis/recommendations
for future research
NA
Study strengths (as identiﬁed by authors) None explicitly referenced in the text
Study limitations (as identiﬁed by authors) (1) Simplifying model assumptions are in their own right a potential
limitation (e.g. it was assumed that the improvement in lifestyle was
maintained beyond the intervention period); (2) it should be noted
that the greater effect in the GP group could be caused by other
factors, for example GPs may give wider lifestyle advice than dietitians
(e.g. on smoking cessation); (3) the applied costing method can give
rise to methodological concerns because time estimates are compared
with standard agreed salaries; transferability of results may thus
be limited; (4) the GPs that partook in the study may not be
representative as they may have an unrepresentative interest in
preventative care
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Key author conclusions
GP counselling appears more cost-effective than dietitian counselling. Both dietitian- and GP-provided interventions were
considered potentially cost-effective. The results were not so clear for the male-only group with some ICERs excessively high
because of small outcome differences. For all age groups the base-case analysis showed both counselling strategies to be
cost-effective. Although GP counselling was more cost-effective and had a lower ICER than the dietitian intervention, the
dietitian intervention could also be considered potentially cost-effective, costing an additional 59,987 DKK per life-year
gained. Basing conclusions on the assumption that the WTP for a life-year and a QALY gained is similar, then both GP and
dietician advice could offer good value for money, given that society typically places the WTP for a QALY gain at
88,000 DKK
Recommendations for future research
The results indicate that nutritional counselling should be combined with advice regarding other lifestyle changes.
No sex-speciﬁc recommendations were made
DKK, Danish kroner; NA, not applicable; NR, not reported; PSA, probabilistic sensitivity analysis.
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DOI: 10.3310/hta18350 HEALTH TECHNOLOGY ASSESSMENT 2014 VOL. 18 NO. 35Segal 1998163Title: Cost-effectiveness of the primary prevention of non-insulin dependent diabetes mellitus
Study characteristics
Country of study Australia
Study setting Hospital, community and primary care, depending on programme
delivered; programme IV appears to be delivered in a primary
care/community setting
Research question/objective To investigate whether the prevention of NIDDM is cost-effective
compared with other possible uses of health-care resources and
whether some approaches to NIDDM prevention are more
cost-effective than others
Study design (model/RCT) Markov model (speciﬁc Markov submodel for each of the
six programmes considered)
Inclusion criteria Those with IGT, overweight/obese men, seriously obese people,
women with previous gestational diabetes and the general Australian
population. Detailed inclusion criteria for each programme are not
reported. For programme IV the target was obese and overweight
men, a mixed group (10% impaired glucose tolerance, 90% normal
glucose tolerance) and those with impaired glucose tolerance only
Exclusion criteria Not reported. The use of antidiabetic drugs was not included as a
programme for evaluation as this was deemed management rather
than prevention of diabetes and was outwith the scope of the study
Intervention A total of six programmes were considered of which only one was
male speciﬁc. Programme IV was a group behavioural modiﬁcation for
men (ﬁve to six group sessions; aim to reduce waist size through diet
change and increased activity; empowerment philosophy). Information
regarding potentially relevant male-speciﬁc data from other
programmes was not available
Control/comparison Standard care – no active intervention in the control cohort of the
models/submodels
Methods: costing
Perspective Health-care providers
Currency Australian dollar. Conversion to US dollars was carried out using a
median exchange rate for August/September/October 1997 of AUS
$1 = US$0.72
Currency year of reporting 1997
Discount rate for costs 5%, applied to downstream costs
Other information on costing Average programme costs were reported; however, individual cost
components or detailed resource use was not. Costs were reported in
the study results as gross costs (i.e. programme costs) and net costs
(i.e. programme/intervention delivery costs less any downstream cost
savings from the treatment of diabetes). The cost of managing
NIDDM was AUS$1800 per diabetic per year in the model
Methods: outcome measures
Primary economic outcome measures LYG, reduction in diabetes years
Discount rate for outcomes 5%
Time horizon for outcomes Mortality vectors applied to intervention and control cohorts for
25 years post intervention. Remaining life expectancy calculated by
adjusting the population life expectancy for the diabetic state and
whether or not weight loss was achieved
367
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Methods: modelling
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368Type of model used Markov models (a set of sub Markov models for each
individual programme)
Size of model cohort NR
Model time horizon 25 years post intervention
Health states modelled/model description NIDDM, normal glucose tolerance, impaired glucose tolerance
Methods: economic evaluations alongside RCTs
Age group NA
Sex breakdown NA
Period of intervention NA
Period of follow-up NA
n randomised to intervention NA
n randomised to control NA
Data completeness intervention NA
Data completeness control NA
Results, base-case costs
Intervention group programme IV (men only) Gross cost: AUS$577 (AUS$195 excluding screening cost per case
detected); net cost: NR
Comparator group programme IV (men only) Assumed AUS$0
Incremental costs Final discounted incremental costs were not directly reported;
therefore, incremental gross cost for programme IV can only be
extracted as AUS$577 (AUS$195 excluding screening cost per
case detected)
Results, base-case primary economic outcome
Programme IV (per 100)
Group Diabetes years prevented LYG
Intervention group
Mixed 135 3016
IGT 484 2750
Comparator group
Mixed 172 2905
IGT 639 2888
Incremental outcomes
Mixed 37 111
IGT 155 138
NIHR Journals Library www.journalslibrary.nihr.ac.uk
Results, primary economic analysis (base-case results)
Incremental costs (programme IV) Gross cost: AUS$577 (AUS$195 excluding screening cost per case
detected); net cost: NR
Incremental outcomes (programme IV, per 100)
ICER, reported only as incremental cost per
life-year gained
Results, secondary analysis
None applicable to programme IV
Results, sensitivity analysis (1): the impact of a change in the programme success rate on cost-effectiveness
(programme IV, men only)
Incremental net cost per life-year saved:
Results, sensitivity analysis (2)
A range of other sensitivity analyses was carried out on various programmes but none of those reported was for the
male-speciﬁc programme IV. Additional male-speciﬁc data from other programmes were requested from the study authors
but were not available at the time of publication
Uncertainty
Probabilistic analysis undertaken? No
Results reported for male subgroup? NA
Distribution for costs NA
Parameter a NA
Parameter b NA
Group Diabetes years prevented LYG
Mixed 37 111
IGT 155 138
Group Gross cost per
life-year gained
Net cost per
life-year gained
IGT 500 NS
IGTa 1600 NS
Mixed 700 NS
Programme type Analysis Assumed success rate (%) Net cost per life-year saved
IV (men only) Low 20 100
Base caseb 33 NS
High 45 NS
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Distribution for utilities NA
Parameter a NA
Parameter b NA
Distribution for other NA
Parameter a NA
Parameter b NA
Results illustrated using (e.g. CEAC, scatterplot) NA
Key results of PSA NA
Conclusion of sensitivity analysis Net cost per life-year gained is sensitive to the rate of programme
success. However, despite varying the success rate of the male-only
programme IV, the intervention remained highly cost-effective and
there was a net saving for all but the lowest success rate considered
Conclusions of subgroup analysis The group behavioural programme was cost-effective for both the
impaired glucose tolerance subgroup and the mixed levels of glucose
tolerance subgroup of men. Cost-effectiveness appeared even more
deﬁnitive in those with impaired glucose tolerance
Conclusions drawn from PSA NA
Other methodological issues
Expected value of perfect information (EVPI)
analysis undertaken?
None
Type NA
Results NA
Conclusions of EVPI analysis/recommendations
for future research
NA
Study strengths (as identiﬁed by authors) NR
Study limitations (as identiﬁed by authors) (1) A single transition matrix for most programmes has been used to
progress each cohort between diabetic states; a more dynamic model
of progression between diabetic states might have been preferred;
(2) a further simpliﬁcation is the selection of a single target age group;
(3) costs have been limited to direct costs; no account is taken of
other programme costs (e.g. time commitment of participants);
(4) the results do not account for quality of life; the authors state
that this was not possible given the poor evidence base at the time
of the study
Key author conclusions
For the prevention of NIDDM, the interventions considered may be cost saving or highly cost-effective relative to other
possible uses of health-care resources. The behavioural diet programmes for high-risk groups were found to be
highly cost-effective relative to other health-care programmes. The male-speciﬁc group behavioural programme was
particularly cost-effective or cost saving when accounting for downstream cost savings associated with the prevention of
and lesser need for costly management of NIDDM
Recommendations for future research
(1) There is a need to focus on NIDDM prevention; if the incidence of NIDDM is not contained, the cost to the community
in terms of illness, loss of quality of life, premature death and allocation of scarce health-care resources will be an
ever-increasing burden; (2) broader population-based programmes targeting high-risk groups; (3) the application of studies
to a more international context; (4) the pilot introduction of programmes is recommended
NA, not applicable; NR, not reported; NS, net saving.
a Based on the cost of a new case of diabetes found through the
screening programme.
b Parameter value for the base-case analysis shown in bold.
Gross cost-effectiveness is the quotient of programme cost and diabetes years avoided or life-years saved. Net cost is
calculated by subtracting the discounted future health service costs avoided through the prevention of NIDDM from the
cost of programme implementation. Net costs are not directly reported.
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qualitative reviewAbildso 2010Abildso C, Zizzi S, Gilleland D, Thomas J, Bonner D. A mixed methods evaluation of a 12-week
insurance-sponsored weight management program incorporating cognitive-behavioral counseling.
J Mix Methods Res 2010;4:278–94.De Souza 2005De Souza P, Ciclitira KE. Men and dieting: a qualitative analysis. J Health Psychol 2005;10:793–804.Gallagher 2012Gallagher R, Kirkness A, Armari E, Davidson PM. Weight management issues and strategies for people
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study. Counsell Psychother Res 2003;3:25–32.Gough 2006Gough B, Conner MT. Barriers to healthy eating amongst men: a qualitative analysis. Soc Sci Med
2006;62:387–95.Gough 2009Gough B, Flanders G. Celebrating ‘obese’ bodies: Gay ‘bears’ talk about weight, body image and health.
Int J Mens Health 2009;8:235–53.Gray 2009Gray CM, Anderson AS, Clarke AM, Dalziel A, Hunt K, Leishman J, et al. Addressing male obesity:
an evaluation of a group-based weight management intervention for Scottish men. J Mens Health
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372Harrison 2007Harrison A. Weight management in the workplace. In Conrad D, White A, editors. Men’s Health: How To
Do It. Oxford: Radcliffe Publishing; 2007. pp. 59–72.Hunt 2013Hunt K, McCann C, Gray CM, Mutrie N, Wyke S. ‘You’ve got to walk before you run’: positive evaluations
of a walking program as part of a gender-sensitized, weight-management program delivered to men
through professional football clubs. Health Psychol 2013;32:57–65.Kim 2008Kim KH, Linnan L, Campbell MK, Brooks C, Koenig HG, Wiesen C. The WORD (Wholeness, Oneness,
Righteousness, Deliverance): a faith-based weight-loss program utilizing a community-based participatory
research approach. Health Educ Behav 2008;35:634–50.Leishman 2007Leishman J. Working with men in groups – experience from a weight management programme in
Scotland. In White A, Pettifer M, editors. Hazardous Waist: Tackling Male Weight Problems. Oxford:
Radcliffe; 2007. pp. 75–86.Mallyon 2010Mallyon A, Holmes M, Coveney J, Zadoroznyj M. ‘I’m not dieting, I’m doing it for science’: masculinities
and the experience of dieting. Health Sociol Rev 2010;19:330–42.McCullagh 2005McCullagh J. ‘Tommy the Trucker’: a Consultation and Lifestyle Survey of Lorry Drivers Visiting Sefton.
South Sefton: Sefton Health Improvement Support Services; 2005.Monaghan 2007aMonaghan LF. McDonaldizing men’s bodies? Slimming, associated (ir)rationalities and resistances.
Body Soc 2007;13:67–93.Monaghan 2007bMonaghan L. Body mass index, masculinities and moral worth: men’s critical understandings of
‘appropriate’ weight-for-height. Sociol Health Illn 2007;29:584–609.NIHR Journals Library www.journalslibrary.nihr.ac.uk
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study. Sociol Sport J 2008;25:97–129.Morgan 2011aMorgan PJ, Lubans DR, Collins CE, Warren JM, Callister R. 12-Month outcomes and process evaluation of
the SHED-IT RCT: an internet-based weight loss program targeting men. Obesity 2011;19:142–51.Morgan 2011bMorgan PJ, Warren JM, Lubans DR, Collins CE, Callister R. Engaging men in weight loss: experiences of
men who participated in the male only SHED-IT pilot study. Obes Res Clinical Pract 2011;5:e169–266.Ogden 2006Ogden J, Sidhu S. Adherence, behavior change, and visualization: a qualitative study of the experiences of
taking an obesity medication. J Psychosom Res 2006;61:545–52.Weaver 2008Weaver NF, Hayes L, Unwin NC, Murtagh MJ. ‘Obesity’ and ‘clinical obesity’. Men’s understandings of
obesity and its relation to the risk of diabetes: a qualitative study. BMC Public Health 2008;8:311.White 2008White A, Conrad D, Branney P. Targeting men’s weight in the workplace. J Mens Health 2008;5:133–40.Witty 2010Witty K, White A. The Tackling Men’s Health Evaluation Study: Final Report. Leeds: Leeds
Metropolitan University, Centre for Men’s Health; 2010. URL: www.leedsmet.ac.uk/hss/docs/
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qualitative review1. Bibliographic information
Article title:
Extracted by:
Checked by:
Type of publication, date and page numbers (if journal article also give title of the journal):
Linked to RCT or non-randomised intervention:
Country of setting:
2. Researcher details
Authors and afﬁliations (list as presented on paper):
Gender of researchers who collect the qualitative data:
Academic discipline of authors:
3. Aims and methods
Study aims:
Research questions – Stated explicitly or implicit within the general text/topic guide? In what section(s) of the paper are
questions mentioned? Are they prospective or retrospective?
Theoretical and epistemological perspective underpinning the qualitative research (if not explicitly stated the extractor
should offer an interpretation):
Theoretical perspective underpinning the intervention:
Qualitative methods used:
Data analysis technique and procedure:
4. Findings
(a) Themes
Which key themes are stated to have emerged from the qualitative research?
(b) Engagement
How are men attracted to taking part in the trial/intervention? Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
How are men motivated to lose weight? Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
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(c) Intervention
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376Characteristics of the intervention:
Timing of the intervention (when, how often, for how long):
Who delivers the intervention? (discipline, gender)
Focus of the programme (i.e. diet, exercise, behavioural counselling):
Results:
Demographic information:
Dropout rate:
Sex breakdown (if programme not for men only):
(d) Intervention (communication) process
Are communication processes referred to in the protocol? Notes:
Any speciﬁc training provided as part of the intervention? (e.g. psychological
behaviour change techniques). If so, are certain features of behaviour change
found to be more attractive for obese men? How and why are these features
more attractive?
Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
Is ﬁdelity to protocol mentioned?
What are men’s perceptions of the communication process? Notes:
Participant quotes (ﬁrst order):
Author statements (second order):
Summary (third order):
(e) Central research questions derived from quantitative review to guide data extraction
How are men consulted in the design of the intervention (if they are)?
Should also include which literature is consulted to aid conception of the
design. Was the literature gender speciﬁc?
Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
If it is found that interventions for men should be different from those for
women, how should they be different and why?
Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
Are group-based interventions for men found to be more effective for weight
loss than interventions delivered to individual men? How and why are they
more effective?
Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
Are certain features of diets found to be more attractive for obese men? How
and why are these features more attractive?
Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
Are certain features of physical activity stated to be more attractive for obese
men? How and why are these features more attractive?
Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
NIHR Journals Library www.journalslibrary.nihr.ac.uk
What is stated with regard to participant attrition and what efforts are made to
help men continue with the programme?
Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
Do men state who they believe to be the best person/persons to deliver the
intervention? If so, why are they preferred?
Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
Are programmes deliberately involving partners/families more effective?
How, why and at what stage?
Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
Were there any other emergent themes or gaps/omissions not covered by
the above?
Notes:
Summary (third order):
Participant quotes (ﬁrst order):
Author statements (second order):
5. Area and context (micro, meso and macro levels)
Rationale for setting choice (for intervention and where qualitative research is conducted):
Meaning attributed to where the intervention is delivered:
Perceptions about the venue (micro) and area of setting (meso):
What else is going on at the time of the intervention (e.g. clinic appointment) (meso):
Does the setting potentially exclude/target populations? (meso)
Are there any wider media, cultural, political or contextual factors that might be
inﬂuencing the intervention? (macro)
6. Quality
(a) Sample
Sample size:
Sample characteristics:
Sample selection process:
Sample inclusion and exclusion criteria:
(b) Reflexivity
Evidence of researcher reﬂexivity:
(c) Ethics
Evidence of attention to ethical issues:
(d) General
Are the ﬁndings adequately supported by the data presented?
Is there potential for a ‘charisma effect’ in this study? (this relates to the potential inﬂuence of the principal investigator)
Any other quality issues not covered above?
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randomised controlled trials of men and women compared
Abstracts, commentaries, errata, evidence summaries, protocols,
recommendations and news articlesFirst year of Look AHEAD trial yields encouraging results. Diabetes Dateline spring/summer 2008, pp. 7–8.
Collins CE, Morgan PJ, Jones P, Fletcher K, Martin J, Aguiar EJ, et al. Evaluation of a commercial
web-based weight loss and weight loss maintenance program in overweight and obese adults:
a randomized controlled trial. BMC Public Health 2010;10:669.
Cudjoe S, Moss S, Nguyen L. How do exercise and diet compare for weight loss? J Fam Pract
2007;56:841–4.
Donaldson E, Fallows S. A text message-based weight management intervention for overweight adults.
J Hum Nutr Diet 2011;24:385–6.
Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK; American College of Sports Medicine.
Appropriate physical activity intervention strategies for weight loss and prevention of weight regain in
adults. Med Sci Sports Exerc 2009;41:459–71.
Gordon J, Dibble T, Adams C, McGee E. An evaluation of the long-term effectiveness of two adult
community-based group weight management interventions. J Hum Nutr Diet 2011;24:388.
Kumanyika SK, Shults J, Fassbender J, Whitt MC, Brake V, Kallan MJ, et al. Corrigendum to ‘Outpatient
weight management in African-Americans: the Healthy Eating and Lifestyle Program (HELP) study’.
Prev Med 2006;42:1
Miyachi M, Ohmori Y, Morita A, Aiba N. Effects of pedometer-based physical activity intervention on
abdominal fat and blood pressure: Saku community-based randomized crossover intervention study.
J Clin Hypertens 2010;12:A14.
Morgan PJ, Collins CE, Plotnikoff RC, McElduff P, Burrows T, Warren JM, et al. The SHED-IT community
trial study protocol: a randomised controlled trial of weight loss programs for overweight and obese men.
BMC Public Health 2010;10:701.
Resch KL. Dietary Intervention Randomized Controlled Trial (DIRECT) group: weight loss with a
low-carbohydrate, Mediterranean, or low-fat diet. Forsch Komplementmed 2008;15:351–2.
Rossner S. Atkins – the superior slimming diet? Scand J Food Nutr 2007;51:4.
Wycherley TP, Brinkworth GD, Clifton PM, Noakes M. A one year high protein, low fat weight loss diet
improves body composition and cardiometabolic risk factors in overweight males with features of the
metabolic syndrome. Australas Med J 2011;4:731.379
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Kiernan M, King AC, Stefanick ML, Killen JD. Men gain additional psychological beneﬁts by adding
exercise to a weight-loss program. Obes Res 2001;9:770–7.
Torgerson JS, Lissner L, Lindroos AK, Kruijer H, Sjostrom L. VLCD plus dietary and behavioural support
versus support alone in the treatment of severe obesity. A randomised two-year clinical trial. Int J Obes
1997;21:987–94.
Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent
weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med
1991;325:461–6.Cost-effectiveness reviews
Bogers RP, Barte JC, Schipper CM, Vijgen SM, de Hollander EL, Tariq L, et al. Relationship between costs
of lifestyle interventions and weight loss in overweight adults. Obes Rev 2010;11:51–61.
Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-Barron V, Chisholm D. Tackling of unhealthy diets,
physical inactivity, and obesity: health effects and cost-effectiveness. Lancet 2010;376:1775–84.
Cobiac L, Vos T, Veerman L. Cost-effectiveness of Weight Watchers and the Lighten Up to a Healthy
Lifestyle program. Aust N Z J Public Health 2010;34:240–7.
Joo NS, Park YW, Park KH, Kim CW, Kim BT. Cost-effectiveness of a community-based obesity control
programme. J Telemed Telecare 2010;16:63–7.Follow-up < 12 months
Apekey T, Morris A, Fagbemi S, Grifﬁths G. Beneﬁts of moderate-intensity exercise during a
calorie-restricted low-fat diet. Health Educ J 2012;71:154–64.
Azadbakht L, Parvin M, Ahmad E, Tohid A, Fereidoun A. Beneﬁcial effects of a Dietary Approaches to Stop
Hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005;28:2823–31.
Brownell KD, Cohen RY, Stunkard AJ, Felix MR, Cooley NB. Weight loss competitions at the work site:
impact on weight, morale and cost-effectiveness. Am J Public Health 1984;74:1283–5.
Janiszewski PM, Ross R. Effects of weight loss among metabolically healthy obese men and women.
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